INMB NASDAQ
INmune Bio, Inc.
1W: -7.1%
1M: -29.6%
3M: -16.4%
YTD: -7.1%
1Y: -20.1%
3Y: -80.9%
5Y: -92.3%
$1.52
+0.09 (+6.29%)
Weekly Expected Move ±6.7%
$1
$1
$1
$2
$2
Credit Risk of going bust: lower than 52% of companies Debt: 3.4% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.5%), INmune Bio, Inc. would be worth roughly what it owes.
Total debt $1.4M against a stock market value of $39.7M.
Distance to default 5.37 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $702K (short-term plus half of long-term), stock volatility 72.7%; Altman Z'' -23.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down 99.5%), INmune Bio, Inc. would be worth roughly what it owes.
Total debt $1.4M against a stock market value of $39.7M.
Distance to default 5.37 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $702K (short-term plus half of long-term), stock volatility 72.7%; Altman Z'' -23.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
#624
of 1061
Biotechnology
Technical Signal Map
100 Bullish
38 Neutral
641 Bearish
INMB
$40M
INmune Bio, Inc.
BEARISH
-87
SGP
$950M
SpyGlass Pharma, Inc. Common Stock
BULLISH
+100
VSTM
$910M
Verastem, Inc.
BULLISH
+100
SOLTF
$770M
Nxera Pharma Co., Ltd.
BULLISH
+100
GRDX
$40M
GridAI Technologies Corp.
BULLISH
+100
ENTX
$510M
Entera Bio Ltd.
BULLISH
+91
ATNM
$50M
Actinium Pharmaceuticals, Inc.
BULLISH
+91
XFOR
$320M
X4 Pharmaceuticals, Inc.
BULLISH
+87
ESLA
$40M
Estrella Immunopharma, Inc.
BULLISH
+87
KRRO
$180M
Korro Bio, Inc.
BULLISH
+84
HURA
$140M
TuHURA Biosciences, Inc.
BULLISH
+84
ZIVO
$20M
ZIVO Bioscience, Inc.
BULLISH
+78
RIGL
$900M
Rigel Pharmaceuticals, Inc.
BULLISH
+75
CING
$70M
Cingulate Inc.
BULLISH
+73
AGTX
—
Agentix Corp.
BULLISH
+73
ACUT
—
Accustem Sciences Inc.
BULLISH
+68
XNCR
$1.9B
Xencor, Inc.
BULLISH
+66
KLRA
$1.7B
Kailera Therapeutics, Inc.
BULLISH
+66
TRAX
$1.6B
First Tracks Biotherapeutics Inc
BULLISH
+66
LBRX
$1.2B
LB Pharmaceuticals Inc Common Stock
BULLISH
+66
SLN
$930M
Silence Therapeutics plc
BULLISH
+66
PBYI
$570M
Puma Biotechnology, Inc.
BULLISH
+66
MXCT
$140M
MaxCyte, Inc.
BULLISH
+66
IRLA
$30M
IRulya Therapeutics Inc.
BULLISH
+65
MBXBF
$30M
Microbix Biosystems Inc.
BULLISH
+65
BOLT
$10M
Bolt Biotherapeutics, Inc.
BULLISH
+62
AZTR
—
Azitra, Inc.
BULLISH
+62
BDRX
—
Biodexa Pharmaceuticals Plc
BULLISH
+62
CBDG
—
THC Farmaceuticals, Inc.
BULLISH
+60
PHAR
$710M
Pharming Group N.V.
BULLISH
+59
INDP
$360M
Indaptus Therapeutics, Inc.
BULLISH
+59
ANIX
$100M
Anixa Biosciences, Inc.
BULLISH
+59
NRXS
$90M
NeurAxis, Inc.
BULLISH
+59
OABIW
$1.1B
OmniAb, Inc.
BULLISH
+58
DMAC
$470M
DiaMedica Therapeutics Inc.
BULLISH
+58
SCNLF
$170M
Scancell Holdings plc
BULLISH
+58
ICCC
$90M
ImmuCell Corporation
BULLISH
+58
SPTX
$1.1B
Seaport Therapeutics, Inc. Common Stock
BULLISH
+55
CASBF
$1.4B
CanSino Biologics Inc.
BULLISH
+52
BRVE
$1.5B
Braveheart Bio, Inc.
BULLISH
+51
TXTM
$90M
ProText Mobility, Inc.
BULLISH
+51
IMNN
$10M
Imunon, Inc.
BULLISH
+51
HALB
—
Halberd Corporation
BULLISH
+51
SEPN
$1.9B
Septerna Inc
BULLISH
+50
MAZE
$1.7B
Maze Therapeutics, Inc.
BULLISH
+50
COAG
$1.6B
Hemab Therapeutics Holdings, Inc. Common Stock
BULLISH
+50
CRMD
$610M
CorMedix Inc.
BULLISH
+50
PYPD
$110M
PolyPid Ltd.
BULLISH
+50
ADCT
$180M
ADC Therapeutics S.A.
BULLISH
+49
NYMXF
$10M
Nymox Pharmaceutical Corporation
BULLISH
+47
PRME
$670M
Prime Medicine, Inc.
BULLISH
+44
NAUT
$410M
Nautilus Biotechnolgy, Inc.
BULLISH
+44
TCRT
$10M
Alaunos Therapeutics, Inc.
BULLISH
+44
RARE
$1.5B
Ultragenyx Pharmaceutical Inc.
BULLISH
+43
IUGNF
$30M
Imugene Limited
BULLISH
+43
PCSA
$10M
Processa Pharmaceuticals, Inc.
BULLISH
+43
HEPA
—
Hepion Pharmaceuticals, Inc.
BULLISH
+43
IMCR
$1.6B
Immunocore Holdings plc
BULLISH
+41
XERS
$1.9B
Xeris Biopharma Holdings, Inc.
BULLISH
+40
VSBC
$10M
VitaSpring Biomedical Co. Ltd.
BULLISH
+40
IPIX
—
Innovation Pharmaceuticals Inc.
BULLISH
+38
IMUC
$10M
EOM Pharmaceuticals Holdings, Inc.
BULLISH
+36
NBTX
$1.5B
Nanobiotix S.A.
BULLISH
+35
CKDXF
$10M
Ceryvyn Therapeutics Ltd
BULLISH
+35
ZEOX
$10M
Zeo ScientifiX, Inc.
BULLISH
+35
CYYNF
—
Cynata Therapeutics Limited
BULLISH
+35
DMRA
$1.3B
Damora Therapeutics, Inc.
BULLISH
+34
VIR
$1.8B
Vir Biotechnology, Inc.
BULLISH
+33
SLGL
$230M
Sol-Gel Technologies Ltd.
BULLISH
+33
CYDY
$380M
CytoDyn Inc.
BULLISH
+31
PDSB
$60M
PDS Biotechnology Corporation
BULLISH
+30
ABOS
$140M
Acumen Pharmaceuticals, Inc.
LEAN BULL
+27
HOWL
$50M
Werewolf Therapeutics, Inc.
LEAN BULL
+27
ATOS
$30M
Atossa Therapeutics, Inc.
LEAN BULL
+27
ARDS
—
Aridis Pharmaceuticals, Inc.
LEAN BULL
+27
INFIQ
—
Infinity Pharmaceuticals, Inc.
LEAN BULL
+27
PPCB
—
Propanc Biopharma, Inc.
LEAN BULL
+27
BSSP
—
Baseline Productions, Inc.
LEAN BULL
+27
PTCHF
$390M
PureTech Health plc
LEAN BULL
+26
ACHFF
$40M
Arch Biopartners Inc.
LEAN BULL
+26
PRVCF
$10M
PreveCeutical Medical Inc.
LEAN BULL
+26
SGMT
$310M
Sagimet Biosciences Inc.
LEAN BULL
+25
ABPO
—
Abpro Holdings, Inc.
LEAN BULL
+24
MLTX
$1.0B
MoonLake Immunotherapeutics
LEAN BULL
+23
NTRR
—
Neutra Corp.
LEAN BULL
+20
PXMD
—
PaxMedica, Inc. Common Stock
LEAN BULL
+18
BTAX
—
Biostax Corp.
LEAN BULL
+18
LYRA
—
Lyra Therapeutics, Inc.
LEAN BULL
+18
REVB
—
Revelation Biosciences, Inc.
LEAN BULL
+18
NNVC
$40M
NanoViricides, Inc.
LEAN BULL
+15
HSTC
$210M
HST Global, Inc.
LEAN BULL
+13
EVAX
$20M
Evaxion Biotech A/S
LEAN BULL
+13
OCEA
—
Ocean Biomedical, Inc.
LEAN BULL
+13
RXRX
$2.0B
Recursion Pharmaceuticals, Inc.
LEAN BULL
+12
ENSC
$10M
Ensysce Biosciences, Inc.
LEAN BULL
+12
LCTX
$250M
Lineage Cell Therapeutics, Inc.
LEAN BULL
+11
GDTC
$10M
CytoMed Therapeutics Limited
LEAN BULL
+11
OKYO
$70M
OKYO Pharma Limited
LEAN BULL
+10
MBRX
$10M
Moleculin Biotech, Inc.
LEAN BULL
+10
DNAG
—
DNAPrint Genomics, Inc.
LEAN BULL
+10
RBSH
—
Rebus Holdings, Inc.
LEAN BULL
+10
OBX
$10M
Obsidian Therapeutics Inc.
NEUTRAL
+9
STAB
—
Statera Biopharma, Inc.
NEUTRAL
+8
LYEL
$230M
Lyell Immunopharma, Inc.
NEUTRAL
+7
PRLD
$210M
Prelude Therapeutics Incorporated
NEUTRAL
+7
NMAD
$50M
NOMAD Power Solutions, Inc.
NEUTRAL
+5
CNBX
—
CNBX Pharmaceuticals Inc.
NEUTRAL
+4
CALC
—
CalciMedica, Inc.
NEUTRAL
+4
NWBO
$260M
Northwest Biotherapeutics, Inc.
NEUTRAL
+2
MLLCF
$150M
Molecular Partners AG
NEUTRAL
+2
EHOS
—
Ehouse Global, Inc.
NEUTRAL
+2
HESG
—
Health Sciences Group, Inc.
NEUTRAL
+2
REPL
$1.1B
Replimune Group, Inc.
NEUTRAL
+1
RGIN
—
Regenicin, Inc.
NEUTRAL
+1
RCAR
—
RenovaCare, Inc.
NEUTRAL
+1
NMTRQ
—
9 Meters Biopharma, Inc.
NEUTRAL
+1
CFRXQ
—
ContraFect Corp.
NEUTRAL
+1
LYCA
$1.6B
Lycia Therapeutics Inc.
N/A
0
CTY
$200M
City Therapeutics Inc.
N/A
0
IAM
$130M
Iambic Therapeutics Inc.
N/A
0
LONA
$20M
LeonaBio, Inc.
NEUTRAL
0
JUNS
—
Jupiter Neurosciences, Inc.
NEUTRAL
0
PHMMF
$1.6B
Pharma Mar, S.A.
NEUTRAL
-3
SRZN
$190M
Surrozen, Inc.
NEUTRAL
-3
KLDO
—
Kaleido Biosciences, Inc.
NEUTRAL
-5
YARW
$180M
Yarrow Bioscience Inc
NEUTRAL
-6
ELUT
$40M
Elutia Inc
NEUTRAL
-6
GSTC
—
GlobeStar Therapeutics Corporation
NEUTRAL
-6
BPTH
—
Bio-Path Holdings, Inc.
NEUTRAL
-6
ABVC
$30M
ABVC BioPharma, Inc.
NEUTRAL
-7
USRM
—
U.S. Stem Cell, Inc.
NEUTRAL
-7
VCRE
$260M
Vicore Pharma Holding AB
NEUTRAL
-8
KROS
$220M
Keros Therapeutics, Inc.
NEUTRAL
-8
ENGNW
$10M
enGene Holdings Inc. Warrants
NEUTRAL
-8
PULM
$10M
Pulmatrix, Inc.
NEUTRAL
-8
ANAB
$1.5B
AnaptysBio, Inc.
NEUTRAL
-9
MRPI
—
Mera Pharmaceuticals, Inc.
NEUTRAL
-9
KNBIF
—
Kane Biotech Inc.
NEUTRAL
-9
LIANY
—
LianMedical
NEUTRAL
-9
ODTX
$940M
Odyssey Therapeutics, Inc.
LEAN BEAR
-11
INRLF
$640M
Valneva SE
LEAN BEAR
-12
POLBF
$70M
Poolbeg Pharma PLC
LEAN BEAR
-12
CLYYF
$10M
Celyad Oncology S.A.
LEAN BEAR
-12
PLUR
$10M
Pluri Inc.
LEAN BEAR
-13
GBIM
—
GlobeImmune, Inc.
LEAN BEAR
-13
INVA
$1.5B
Innoviva, Inc.
LEAN BEAR
-15
MDNAF
$20M
Medicenna Therapeutics Corp.
LEAN BEAR
-15
ONCSQ
—
OncoSec Medical Incorporated
LEAN BEAR
-15
BIXT
—
Bioxytran, Inc.
LEAN BEAR
-15
NKGN
—
NKGen Biotech, Inc.
LEAN BEAR
-16
HLSQ
—
Tessera Defense and Homeland Security Inc
LEAN BEAR
-16
EMMA
—
Emmaus Life Sciences, Inc.
LEAN BEAR
-16
REPCF
—
RepliCel Life Sciences Inc.
LEAN BEAR
-16
MCET
—
MultiCell Technologies, Inc.
LEAN BEAR
-16
CMND
—
Clearmind Medicine Inc.
LEAN BEAR
-16
NURPF
$1.8B
Neuren Pharmaceuticals Limited
LEAN BEAR
-17
DTIL
$180M
Precision BioSciences, Inc.
LEAN BEAR
-17
PEPG
$170M
PepGen Inc.
LEAN BEAR
-17
MMIRF
$30M
MedMira Inc.
LEAN BEAR
-17
JBIO
$930M
Jade Biosciences, Inc.
LEAN BEAR
-18
ACRS
$550M
Aclaris Therapeutics, Inc.
LEAN BEAR
-18
PARD
—
Poniard Pharmaceuticals, Inc.
LEAN BEAR
-18
KRSA
$150M
Korsana Biosciences, Inc.
LEAN BEAR
-20
AOBI
—
American Oriental Bioengineering, Inc.
LEAN BEAR
-20
TYRA
$1.2B
Tyra Biosciences, Inc.
LEAN BEAR
-22
IMMB
—
Immunotech Laboratories, Inc.
LEAN BEAR
-22
FPMI
—
FluoroPharma Medical, Inc.
LEAN BEAR
-22
GBLX
—
GB Sciences, Inc.
LEAN BEAR
-22
ZBIO
$1.8B
Zenas BioPharma, Inc.
LEAN BEAR
-24
ENTA
$340M
Enanta Pharmaceuticals, Inc.
LEAN BEAR
-24
APLMW
$170M
Apollomics, Inc.
LEAN BEAR
-24
ARMP
$140M
Armata Pharmaceuticals, Inc.
LEAN BEAR
-24
NTHI
$90M
Neonc Technologies Holdings, Inc.
LEAN BEAR
-24
SRBCF
—
Sirona Biochem Corp.
LEAN BEAR
-24
PZRXQ
—
PhaseRx, Inc.
LEAN BEAR
-24
RNAZ
—
TransCode Therapeutics, Inc.
LEAN BEAR
-24
NNBP
—
Nanobac Pharmaceuticals, Incorporated
LEAN BEAR
-24
NNLX
—
NanoLogix, Inc.
LEAN BEAR
-24
CLAZF
—
Claritas Pharmaceuticals, Inc.
LEAN BEAR
-24
IMVIF
—
IMV Inc.
LEAN BEAR
-24
PREDQ
—
Predictive Discovery Limited
LEAN BEAR
-24
FGHQF
$360M
Frontage Holdings Corporation
LEAN BEAR
-25
GWIN
$360M
Glorywin Entertainment Group, Inc.
LEAN BEAR
-25
SPHRY
$220M
Starpharma Holdings Limited
LEAN BEAR
-25
KNTPF
$120M
Kintor Pharmaceutical Limited
LEAN BEAR
-25
LVCLF
$20M
Algorae Pharmaceuticals Limited
LEAN BEAR
-25
BCLI
$10M
Brainstorm Cell Therapeutics Inc.
LEAN BEAR
-25
QPTFF
$10M
Quest PharmaTech Inc.
LEAN BEAR
-25
FORU
—
ForU Holdings, Inc.
LEAN BEAR
-25
CHNXF
—
ChitogenX Inc.
LEAN BEAR
-25
CLGN
—
CollPlant Biotechnologies Ltd.
LEAN BEAR
-25
VINC
—
Vincerx Pharma, Inc.
LEAN BEAR
-25
ALEC
$200M
Alector, Inc.
LEAN BEAR
-26
RLYB
$90M
Rallybio Corporation
LEAN BEAR
-26
AEON
$10M
AEON Biopharma, Inc.
LEAN BEAR
-26
ATXI
—
Avenue Therapeutics, Inc.
LEAN BEAR
-26
STOK
$1.6B
Stoke Therapeutics, Inc.
LEAN BEAR
-27
CURX
$10M
Curanex Pharmaceuticals Inc Common Stock
LEAN BEAR
-27
ENZC
—
Enzolytics Inc.
BEARISH
-30
AVLN
$1.1B
Avalyn Pharma Inc. Common Stock
BEARISH
-31
DBVT
$230M
DBV Technologies S.A.
BEARISH
-31
RNA
$140M
Atrium Therapeutics, Inc.
BEARISH
-31
PBIGF
$10M
Paradigm Biopharmaceuticals Limited
BEARISH
-31
PKTX
—
ProtoKinetix, Incorporated
BEARISH
-31
CARM
—
Carisma Therapeutics, Inc.
BEARISH
-31
TRVN
—
Trevena, Inc.
BEARISH
-31
DRUG
$520M
Bright Minds Biosciences Inc.
BEARISH
-32
TRDA
$170M
Entrada Therapeutics, Inc.
BEARISH
-32
BDTX
$110M
Black Diamond Therapeutics, Inc.
BEARISH
-32
INNMF
$30M
Amplia Therapeutics Limited
BEARISH
-32
KPTI
$10M
Karyopharm Therapeutics Inc.
BEARISH
-32
AAGH
—
America Great Health
BEARISH
-32
BXRXQ
—
Baudax Bio, Inc.
BEARISH
-32
ADXN
—
Addex Therapeutics Ltd
BEARISH
-32
ABSI
$1.6B
Absci Corporation
BEARISH
-33
SNBIF
$1.3B
SanBio Company Limited
BEARISH
-33
FATE
$250M
Fate Therapeutics, Inc.
BEARISH
-33
DYAI
$20M
Dyadic International, Inc.
BEARISH
-33
BIVI
$10M
BioVie Inc.
BEARISH
-33
LSTA
$10M
Lisata Therapeutics, Inc.
BEARISH
-33
XCUR
$10M
Exicure, Inc.
BEARISH
-33
VRCI
—
Verde Science, Inc.
BEARISH
-33
HLUN
—
HEALTHeUNIVERSE, Inc.
BEARISH
-33
SNNAQ
—
Sienna Biopharmaceuticals, Inc.
BEARISH
-33
NTII
—
Neurobiological Technologies, Inc.
BEARISH
-33
CMRA
—
Comera Life Sciences Holdings, Inc.
BEARISH
-33
HAVLF
—
HAVN Life Sciences Inc.
BEARISH
-33
GLSHQ
—
Gelesis Holdings, Inc.
BEARISH
-33
PSYBF
—
PsyBio Therapeutics Corp
BEARISH
-33
MRZM
—
Marizyme, Inc.
BEARISH
-33
TLOG
—
TetraLogic Pharmaceuticals Corporation
BEARISH
-33
NTLA
$1.6B
Intellia Therapeutics, Inc.
BEARISH
-34
JANX
$1.0B
Janux Therapeutics, Inc.
BEARISH
-34
BPMUF
$960M
Basilea Pharmaceutica AG
BEARISH
-34
BETRF
$110M
BetterLife Pharma Inc.
BEARISH
-34
SYGGF
—
Synairgen plc
BEARISH
-34
VAXX
—
Vaxxinity, Inc.
BEARISH
-34
PVLA
$1.8B
Palvella Therapeutics, Inc.
BEARISH
-35
IFRX
$230M
InflaRx N.V.
BEARISH
-35
ATGGF
$140M
Actinogen Medical Limited
BEARISH
-35
SQZB
—
SQZ Biotechnologies Company
BEARISH
-35
MEOBF
$2.0B
Mesoblast Limited
BEARISH
-37
CLNN
$60M
Clene Inc.
BEARISH
-39
CEROW
—
CERo Therapeutics Holdings, Inc.
BEARISH
-39
OCS
$490M
Oculis Holding AG
BEARISH
-40
ALXO
$160M
ALX Oncology Holdings Inc.
BEARISH
-40
FBIOP
$130M
Fortress Biotech, Inc.
BEARISH
-40
FHTX
$120M
Foghorn Therapeutics Inc.
BEARISH
-40
AURX
$60M
Nuo Therapeutics, Inc.
BEARISH
-40
VRPX
—
Virpax Pharmaceuticals, Inc.
BEARISH
-40
PBMWW
—
Psyence Biomedical Ltd. Warrant
BEARISH
-40
JAGX
—
Jaguar Health, Inc.
BEARISH
-40
HTDS
—
Hard to Treat Diseases Inc.
BEARISH
-40
CALA
—
Calithera Biosciences, Inc.
BEARISH
-40
KARD
$1.1B
Kardigan, Inc.
BEARISH
-41
PPTDF
$870M
PeptiDream Inc.
BEARISH
-41
EQ
$80M
Equillium, Inc.
BEARISH
-41
LOBEF
$10M
Lobe Sciences Ltd.
BEARISH
-41
SNTI
$10M
Senti Biosciences, Inc.
BEARISH
-41
SRPT
$1.9B
Sarepta Therapeutics, Inc.
BEARISH
-42
CSPHF
$1.4B
CStone Pharmaceuticals
BEARISH
-42
DRTSW
$1.2B
Alpha Tau Medical Ltd.
BEARISH
-42
OVID
$420M
Ovid Therapeutics Inc.
BEARISH
-42
NGNE
$370M
Neurogene Inc.
BEARISH
-42
DTCFF
$20M
Defence Therapeutics Inc.
BEARISH
-42
MRKR
$20M
Marker Therapeutics, Inc.
BEARISH
-42
PROT
—
Proteonomix, Inc.
BEARISH
-42
SIGY
—
Sigyn Therapeutics, Inc.
BEARISH
-42
BRAXF
—
Braxia Scientific Corp.
BEARISH
-42
EFTR
—
eFFECTOR Therapeutics, Inc.
BEARISH
-42
RNUGF
—
ReNeuron Group plc
BEARISH
-42
PANC
—
Panacos Pharmaceuticals, Inc.
BEARISH
-42
SYVC
—
Synovics Pharmaceuticals, Inc.
BEARISH
-42
CDXI
—
Cardax, Inc.
BEARISH
-42
PFND
—
Pathfinder Cell Therapy, Inc.
BEARISH
-42
NBIO
—
Nascent Biotech, Inc.
BEARISH
-42
ADYX
—
Adynxx, Inc.
BEARISH
-42
LADX
—
LadRx Corporation
BEARISH
-43
RAPP
$1.2B
Rapport Therapeutics, Inc. Common Stock
BEARISH
-44
CGEM
$880M
Cullinan Therapeutics, Inc.
BEARISH
-44
VICP
$10M
Vicapsys Life Sciences, Inc.
BEARISH
-44
CNSP
$10M
CNS Pharmaceuticals, Inc.
BEARISH
-44
ADRX
$1.9B
ADARx Pharmaceuticals, Inc.
BEARISH
-46
CASIF
—
CASI Pharmaceuticals, Inc.
BEARISH
-46
CRVS
$890M
Corvus Pharmaceuticals, Inc.
BEARISH
-48
GLSI
$240M
Greenwich LifeSciences, Inc.
BEARISH
-48
ADAPY
$10M
Adaptimmune Therapeutics plc
BEARISH
-48
TSHA
$1.3B
Taysha Gene Therapies, Inc.
BEARISH
-49
ARVN
$470M
Arvinas, Inc.
BEARISH
-49
PRTA
$420M
Prothena Corporation plc
BEARISH
-49
CCCC
$380M
C4 Therapeutics, Inc.
BEARISH
-49
ELTX
$40M
Elicio Therapeutics, Inc.
BEARISH
-49
DVHGF
$20M
Devonian Health Group, Inc.
BEARISH
-49
LEXX
$10M
Lexaria Bioscience Corp.
BEARISH
-49
ALLR
$10M
Allarity Therapeutics, Inc.
BEARISH
-49
ANEB
$10M
Anebulo Pharmaceuticals, Inc.
BEARISH
-49
SCPS
—
Scopus BioPharma Inc.
BEARISH
-49
RLFTY
—
MindMaze Therapeutics Holding S.A.
BEARISH
-49
BITRF
—
Biotron Limited
BEARISH
-49
BIORQ
—
Biora Therapeutics, Inc.
BEARISH
-49
SLXN
—
Silexion Therapeutics Ltd.
BEARISH
-49
THER
—
Theralink Technologies, Inc.
BEARISH
-49
AAPG
$1.4B
Ascentage Pharma Group International
BEARISH
-50
EDIT
$370M
Editas Medicine, Inc.
BEARISH
-50
TTRX
$310M
Turn Therapeutics Inc.
BEARISH
-50
NTRB
$70M
Nutriband Inc.
BEARISH
-50
CSBR
$70M
Champions Oncology, Inc.
BEARISH
-50
HRGN
$30M
Harvard Apparatus Regenerative Technology Inc.
BEARISH
-50
JSPR
$20M
Jasper Therapeutics, Inc.
BEARISH
-50
APUS
—
Apimeds Pharmaceuticals US, Inc
BEARISH
-50
IBOGF
—
Universal Ibogaine Inc.
BEARISH
-50
ERNA
—
Ernexa Therapeutics Inc.
BEARISH
-50
VRAX
—
Virax Biolabs Group Limited
BEARISH
-50
PHRRF
—
PharmaTher Holdings Ltd.
BEARISH
-50
MRES
—
Institute of Biomedical Research Corp.
BEARISH
-50
SCNI
—
Scinai Immunotherapeutics Ltd.
BEARISH
-50
DNA
$670M
Ginkgo Bioworks Holdings, Inc.
BEARISH
-51
INKT
$50M
MiNK Therapeutics, Inc.
BEARISH
-51
HOPHF
$20M
Hemogenyx Pharmaceuticals Plc
BEARISH
-52
HNSBF
$330M
Hansa Biopharma AB (publ)
BEARISH
-53
INTI
$10M
Inhibitor Therapeutics, Inc.
BEARISH
-53
ORGS
—
Orgenesis Inc.
BEARISH
-53
AFFY
—
Affymax, Inc.
BEARISH
-53
PLYX
$90M
Polaryx Therapeutics, Inc. Common Stock
BEARISH
-55
VBIZF
$400M
Viva Biotech Holdings
BEARISH
-56
SPRB
$130M
Spruce Biosciences, Inc.
BEARISH
-56
OKUR
$100M
OnKure Therapeutics, Inc.
BEARISH
-56
SYRS
—
Syros Pharmaceuticals, Inc.
BEARISH
-56
IMTX
$1.1B
Immatics N.V.
BEARISH
-58
AVBP
$1.0B
ArriVent BioPharma, Inc.
BEARISH
-58
ZURA
$320M
Zura Bio Limited
BEARISH
-58
CLVLF
$250M
Clinuvel Pharmaceuticals Limited
BEARISH
-58
BCYC
$250M
Bicycle Therapeutics plc
BEARISH
-58
CDXS
$140M
Codexis, Inc.
BEARISH
-58
RNXT
$60M
RenovoRx, Inc.
BEARISH
-58
SGMOQ
$50M
Sangamo Therapeutics, Inc.
BEARISH
-58
SEOVF
$30M
Sernova Corp.
BEARISH
-58
SNANF
$20M
Sona Nanotech Inc.
BEARISH
-58
RVXCF
$20M
Resverlogix Corp.
BEARISH
-58
HMTXF
$10M
Hemostemix Inc.
BEARISH
-58
AMBS
—
Amarantus BioScience Holdings, Inc.
BEARISH
-58
ANTH
—
Anthera Pharmaceuticals, Inc.
BEARISH
-58
BRTX
—
BioRestorative Therapies, Inc.
BEARISH
-58
ATRX
—
Adhera Therapeutics Inc
BEARISH
-58
AMPE
—
Ampio Pharmaceuticals, Inc.
BEARISH
-58
LIPO
—
Lipella Pharmaceuticals Inc.
BEARISH
-58
CVKD
—
Cadrenal Therapeutics, Inc. Common Stock
BEARISH
-58
MAJI
—
Nextel Medical Corp.
BEARISH
-58
AURA
$650M
Aura Biosciences, Inc.
BEARISH
-59
ARCT
$280M
Arcturus Therapeutics Holdings Inc.
BEARISH
-59
ATRA
$90M
Atara Biotherapeutics, Inc.
BEARISH
-59
IMRN
$10M
Immuron Limited
BEARISH
-59
SKYE
$10M
Skye Bioscience, Inc.
BEARISH
-59
ERNAW
—
Ernexa Therapeutics Inc. Warrants
BEARISH
-59
CUBT
—
Curative Biotechnology, Inc.
BEARISH
-59
IDRSF
$1.4B
Idorsia Ltd
BEARISH
-60
QTTB
$260M
Q32 Bio Inc.
BEARISH
-60
BRIBF
$90M
Brii Biosciences Limited
BEARISH
-60
AUTL
$410M
Autolus Therapeutics plc
BEARISH
-62
BVAXF
—
BioVaxys Technology Corp.
BEARISH
-62
TELO
$70M
Telomir Pharmaceuticals, Inc. Common Stock
BEARISH
-65
RECEF
$70M
Recce Pharmaceuticals Ltd
BEARISH
-65
CVM
$30M
CEL-SCI Corporation
BEARISH
-65
SNGX
$10M
Soligenix, Inc.
BEARISH
-65
ARTL
$10M
Artelo Biosciences, Inc.
BEARISH
-65
LIFS
—
Life Stem Genetics Inc.
BEARISH
-65
FNAM
—
Evolutionary Genomics, Inc.
BEARISH
-65
WINT
—
Windtree Therapeutics, Inc.
BEARISH
-65
RGRX
—
RegeneRx Biopharmaceuticals, Inc.
BEARISH
-65
SYBE
—
SYBLEU Inc
BEARISH
-65
BICTF
—
Biocure Technology Inc.
BEARISH
-65
VOR
$990M
Vor Biopharma Inc.
BEARISH
-66
ASCLF
$770M
Ascletis Pharma Inc.
BEARISH
-66
YDES
$350M
YD Bio Limited Ordinary Shares
BEARISH
-66
CAMP
$210M
CAMP4 Therapeutics Corporation
BEARISH
-66
RNAC
$190M
Cartesian Therapeutics, Inc.
BEARISH
-66
VRXA
$140M
Veraxa Biotech Holding AG
BEARISH
-66
OTLK
$130M
Outlook Therapeutics, Inc.
BEARISH
-66
ONCY
$50M
Oncolytics Biotech Inc.
BEARISH
-66
CNTB
$50M
Connect Biopharma Holdings Limited
BEARISH
-66
ALPS
$50M
Alps Group Inc
BEARISH
-66
CLCS
$40M
Cell Source, Inc.
BEARISH
-66
BYSI
$20M
BeyondSpring Inc.
BEARISH
-66
CNTX
$20M
Context Therapeutics Inc.
BEARISH
-66
PLRZ
$10M
Polyrizon Ltd.
BEARISH
-66
ADIL
$10M
Adial Pharmaceuticals, Inc.
BEARISH
-66
LPCN
$10M
Lipocine Inc.
BEARISH
-66
GLWLF
$10M
Glow Lifetech Corp.
BEARISH
-66
KTTA
$10M
Pasithea Therapeutics Corp.
BEARISH
-66
ICU
$10M
SeaStar Medical Holding Corporation
BEARISH
-66
ONCO
—
Onconetix, Inc.
BEARISH
-66
BBLG
—
Bone Biologics Corporation
BEARISH
-66
AFMDQ
—
Affimed N.V.
BEARISH
-66
EVLO
—
Evelo Biosciences, Inc.
BEARISH
-66
VCNX
—
Vaccinex, Inc.
BEARISH
-66
VIVS
—
VivoSim Labs, Inc.
BEARISH
-66
SXTP
—
60 Degrees Pharmaceuticals, Inc.
BEARISH
-66
SPRC
—
SciSparc Ltd.
BEARISH
-66
MTNB
—
Matinas BioPharma Holdings, Inc.
BEARISH
-66
NCEL
—
NewcelX Ltd.
BEARISH
-66
DRMA
—
Dermata Therapeutics, Inc.
BEARISH
-66
ITMC
—
Itoco Inc.
BEARISH
-66
OBIO
$340M
Orchestra BioMed Holdings, Inc.
BEARISH
-68
ACOG
$130M
Alpha Cognition Inc
BEARISH
-68
LITS
$40M
Lite Strategy, Inc.
BEARISH
-68
NXTC
$20M
NextCure, Inc.
BEARISH
-68
BCTXZ
—
BriaCell Therapeutics Corp. Warrant
BEARISH
-68
TRVI
$1.8B
Trevi Therapeutics, Inc.
BEARISH
-69
QURE
$1.6B
uniQure N.V.
BEARISH
-69
MGTX
$880M
MeiraGTx Holdings plc
BEARISH
-69
ABUS
$830M
Arbutus Biopharma Corp
BEARISH
-69
AMGXF
$140M
AnGes, Inc.
BEARISH
-69
BBIXF
$50M
Bonus BioGroup Ltd.
BEARISH
-69
XTLB
—
XTL Biopharmaceuticals Ltd.
BEARISH
-69
MYMX
—
Mymetics Corporation
BEARISH
-69
NWPHF
$410M
Newron Pharmaceuticals S.p.A.
BEARISH
-71
SRNE
—
Sorrento Therapeutics, Inc.
BEARISH
-73
PBLA
—
Panbela Therapeutics, Inc.
BEARISH
-73
CPMV
—
Mosaic ImmunoEngineering Inc.
BEARISH
-73
MNKD
$1.0B
MannKind Corporation
BEARISH
-74
APMD
$790M
Apnimed, Inc.
BEARISH
-74
SABS
$260M
SAB Biotherapeutics, Inc.
BEARISH
-74
IMRX
$240M
Immuneering Corporation
BEARISH
-74
HUMA
$120M
Humacyte, Inc.
BEARISH
-74
BTAIQ
—
BioXcel Therapeutics, Inc.
BEARISH
-74
TSOI
—
Therapeutic Solutions International, Inc.
BEARISH
-74
BCRX
$1.9B
BioCryst Pharmaceuticals, Inc.
BEARISH
-75
GENB
$1.6B
Generate Biomedicines, Inc.
BEARISH
-75
CMPS
$1.6B
COMPASS Pathways plc
BEARISH
-75
INBX
$1.4B
Inhibrx Biosciences Inc.
BEARISH
-75
OMER
$1.2B
Omeros Corporation
BEARISH
-75
ACHV
$670M
Achieve Life Sciences, Inc.
BEARISH
-75
NVCT
$650M
Nuvectis Pharma, Inc.
BEARISH
-75
MDXG
$570M
MiMedx Group, Inc.
BEARISH
-75
STTK
$550M
Shattuck Labs, Inc.
BEARISH
-75
CBIO
$480M
Crescent Biopharma, Inc.
BEARISH
-75
RZLT
$370M
Rezolute, Inc.
BEARISH
-75
FENC
$350M
Fennec Pharmaceuticals Inc.
BEARISH
-75
DMTRF
$310M
3-D Matrix, Ltd.
BEARISH
-75
CUE
$140M
Cue Biopharma, Inc.
BEARISH
-75
VANI
$100M
Vivani Medical, Inc.
BEARISH
-75
MNOV
$70M
MediciNova, Inc.
BEARISH
-75
NDTP
$50M
NDT Pharmaceuticals Inc.
BEARISH
-75
CRVO
$30M
CervoMed Inc.
BEARISH
-75
CELU
$30M
Celularity Inc.
BEARISH
-75
TELIF
$20M
Telescope Innovations Corp.
BEARISH
-75
COCP
$20M
Cocrystal Pharma, Inc.
BEARISH
-75
PVCT
$20M
Provectus Biopharmaceuticals, Inc.
BEARISH
-75
LTRN
$10M
Lantern Pharma Inc.
BEARISH
-75
PHYOF
$10M
IXICO plc
BEARISH
-75
PASG
$10M
Passage Bio, Inc.
BEARISH
-75
CDT
—
CDT Equity Inc.
BEARISH
-75
ADTX
—
Aditxt, Inc.
BEARISH
-75
YDESW
—
YD Bio Limited Warrants
BEARISH
-75
HMGN
—
Hemagen Diagnostics, Inc.
BEARISH
-75
YECO
—
EV Biologics, Inc.
BEARISH
-75
LIMNW
—
Liminatus Pharma, Inc. Warrants
BEARISH
-75
AXIM
—
AXIM Biotechnologies, Inc.
BEARISH
-75
RGBPP
—
Regen BioPharma, Inc.
BEARISH
-75
CHMMF
—
Chimeric Therapeutics Limited
BEARISH
-75
BLEG
—
Branded Legacy, Inc.
BEARISH
-75
GRI
—
GRI Bio, Inc.
BEARISH
-75
NMLSF
—
Restart Life Sciences Corp.
BEARISH
-75
AGNPF
—
Grey Matters Health Inc.
BEARISH
-75
LNAI
—
Lunai Bioworks Inc.
BEARISH
-75
GHRS
$1.2B
GH Research PLC
BEARISH
-78
ANRO
$860M
Alto Neuroscience, Inc.
BEARISH
-78
AKTS
$850M
Aktis Oncology, Inc.
BEARISH
-78
DSGN
$640M
Design Therapeutics, Inc.
BEARISH
-78
SLDB
$630M
Solid Biosciences Inc.
BEARISH
-78
LXRX
$630M
Lexicon Pharmaceuticals, Inc.
BEARISH
-78
ANL
$560M
Adlai Nortye Ltd.
BEARISH
-78
MNPR
$470M
Monopar Therapeutics Inc.
BEARISH
-78
AVIR
$320M
Atea Pharmaceuticals, Inc.
BEARISH
-78
ARTV
$300M
Artiva Biotherapeutics, Inc.
BEARISH
-78
WHWK
$180M
Whitehawk Therapeutics Inc
BEARISH
-78
ANTX
$130M
AN2 Therapeutics, Inc.
BEARISH
-78
NRXP
$110M
NRx Pharmaceuticals, Inc.
BEARISH
-78
ELOX
$40M
Eloxx Pharmaceuticals, Inc.
BEARISH
-78
BMEA
$40M
Biomea Fusion, Inc.
BEARISH
-78
TVGN
$30M
Tevogen Bio Holdings Inc.
BEARISH
-78
AVEFF
$20M
Avecho Biotechnology Limited
BEARISH
-78
CMMB
$10M
Chemomab Therapeutics Ltd.
BEARISH
-78
KZIA
$10M
Kazia Therapeutics Ltd ADR
BEARISH
-78
SYBX
$10M
Synlogic, Inc.
BEARISH
-78
XRTX
—
XORTX Therapeutics Inc.
BEARISH
-78
HXBM
—
Helix BioMedix, Inc.
BEARISH
-78
OZYMF
—
Strategic Partners A/S
BEARISH
-78
GNLKQ
—
GeneLink, Inc.
BEARISH
-78
RMTG
—
Regenerative Medical Technology Group Inc.
BEARISH
-78
GLABF
—
Gemina Laboratories Ltd.
BEARISH
-78
HBMHF
$1.3B
HBM Holdings Limited
BEARISH
-82
BCAX
$1.1B
Bicara Therapeutics Inc. Common Stock
BEARISH
-82
NKTR
$1.1B
Nektar Therapeutics
BEARISH
-82
GLUE
$920M
Monte Rosa Therapeutics, Inc.
BEARISH
-82
ALMS
$880M
Alumis Inc.
BEARISH
-82
AGMB
$450M
AgomAb Therapeutics N.V. American Depositary Shares
BEARISH
-82
BLSM
$430M
BlossomHill Therapeutics, Inc.
BEARISH
-82
EIKN
$390M
Eikon Therapeutics, Inc. Common Stock
BEARISH
-82
RLMD
$350M
Relmada Therapeutics, Inc.
BEARISH
-82
BNTC
$300M
Benitec Biopharma Inc.
BEARISH
-82
IPSC
$260M
Century Therapeutics, Inc.
BEARISH
-82
RCKT
$250M
Rocket Pharmaceuticals, Inc.
BEARISH
-82
BOVNF
$220M
BioInvent International AB (publ)
BEARISH
-82
CHRS
$160M
Coherus Oncology, Inc.
BEARISH
-82
VXRT
$100M
Vaxart, Inc.
BEARISH
-82
IMUX
$100M
Immunic, Inc.
BEARISH
-82
ADAG
$90M
Adagene Inc.
BEARISH
-82
NMRA
$70M
Neumora Therapeutics, Inc. Common Stock
BEARISH
-82
TENX
$50M
Tenax Therapeutics, Inc.
BEARISH
-82
IMA
$50M
ImageneBio Inc
BEARISH
-82
IBO
$30M
Impact BioMedical Inc.
BEARISH
-82
NEUP
$20M
Neuphoria Therapeutics Inc.
BEARISH
-82
PRRUF
$20M
Immutep Limited
BEARISH
-82
CLRB
$10M
Cellectar Biosciences, Inc.
BEARISH
-82
AIM
$10M
AIM ImmunoTech Inc.
BEARISH
-82
CTXR
$10M
Citius Pharmaceuticals, Inc.
BEARISH
-82
RADX
—
Radiopharm Theranostics Limited
BEARISH
-82
LGVN
—
Longeveron Inc.
BEARISH
-82
APVO
—
Aptevo Therapeutics Inc.
BEARISH
-82
ARNI
—
Arno Therapeutics, Inc.
BEARISH
-82
MYNDF
—
MYND Life Sciences Inc.
BEARISH
-82
SEPSF
—
Asep Medical Holdings Inc
BEARISH
-82
BIOAF
—
Bioasis Technologies Inc.
BEARISH
-82
ARUXF
—
Acrux Limited
BEARISH
-82
ORIC
$1.4B
ORIC Pharmaceuticals, Inc.
BEARISH
-84
KURA
$850M
Kura Oncology, Inc.
BEARISH
-84
FDMT
$600M
4D Molecular Therapeutics, Inc.
BEARISH
-84
ZVRA
$580M
Zevra Therapeutics, Inc.
BEARISH
-84
EPRX
$450M
Eupraxia Pharmaceuticals Inc.
BEARISH
-84
AGEN
$290M
Agenus Inc.
BEARISH
-84
IRD
$290M
Opus Genetics, Inc.
BEARISH
-84
GALT
$210M
Galectin Therapeutics Inc.
BEARISH
-84
CGEN
$180M
Compugen Ltd.
BEARISH
-84
MGNX
$140M
MacroGenics, Inc.
BEARISH
-84
SEER
$110M
Seer, Inc.
BEARISH
-84
COYA
$90M
Coya Therapeutics, Inc.
BEARISH
-84
ACRV
$70M
Acrivon Therapeutics, Inc. Common Stock
BEARISH
-84
PMVP
$70M
PMV Pharmaceuticals, Inc.
BEARISH
-84
HRTX
$60M
Heron Therapeutics, Inc.
BEARISH
-84
OSTX
$60M
OS Therapies Incorporated
BEARISH
-84
SPRO
$60M
Spero Therapeutics, Inc.
BEARISH
-84
XLO
$50M
Xilio Therapeutics, Inc.
BEARISH
-84
AKTX
$20M
Akari Therapeutics, Plc
BEARISH
-84
KPRX
$10M
Kiora Pharmaceuticals, Inc.
BEARISH
-84
OTLC
$10M
Oncotelic Therapeutics, Inc.
BEARISH
-84
ENVB
$10M
Enveric Biosciences, Inc.
BEARISH
-84
PTIX
—
Protagenic Therapeutics, Inc.
BEARISH
-84
ISCO
—
International Stem Cell Corporation
BEARISH
-84
PBM
—
Psyence Biomedical Ltd.
BEARISH
-84
RVLPQ
—
RVL Pharmaceuticals plc
BEARISH
-84
URGN
$1.7B
UroGen Pharma Ltd.
BEARISH
-87
NVAX
$1.6B
Novavax, Inc.
BEARISH
-87
NUVB
$1.6B
Nuvation Bio Inc.
BEARISH
-87
DRTS
$1.2B
Alpha Tau Medical Ltd
BEARISH
-87
MDCLF
$1.1B
MedinCell S.A.
BEARISH
-87
IMMX
$680M
Immix Biopharma, Inc.
BEARISH
-87
CADL
$610M
Candel Therapeutics, Inc.
BEARISH
-87
CLYM
$590M
Climb Bio, Inc.
BEARISH
-87
GNFTF
$470M
Genfit S.A.
BEARISH
-87
AVCTF
$420M
Avacta Group Plc
BEARISH
-87
IKT
$220M
Inhibikase Therapeutics, Inc.
BEARISH
-87
PLX
$210M
Protalix BioTherapeutics, Inc.
BEARISH
-87
PRQR
$180M
ProQR Therapeutics N.V.
BEARISH
-87
ORMP
$170M
Oramed Pharmaceuticals Inc.
BEARISH
-87
TRGNF
$120M
Transgene S.A.
BEARISH
-87
PYXS
$110M
Pyxis Oncology, Inc.
BEARISH
-87
PRNAF
$50M
Alterity Therapeutics Limited
BEARISH
-87
BOLD
$50M
Boundless Bio, Inc.
BEARISH
-87
BMNDF
$20M
Biomind Labs Inc.
BEARISH
-87
SER
$20M
Serina Therapeutics, Inc.
BEARISH
-87
ALZN
$10M
Alzamend Neuro Inc
BEARISH
-87
XBIO
—
Xenetic Biosciences, Inc.
BEARISH
-87
SNDX
$1.2B
Syndax Pharmaceuticals, Inc.
BEARISH
-91
ARDX
$770M
Ardelyx, Inc.
BEARISH
-91
GERN
$720M
Geron Corporation
BEARISH
-91
SANA
$700M
Sana Biotechnology, Inc.
BEARISH
-91
SLBT
$640M
SL Science Holding Ltd
BEARISH
-91
WVE
$630M
Wave Life Sciences Ltd.
BEARISH
-91
GYRE
$620M
Gyre Therapeutics, Inc.
BEARISH
-91
ANNX
$610M
Annexon, Inc.
BEARISH
-91
OLMA
$560M
Olema Pharmaceuticals, Inc.
BEARISH
-91
CTMX
$510M
CytomX Therapeutics, Inc.
BEARISH
-91
SPRY
$400M
ARS Pharmaceuticals, Inc.
BEARISH
-91
MPLT
$340M
MapLight Therapeutics, Inc.
BEARISH
-91
SPHDF
$280M
Santhera Pharmaceuticals Holding AG
BEARISH
-91
VOGX
$260M
Vogenx Inc.
BEARISH
-91
ORYZF
$250M
Oryzon Genomics S.A.
BEARISH
-91
VNDA
$240M
Vanda Pharmaceuticals Inc.
BEARISH
-91
LRMR
$240M
Larimar Therapeutics, Inc.
BEARISH
-91
HLOSF
$240M
Healios K.K.
BEARISH
-91
LXEO
$230M
Lexeo Therapeutics, Inc. Common Stock
BEARISH
-91
IPHYF
$210M
Innate Pharma S.A.
BEARISH
-91
BBOT
$210M
BridgeBio Oncology Therapeutics Inc.
BEARISH
-91
ELDN
$190M
Eledon Pharmaceuticals, Inc.
BEARISH
-91
BIOA
$190M
BioAge Labs Inc.
BEARISH
-91
EVMN
$190M
Evommune, Inc.
BEARISH
-91
AKBA
$160M
Akebia Therapeutics, Inc.
BEARISH
-91
ZNTL
$160M
Zentalis Pharmaceuticals, Inc.
BEARISH
-91
NBP
$160M
NovaBridge Biosciences
BEARISH
-91
NGEN
$150M
NervGen Pharma Corp. Common stock
BEARISH
-91
MDWD
$150M
MediWound Ltd.
BEARISH
-91
TARA
$140M
Protara Therapeutics, Inc.
BEARISH
-91
NKTX
$130M
Nkarta, Inc.
BEARISH
-91
MENS
$130M
Jyong Biotech Ltd. Ordinary Shares
BEARISH
-91
AVXL
$120M
Anavex Life Sciences Corp.
BEARISH
-91
UNCY
$110M
Unicycive Therapeutics, Inc.
BEARISH
-91
CBUS
$110M
Cibus, Inc.
BEARISH
-91
LENZ
$100M
LENZ Therapeutics, Inc.
BEARISH
-91
ORPOF
$100M
OSE Immunotherapeutics S.A.
BEARISH
-91
TNYA
$90M
Tenaya Therapeutics, Inc.
BEARISH
-91
TNXP
$90M
Tonix Pharmaceuticals Holding Corp.
BEARISH
-91
CNXU
$90M
Conexeu Sciences Inc.
BEARISH
-91
CRBP
$80M
Corbus Pharmaceuticals Holdings, Inc.
BEARISH
-91
MIST
$80M
Milestone Pharmaceuticals Inc.
BEARISH
-91
JWCTF
$80M
JW (Cayman) Therapeutics Co. Ltd
BEARISH
-91
PMN
$70M
ProMIS Neurosciences, Inc.
BEARISH
-91
MAIA
$70M
MAIA Biotechnology, Inc.
BEARISH
-91
CGTX
$70M
Cognition Therapeutics, Inc.
BEARISH
-91
CRBU
$60M
Caribou Biosciences, Inc.
BEARISH
-91
TLSA
$60M
Tiziana Life Sciences Ltd
BEARISH
-91
GOSS
$60M
Gossamer Bio, Inc.
BEARISH
-91
HBPCF
$60M
Helix BioPharma Corp.
BEARISH
-91
INO
$60M
Inovio Pharmaceuticals, Inc.
BEARISH
-91
VTIAF
$50M
FamiCord AG
BEARISH
-91
PLRX
$50M
Pliant Therapeutics, Inc.
BEARISH
-91
GANX
$50M
Gain Therapeutics, Inc.
BEARISH
-91
HYFT
$50M
MindWalk Holdings Corp.
BEARISH
-91
DWTX
$40M
Dogwood Therapeutics, Inc.
BEARISH
-91
ALDX
$40M
Aldeyra The
BEARISH
-91
RANI
$40M
Rani Therapeutics Holdings, Inc.
BEARISH
-91
IGC
$30M
IGC Pharma, Inc.
BEARISH
-91
FLNA
$30M
Filana Therapeutics, Inc.
BEARISH
-91
IXHL
$30M
Incannex Healthcare Limited
BEARISH
-91
MCRB
$20M
Seres Therapeutics, Inc.
BEARISH
-91
ATYR
$20M
aTyr Pharma, Inc.
BEARISH
-91
TCRX
$10M
TScan Therapeutics, Inc.
BEARISH
-91
RDTCF
$10M
Rapid Dose Therapeutics Corp.
BEARISH
-91
GUTS
$10M
Fractyl Health, Inc.
BEARISH
-91
TPST
$10M
Tempest Therapeutics, Inc.
BEARISH
-91
HIND
$10M
Vyome Holdings, Inc.
BEARISH
-91
ACTU
$10M
Actuate Therapeutics Inc
BEARISH
-91
QNRX
$10M
Quoin Pharmaceuticals, Ltd.
BEARISH
-91
NCNA
$10M
NuCana plc
BEARISH
-91
GSGTF
$10M
GenSight Biologics S.A.
BEARISH
-91
INTS
$10M
Intensity Therapeutics, Inc.
BEARISH
-91
PXXLF
$10M
Poxel S.A.
BEARISH
-91
TOVX
$10M
Theriva Biologics, Inc.
BEARISH
-91
QNTM
$10M
Quantum BioPharma Ltd.
BEARISH
-91
CDIO
$10M
Cardio Diagnostics Holdings, Inc.
BEARISH
-91
VTGN
$10M
VistaGen Therapeutics, Inc.
BEARISH
-91
OPTBF
$10M
OptiBiotix Health Plc
BEARISH
-91
DARE
$10M
Dare Bioscience, Inc.
BEARISH
-91
RASP
—
Actavia Life Sciences, Inc.
BEARISH
-91
LIMN
—
Liminatus Pharma, Inc. Class A Common Stock
BEARISH
-91
NAVBQ
—
Navidea Biopharmaceuticals, Inc.
BEARISH
-91
SUVZ
—
Suvanza Pharma, LLC
BEARISH
-91
HCWB
—
HCW Biologics Inc.
BEARISH
-91
KAPA
—
Kairos Pharma, Ltd.
BEARISH
-91
GOVX
—
GeoVax Labs, Inc.
BEARISH
-91
VBIO
—
Valion Bio, Inc.
BEARISH
-91
TNGNQ
—
Tengion, Inc.
BEARISH
-91
CELZ
—
Creative Medical Technology Holdings, Inc.
BEARISH
-91
ENDV
—
Endonovo Therapeutics, Inc.
BEARISH
-91
VPRO
—
Viropro Inc.
BEARISH
-91
ZVSA
—
ZyVersa Therapeutics, Inc.
BEARISH
-91
EVFM
—
Evofem Biosciences, Inc.
BEARISH
-91
NBRVF
—
Nabriva Therapeutics plc
BEARISH
-91
KALA
—
KALA BIO, Inc.
BEARISH
-91
WSNAF
—
Wesana Health Holdings Inc.
BEARISH
-91
BNIGF
—
Beroni Group Limited
BEARISH
-91
SILO
—
Silo Pharma, Inc.
BEARISH
-91
ENLV
—
Enlivex Therapeutics Ltd.
BEARISH
-91
EVGN
—
Evogene Ltd.
BEARISH
-91
XENO
—
Xeno Transplants Corporation
BEARISH
-91
ZHCLF
—
Zenith Capital Corp.
BEARISH
-91
PMCB
—
PharmaCyte Biotech, Inc.
BEARISH
-91
MLECW
—
Moolec Science S.A.
BEARISH
-91
GENSF
$1.8B
Genus plc
BEARISH
-100
MLYS
$1.8B
Mineralys Therapeutics, Inc.
BEARISH
-100
OCUL
$1.4B
Ocular Therapeutix, Inc.
BEARISH
-100
GPCR
$1.2B
Structure Therapeutics Inc.
BEARISH
-100
SVRA
$870M
Savara Inc.
BEARISH
-100
IVEVF
$750M
Inventiva S.A.
BEARISH
-100
ATTO
$630M
Attovia Therapeutics, Inc.
BEARISH
-100
PROK
$470M
ProKidney Corp.
BEARISH
-100
PHAT
$460M
Phathom Pharmaceuticals, Inc.
BEARISH
-100
FTH
$440M
Faeth Therapeutics, Inc.
BEARISH
-100
RGNX
$440M
REGENXBIO Inc.
BEARISH
-100
ALLO
$430M
Allogene Therapeutics, Inc.
BEARISH
-100
ALT
$410M
Altimmune, Inc.
BEARISH
-100
ASMB
$400M
Assembly Biosciences, Inc.
BEARISH
-100
TECX
$390M
Tectonic Therapeutic, Inc.
BEARISH
-100
AVTX
$370M
Avalo Therapeutics, Inc.
BEARISH
-100
CAPR
$340M
Capricor Therapeutics, Inc.
BEARISH
-100
KYTX
$330M
Kyverna Therapeutics, Inc.
BEARISH
-100
FULC
$280M
Fulcrum Therapeutics, Inc.
BEARISH
-100
CTNM
$270M
Contineum Therapeutics, Inc.
BEARISH
-100
ACIU
$250M
AC Immune S.A.
BEARISH
-100
ABEO
$250M
Abeona Therapeutics Inc.
BEARISH
-100
CABA
$250M
Cabaletta Bio, Inc.
BEARISH
-100
SCTX
$250M
Scribe Therapeutics Inc.
BEARISH
-100
OCGN
$250M
Ocugen, Inc.
BEARISH
-100
PALI
$230M
Palisade Bio, Inc.
BEARISH
-100
NAGE
$190M
Niagen Bioscience Inc
BEARISH
-100
IVVD
$180M
Invivyd, Inc.
BEARISH
-100
SION
$160M
Sionna Therapeutics, Inc.
BEARISH
-100
UPB
$150M
Upstream Bio, Inc.
BEARISH
-100
STRO
$150M
Sutro Biopharma, Inc.
BEARISH
-100
CNTN
$150M
Canton Strategic Holdings Inc
BEARISH
-100
CMPX
$140M
Compass Therapeutics, Inc.
BEARISH
-100
VYGR
$110M
Voyager Therapeutics, Inc.
BEARISH
-100
NERV
$110M
Minerva Neurosciences, Inc.
BEARISH
-100
VTVT
$100M
vTv Therapeutics Inc.
BEARISH
-100
CLLS
$100M
Cellectis S.A.
BEARISH
-100
ENGN
$100M
enGene Holdings Inc.
BEARISH
-100
GNLX
$90M
Genelux Corporation
BEARISH
-100
CRDF
$70M
Cardiff Oncology, Inc.
BEARISH
-100
PTHS
$70M
Pelthos Therapeutics Inc.
BEARISH
-100
VRCA
$60M
Verrica Pharmaceuticals Inc.
BEARISH
-100
XBIT
$60M
XBiotech Inc.
BEARISH
-100
IBIO
$50M
iBio, Inc.
BEARISH
-100
RNTX
$50M
Rein Therapeutics Inc.
BEARISH
-100
EXOZ
$40M
eXoZymes, Inc.
BEARISH
-100
VERU
$40M
Veru Inc.
BEARISH
-100
ANVS
$40M
Annovis Bio, Inc.
BEARISH
-100
KLRS
$40M
Kalaris Therapeutics Inc
BEARISH
-100
ACET
$40M
Adicet Bio, Inc.
BEARISH
-100
TIL
$40M
Instil Bio, Inc.
BEARISH
-100
MREO
$40M
Mereo BioPharma Group plc
BEARISH
-100
ALGS
$30M
Aligos Therapeutics, Inc.
BEARISH
-100
EDSA
$30M
Edesa Biotech, Inc.
BEARISH
-100
AARD
$30M
Aardvark Therapeutics, Inc. Common Stock
BEARISH
-100
BSEM
$30M
BioStem Technologies, Inc.
BEARISH
-100
NRXBF
$30M
NurExone Biologic Inc.
BEARISH
-100
EYPT
$30M
EyePoint Pharmaceuticals, Inc.
BEARISH
-100
BCTX
$30M
BriaCell Therapeutics Corp.
BEARISH
-100
MGX
$30M
Metagenomi, Inc. Common Stock
BEARISH
-100
GRCE
$30M
Grace Therapeutics, Inc.
BEARISH
-100
BXPHF
$20M
Botanix Pharmaceuticals Limited
BEARISH
-100
KYNB
$20M
Kyntra Bio, Inc.
BEARISH
-100
MVMDF
$20M
More Life Company Corp.
BEARISH
-100
MSLE
$10M
Satellos Bioscience Inc.
BEARISH
-100
FBLG
$10M
FibroBiologics, Inc. Common Stock
BEARISH
-100
INAB
$10M
IN8bio, Inc.
BEARISH
-100
APRE
$10M
Aprea Therapeutics, Inc.
BEARISH
-100
PTN
$10M
Palatin Technologies, Inc.
BEARISH
-100
AIMD
$10M
Ainos, Inc.
BEARISH
-100
TRAW
$10M
Traws Pharma, Inc.
BEARISH
-100
BCDA
$10M
BioCardia, Inc.
BEARISH
-100
ACXP
$10M
Acurx Pharmaceuticals, Inc.
BEARISH
-100
BLRX
$10M
BioLineRx Ltd.
BEARISH
-100
MTVA
$10M
MetaVia Inc.
BEARISH
-100
TVRD
$10M
Tvardi Therapeutics, Inc.
BEARISH
-100
GTBP
$10M
GT Biopharma, Inc.
BEARISH
-100
PHIO
$10M
Phio Pharmaceuticals Corp.
BEARISH
-100
RVPH
$10M
Reviva Pharmaceuticals Holdings, Inc.
BEARISH
-100
CODX
—
Co-Diagnostics, Inc.
BEARISH
-100
FAMDF
—
Futura Medical plc
BEARISH
-100
PPBT
—
Purple Biotech Ltd.
BEARISH
-100
GNPX
—
Genprex, Inc.
BEARISH
-100
OGEN
—
Oragenics, Inc.
BEARISH
-100
LABT
—
Lakewood-Amedex Biotherapeutics, Inc.
BEARISH
-100
MBAI
—
MBody AI Ltd.
BEARISH
-100
DCOY
—
Decoy Therapeutics Inc.
BEARISH
-100
NSHSF
—
NanoSphere Health Sciences Inc.
BEARISH
-100
ELAB
—
PMGC Holdings Inc.
BEARISH
-100
VRXAW
—
Veraxa Biotech AG
BEARISH
-100
CLDI
—
Calidi Biotherapeutics, Inc.
BEARISH
-100
MBIO
—
Mustang Bio, Inc.
BEARISH
-100
SCPX
—
Scorpius Holdings, Inc.
BEARISH
-100
MDCX
—
Medicus Pharma Ltd. Common Stock
BEARISH
-100
NRSN
—
NeuroSense Therapeutics Ltd.
BEARISH
-100
ZLDAF
—
Zelira Therapeutics Limited
BEARISH
-100
CANF
—
Can-Fite BioPharma Ltd.
BEARISH
-100
CRIS
—
Curis, Inc.
BEARISH
-100
NIKI
—
Niki BioSolutions, Inc.
BEARISH
-100
OXBOF
—
Oxford BioDynamics Plc
BEARISH
-100
XSNX
—
NovAccess Global Inc.
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| INMB INmune Bio, Inc. | $40M | -2.2 | -74.8 | -475.4 | — | -100.0 | 2 | BEARISH | -20.1 |
| SGP SpyGlass Pharma, Inc. Common Stock | $950M | — | — | — | — | — | — | BULLISH | — |
| VSTM Verastem, Inc. | $910M | -4.1 | -471.2 | 6197.3 | -86.5 | 3995.7 | 4 | BULLISH | 28.0 |
| SOLTF Nxera Pharma Co., Ltd. | $770M | -15.8 | -12.0 | -1.7 | -2.6 | 7.5 | 4 | BULLISH | 41.9 |
| GRDX GridAI Technologies Corp. | $40M | -1.4 | -55.6 | -51.7 | -14927.4 | 67.4 | 2 | BULLISH | 27.3 |
| ENTX Entera Bio Ltd. | $510M | -8.8 | -138.9 | 314.4 | — | -100.0 | 1 | BULLISH | 33.6 |
| ATNM Actinium Pharmaceuticals, Inc. | $50M | 4.0 | 45.9 | -197.8 | 79.7 | — | 3 | BULLISH | -2.1 |
| XFOR X4 Pharmaceuticals, Inc. | $320M | -2.7 | -113.1 | -281.1 | -183.5 | -51.6 | 4 | BULLISH | 5.2 |
| ESLA Estrella Immunopharma, Inc. | $40M | -3.8 | 148.1 | 102.1 | — | — | 3 | BULLISH | -60.6 |
| KRRO Korro Bio, Inc. | $180M | -1.3 | -97.7 | -196.6 | — | -62.1 | 2 | BULLISH | -68.0 |
| HURA TuHURA Biosciences, Inc. | $140M | -3.8 | -161.4 | -137.6 | — | — | 2 | BULLISH | -8.5 |
| ZIVO ZIVO Bioscience, Inc. | $20M | -4.5 | 185.9 | 147.5 | — | -62.5 | 2 | BULLISH | -53.1 |
| RIGL Rigel Pharmaceuticals, Inc. | $900M | 2.8 | 126.9 | 88.5 | 22.0 | 3.3 | 4 | BULLISH | 69.9 |
| CING Cingulate Inc. | $70M | -1.1 | -198.7 | -1452.8 | — | — | 4 | BULLISH | 44.7 |
| AGTX Agentix Corp. | — | -5.1 | 12.0 | 8.1 | — | — | 3 | BULLISH | 6.9 |
| ACUT Accustem Sciences Inc. | — | -1.4 | 49.7 | 34.0 | -256.7 | 2610.7 | 4 | BULLISH | -87.3 |
| XNCR Xencor, Inc. | $1.9B | -13.7 | -29.1 | -152.4 | -42.4 | -36.1 | 2 | BULLISH | 136.5 |
| KLRA Kailera Therapeutics, Inc. | $1.7B | — | — | — | — | — | — | BULLISH | — |
| TRAX First Tracks Biotherapeutics Inc | $1.6B | — | — | — | — | — | — | BULLISH | — |
| LBRX LB Pharmaceuticals Inc Common Stock | $1.2B | -13.4 | -25.8 | -768.9 | — | — | 2 | BULLISH | 148.4 |
| SLN Silence Therapeutics plc | $930M | -5.2 | -90.4 | 157.8 | — | -97.6 | 1 | BULLISH | 172.8 |
| PBYI Puma Biotechnology, Inc. | $570M | 20.3 | 22.0 | 52.8 | 14.5 | -2.9 | 6 | BULLISH | 115.3 |
| MXCT MaxCyte, Inc. | $140M | -4.7 | -20.4 | -38.9 | -122.0 | -13.2 | 2 | BULLISH | -6.8 |
| IRLA IRulya Therapeutics Inc. | $30M | — | — | — | — | — | — | BULLISH | — |
| MBXBF Microbix Biosystems Inc. | $30M | -8.6 | -16.4 | -14.6 | -19.9 | -27.1 | 3 | BULLISH | 29.9 |
| BOLT Bolt Biotherapeutics, Inc. | $10M | -0.4 | -111.6 | -138.8 | -154400.0 | 12.8 | 3 | BULLISH | 14.4 |
| AZTR Azitra, Inc. | — | -0.1 | -256.7 | -959.6 | — | — | 5 | BULLISH | 118.9 |
| BDRX Biodexa Pharmaceuticals Plc | — | -0.1 | -42.3 | -117.9 | — | — | 2 | BULLISH | -89.2 |
| CBDG THC Farmaceuticals, Inc. | — | -30.9 | 2.0 | -0.9 | — | 28.1 | 5 | BULLISH | -60.2 |
| PHAR Pharming Group N.V. | $710M | 81.8 | 3.6 | 3.2 | 1.8 | 7.8 | 7 | BULLISH | -19.6 |
| INDP Indaptus Therapeutics, Inc. | $360M | -0.5 | -318.0 | 6437.4 | — | — | 4 | BULLISH | -5.9 |
| ANIX Anixa Biosciences, Inc. | $100M | -10.7 | -67.1 | -1110.2 | — | — | 3 | BULLISH | -29.9 |
| NRXS NeurAxis, Inc. | $90M | -9.6 | -143.2 | 464.1 | -118.1 | 65.2 | 6 | BULLISH | 89.8 |
| OABIW OmniAb, Inc. | $1.1B | -13.8 | -16.9 | -16.8 | -43.7 | 66.9 | 6 | BULLISH | -42.2 |
| DMAC DiaMedica Therapeutics Inc. | $470M | -11.9 | -114.6 | 616.3 | — | — | 2 | BULLISH | 29.3 |
| SCNLF Scancell Holdings plc | $170M | -5.1 | 153.2 | 179.2 | — | -100.0 | 2 | BULLISH | 969.8 |
| ICCC ImmuCell Corporation | $90M | 124.9 | 2.6 | 10.2 | 25.5 | 8.5 | 6 | BULLISH | 69.0 |
| SPTX Seaport Therapeutics, Inc. Common Stock | $1.1B | — | — | — | — | — | — | BULLISH | — |
| CASBF CanSino Biologics Inc. | $1.4B | 367.7 | 0.8 | -1.2 | 11.0 | 32.5 | 7 | BULLISH | -25.5 |
| BRVE Braveheart Bio, Inc. | $1.5B | — | — | — | — | — | — | BULLISH | — |
| TXTM ProText Mobility, Inc. | $90M | 90.0 | -0.4 | -0.3 | — | -100.0 | 1 | BULLISH | 377.3 |
| IMNN Imunon, Inc. | $10M | -0.2 | -429.7 | -226.7 | — | — | 2 | BULLISH | -75.0 |
| HALB Halberd Corporation | — | -25.4 | 11.6 | 12.4 | — | -52.1 | 1 | BULLISH | -13.9 |
| SEPN Septerna Inc | $1.9B | -81.5 | -6.3 | -93.1 | -48.7 | 17878.5 | 5 | BULLISH | 89.9 |
| MAZE Maze Therapeutics, Inc. | $1.7B | -11.4 | -37.3 | -112.3 | — | — | 3 | BULLISH | 3.9 |
| COAG Hemab Therapeutics Holdings, Inc. Common Stock | $1.6B | — | — | — | — | — | — | BULLISH | — |
| CRMD CorMedix Inc. | $610M | 3.3 | 54.9 | 57.2 | 25.5 | 280.5 | 5 | BULLISH | -29.8 |
| PYPD PolyPid Ltd. | $110M | -3.9 | -1913.8 | 231.6 | — | — | 3 | BULLISH | 53.8 |
| ADCT ADC Therapeutics S.A. | $180M | -2.4 | 45.3 | 260.9 | -86.1 | 2.0 | 2 | BULLISH | -62.9 |
| NYMXF Nymox Pharmaceutical Corporation | $10M | -0.9 | 193.9 | 89.4 | — | — | 2 | BULLISH | -62.8 |
| PRME Prime Medicine, Inc. | $670M | -4.0 | -373.3 | -271.3 | -3649.0 | -17.9 | 3 | BULLISH | -32.9 |
| NAUT Nautilus Biotechnolgy, Inc. | $410M | -6.5 | -41.0 | -89.2 | -6682.1 | — | 2 | BULLISH | 68.3 |
| TCRT Alaunos Therapeutics, Inc. | $10M | -1.1 | -185.9 | -607.2 | — | -50.0 | 1 | BULLISH | -21.4 |
| RARE Ultragenyx Pharmaceutical Inc. | $1.5B | -2.9 | 839.4 | -67.5 | -43.0 | 17.5 | 2 | BULLISH | -52.2 |
| IUGNF Imugene Limited | $30M | -0.1 | -389.5 | -458.5 | — | -100.0 | 1 | BULLISH | -74.4 |
| PCSA Processa Pharmaceuticals, Inc. | $10M | -0.3 | -464.2 | 1977.5 | — | — | 2 | BULLISH | -76.5 |
| HEPA Hepion Pharmaceuticals, Inc. | — | -0.5 | -125.6 | 710.2 | — | — | 3 | BULLISH | 92.9 |
| IMCR Immunocore Holdings plc | $1.6B | -176.2 | -2.3 | -472.0 | -0.7 | 13.4 | 4 | BULLISH | -1.0 |
| XERS Xeris Biopharma Holdings, Inc. | $1.9B | -107.0 | 118.2 | 18.3 | -33.8 | 36.3 | 6 | BULLISH | 11.8 |
| VSBC VitaSpring Biomedical Co. Ltd. | $10M | -13.8 | 10.3 | 15.9 | — | -100.0 | 4 | BULLISH | -96.8 |
| IPIX Innovation Pharmaceuticals Inc. | — | -0.2 | -115.7 | -377.9 | — | -133.3 | 3 | BULLISH | -22.2 |
| IMUC EOM Pharmaceuticals Holdings, Inc. | $10M | -4.9 | 64.4 | 131.0 | — | — | 4 | BULLISH | 20.6 |
| NBTX Nanobiotix S.A. | $1.5B | -27.5 | 104.2 | 62.0 | -626.0 | 49.1 | 4 | BULLISH | 63.5 |
| CKDXF Ceryvyn Therapeutics Ltd | $10M | 0.1 | -243.9 | 2882.8 | — | -97.3 | 3 | BULLISH | -97.6 |
| ZEOX Zeo ScientifiX, Inc. | $10M | -2.0 | -140.0 | 105.8 | -5.6 | — | 2 | BULLISH | — |
| CYYNF Cynata Therapeutics Limited | — | -0.3 | -326.4 | 584.9 | — | -100.0 | 1 | BULLISH | -93.9 |
| DMRA Damora Therapeutics, Inc. | $1.3B | — | — | — | — | — | — | BULLISH | — |
| VIR Vir Biotechnology, Inc. | $1.8B | -6.2 | -26.1 | -38.8 | 33.5 | 1495.9 | 5 | BULLISH | 91.0 |
| SLGL Sol-Gel Technologies Ltd. | $230M | -12.4 | -35.9 | -228.0 | 36.4 | 282.9 | 3 | BULLISH | 74.5 |
| CYDY CytoDyn Inc. | $380M | -4.9 | 57.8 | 24.6 | — | 100.0 | 4 | BULLISH | -5.6 |
| PDSB PDS Biotechnology Corporation | $60M | -2.1 | -544.0 | 456.9 | — | — | 1 | BULLISH | 16.3 |
| ABOS Acumen Pharmaceuticals, Inc. | $140M | -1.5 | -162.7 | 466.8 | — | — | 2 | LEAN BULL | 7.6 |
| HOWL Werewolf Therapeutics, Inc. | $50M | -1.4 | -119.9 | 354.7 | 17.5 | — | 4 | LEAN BULL | -37.5 |
| ATOS Atossa Therapeutics, Inc. | $30M | -0.6 | -89.2 | -4213.1 | — | — | 2 | LEAN BULL | -82.2 |
| ARDS Aridis Pharmaceuticals, Inc. | — | -0.0 | 4.8 | 10.0 | -19.9 | 2227.6 | 4 | LEAN BULL | -92.3 |
| INFIQ Infinity Pharmaceuticals, Inc. | — | -0.0 | 109.5 | 60.9 | -1707.7 | — | 2 | LEAN BULL | 0.0 |
| PPCB Propanc Biopharma, Inc. | — | -0.1 | -161.9 | -166.7 | — | — | 4 | LEAN BULL | 54.7 |
| BSSP Baseline Productions, Inc. | — | -0.0 | 167.7 | 64.9 | — | — | 2 | LEAN BULL | 100.0 |
| PTCHF PureTech Health plc | $390M | 157.1 | 0.2 | 50.8 | 1890.6 | 7.7 | 4 | LEAN BULL | -5.4 |
| ACHFF Arch Biopartners Inc. | $40M | -20.0 | 73.5 | 165.4 | — | 100.0 | 2 | LEAN BULL | -10.0 |
| PRVCF PreveCeutical Medical Inc. | $10M | -16.7 | 9.9 | 96.4 | — | — | 3 | LEAN BULL | -44.7 |
| SGMT Sagimet Biosciences Inc. | $310M | -8.2 | -24.4 | -231.4 | — | — | 3 | LEAN BULL | 30.4 |
| ABPO Abpro Holdings, Inc. | — | — | — | — | — | — | — | LEAN BULL | — |
| MLTX MoonLake Immunotherapeutics | $1.0B | -3.1 | -67.4 | 2902.7 | — | — | 1 | LEAN BULL | 24.8 |
| NTRR Neutra Corp. | — | 2.0 | -139.6 | -802.5 | -3.8 | 142.2 | 7 | LEAN BULL | -33.3 |
| PXMD PaxMedica, Inc. Common Stock | — | -0.0 | -7716.2 | 572.1 | — | — | 2 | LEAN BULL | 600.0 |
| BTAX Biostax Corp. | — | -0.0 | 7.3 | 5.8 | — | — | 2 | LEAN BULL | 100.0 |
| LYRA Lyra Therapeutics, Inc. | — | -0.0 | -6595.0 | -671.6 | -99300.0 | -74.1 | 4 | LEAN BULL | -97.7 |
| REVB Revelation Biosciences, Inc. | — | -0.1 | -154.8 | 1317.2 | — | — | 4 | LEAN BULL | 195.0 |
| NNVC NanoViricides, Inc. | $40M | -3.6 | -101.5 | -111.4 | — | — | 3 | LEAN BULL | -4.9 |
| HSTC HST Global, Inc. | $210M | -538.5 | -2.5 | -1.2 | -13.7 | 564.0 | 5 | LEAN BULL | 349900.0 |
| EVAX Evaxion Biotech A/S | $20M | -0.5 | -109.8 | -260.4 | — | 135.9 | 6 | LEAN BULL | -45.1 |
| OCEA Ocean Biomedical, Inc. | — | -0.0 | 36.5 | 0.3 | — | — | 1 | LEAN BULL | -20.0 |
| RXRX Recursion Pharmaceuticals, Inc. | $2.0B | -3.9 | -56.6 | -99.7 | -1708.0 | -14.9 | 4 | LEAN BULL | -33.7 |
| ENSC Ensysce Biosciences, Inc. | $10M | -0.2 | -968.3 | 792.9 | -220.8 | -77.6 | 3 | LEAN BULL | -78.7 |
| LCTX Lineage Cell Therapeutics, Inc. | $250M | -7.3 | -59.0 | -171.3 | 138.6 | 19.9 | 5 | LEAN BULL | -38.7 |
| GDTC CytoMed Therapeutics Limited | $10M | -2.5 | -66.1 | -87.8 | -1125.6 | -11.3 | 0 | LEAN BULL | -61.9 |
| OKYO OKYO Pharma Limited | $70M | -6.1 | -263.8 | 88.0 | — | — | 3 | LEAN BULL | -35.7 |
| MBRX Moleculin Biotech, Inc. | $10M | -0.0 | -1371.6 | -494.1 | — | — | 3 | LEAN BULL | -43.1 |
| DNAG DNAPrint Genomics, Inc. | — | -0.0 | 63.1 | -156.0 | -826.7 | -15.2 | 3 | LEAN BULL | 100.0 |
| RBSH Rebus Holdings, Inc. | — | -0.0 | -9.7 | 8.9 | — | — | 2 | LEAN BULL | 0.0 |
| OBX Obsidian Therapeutics Inc. | $10M | — | — | — | — | — | — | NEUTRAL | — |
| STAB Statera Biopharma, Inc. | — | -0.0 | -298.8 | 2085.4 | -769.5 | 1459.1 | 3 | NEUTRAL | -50.0 |
| LYEL Lyell Immunopharma, Inc. | $230M | -0.6 | -93.3 | -227.7 | -1118875.0 | -55.0 | 3 | NEUTRAL | -49.2 |
| PRLD Prelude Therapeutics Incorporated | $210M | -4.9 | -57.7 | 14236.3 | -244.1 | 220.3 | 5 | NEUTRAL | 146.7 |
| NMAD NOMAD Power Solutions, Inc. | $50M | — | — | — | — | — | — | NEUTRAL | — |
| CNBX CNBX Pharmaceuticals Inc. | — | -1.0 | 17.8 | 13.3 | — | 100.0 | 3 | NEUTRAL | -50.0 |
| CALC CalciMedica, Inc. | — | -0.2 | -365.7 | 118.3 | — | — | 4 | NEUTRAL | -91.5 |
| NWBO Northwest Biotherapeutics, Inc. | $260M | -6.7 | 55.8 | -188.7 | -1142.6 | 98.6 | 3 | NEUTRAL | -16.3 |
| MLLCF Molecular Partners AG | $150M | -2.3 | -62.1 | 650.3 | — | -100.0 | 2 | NEUTRAL | 14.6 |
| EHOS Ehouse Global, Inc. | — | -0.0 | 161.0 | 52.5 | — | — | 1 | NEUTRAL | 0.0 |
| HESG Health Sciences Group, Inc. | — | -0.0 | 69.4 | 44.6 | -19219.1 | 101.6 | 3 | NEUTRAL | 900.0 |
| REPL Replimune Group, Inc. | $1.1B | -4.2 | -134.3 | -1055.2 | — | — | 1 | NEUTRAL | 48.1 |
| RGIN Regenicin, Inc. | — | -0.0 | 16.9 | 4.1 | — | — | 4 | NEUTRAL | 0.0 |
| RCAR RenovaCare, Inc. | — | -0.0 | -436.6 | 812.3 | — | — | 2 | NEUTRAL | 9900.0 |
| NMTRQ 9 Meters Biopharma, Inc. | — | — | — | — | — | — | — | NEUTRAL | 900.0 |
| CFRXQ ContraFect Corp. | — | -0.0 | 544.7 | 276.9 | — | — | 1 | NEUTRAL | -90.0 |
| LYCA Lycia Therapeutics Inc. | $1.6B | — | — | — | — | — | — | N/A | — |
| CTY City Therapeutics Inc. | $200M | — | — | — | — | — | — | N/A | — |
| IAM Iambic Therapeutics Inc. | $130M | — | — | — | — | — | — | N/A | — |
| LONA LeonaBio, Inc. | $20M | — | — | — | — | — | — | NEUTRAL | — |
| JUNS Jupiter Neurosciences, Inc. | — | -0.1 | -1888.7 | 5586.0 | -9380.9 | — | 3 | NEUTRAL | -97.4 |
| PHMMF Pharma Mar, S.A. | $1.6B | 21.2 | 24.9 | 35.9 | -2.0 | 15.5 | 7 | NEUTRAL | 1.7 |
| SRZN Surrozen, Inc. | $190M | -0.7 | 387.2 | 11.1 | 1003.5 | -8.8 | 2 | NEUTRAL | 99.0 |
| KLDO Kaleido Biosciences, Inc. | — | -0.0 | -591.2 | 1121.9 | -4292.5 | 13.2 | 2 | NEUTRAL | -80.0 |
| YARW Yarrow Bioscience Inc | $180M | — | — | — | — | — | — | NEUTRAL | — |
| ELUT Elutia Inc | $40M | 0.6 | -397.0 | -290.2 | -315.0 | -48.8 | 6 | NEUTRAL | -11.9 |
| GSTC GlobeStar Therapeutics Corporation | — | -0.0 | 60.9 | 49.1 | — | — | 4 | NEUTRAL | 9900.0 |
| BPTH Bio-Path Holdings, Inc. | — | -0.0 | 49.0 | 15.2 | — | -100.0 | 1 | NEUTRAL | -99.6 |
| ABVC ABVC BioPharma, Inc. | $30M | -3.6 | -82.2 | -43.0 | — | -100.0 | 2 | NEUTRAL | -64.0 |
| USRM U.S. Stem Cell, Inc. | — | -0.0 | 20.8 | 23.4 | -2836.8 | -59.1 | 5 | NEUTRAL | 100.0 |
| VCRE Vicore Pharma Holding AB | $260M | — | — | — | — | — | — | NEUTRAL | — |
| KROS Keros Therapeutics, Inc. | $220M | -3.1 | -17.2 | -392.2 | — | -93.6 | 3 | NEUTRAL | -23.9 |
| ENGNW enGene Holdings Inc. Warrants | $10M | -5.6 | -2.3 | 134.1 | — | -100.0 | 2 | NEUTRAL | -64.6 |
| PULM Pulmatrix, Inc. | $10M | -1.3 | -98.3 | -835.1 | — | -100.0 | 3 | NEUTRAL | -70.3 |
| ANAB AnaptysBio, Inc. | $1.5B | 7.3 | -1146.3 | 466.0 | 668.9 | 92.9 | 5 | NEUTRAL | 115.1 |
| MRPI Mera Pharmaceuticals, Inc. | — | -10000.0 | 24.3 | 18.3 | -159.9 | 4.8 | 5 | NEUTRAL | 0.0 |
| KNBIF Kane Biotech Inc. | — | -2.4 | 439.7 | -2166.6 | -10238.1 | -97.9 | 2 | NEUTRAL | -37.9 |
| LIANY LianMedical | — | 1.1 | 74.7 | -612.1 | — | — | 6 | NEUTRAL | -15.0 |
| ODTX Odyssey Therapeutics, Inc. | $940M | — | — | — | — | — | — | LEAN BEAR | — |
| INRLF Valneva SE | $640M | -2.8 | -118.0 | -54.8 | -89.3 | -27.2 | 1 | LEAN BEAR | -25.4 |
| POLBF Poolbeg Pharma PLC | $70M | -8.5 | -58.8 | -255.9 | — | — | 1 | LEAN BEAR | 125.4 |
| CLYYF Celyad Oncology S.A. | $10M | 2.5 | -11.7 | -979.7 | 64360.6 | -88.7 | 5 | LEAN BEAR | -31.7 |
| PLUR Pluri Inc. | $10M | -0.5 | 163.6 | -483.9 | -1755.2 | -24.0 | 2 | LEAN BEAR | -73.2 |
| GBIM GlobeImmune, Inc. | — | -0.0 | -66.2 | 25.0 | -91.5 | 55.1 | 4 | LEAN BEAR | 0.0 |
| INVA Innoviva, Inc. | $1.5B | 4.3 | 36.7 | 15.0 | -69.8 | 19.8 | 7 | LEAN BEAR | 15.3 |
| MDNAF Medicenna Therapeutics Corp. | $20M | — | — | — | — | — | — | LEAN BEAR | — |
| ONCSQ OncoSec Medical Incorporated | — | -0.0 | -410.2 | 452.1 | — | — | 2 | LEAN BEAR | -90.0 |
| BIXT Bioxytran, Inc. | — | -0.7 | 92.2 | 68.7 | — | — | 4 | LEAN BEAR | -64.9 |
| NKGN NKGen Biotech, Inc. | — | -0.0 | 150.9 | — | -4511.3 | — | 3 | LEAN BEAR | -47.5 |
| HLSQ Tessera Defense and Homeland Security Inc | — | — | — | — | — | — | — | LEAN BEAR | — |
| EMMA Emmaus Life Sciences, Inc. | — | -0.4 | 9.9 | -9.3 | 21.2 | 11.0 | 4 | LEAN BEAR | 351.0 |
| REPCF RepliCel Life Sciences Inc. | — | -9.4 | -248.8 | -13.9 | -80.9 | 200.0 | 6 | LEAN BEAR | 0.0 |
| MCET MultiCell Technologies, Inc. | — | -0.1 | 101.2 | 99.1 | -81.8 | 1532.7 | 5 | LEAN BEAR | 900.0 |
| CMND Clearmind Medicine Inc. | — | -0.1 | -104.0 | 593.4 | — | — | 2 | LEAN BEAR | -99.8 |
| NURPF Neuren Pharmaceuticals Limited | $1.8B | 118.1 | 6.2 | 22.4 | 14.6 | -68.5 | 5 | LEAN BEAR | 20.8 |
| DTIL Precision BioSciences, Inc. | $180M | -2.4 | -135.1 | 203.1 | — | 3473.0 | 5 | LEAN BEAR | -7.5 |
| PEPG PepGen Inc. | $170M | -1.7 | -75.5 | -327.5 | — | — | 4 | LEAN BEAR | -44.7 |
| MMIRF MedMira Inc. | $30M | -11.4 | 11.8 | 21.7 | -200.5 | 45.7 | 4 | LEAN BEAR | -20.4 |
| JBIO Jade Biosciences, Inc. | $930M | -5.4 | -47.8 | 629.9 | — | — | 3 | LEAN BEAR | 46.0 |
| ACRS Aclaris Therapeutics, Inc. | $550M | -6.6 | -59.1 | -206.5 | -1320.1 | -51.0 | 3 | LEAN BEAR | 67.7 |
| PARD Poniard Pharmaceuticals, Inc. | — | -0.0 | -210.4 | -442.5 | — | — | 3 | LEAN BEAR | 0.0 |
| KRSA Korsana Biosciences, Inc. | $150M | — | — | — | — | — | — | LEAN BEAR | — |
| AOBI American Oriental Bioengineering, Inc. | — | -0.0 | -28.2 | -16.5 | -118.1 | -10.2 | 3 | LEAN BEAR | 1081.8 |
| TYRA Tyra Biosciences, Inc. | $1.2B | -8.9 | -45.3 | -2390.9 | — | — | 2 | LEAN BEAR | 44.6 |
| IMMB Immunotech Laboratories, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 100.0 |
| FPMI FluoroPharma Medical, Inc. | — | -0.0 | 22.7 | 39.7 | — | — | 2 | LEAN BEAR | 100.0 |
| GBLX GB Sciences, Inc. | — | -0.0 | 19.5 | 17.2 | -103.2 | — | 3 | LEAN BEAR | -66.7 |
| ZBIO Zenas BioPharma, Inc. | $1.8B | -2.9 | -199.0 | 5842.1 | -11145.6 | -93.3 | 2 | LEAN BEAR | 8.9 |
| ENTA Enanta Pharmaceuticals, Inc. | $340M | -5.0 | -70.1 | 141.5 | -135.8 | 0.7 | 4 | LEAN BEAR | 12.5 |
| APLMW Apollomics, Inc. | $170M | -2.6 | -233.7 | 845.7 | 1188.0 | -75.9 | 3 | LEAN BEAR | -60.0 |
| ARMP Armata Pharmaceuticals, Inc. | $140M | -0.7 | 127.8 | -54.7 | 2953.8 | -35.1 | 2 | LEAN BEAR | -51.4 |
| NTHI Neonc Technologies Holdings, Inc. | $90M | — | — | — | — | — | — | LEAN BEAR | -66.2 |
| SRBCF Sirona Biochem Corp. | — | -0.7 | 111.4 | 1025.7 | -34808.5 | -119.4 | 2 | LEAN BEAR | -50.5 |
| PZRXQ PhaseRx, Inc. | — | -0.0 | -228.2 | 8803.4 | — | — | 2 | LEAN BEAR | 0.0 |
| RNAZ TransCode Therapeutics, Inc. | — | -0.0 | -59.2 | -21.0 | — | — | 1 | LEAN BEAR | -87.0 |
| NNBP Nanobac Pharmaceuticals, Incorporated | — | 0.0 | 358.0 | 221.2 | -26718.6 | -92.2 | 3 | LEAN BEAR | 0.0 |
| NNLX NanoLogix, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -20.0 |
| CLAZF Claritas Pharmaceuticals, Inc. | — | 0.0 | -170.1 | 15.9 | — | — | 3 | LEAN BEAR | 0.0 |
| IMVIF IMV Inc. | — | -0.2 | -503.3 | -2870.5 | — | — | 1 | LEAN BEAR | 1900.0 |
| PREDQ Predictive Discovery Limited | — | — | — | — | — | — | — | LEAN BEAR | — |
| FGHQF Frontage Holdings Corporation | $360M | 36.5 | 3.1 | 3.0 | 4.6 | 9.8 | 7 | LEAN BEAR | 16.8 |
| GWIN Glorywin Entertainment Group, Inc. | $360M | -26081.4 | 11.7 | 5.1 | — | — | 1 | LEAN BEAR | 229.5 |
| SPHRY Starpharma Holdings Limited | $220M | -26.0 | -46.5 | -441.4 | -725.1 | 186.8 | 4 | LEAN BEAR | 100.0 |
| KNTPF Kintor Pharmaceutical Limited | $120M | -2.9 | -116.6 | -74.4 | -145.6 | 2237.9 | 3 | LEAN BEAR | -10.2 |
| LVCLF Algorae Pharmaceuticals Limited | $20M | -5.4 | -47.4 | -24288.6 | — | -100.0 | 3 | LEAN BEAR | 51.6 |
| BCLI Brainstorm Cell Therapeutics Inc. | $10M | -0.8 | 119.2 | 76.7 | — | -100.0 | 1 | LEAN BEAR | 11.9 |
| QPTFF Quest PharmaTech Inc. | $10M | 1.6 | 3.9 | -1.7 | — | — | 4 | LEAN BEAR | 125.6 |
| FORU ForU Holdings, Inc. | — | -0.0 | 759.2 | -476.4 | — | -100.0 | 2 | LEAN BEAR | 100.0 |
| CHNXF ChitogenX Inc. | — | -0.2 | 23.2 | 36.2 | — | — | 2 | LEAN BEAR | 48.0 |
| CLGN CollPlant Biotechnologies Ltd. | — | -0.4 | -162.0 | -369.3 | -2524.1 | -86.8 | 2 | LEAN BEAR | -83.5 |
| VINC Vincerx Pharma, Inc. | — | -0.0 | -3136.4 | 910.2 | — | -18.7 | 5 | LEAN BEAR | -55.9 |
| ALEC Alector, Inc. | $200M | -1.9 | -385.1 | 66.8 | -692.5 | -82.9 | 1 | LEAN BEAR | 24.5 |
| RLYB Rallybio Corporation | $90M | 3.4 | 34.5 | -1198.7 | — | -35.6 | 6 | LEAN BEAR | 2640.0 |
| AEON AEON Biopharma, Inc. | $10M | -0.1 | 350.0 | 98.0 | — | — | 2 | LEAN BEAR | -73.6 |
| ATXI Avenue Therapeutics, Inc. | — | -0.5 | -120.0 | 178.4 | — | -100.0 | 2 | LEAN BEAR | -41.9 |
| STOK Stoke Therapeutics, Inc. | $1.6B | -7.8 | -61.1 | -318.5 | -660.8 | -86.2 | 2 | LEAN BEAR | -19.7 |
| CURX Curanex Pharmaceuticals Inc Common Stock | $10M | -0.6 | -218.7 | -392.2 | — | — | 1 | LEAN BEAR | -62.8 |
| ENZC Enzolytics Inc. | — | -11.2 | 105.9 | 1.4 | — | — | 7 | BEARISH | 66.7 |
| AVLN Avalyn Pharma Inc. Common Stock | $1.1B | — | — | — | — | — | — | BEARISH | — |
| DBVT DBV Technologies S.A. | $230M | -2.6 | -142.6 | -2201.5 | — | -100.0 | 2 | BEARISH | -32.8 |
| RNA Atrium Therapeutics, Inc. | $140M | -2.1 | -36.9 | 455.9 | -672.0 | 235.3 | 5 | BEARISH | -82.8 |
| PBIGF Paradigm Biopharmaceuticals Limited | $10M | -1.6 | -456.6 | 1081.8 | -60158.9 | 53.6 | 4 | BEARISH | -95.6 |
| PKTX ProtoKinetix, Incorporated | — | -1.0 | -117.2 | -115.0 | — | — | 2 | BEARISH | -95.6 |
| CARM Carisma Therapeutics, Inc. | — | 0.0 | -134.1 | -376.4 | 98.8 | 159.7 | 3 | BEARISH | -99.2 |
| TRVN Trevena, Inc. | — | -0.0 | 344.3 | -3198.4 | -1745.2 | -82.9 | 3 | BEARISH | -7.5 |
| DRUG Bright Minds Biosciences Inc. | $520M | -26.2 | -13.7 | -105758.3 | — | — | 3 | BEARISH | -17.0 |
| TRDA Entrada Therapeutics, Inc. | $170M | -1.1 | -54.1 | -236.6 | -4762.0 | -94.1 | 1 | BEARISH | -25.8 |
| BDTX Black Diamond Therapeutics, Inc. | $110M | -2.4 | -37.2 | -1604.9 | — | -100.0 | 1 | BEARISH | -56.4 |
| INNMF Amplia Therapeutics Limited | $30M | -4.7 | -24.9 | -86.9 | — | -100.0 | 2 | BEARISH | -45.0 |
| KPTI Karyopharm Therapeutics Inc. | $10M | -0.0 | 79.0 | 36.3 | -200.5 | 6.8 | 2 | BEARISH | -92.2 |
| AAGH America Great Health | — | 2.0 | -12.2 | 22.4 | -635.8 | -5.1 | 4 | BEARISH | 100.0 |
| BXRXQ Baudax Bio, Inc. | — | — | — | — | — | — | — | BEARISH | 900.0 |
| ADXN Addex Therapeutics Ltd | — | -0.4 | -150.5 | -168.4 | -17543.0 | -48.1 | 2 | BEARISH | -70.6 |
| ABSI Absci Corporation | $1.6B | -13.4 | -57.7 | -213.1 | -10443.4 | -62.3 | 5 | BEARISH | 120.8 |
| SNBIF SanBio Company Limited | $1.3B | -19.5 | -55.8 | -2935.2 | — | — | 3 | BEARISH | 0.0 |
| FATE Fate Therapeutics, Inc. | $250M | -2.0 | -60.7 | -140.1 | -1448.6 | -23.4 | 2 | BEARISH | 106.0 |
| DYAI Dyadic International, Inc. | $20M | -1.9 | 522.6 | 1288.0 | -221.0 | 1.5 | 3 | BEARISH | -64.8 |
| BIVI BioVie Inc. | $10M | -0.4 | -0.0 | -0.0 | — | — | 3 | BEARISH | -29.6 |
| LSTA Lisata Therapeutics, Inc. | $10M | -0.6 | -99.9 | 590.1 | — | -90.7 | 2 | BEARISH | -54.9 |
| XCUR Exicure, Inc. | $10M | -0.8 | -168.4 | 779.8 | — | — | 2 | BEARISH | -77.0 |
| VRCI Verde Science, Inc. | — | -0.0 | 72.3 | 23.0 | — | — | 5 | BEARISH | 100.0 |
| HLUN HEALTHeUNIVERSE, Inc. | — | — | — | — | — | — | — | BEARISH | 900.0 |
| SNNAQ Sienna Biopharmaceuticals, Inc. | — | -0.0 | -140.9 | -331.4 | — | — | 2 | BEARISH | 0.0 |
| NTII Neurobiological Technologies, Inc. | — | 0.0 | 48.7 | 441.6 | 89.7 | 99.7 | 4 | BEARISH | 0.0 |
| CMRA Comera Life Sciences Holdings, Inc. | — | -0.0 | 235.6 | 124.2 | -1580.0 | 81.8 | 4 | BEARISH | 0.0 |
| HAVLF HAVN Life Sciences Inc. | — | -0.0 | -275.3 | -163.4 | 5734.1 | 876.8 | 3 | BEARISH | 0.0 |
| GLSHQ Gelesis Holdings, Inc. | — | -0.0 | 391.0 | -233.6 | -693.9 | -45.8 | 3 | BEARISH | 0.0 |
| PSYBF PsyBio Therapeutics Corp | — | -0.0 | 344.6 | 135.0 | — | — | 2 | BEARISH | -90.0 |
| MRZM Marizyme, Inc. | — | -0.0 | 117.5 | -190.1 | — | -69.0 | 3 | BEARISH | 0.0 |
| TLOG TetraLogic Pharmaceuticals Corporation | — | -0.0 | 382.3 | 479.8 | — | — | 1 | BEARISH | 0.0 |
| NTLA Intellia Therapeutics, Inc. | $1.6B | -3.6 | -55.4 | -92.1 | -1392.3 | 12.6 | 5 | BEARISH | -56.5 |
| JANX Janux Therapeutics, Inc. | $1.0B | -10.4 | -10.7 | 516.9 | -214.0 | 7162.0 | 4 | BEARISH | -31.8 |
| BPMUF Basilea Pharmaceutica AG | $960M | 16.9 | 39.5 | 75.9 | 23.5 | 4.5 | 7 | BEARISH | 27.1 |
| BETRF BetterLife Pharma Inc. | $110M | -10.0 | 34.9 | 21.6 | — | — | 4 | BEARISH | 220.0 |
| SYGGF Synairgen plc | — | -0.2 | -71.9 | -381.4 | — | — | 1 | BEARISH | -50.0 |
| VAXX Vaxxinity, Inc. | — | -0.2 | -150.6 | 2534.7 | — | — | 0 | BEARISH | 0.0 |
| PVLA Palvella Therapeutics, Inc. | $1.8B | -27.4 | -46.6 | 137.5 | — | — | 3 | BEARISH | 77.0 |
| IFRX InflaRx N.V. | $230M | -3.0 | -38.5 | 251.5 | — | -106.2 | 4 | BEARISH | 29.5 |
| ATGGF Actinogen Medical Limited | $140M | -8.5 | -77.5 | -235.8 | — | -100.0 | 1 | BEARISH | 40.0 |
| SQZB SQZ Biotechnologies Company | — | -0.0 | -203.4 | -410.2 | — | -44.6 | 0 | BEARISH | 4.3 |
| MEOBF Mesoblast Limited | $2.0B | -29.4 | -9.9 | -14.4 | -23.4 | 613.8 | 5 | BEARISH | -9.0 |
| CLNN Clene Inc. | $60M | -1.1 | 237.2 | 132.5 | -14915.6 | -31.1 | 2 | BEARISH | -52.9 |
| CEROW CERo Therapeutics Holdings, Inc. | — | -0.0 | 101.5 | 60.5 | — | -100.0 | 1 | BEARISH | -75.2 |
| OCS Oculis Holding AG | $490M | -4.7 | -44.0 | -31.0 | — | -6.9 | 3 | BEARISH | -62.7 |
| ALXO ALX Oncology Holdings Inc. | $160M | -1.0 | -80.6 | -851.1 | — | — | 4 | BEARISH | -35.4 |
| FBIOP Fortress Biotech, Inc. | $130M | 0.6 | 107.5 | -87.8 | -2.5 | 15.5 | 6 | BEARISH | 140.0 |
| FHTX Foghorn Therapeutics Inc. | $120M | -2.0 | 81.9 | 26.3 | -44.7 | 52.0 | 4 | BEARISH | -47.4 |
| AURX Nuo Therapeutics, Inc. | $60M | -31.1 | 170.6 | 280.3 | -15.7 | 166.6 | 3 | BEARISH | -47.8 |
| VRPX Virpax Pharmaceuticals, Inc. | — | -0.0 | 2.6 | 0.4 | — | — | 1 | BEARISH | -92.7 |
| PBMWW Psyence Biomedical Ltd. Warrant | — | — | — | — | — | — | — | BEARISH | -49.9 |
| JAGX Jaguar Health, Inc. | — | -0.0 | -501.9 | -118.9 | -1035.3 | 135.5 | 4 | BEARISH | -99.8 |
| HTDS Hard to Treat Diseases Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CALA Calithera Biosciences, Inc. | — | -0.0 | -141.5 | 979.6 | — | -100.0 | 1 | BEARISH | 0.0 |
| KARD Kardigan, Inc. | $1.1B | — | — | — | — | — | — | BEARISH | — |
| PPTDF PeptiDream Inc. | $870M | -38.0 | -7.1 | -9.6 | -25.7 | 47.8 | 4 | BEARISH | -38.7 |
| EQ Equillium, Inc. | $80M | -5.2 | -59.0 | 2703.6 | — | -100.0 | 3 | BEARISH | -6.0 |
| LOBEF Lobe Sciences Ltd. | $10M | -2.7 | 359.0 | 181.6 | — | — | 2 | BEARISH | 0.7 |
| SNTI Senti Biosciences, Inc. | $10M | -0.1 | -466.5 | -430.9 | -75000.0 | — | 2 | BEARISH | -91.2 |
| SRPT Sarepta Therapeutics, Inc. | $1.9B | -13.0 | -9.5 | -6.3 | -1.2 | -20.4 | 4 | BEARISH | -17.9 |
| CSPHF CStone Pharmaceuticals | $1.4B | -14.4 | -51.4 | -340.2 | -123.0 | 135.6 | 5 | BEARISH | -15.4 |
| DRTSW Alpha Tau Medical Ltd. | $1.2B | -13.0 | -141.7 | -17.1 | — | — | 3 | BEARISH | 614.5 |
| OVID Ovid Therapeutics Inc. | $420M | -4.7 | -26.0 | -43.7 | -2047.6 | -76.2 | 3 | BEARISH | 37.8 |
| NGNE Neurogene Inc. | $370M | -4.9 | -45.3 | -111469.0 | — | — | 2 | BEARISH | -18.0 |
| DTCFF Defence Therapeutics Inc. | $20M | -3.8 | -237.8 | -86.8 | — | — | 4 | BEARISH | -52.8 |
| MRKR Marker Therapeutics, Inc. | $20M | -2.0 | -76.9 | -1014.3 | — | -77.1 | 2 | BEARISH | -8.9 |
| PROT Proteonomix, Inc. | — | -0.0 | 77.5 | -1239.4 | — | -63.1 | 4 | BEARISH | 0.0 |
| SIGY Sigyn Therapeutics, Inc. | — | -0.0 | 61.7 | 32.8 | — | -100.0 | 1 | BEARISH | -98.5 |
| BRAXF Braxia Scientific Corp. | — | -0.1 | -254.6 | -2393.3 | -184.2 | 27.6 | 3 | BEARISH | -99.9 |
| EFTR eFFECTOR Therapeutics, Inc. | — | -0.0 | 1737.6 | 607.9 | — | -91.9 | 4 | BEARISH | 0.0 |
| RNUGF ReNeuron Group plc | — | -0.0 | -106.8 | 210.1 | -1809.6 | -68.2 | 1 | BEARISH | 0.0 |
| PANC Panacos Pharmaceuticals, Inc. | — | -0.0 | -168.8 | -792.8 | -33966.7 | -45.9 | 1 | BEARISH | 0.0 |
| SYVC Synovics Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CDXI Cardax, Inc. | — | -0.0 | 81.1 | 38.5 | -1740.8 | -27.3 | 2 | BEARISH | 0.0 |
| PFND Pathfinder Cell Therapy, Inc. | — | -0.0 | 22.4 | 46.3 | — | — | 2 | BEARISH | 0.0 |
| NBIO Nascent Biotech, Inc. | — | -0.0 | 230.6 | 328.8 | — | — | 5 | BEARISH | -75.0 |
| ADYX Adynxx, Inc. | — | -0.0 | 1148.3 | 259.7 | — | -95.1 | 2 | BEARISH | 0.0 |
| LADX LadRx Corporation | — | -0.0 | 278.9 | 118.4 | — | -61.0 | 1 | BEARISH | -99.0 |
| RAPP Rapport Therapeutics, Inc. Common Stock | $1.2B | -9.1 | -40.0 | 3981.5 | — | — | 4 | BEARISH | -3.3 |
| CGEM Cullinan Therapeutics, Inc. | $880M | -4.4 | -50.3 | 1635.6 | — | — | 1 | BEARISH | 88.1 |
| VICP Vicapsys Life Sciences, Inc. | $10M | -20.5 | 31.3 | 17.6 | — | — | 5 | BEARISH | -77.4 |
| CNSP CNS Pharmaceuticals, Inc. | $10M | -0.2 | -106.6 | 748.6 | — | — | 3 | BEARISH | -42.5 |
| ADRX ADARx Pharmaceuticals, Inc. | $1.9B | — | — | — | — | — | — | BEARISH | — |
| CASIF CASI Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| CRVS Corvus Pharmaceuticals, Inc. | $890M | -16.5 | -35.4 | -415.6 | — | — | 4 | BEARISH | 46.0 |
| GLSI Greenwich LifeSciences, Inc. | $240M | -11.0 | -951.6 | 299.9 | — | — | 2 | BEARISH | 86.4 |
| ADAPY Adaptimmune Therapeutics plc | $10M | -0.1 | -1341.1 | 268.4 | -221.8 | -54.0 | 0 | BEARISH | -64.1 |
| TSHA Taysha Gene Therapies, Inc. | $1.3B | -10.1 | -47.1 | 961.0 | — | -32.3 | 3 | BEARISH | -18.8 |
| ARVN Arvinas, Inc. | $470M | 39.1 | 1.6 | -519.3 | 67.8 | -15.0 | 4 | BEARISH | -20.2 |
| PRTA Prothena Corporation plc | $420M | -10.5 | -14.4 | -871.5 | -1839.9 | 427.3 | 5 | BEARISH | -13.8 |
| CCCC C4 Therapeutics, Inc. | $380M | -3.2 | -48.1 | -175.0 | -355.9 | 2.3 | 4 | BEARISH | 25.2 |
| ELTX Elicio Therapeutics, Inc. | $40M | -0.8 | -774.6 | 2147.3 | — | — | 4 | BEARISH | -82.1 |
| DVHGF Devonian Health Group, Inc. | $20M | — | -76.1 | -75.1 | -1098.1 | -91.5 | 1 | BEARISH | 37.7 |
| LEXX Lexaria Bioscience Corp. | $10M | -0.6 | -150.3 | -504.2 | — | -68.5 | 4 | BEARISH | -77.8 |
| ALLR Allarity Therapeutics, Inc. | $10M | -1.2 | -157.1 | -96.5 | — | — | 2 | BEARISH | -34.2 |
| ANEB Anebulo Pharmaceuticals, Inc. | $10M | -1.7 | -69.7 | 650.7 | — | — | 1 | BEARISH | -89.9 |
| SCPS Scopus BioPharma Inc. | — | -0.0 | 132.3 | 53.6 | — | — | 2 | BEARISH | 33.3 |
| RLFTY MindMaze Therapeutics Holding S.A. | — | -4.6 | -36.8 | -30.3 | -1182.3 | -95.8 | 2 | BEARISH | -95.2 |
| BITRF Biotron Limited | — | -3.6 | -87.5 | -87.8 | -113.4 | -71.0 | 0 | BEARISH | 0.0 |
| BIORQ Biora Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| SLXN Silexion Therapeutics Ltd. | — | -0.0 | -17022.0 | -931.4 | — | — | 3 | BEARISH | -94.5 |
| THER Theralink Technologies, Inc. | — | -0.0 | 6.0 | -69.7 | 5363.6 | 32.8 | 2 | BEARISH | 0.0 |
| AAPG Ascentage Pharma Group International | $1.4B | -6.1 | -236.8 | -144.8 | -270.2 | 170.9 | 3 | BEARISH | -55.2 |
| EDIT Editas Medicine, Inc. | $370M | -3.4 | -118.8 | 71.4 | -153.3 | 20.8 | 4 | BEARISH | -34.2 |
| TTRX Turn Therapeutics Inc. | $310M | -36.1 | -952.4 | 115.0 | — | — | 2 | BEARISH | 114.3 |
| NTRB Nutriband Inc. | $70M | -10.6 | -100.7 | -264.9 | -201.3 | -37.3 | 3 | BEARISH | -14.7 |
| CSBR Champions Oncology, Inc. | $70M | -60.8 | -30.7 | -7.8 | -2.8 | 6.7 | 3 | BEARISH | -28.0 |
| HRGN Harvard Apparatus Regenerative Technology Inc. | $30M | -4.9 | 239.0 | 256.6 | -409.4 | — | 2 | BEARISH | — |
| JSPR Jasper Therapeutics, Inc. | $20M | -0.3 | -255.0 | 773.9 | — | — | 2 | BEARISH | -78.3 |
| APUS Apimeds Pharmaceuticals US, Inc | — | -0.1 | -100.1 | -12.6 | — | — | 2 | BEARISH | -83.8 |
| IBOGF Universal Ibogaine Inc. | — | -0.5 | -94.8 | 5.5 | -9.4 | 208.2 | 4 | BEARISH | -98.4 |
| ERNA Ernexa Therapeutics Inc. | — | -0.1 | -320.7 | 626.9 | — | -100.0 | 5 | BEARISH | -93.4 |
| VRAX Virax Biolabs Group Limited | — | -0.0 | -110.9 | -481.7 | -40439.1 | 121.6 | 4 | BEARISH | 101.7 |
| PHRRF PharmaTher Holdings Ltd. | — | -7.6 | -76.9 | 234.4 | — | — | 2 | BEARISH | -51.7 |
| MRES Institute of Biomedical Research Corp. | — | -2.3 | 301783.0 | -6062.7 | — | — | 1 | BEARISH | -80.1 |
| SCNI Scinai Immunotherapeutics Ltd. | — | -0.0 | -19.2 | -53.3 | -435.4 | 162.7 | 2 | BEARISH | -62.7 |
| DNA Ginkgo Bioworks Holdings, Inc. | $670M | -2.3 | -56.3 | -44.0 | -231.7 | -51.5 | 2 | BEARISH | -24.4 |
| INKT MiNK Therapeutics, Inc. | $50M | -4.4 | 57.9 | 42.8 | — | — | 4 | BEARISH | -26.3 |
| HOPHF Hemogenyx Pharmaceuticals Plc | $20M | -3.7 | -628.5 | -474.6 | — | — | 4 | BEARISH | 0.0 |
| HNSBF Hansa Biopharma AB (publ) | $330M | -4.6 | 159.8 | 1182.7 | -541.7 | -3.7 | 2 | BEARISH | -28.2 |
| INTI Inhibitor Therapeutics, Inc. | $10M | -3.2 | 358.8 | 88.0 | — | — | 1 | BEARISH | 22.2 |
| ORGS Orgenesis Inc. | — | -0.2 | 764.3 | 1083.0 | 2628.2 | -192.0 | 1 | BEARISH | -81.3 |
| AFFY Affymax, Inc. | — | -0.0 | 98.1 | -302.0 | 17164.3 | -99.9 | 5 | BEARISH | -11.1 |
| PLYX Polaryx Therapeutics, Inc. Common Stock | $90M | -15.3 | -35.9 | 437.3 | — | — | 2 | BEARISH | — |
| VBIZF Viva Biotech Holdings | $400M | 13.1 | 4.5 | 4.2 | 8.0 | 2.9 | 7 | BEARISH | -35.1 |
| SPRB Spruce Biosciences, Inc. | $130M | -1.1 | -106.0 | 772.2 | — | -100.0 | 4 | BEARISH | -66.1 |
| OKUR OnKure Therapeutics, Inc. | $100M | -0.7 | -46.9 | 1464.5 | — | — | 4 | BEARISH | -16.8 |
| SYRS Syros Pharmaceuticals, Inc. | — | -0.0 | -777.0 | 960.6 | — | -90.5 | 0 | BEARISH | -33.3 |
| IMTX Immatics N.V. | $1.1B | -4.1 | -47.8 | -858.3 | -683.4 | -68.0 | 2 | BEARISH | -29.8 |
| AVBP ArriVent BioPharma, Inc. | $1.0B | -4.1 | -53.1 | 2345.1 | — | — | 3 | BEARISH | -15.1 |
| ZURA Zura Bio Limited | $320M | -3.8 | -65.4 | 806.5 | — | — | 2 | BEARISH | 6.0 |
| CLVLF Clinuvel Pharmaceuticals Limited | $250M | 10.6 | 13.2 | 126.7 | 41.1 | -1.1 | 6 | BEARISH | -32.0 |
| BCYC Bicycle Therapeutics plc | $250M | -1.4 | -32.3 | -1197.0 | -8002.1 | 217.4 | 4 | BEARISH | -53.3 |
| CDXS Codexis, Inc. | $140M | -3.8 | -69.4 | -37.8 | -80.5 | 35.9 | 3 | BEARISH | -49.8 |
| RNXT RenovoRx, Inc. | $60M | -4.3 | -125.2 | 4391.9 | -320.2 | 198.5 | 3 | BEARISH | 13.9 |
| SGMOQ Sangamo Therapeutics, Inc. | $50M | — | — | — | — | — | — | BEARISH | — |
| SEOVF Sernova Corp. | $30M | -3.7 | 57.0 | 76.3 | — | — | 3 | BEARISH | -37.2 |
| SNANF Sona Nanotech Inc. | $20M | -12.9 | 526.4 | 236.5 | — | — | 1 | BEARISH | -63.9 |
| RVXCF Resverlogix Corp. | $20M | -1.6 | 11.5 | 25.3 | — | — | 4 | BEARISH | -25.0 |
| HMTXF Hemostemix Inc. | $10M | -2.0 | 69.9 | 190.1 | — | — | 1 | BEARISH | -44.5 |
| AMBS Amarantus BioScience Holdings, Inc. | — | -0.0 | 7.3 | 3.8 | -4080.5 | — | 3 | BEARISH | -66.7 |
| ANTH Anthera Pharmaceuticals, Inc. | — | -0.0 | -251.4 | 1107.5 | — | — | 1 | BEARISH | 0.0 |
| BRTX BioRestorative Therapies, Inc. | — | -0.1 | -241.1 | 2112.9 | -9298.3 | -8.5 | 3 | BEARISH | -95.2 |
| ATRX Adhera Therapeutics Inc | — | -0.0 | 18.6 | 6.5 | — | — | 1 | BEARISH | 0.0 |
| AMPE Ampio Pharmaceuticals, Inc. | — | -0.0 | -114.0 | 1652.6 | -838.4 | — | 4 | BEARISH | 6681.5 |
| LIPO Lipella Pharmaceuticals Inc. | — | -0.0 | -361.8 | 4105.8 | — | -64.1 | 1 | BEARISH | -99.9 |
| CVKD Cadrenal Therapeutics, Inc. Common Stock | — | -0.2 | -275.2 | -540.4 | — | — | 3 | BEARISH | -93.2 |
| MAJI Nextel Medical Corp. | — | 0.6 | -2.6 | 42.9 | — | — | 1 | BEARISH | — |
| AURA Aura Biosciences, Inc. | $650M | -3.5 | -53.5 | -1360.0 | — | — | 4 | BEARISH | 8.8 |
| ARCT Arcturus Therapeutics Holdings Inc. | $280M | -3.4 | -46.3 | -2501.0 | -803.8 | -79.1 | 1 | BEARISH | -17.4 |
| ATRA Atara Biotherapeutics, Inc. | $90M | -7.1 | 46.3 | 30.3 | -767.3 | -96.7 | 2 | BEARISH | -40.9 |
| IMRN Immuron Limited | $10M | -2.9 | -40.2 | -187.8 | -54.4 | -29.7 | 5 | BEARISH | -57.4 |
| SKYE Skye Bioscience, Inc. | $10M | -0.1 | -233.9 | 389.5 | — | — | 3 | BEARISH | 8.3 |
| ERNAW Ernexa Therapeutics Inc. Warrants | — | — | — | — | — | — | — | BEARISH | — |
| CUBT Curative Biotechnology, Inc. | — | -1.9 | 31.0 | 15.3 | — | — | 4 | BEARISH | -24.9 |
| IDRSF Idorsia Ltd | $1.4B | -3.5 | 27.1 | -344.5 | -203.1 | -8.1 | 1 | BEARISH | -7.6 |
| QTTB Q32 Bio Inc. | $260M | 3.1 | 72.1 | 435.2 | — | — | 5 | BEARISH | 201.8 |
| BRIBF Brii Biosciences Limited | $90M | -3.3 | -10.3 | -62.6 | — | 22.5 | 4 | BEARISH | -46.0 |
| AUTL Autolus Therapeutics plc | $410M | -1.5 | -132.9 | 451.5 | -85.6 | 292.0 | 3 | BEARISH | 2.0 |
| BVAXF BioVaxys Technology Corp. | — | -0.9 | 310.6 | 48.4 | — | — | 1 | BEARISH | -45.4 |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | $70M | -0.7 | -213.1 | 3515.1 | — | — | 4 | BEARISH | -30.4 |
| RECEF Recce Pharmaceuticals Ltd | $70M | -6.0 | 151.4 | 200.5 | — | -100.0 | 2 | BEARISH | -56.0 |
| CVM CEL-SCI Corporation | $30M | -0.6 | -252.5 | -142.9 | — | -100.0 | 4 | BEARISH | -82.3 |
| SNGX Soligenix, Inc. | $10M | -0.3 | -241.7 | 304.6 | — | — | 4 | BEARISH | -87.3 |
| ARTL Artelo Biosciences, Inc. | $10M | -0.0 | -705.7 | -1031.2 | — | — | 5 | BEARISH | -92.8 |
| LIFS Life Stem Genetics Inc. | — | -2.5 | -126.7 | -111.5 | — | — | 2 | BEARISH | -50.0 |
| FNAM Evolutionary Genomics, Inc. | — | -0.0 | 62.2 | -99.6 | — | — | 2 | BEARISH | 0.0 |
| WINT Windtree Therapeutics, Inc. | — | -0.0 | 1111.0 | -2375.5 | — | — | 3 | BEARISH | -99.6 |
| RGRX RegeneRx Biopharmaceuticals, Inc. | — | -0.0 | 53.5 | 45.8 | -2006.3 | -0.0 | 3 | BEARISH | 450.0 |
| SYBE SYBLEU Inc | — | -3.1 | 71.5 | -202.2 | -685.7 | — | 2 | BEARISH | 0.0 |
| BICTF Biocure Technology Inc. | — | -0.1 | -889.9 | 60.0 | — | — | 1 | BEARISH | 0.0 |
| VOR Vor Biopharma Inc. | $990M | 0.1 | -73.6 | 22.2 | — | — | 3 | BEARISH | -34.0 |
| ASCLF Ascletis Pharma Inc. | $770M | -7.8 | -28.4 | -7144.0 | — | -60.6 | 2 | BEARISH | -40.2 |
| YDES YD Bio Limited Ordinary Shares | $350M | — | — | — | — | — | — | BEARISH | -70.0 |
| CAMP CAMP4 Therapeutics Corporation | $210M | -1.6 | -545.9 | 48.4 | -1884.8 | 40.2 | 2 | BEARISH | -7.8 |
| RNAC Cartesian Therapeutics, Inc. | $190M | -1.1 | 241.0 | 37.3 | — | 44.0 | 2 | BEARISH | -30.2 |
| VRXA Veraxa Biotech Holding AG | $140M | — | — | — | — | — | — | BEARISH | — |
| OTLK Outlook Therapeutics, Inc. | $130M | -0.5 | 256.9 | 1372.0 | -225766.7 | -169.4 | 3 | BEARISH | -60.5 |
| ONCY Oncolytics Biotech Inc. | $50M | -1.9 | 90135.4 | 285.1 | — | — | 1 | BEARISH | -59.9 |
| CNTB Connect Biopharma Holdings Limited | $50M | -0.9 | -105.5 | 1034.1 | -1249.0 | 49.8 | 2 | BEARISH | -47.6 |
| ALPS Alps Group Inc | $50M | — | — | — | — | — | — | BEARISH | — |
| CLCS Cell Source, Inc. | $40M | -4.6 | 27.7 | 34.5 | — | — | 4 | BEARISH | 21.7 |
| BYSI BeyondSpring Inc. | $20M | -2.9 | 20.3 | 15.7 | — | 100.0 | 2 | BEARISH | -77.2 |
| CNTX Context Therapeutics Inc. | $20M | -0.5 | -76.1 | 841.7 | — | — | 2 | BEARISH | -81.3 |
| PLRZ Polyrizon Ltd. | $10M | -2.0 | -21.4 | -68.2 | — | — | 0 | BEARISH | 38.3 |
| ADIL Adial Pharmaceuticals, Inc. | $10M | -0.2 | -2011.6 | 159.6 | — | — | 3 | BEARISH | -60.2 |
| LPCN Lipocine Inc. | $10M | -0.8 | -60.9 | 662.3 | -1379.6 | -62.7 | 2 | BEARISH | -48.8 |
| GLWLF Glow Lifetech Corp. | $10M | -50.0 | -11.1 | -21.1 | -26.6 | 59.2 | 5 | BEARISH | -19.5 |
| KTTA Pasithea Therapeutics Corp. | $10M | -0.2 | -65.5 | -453.2 | — | — | 4 | BEARISH | -45.2 |
| ICU SeaStar Medical Holding Corporation | $10M | -0.6 | -356.9 | 415.0 | -606.5 | 123.6 | 4 | BEARISH | -60.9 |
| ONCO Onconetix, Inc. | — | -0.1 | -105.2 | -83.7 | -16748.3 | -51.3 | 3 | BEARISH | -88.1 |
| BBLG Bone Biologics Corporation | — | -0.2 | -47.5 | 1744.6 | — | — | 2 | BEARISH | -82.9 |
| AFMDQ Affimed N.V. | — | — | — | — | — | — | — | BEARISH | — |
| EVLO Evelo Biosciences, Inc. | — | -0.0 | 948.0 | 605.0 | — | — | 2 | BEARISH | -80.0 |
| VCNX Vaccinex, Inc. | — | -0.4 | 776.6 | 414.6 | -1584.0 | 226.6 | 3 | BEARISH | -20.6 |
| VIVS VivoSim Labs, Inc. | — | -0.0 | -343.1 | 241.9 | -7433.3 | 202.7 | 2 | BEARISH | -93.1 |
| SXTP 60 Degrees Pharmaceuticals, Inc. | — | -0.1 | -321.8 | -390.2 | -1089.2 | 68.0 | 3 | BEARISH | -40.1 |
| SPRC SciSparc Ltd. | — | -0.0 | -519.9 | -161.9 | -1891.2 | -26.8 | 5 | BEARISH | -67.6 |
| MTNB Matinas BioPharma Holdings, Inc. | — | -0.1 | -154.3 | -504.1 | — | — | 4 | BEARISH | -93.1 |
| NCEL NewcelX Ltd. | — | 8.0 | -48.0 | -39.1 | — | — | 2 | BEARISH | — |
| DRMA Dermata Therapeutics, Inc. | — | -0.2 | -183.9 | 734.5 | — | — | 2 | BEARISH | -82.8 |
| ITMC Itoco Inc. | — | -0.0 | 303.4 | 96.7 | — | — | 2 | BEARISH | 0.0 |
| OBIO Orchestra BioMed Holdings, Inc. | $340M | -5.6 | -397.3 | 468.3 | -26994.3 | 986.1 | 4 | BEARISH | 46.0 |
| ACOG Alpha Cognition Inc | $130M | -8.1 | -55.3 | -198.4 | -144.3 | 232.7 | 2 | BEARISH | -3.3 |
| LITS Lite Strategy, Inc. | $40M | -0.1 | -170.9 | -28.2 | — | — | 2 | BEARISH | -40.1 |
| NXTC NextCure, Inc. | $20M | -0.5 | -195.2 | 949.7 | — | — | 2 | BEARISH | -41.2 |
| BCTXZ BriaCell Therapeutics Corp. Warrant | — | -0.3 | -168.1 | -2016.9 | — | — | 1 | BEARISH | -72.9 |
| TRVI Trevi Therapeutics, Inc. | $1.8B | -39.6 | -19.7 | -1451.7 | — | — | 3 | BEARISH | 17.5 |
| QURE uniQure N.V. | $1.6B | -5.9 | -157.6 | 37.9 | -1387.8 | 30.2 | 4 | BEARISH | -63.5 |
| MGTX MeiraGTx Holdings plc | $880M | 12.3 | 72.3 | 96.7 | 50.0 | 948.3 | 7 | BEARISH | 4.9 |
| ABUS Arbutus Biopharma Corp | $830M | 5.4 | 89.6 | 86.7 | -507.2 | 1078.8 | 4 | BEARISH | -1.9 |
| AMGXF AnGes, Inc. | $140M | -3.0 | -160.6 | -111.8 | -531.3 | -16.1 | 4 | BEARISH | 0.0 |
| BBIXF Bonus BioGroup Ltd. | $50M | -17.4 | 3245.0 | 2543.1 | — | — | 2 | BEARISH | 100.0 |
| XTLB XTL Biopharmaceuticals Ltd. | — | -0.6 | -26.8 | -38.7 | -88.2 | — | 3 | BEARISH | 46.8 |
| MYMX Mymetics Corporation | — | -0.0 | 16.6 | 357.9 | -3012.0 | -62.8 | 2 | BEARISH | 0.0 |
| NWPHF Newron Pharmaceuticals S.p.A. | $410M | -6.7 | 83.9 | -32.1 | -513.4 | — | 1 | BEARISH | — |
| SRNE Sorrento Therapeutics, Inc. | — | -0.0 | 1502.8 | 468.4 | -633.7 | 16.9 | 2 | BEARISH | -96.0 |
| PBLA Panbela Therapeutics, Inc. | — | -0.0 | 270.3 | 240.0 | — | 100.0 | 3 | BEARISH | -91.0 |
| CPMV Mosaic ImmunoEngineering Inc. | — | -2.0 | 9.2 | 7.5 | — | — | 2 | BEARISH | -87.7 |
| MNKD MannKind Corporation | $1.0B | -23.4 | 71.4 | 4.0 | -17.4 | 30.5 | 2 | BEARISH | -41.2 |
| APMD Apnimed, Inc. | $790M | — | — | — | — | — | — | BEARISH | — |
| SABS SAB Biotherapeutics, Inc. | $260M | 0.9 | -11.3 | -48.4 | — | -100.0 | 3 | BEARISH | -4.5 |
| IMRX Immuneering Corporation | $240M | -3.7 | -52.1 | -112.8 | — | — | 4 | BEARISH | -34.1 |
| HUMA Humacyte, Inc. | $120M | -0.9 | -547.9 | -500.7 | -9064.5 | -73.6 | 3 | BEARISH | -76.3 |
| BTAIQ BioXcel Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| TSOI Therapeutic Solutions International, Inc. | — | -0.1 | -187.6 | -130.3 | -5123.0 | -99.7 | 4 | BEARISH | -99.0 |
| BCRX BioCryst Pharmaceuticals, Inc. | $1.9B | -5.6 | 87.8 | 62.3 | 35.9 | 68.7 | 5 | BEARISH | 9.6 |
| GENB Generate Biomedicines, Inc. | $1.6B | -7.9 | -28.2 | -175.0 | -1065.2 | — | 1 | BEARISH | — |
| CMPS COMPASS Pathways plc | $1.6B | -2.1 | -319.1 | 48.8 | — | — | 2 | BEARISH | 77.1 |
| INBX Inhibrx Biosciences Inc. | $1.4B | -11.2 | -1773.6 | 55.8 | — | -100.0 | 4 | BEARISH | 212.4 |
| OMER Omeros Corporation | $1.2B | 9.1 | -89.2 | 71.8 | 46.4 | — | 5 | BEARISH | 112.9 |
| ACHV Achieve Life Sciences, Inc. | $670M | -4.4 | -845.0 | 24.6 | — | — | 2 | BEARISH | 32.9 |
| NVCT Nuvectis Pharma, Inc. | $650M | -14.0 | -214.6 | 174.4 | — | — | 1 | BEARISH | 207.7 |
| MDXG MiMedx Group, Inc. | $570M | 96.6 | 2.9 | 5.8 | -23.1 | -2.4 | 6 | BEARISH | -42.0 |
| STTK Shattuck Labs, Inc. | $550M | -11.4 | -39.2 | -29.3 | — | -66.6 | 4 | BEARISH | 199.5 |
| CBIO Crescent Biopharma, Inc. | $480M | -1.8 | -107.7 | 1928.6 | — | — | 5 | BEARISH | -0.2 |
| RZLT Rezolute, Inc. | $370M | -5.4 | -59.0 | 1060.6 | — | — | 2 | BEARISH | -57.6 |
| FENC Fennec Pharmaceuticals Inc. | $350M | -81.5 | -18.6 | -76.2 | 11.0 | 77.8 | 6 | BEARISH | 13.3 |
| DMTRF 3-D Matrix, Ltd. | $310M | 11.9 | 75.0 | 31.1 | 9.4 | 57.0 | 6 | BEARISH | 61.3 |
| CUE Cue Biopharma, Inc. | $140M | -0.7 | -1603.5 | 1241.9 | -1943.2 | 354.4 | 3 | BEARISH | -21.2 |
| VANI Vivani Medical, Inc. | $100M | -3.3 | -220.4 | -127.1 | — | — | 4 | BEARISH | -30.7 |
| MNOV MediciNova, Inc. | $70M | -6.5 | -25.6 | -78.2 | -504.8 | 583.9 | 3 | BEARISH | 14.8 |
| NDTP NDT Pharmaceuticals Inc. | $50M | -39.2 | -3.8 | -1.5 | -458.3 | — | 4 | BEARISH | -77.5 |
| CRVO CervoMed Inc. | $30M | -0.7 | -107.6 | 1244.8 | — | — | 2 | BEARISH | -68.4 |
| CELU Celularity Inc. | $30M | -0.4 | 150.9 | 40592.8 | 13.0 | -58.1 | 4 | BEARISH | -62.3 |
| TELIF Telescope Innovations Corp. | $20M | 6.0 | -229.2 | -80.7 | -116.8 | 66.3 | 2 | BEARISH | -15.9 |
| COCP Cocrystal Pharma, Inc. | $20M | -1.2 | -311.7 | -3697.6 | -3013.3 | — | 2 | BEARISH | -8.3 |
| PVCT Provectus Biopharmaceuticals, Inc. | $20M | -4.3 | 78.1 | 83.4 | — | -100.0 | 5 | BEARISH | -29.7 |
| LTRN Lantern Pharma Inc. | $10M | -0.4 | -400.9 | 115.9 | — | — | 2 | BEARISH | -83.6 |
| PHYOF IXICO plc | $10M | -6.0 | -15.8 | -23.6 | -28.5 | 13.2 | 2 | BEARISH | 0.0 |
| PASG Passage Bio, Inc. | $10M | -0.3 | -169.1 | 159.0 | — | — | 3 | BEARISH | -55.2 |
| CDT CDT Equity Inc. | — | -0.0 | 13.1 | 5.4 | 9.1 | — | 7 | BEARISH | -97.0 |
| ADTX Aditxt, Inc. | — | -0.0 | 622.6 | 49.4 | -131159.8 | -74.1 | 1 | BEARISH | -100.0 |
| YDESW YD Bio Limited Warrants | — | — | — | — | — | — | — | BEARISH | -81.8 |
| HMGN Hemagen Diagnostics, Inc. | — | -0.0 | 29.1 | -24.6 | -18.6 | -21.4 | 2 | BEARISH | 100.0 |
| YECO EV Biologics, Inc. | — | -0.0 | 16.2 | 18.1 | 18.6 | 264.7 | 5 | BEARISH | -99.9 |
| LIMNW Liminatus Pharma, Inc. Warrants | — | -0.1 | -4165.9 | 252.1 | — | — | 2 | BEARISH | -83.3 |
| AXIM AXIM Biotechnologies, Inc. | — | -1.6 | 3.0 | 24.9 | -90.9 | 2142.6 | 5 | BEARISH | -60.0 |
| RGBPP Regen BioPharma, Inc. | — | -0.0 | 20.3 | 12.8 | -1079.8 | 0.0 | 4 | BEARISH | -98.5 |
| CHMMF Chimeric Therapeutics Limited | — | -0.0 | 655.2 | 80.8 | — | -100.0 | 2 | BEARISH | 0.0 |
| BLEG Branded Legacy, Inc. | — | -0.0 | 2011.7 | 147.0 | — | -29.4 | 2 | BEARISH | -99.5 |
| GRI GRI Bio, Inc. | — | -0.0 | -142.0 | 1227.5 | — | — | 5 | BEARISH | -97.4 |
| NMLSF Restart Life Sciences Corp. | — | -1.8 | -214.3 | -153.9 | -307.0 | — | 2 | BEARISH | -69.2 |
| AGNPF Grey Matters Health Inc. | — | — | -140.9 | -64.7 | — | — | 3 | BEARISH | -58.6 |
| LNAI Lunai Bioworks Inc. | — | -0.3 | -21.6 | 30.2 | — | — | 2 | BEARISH | -96.8 |
| GHRS GH Research PLC | $1.2B | -20.0 | -18.8 | 2015.5 | — | — | 2 | BEARISH | 44.5 |
| ANRO Alto Neuroscience, Inc. | $860M | -9.3 | -49.2 | -201.4 | — | — | 3 | BEARISH | 97.7 |
| AKTS Aktis Oncology, Inc. | $850M | -15.8 | -29.9 | 276.4 | -713.5 | -36.1 | 5 | BEARISH | 245681.2 |
| DSGN Design Therapeutics, Inc. | $640M | -9.1 | -34.1 | 1787.8 | — | — | 1 | BEARISH | 81.4 |
| SLDB Solid Biosciences Inc. | $630M | -3.2 | -65.5 | -1012.6 | — | — | 3 | BEARISH | 5.2 |
| LXRX Lexicon Pharmaceuticals, Inc. | $630M | -9.8 | -40.2 | -99.7 | -4591.8 | -29.0 | 3 | BEARISH | 18.9 |
| ANL Adlai Nortye Ltd. | $560M | -5.5 | -22.4 | -317.5 | -36.3 | 223.4 | 4 | BEARISH | 537.4 |
| MNPR Monopar Therapeutics Inc. | $470M | -30.7 | -19.5 | 523.8 | — | — | 2 | BEARISH | -13.2 |
| AVIR Atea Pharmaceuticals, Inc. | $320M | -2.0 | -58.1 | 974.6 | — | — | 3 | BEARISH | 30.4 |
| ARTV Artiva Biotherapeutics, Inc. | $300M | -1.3 | -36.6 | -954.6 | — | — | 3 | BEARISH | 27.3 |
| WHWK Whitehawk Therapeutics Inc | $180M | -3.0 | -45.0 | 963.4 | — | -100.0 | 1 | BEARISH | 28.2 |
| ANTX AN2 Therapeutics, Inc. | $130M | -3.5 | -50.1 | 1243.3 | — | — | 2 | BEARISH | 210.3 |
| NRXP NRx Pharmaceuticals, Inc. | $110M | -3.6 | 131.2 | 61.3 | -1500.5 | — | 5 | BEARISH | -20.3 |
| ELOX Eloxx Pharmaceuticals, Inc. | $40M | -8.5 | -107.5 | 81.5 | — | — | 4 | BEARISH | 13029900.4 |
| BMEA Biomea Fusion, Inc. | $40M | -1.2 | -164.1 | 210.3 | — | — | 2 | BEARISH | -53.9 |
| TVGN Tevogen Bio Holdings Inc. | $30M | -1.2 | 235.3 | 244.1 | — | — | 5 | BEARISH | 917.3 |
| AVEFF Avecho Biotechnology Limited | $20M | -9.3 | -268.2 | 103.4 | -3227.5 | -46.6 | 3 | BEARISH | 0.0 |
| CMMB Chemomab Therapeutics Ltd. | $10M | -1.0 | -82.7 | -314.7 | — | — | 1 | BEARISH | -65.3 |
| KZIA Kazia Therapeutics Ltd ADR | $10M | -1.1 | -104.5 | 62.7 | — | -99.2 | 4 | BEARISH | 16.8 |
| SYBX Synlogic, Inc. | $10M | -19.6 | -5.3 | 306.3 | — | — | 2 | BEARISH | -39.0 |
| XRTX XORTX Therapeutics Inc. | — | -0.4 | -99.1 | -68.5 | — | — | 3 | BEARISH | 47.6 |
| HXBM Helix BioMedix, Inc. | — | — | — | — | — | — | — | BEARISH | -6.0 |
| OZYMF Strategic Partners A/S | — | 19.0 | 0.8 | -117.5 | 1019.0 | — | 6 | BEARISH | 0.0 |
| GNLKQ GeneLink, Inc. | — | -0.0 | 73.0 | 82.1 | -183.0 | -33.6 | 3 | BEARISH | 0.0 |
| RMTG Regenerative Medical Technology Group Inc. | — | -0.1 | 9.6 | -3.3 | -72.2 | — | 3 | BEARISH | — |
| GLABF Gemina Laboratories Ltd. | — | -3.0 | 42.7 | 32.4 | -7838.5 | — | 5 | BEARISH | -78.3 |
| HBMHF HBM Holdings Limited | $1.3B | 12.5 | 24.1 | 53.0 | 53.0 | 54.6 | 4 | BEARISH | -38.1 |
| BCAX Bicara Therapeutics Inc. Common Stock | $1.1B | -5.6 | -41.0 | 583.9 | — | — | 2 | BEARISH | -0.2 |
| NKTR Nektar Therapeutics | $1.1B | -5.7 | -35.8 | -29.2 | -401.0 | -27.2 | 3 | BEARISH | -41.1 |
| GLUE Monte Rosa Therapeutics, Inc. | $920M | -4.8 | -42.7 | 149.9 | -483.9 | -83.9 | 3 | BEARISH | 1.0 |
| ALMS Alumis Inc. | $880M | -1.8 | -93.6 | 2645.2 | -8557.2 | -63.1 | 2 | BEARISH | 41.2 |
| AGMB AgomAb Therapeutics N.V. American Depositary Shares | $450M | — | — | — | — | — | — | BEARISH | — |
| BLSM BlossomHill Therapeutics, Inc. | $430M | — | — | — | — | — | — | BEARISH | — |
| EIKN Eikon Therapeutics, Inc. Common Stock | $390M | — | — | — | — | — | — | BEARISH | — |
| RLMD Relmada Therapeutics, Inc. | $350M | -3.5 | -55.7 | 460.5 | — | — | 3 | BEARISH | 46.1 |
| BNTC Benitec Biopharma Inc. | $300M | -8.9 | -33.2 | 1840.8 | — | — | 3 | BEARISH | -38.6 |
| IPSC Century Therapeutics, Inc. | $260M | -1.4 | -49.7 | -60.0 | — | -100.0 | 2 | BEARISH | 140.7 |
| RCKT Rocket Pharmaceuticals, Inc. | $250M | -15.5 | -4.8 | -137.8 | — | — | 3 | BEARISH | -39.0 |
| BOVNF BioInvent International AB (publ) | $220M | -2.8 | -88.2 | 20101.5 | -964.0 | -87.2 | 1 | BEARISH | 0.0 |
| CHRS Coherus Oncology, Inc. | $160M | -1.0 | -145.4 | 1854.0 | -144.2 | -64.3 | 2 | BEARISH | -39.5 |
| VXRT Vaxart, Inc. | $100M | 2.7 | 67.0 | 149.6 | -49.6 | 201.1 | 6 | BEARISH | 12.5 |
| IMUX Immunic, Inc. | $100M | -1.6 | -138.2 | 345.6 | — | — | 5 | BEARISH | -6.7 |
| ADAG Adagene Inc. | $90M | -5.6 | -28.6 | 111.8 | -1011.1 | 8927.0 | 5 | BEARISH | 39.1 |
| NMRA Neumora Therapeutics, Inc. Common Stock | $70M | -0.3 | -187.1 | 231.9 | — | — | 2 | BEARISH | -75.0 |
| TENX Tenax Therapeutics, Inc. | $50M | -1.2 | -59.8 | 1235.8 | — | — | 1 | BEARISH | -77.6 |
| IMA ImageneBio Inc | $50M | -0.8 | -40.7 | -594.7 | — | — | 3 | BEARISH | -45.1 |
| IBO Impact BioMedical Inc. | $30M | -3.0 | 10.8 | -30.4 | -23300.0 | — | 5 | BEARISH | -49.4 |
| NEUP Neuphoria Therapeutics Inc. | $20M | -0.5 | -0.2 | -0.2 | -417.7 | -91.9 | 4 | BEARISH | -16.5 |
| PRRUF Immutep Limited | $20M | -0.4 | -77.3 | 1092.5 | -328.8 | 255.0 | 3 | BEARISH | -89.5 |
| CLRB Cellectar Biosciences, Inc. | $10M | -0.3 | -119.6 | 717.6 | — | — | 3 | BEARISH | -68.0 |
| AIM AIM ImmunoTech Inc. | $10M | -0.0 | -2382.3 | -513.5 | -14569.2 | -21.5 | 5 | BEARISH | -93.2 |
| CTXR Citius Pharmaceuticals, Inc. | $10M | -0.2 | -70.3 | -85.4 | -593.3 | 4456.8 | 3 | BEARISH | -73.9 |
| RADX Radiopharm Theranostics Limited | — | — | — | — | — | — | — | BEARISH | -82.1 |
| LGVN Longeveron Inc. | — | -0.2 | -203.6 | -2062.6 | -2116.0 | -42.7 | 4 | BEARISH | -81.1 |
| APVO Aptevo Therapeutics Inc. | — | -0.0 | -420.3 | -4688.7 | — | — | 1 | BEARISH | -94.5 |
| ARNI Arno Therapeutics, Inc. | — | -0.0 | 250.7 | 111.6 | — | — | 3 | BEARISH | 0.0 |
| MYNDF MYND Life Sciences Inc. | — | -2.2 | 9.5 | 34.0 | — | — | 5 | BEARISH | -41.3 |
| SEPSF Asep Medical Holdings Inc | — | -0.3 | -36.4 | -75.5 | -844.8 | 208.8 | 5 | BEARISH | -97.2 |
| BIOAF Bioasis Technologies Inc. | — | -0.1 | 135.1 | 538.8 | -661.8 | 614.1 | 2 | BEARISH | -50.0 |
| ARUXF Acrux Limited | — | -7.1 | -48.5 | -74.2 | -26.5 | 289.9 | 7 | BEARISH | -93.4 |
| ORIC ORIC Pharmaceuticals, Inc. | $1.4B | -6.7 | -39.8 | -102.9 | — | — | 3 | BEARISH | -27.9 |
| KURA Kura Oncology, Inc. | $850M | -2.9 | -167.7 | 56.3 | -327.3 | -7.3 | 1 | BEARISH | 5.7 |
| FDMT 4D Molecular Therapeutics, Inc. | $600M | -4.3 | -43.3 | -182.0 | -1929.0 | 278712.1 | 4 | BEARISH | 10.3 |
| ZVRA Zevra Therapeutics, Inc. | $580M | 10.5 | 34.8 | -1356.4 | 22.1 | 119.4 | 6 | BEARISH | -10.8 |
| EPRX Eupraxia Pharmaceuticals Inc. | $450M | -6.9 | -68.6 | 8742.2 | — | — | 3 | BEARISH | 20.6 |
| AGEN Agenus Inc. | $290M | 2.4 | -33.2 | -20.4 | -1.6 | 30.5 | 6 | BEARISH | 47.4 |
| IRD Opus Genetics, Inc. | $290M | -2.7 | -4796.5 | 59.8 | -1072.6 | -36.1 | 3 | BEARISH | 66.0 |
| GALT Galectin Therapeutics Inc. | $210M | -8.0 | 21.9 | 99.4 | — | — | 2 | BEARISH | -37.8 |
| CGEN Compugen Ltd. | $180M | 5.2 | 49.6 | -90.2 | -269.3 | 886.7 | 5 | BEARISH | 12.6 |
| MGNX MacroGenics, Inc. | $140M | -10.8 | -32.6 | 33.8 | 59.4 | 2.3 | 2 | BEARISH | 19.7 |
| SEER Seer, Inc. | $110M | -1.6 | -26.4 | -58.8 | -544.8 | -13.3 | 3 | BEARISH | -11.1 |
| COYA Coya Therapeutics, Inc. | $90M | -3.9 | -60.5 | -18820.6 | -2723.4 | 1793.8 | 4 | BEARISH | -43.4 |
| ACRV Acrivon Therapeutics, Inc. Common Stock | $70M | -0.9 | -64.6 | 5251.5 | — | — | 1 | BEARISH | -14.0 |
| PMVP PMV Pharmaceuticals, Inc. | $70M | -0.9 | -70.9 | 815.8 | — | — | 2 | BEARISH | -28.5 |
| HRTX Heron Therapeutics, Inc. | $60M | -1.6 | 334.6 | -7.6 | -14.6 | 1.0 | 3 | BEARISH | -74.7 |
| OSTX OS Therapies Incorporated | $60M | -1.1 | 1924.5 | 268.9 | — | — | 1 | BEARISH | -33.1 |
| SPRO Spero Therapeutics, Inc. | $60M | 7.9 | 19.2 | -128.5 | — | -7.0 | 7 | BEARISH | -51.4 |
| XLO Xilio Therapeutics, Inc. | $50M | -4.9 | -55.0 | 43.1 | -34.1 | 327.3 | 6 | BEARISH | 845.5 |
| AKTX Akari Therapeutics, Plc | $20M | -0.0 | -139.9 | -175.8 | — | — | 3 | BEARISH | -74.2 |
| KPRX Kiora Pharmaceuticals, Inc. | $10M | -0.9 | -56.4 | -2884.1 | — | — | 2 | BEARISH | -13.0 |
| OTLC Oncotelic Therapeutics, Inc. | $10M | 0.0 | 181.4 | -1.4 | 155.3 | — | 5 | BEARISH | -82.0 |
| ENVB Enveric Biosciences, Inc. | $10M | -0.1 | -170.0 | 3225.6 | — | — | 4 | BEARISH | -81.1 |
| PTIX Protagenic Therapeutics, Inc. | — | 0.2 | -485.4 | -367.8 | — | 100.0 | 6 | BEARISH | -78.3 |
| ISCO International Stem Cell Corporation | — | -2.4 | 30.4 | -10.8 | -2.7 | 3.4 | 6 | BEARISH | -6.7 |
| PBM Psyence Biomedical Ltd. | — | — | — | — | — | — | — | BEARISH | 9.9 |
| RVLPQ RVL Pharmaceuticals plc | — | -0.0 | -182.4 | -101.1 | -289.3 | 5.6 | 3 | BEARISH | -90.0 |
| URGN UroGen Pharma Ltd. | $1.7B | -17.2 | 86.5 | 119.0 | -19.8 | 169.5 | 2 | BEARISH | 96.4 |
| NVAX Novavax, Inc. | $1.6B | -6.6 | 323.7 | 29.2 | -94.2 | -61.6 | 2 | BEARISH | 12.4 |
| NUVB Nuvation Bio Inc. | $1.6B | -10.3 | -47.8 | 70.2 | -198.3 | 1083.6 | 4 | BEARISH | 2.7 |
| DRTS Alpha Tau Medical Ltd | $1.2B | -13.0 | -141.7 | -17.1 | — | — | 3 | BEARISH | 206.2 |
| MDCLF MedinCell S.A. | $1.1B | -29.2 | 472.2 | 81.6 | -152.1 | -14.8 | 3 | BEARISH | 333.5 |
| IMMX Immix Biopharma, Inc. | $680M | -9.3 | -34.2 | 1509.2 | — | — | 4 | BEARISH | 135.0 |
| CADL Candel Therapeutics, Inc. | $610M | -5.9 | -81.8 | 219.4 | — | — | 2 | BEARISH | 46.7 |
| CLYM Climb Bio, Inc. | $590M | -11.6 | -27.1 | -88.6 | — | — | 2 | BEARISH | 342.7 |
| GNFTF Genfit S.A. | $470M | -5.2 | -5084.0 | -322.7 | -124.0 | 27.5 | 3 | BEARISH | 153.5 |
| AVCTF Avacta Group Plc | $420M | -6.7 | -2083.2 | -753.6 | -33970.3 | -99.7 | 5 | BEARISH | -18.7 |
| IKT Inhibikase Therapeutics, Inc. | $220M | -3.3 | -52.0 | 920.5 | — | — | 3 | BEARISH | -0.7 |
| PLX Protalix BioTherapeutics, Inc. | $210M | 10.5 | 31.2 | 47.1 | 19.0 | 30.1 | 5 | BEARISH | 6.9 |
| PRQR ProQR Therapeutics N.V. | $180M | -3.0 | -57.9 | 139.7 | -99.6 | 12.7 | 2 | BEARISH | -56.0 |
| ORMP Oramed Pharmaceuticals Inc. | $170M | 1.0 | 74.1 | -4.3 | — | -100.0 | 4 | BEARISH | 72.2 |
| TRGNF Transgene S.A. | $120M | -4.1 | -64.1 | -184.9 | -5760.7 | -185.8 | 4 | BEARISH | -53.1 |
| PYXS Pyxis Oncology, Inc. | $110M | -1.3 | -179.1 | 1953.9 | — | 291.4 | 2 | BEARISH | -50.0 |
| PRNAF Alterity Therapeutics Limited | $50M | -2.2 | -55.0 | -401.1 | — | -100.0 | 2 | BEARISH | 8233.3 |
| BOLD Boundless Bio, Inc. | $50M | -0.8 | -67.9 | 807.9 | — | — | 2 | BEARISH | 68.8 |
| BMNDF Biomind Labs Inc. | $20M | -13.3 | 85.8 | 101.7 | — | — | 2 | BEARISH | 1483.5 |
| SER Serina Therapeutics, Inc. | $20M | -0.9 | -206.3 | 1868.6 | — | -100.0 | 3 | BEARISH | -67.9 |
| ALZN Alzamend Neuro Inc | $10M | -0.5 | -163.2 | 401.5 | — | — | 1 | BEARISH | -52.4 |
| XBIO Xenetic Biosciences, Inc. | — | -1.5 | -47.0 | 523.4 | -140.7 | 33.3 | 4 | BEARISH | -55.2 |
| SNDX Syndax Pharmaceuticals, Inc. | $1.2B | -5.4 | -255.9 | -270.9 | -67.8 | 222.3 | 4 | BEARISH | -9.9 |
| ARDX Ardelyx, Inc. | $770M | -13.2 | -38.6 | -22.7 | -13.8 | 16.8 | 4 | BEARISH | -40.7 |
| GERN Geron Corporation | $720M | -11.5 | -29.2 | -74.1 | -29.0 | 24.4 | 2 | BEARISH | -5.7 |
| SANA Sana Biotechnology, Inc. | $700M | -3.2 | -152.9 | -242.3 | — | — | 3 | BEARISH | -57.8 |
| SLBT SL Science Holding Ltd | $640M | — | — | — | — | — | — | BEARISH | — |
| WVE Wave Life Sciences Ltd. | $630M | -3.2 | -80.0 | -1243.7 | -470.5 | -35.1 | 4 | BEARISH | -54.5 |
| GYRE Gyre Therapeutics, Inc. | $620M | -32.8 | -15.6 | -22.3 | -36.4 | 16.8 | 3 | BEARISH | -26.2 |
| ANNX Annexon, Inc. | $610M | -3.2 | -105.3 | -11323.3 | — | — | 2 | BEARISH | 21.3 |
| OLMA Olema Pharmaceuticals, Inc. | $560M | -3.3 | -52.7 | 585.3 | — | — | 2 | BEARISH | -18.2 |
| CTMX CytomX Therapeutics, Inc. | $510M | -5.2 | -37.8 | 305.9 | -1457.4 | -87.0 | 2 | BEARISH | -32.4 |
| SPRY ARS Pharmaceuticals, Inc. | $400M | -1.7 | -210.3 | -424.3 | -185.2 | 4.1 | 2 | BEARISH | -59.4 |
| MPLT MapLight Therapeutics, Inc. | $340M | -1.6 | -57.5 | -366.6 | — | — | 2 | BEARISH | — |
| SPHDF Santhera Pharmaceuticals Holding AG | $280M | -6.6 | 729.6 | 111.3 | -44.5 | 106.3 | 7 | BEARISH | 49.1 |
| VOGX Vogenx Inc. | $260M | — | — | — | — | — | — | BEARISH | — |
| ORYZF Oryzon Genomics S.A. | $250M | -80.4 | -3.0 | -7.2 | -1.6 | 12.6 | 4 | BEARISH | -14.1 |
| VNDA Vanda Pharmaceuticals Inc. | $240M | -0.9 | -77.8 | -201.0 | -123.7 | 6.0 | 3 | BEARISH | -28.2 |
| LRMR Larimar Therapeutics, Inc. | $240M | -1.2 | -139.6 | 590.9 | — | — | 2 | BEARISH | -43.3 |
| HLOSF Healios K.K. | $240M | 56.3 | 3.7 | -129.2 | 17028.6 | -47.1 | 4 | BEARISH | -48.6 |
| LXEO Lexeo Therapeutics, Inc. Common Stock | $230M | -2.5 | -46.8 | -249.1 | — | — | 3 | BEARISH | -70.0 |
| IPHYF Innate Pharma S.A. | $210M | -2.5 | 267.9 | 119.2 | -343.8 | 32.0 | 3 | BEARISH | -24.5 |
| BBOT BridgeBio Oncology Therapeutics Inc. | $210M | -0.0 | -56.4 | -157.3 | — | — | 1 | BEARISH | -75.7 |
| ELDN Eledon Pharmaceuticals, Inc. | $190M | -2.4 | -110.7 | 411.1 | — | — | 2 | BEARISH | -32.8 |
| BIOA BioAge Labs Inc. | $190M | -2.3 | -28.2 | -142.3 | -1064.7 | 168.1 | 4 | BEARISH | -37.2 |
| EVMN Evommune, Inc. | $190M | -1.5 | -29.6 | -82.4 | — | — | 2 | BEARISH | — |
| AKBA Akebia Therapeutics, Inc. | $160M | -6.1 | -109.4 | 15.6 | -18.1 | 7.5 | 6 | BEARISH | -78.4 |
| ZNTL Zentalis Pharmaceuticals, Inc. | $160M | -0.8 | -83.7 | -2245.4 | — | -100.0 | 2 | BEARISH | 26.2 |
| NBP NovaBridge Biosciences | $160M | -2.2 | -45.7 | -617.8 | — | — | 1 | BEARISH | -72.2 |
| NGEN NervGen Pharma Corp. Common stock | $150M | — | — | — | — | — | — | BEARISH | — |
| MDWD MediWound Ltd. | $150M | -7.7 | -72.4 | -255.1 | -239.1 | -40.3 | 2 | BEARISH | -34.8 |
| TARA Protara Therapeutics, Inc. | $140M | -1.8 | -45.8 | -41.3 | — | — | 2 | BEARISH | -54.5 |
| NKTX Nkarta, Inc. | $130M | -1.1 | -38.8 | -75.4 | — | — | 1 | BEARISH | -8.0 |
| MENS Jyong Biotech Ltd. Ordinary Shares | $130M | — | — | — | — | — | — | BEARISH | -97.0 |
| AVXL Anavex Life Sciences Corp. | $120M | -4.9 | -23.6 | 411.7 | — | — | 2 | BEARISH | -85.3 |
| UNCY Unicycive Therapeutics, Inc. | $110M | -2.1 | -101.1 | 349.9 | — | — | 4 | BEARISH | -26.3 |
| CBUS Cibus, Inc. | $110M | -0.8 | -225.9 | -157.2 | -2227.9 | -10.3 | 2 | BEARISH | -11.4 |
| LENZ LENZ Therapeutics, Inc. | $100M | -0.8 | -59.2 | 17313.3 | -581.8 | 329.5 | 3 | BEARISH | -90.0 |
| ORPOF OSE Immunotherapeutics S.A. | $100M | — | — | — | — | — | — | BEARISH | — |
| TNYA Tenaya Therapeutics, Inc. | $90M | -0.7 | -121.9 | 1769.3 | -3909.3 | — | 3 | BEARISH | -75.7 |
| TNXP Tonix Pharmaceuticals Holding Corp. | $90M | -0.4 | -81.8 | -276.2 | -299.4 | 196.0 | 3 | BEARISH | -71.5 |
| CNXU Conexeu Sciences Inc. | $90M | — | — | — | — | — | — | BEARISH | — |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | $80M | -0.6 | -95.6 | 738.2 | — | — | 1 | BEARISH | -77.0 |
| MIST Milestone Pharmaceuticals Inc. | $80M | -1.0 | -35522.6 | 587.8 | -5118.8 | — | 5 | BEARISH | -67.0 |
| JWCTF JW (Cayman) Therapeutics Co. Ltd | $80M | -2.3 | -49.0 | -68.1 | -45.3 | 60.7 | 3 | BEARISH | -55.3 |
| PMN ProMIS Neurosciences, Inc. | $70M | -0.6 | -172.3 | 844.3 | — | — | 2 | BEARISH | -24.9 |
| MAIA MAIA Biotechnology, Inc. | $70M | -1.9 | -218.7 | 330.4 | — | — | 3 | BEARISH | -24.0 |
| CGTX Cognition Therapeutics, Inc. | $70M | -3.9 | -83.8 | 6061.8 | — | — | 3 | BEARISH | -59.1 |
| CRBU Caribou Biosciences, Inc. | $60M | -0.4 | -78.3 | -695.0 | -1619.9 | 10.0 | 3 | BEARISH | -80.3 |
| TLSA Tiziana Life Sciences Ltd | $60M | -4.3 | -780.6 | 375.0 | — | — | 1 | BEARISH | -53.6 |
| GOSS Gossamer Bio, Inc. | $60M | -0.2 | 178.7 | 117.2 | 182.9 | 32.4 | 3 | BEARISH | -94.5 |
| HBPCF Helix BioPharma Corp. | $60M | -23.6 | -50.8 | -21.5 | — | — | 3 | BEARISH | -55.5 |
| INO Inovio Pharmaceuticals, Inc. | $60M | -0.8 | -409.9 | 257.7 | — | -100.0 | 1 | BEARISH | -61.3 |
| VTIAF FamiCord AG | $50M | -6.4 | -84.3 | -13.6 | -5.1 | 0.1 | 5 | BEARISH | -43.6 |
| PLRX Pliant Therapeutics, Inc. | $50M | -0.6 | -50.3 | -438.3 | — | — | 3 | BEARISH | -51.4 |
| GANX Gain Therapeutics, Inc. | $50M | -2.4 | -268.3 | 1288.8 | — | — | 4 | BEARISH | -41.6 |
| HYFT MindWalk Holdings Corp. | $50M | -4.4 | -123.5 | -481.3 | -158.7 | -15.9 | 4 | BEARISH | -25.3 |
| DWTX Dogwood Therapeutics, Inc. | $40M | -0.1 | -47.8 | -39.7 | — | — | 2 | BEARISH | -80.2 |
| ALDX Aldeyra The | $40M | -1.6 | -49.5 | 269.3 | — | — | 4 | BEARISH | -87.5 |
| RANI Rani Therapeutics Holdings, Inc. | $40M | -2.2 | -179.1 | 245.5 | -432.7 | 306.4 | 5 | BEARISH | -70.8 |
| IGC IGC Pharma, Inc. | $30M | -3.0 | -129.2 | -127.6 | -1107.9 | -15.4 | 1 | BEARISH | -33.7 |
| FLNA Filana Therapeutics, Inc. | $30M | -0.7 | -13.5 | 38.9 | — | — | 2 | BEARISH | — |
| IXHL Incannex Healthcare Limited | $30M | -2.4 | -31.9 | 5284.2 | — | -100.0 | 4 | BEARISH | -74.5 |
| MCRB Seres Therapeutics, Inc. | $20M | -0.8 | -66.6 | -87.8 | 622.4 | — | 3 | BEARISH | -88.8 |
| ATYR aTyr Pharma, Inc. | $20M | -0.2 | -98.4 | -1890.1 | — | — | 2 | BEARISH | -84.2 |
| TCRX TScan Therapeutics, Inc. | $10M | -0.2 | -95.8 | -159.4 | -2888.6 | 2.2 | 2 | BEARISH | -91.9 |
| RDTCF Rapid Dose Therapeutics Corp. | $10M | -4.2 | 49.3 | 80.2 | -86.2 | 4.3 | 4 | BEARISH | -58.4 |
| GUTS Fractyl Health, Inc. | $10M | -0.1 | 1063.0 | -568.7 | — | -100.0 | 5 | BEARISH | -93.5 |
| TPST Tempest Therapeutics, Inc. | $10M | -0.1 | -931.1 | -564.2 | — | — | 1 | BEARISH | -95.1 |
| HIND Vyome Holdings, Inc. | $10M | -0.1 | -193.1 | 516.3 | -2543.3 | -98.0 | 4 | BEARISH | -68.7 |
| ACTU Actuate Therapeutics Inc | $10M | -0.4 | 2457.6 | 541.3 | — | — | 3 | BEARISH | -92.7 |
| QNRX Quoin Pharmaceuticals, Ltd. | $10M | -0.3 | -578.6 | 221.3 | — | — | 1 | BEARISH | -70.1 |
| NCNA NuCana plc | $10M | -0.3 | -70.7 | -739.9 | — | — | 4 | BEARISH | -75.2 |
| GSGTF GenSight Biologics S.A. | $10M | -1.0 | 46.5 | 47.3 | 1190.6 | -401.7 | 3 | BEARISH | -57.9 |
| INTS Intensity Therapeutics, Inc. | $10M | -0.7 | -195.9 | 4123.4 | — | — | 5 | BEARISH | -46.8 |
| PXXLF Poxel S.A. | $10M | -0.4 | 34.8 | 129.6 | -624.6 | 41.5 | 4 | BEARISH | -12.0 |
| TOVX Theriva Biologics, Inc. | $10M | -0.3 | -101.9 | -213.5 | — | — | 2 | BEARISH | -43.5 |
| QNTM Quantum BioPharma Ltd. | $10M | -0.4 | -425.3 | 175.1 | — | — | 4 | BEARISH | -84.7 |
| CDIO Cardio Diagnostics Holdings, Inc. | $10M | -0.6 | -75.4 | -230.9 | -28012.5 | -25.9 | 3 | BEARISH | -56.6 |
| VTGN VistaGen Therapeutics, Inc. | $10M | -0.1 | -166.5 | 851.1 | -882.8 | 287.3 | 4 | BEARISH | -95.8 |
| OPTBF OptiBiotix Health Plc | $10M | -1.4 | -102.1 | -102.1 | -231.5 | -12.9 | 4 | BEARISH | 109900.0 |
| DARE Dare Bioscience, Inc. | $10M | -0.8 | 165.3 | 136.8 | -1590.4 | 7816.7 | 3 | BEARISH | -69.2 |
| RASP Actavia Life Sciences, Inc. | — | -0.1 | 20.1 | 14.5 | — | — | 2 | BEARISH | -87.5 |
| LIMN Liminatus Pharma, Inc. Class A Common Stock | — | -0.1 | 294.4 | 252.1 | — | — | 4 | BEARISH | -95.5 |
| NAVBQ Navidea Biopharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| SUVZ Suvanza Pharma, LLC | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HCWB HCW Biologics Inc. | — | -0.0 | -133.5 | -36.8 | -3849.9 | 707.0 | 3 | BEARISH | -95.3 |
| KAPA Kairos Pharma, Ltd. | — | -0.3 | -114.0 | -301.0 | — | — | 3 | BEARISH | -93.0 |
| GOVX GeoVax Labs, Inc. | — | -0.0 | -891.6 | 1530.7 | — | -100.0 | 3 | BEARISH | -98.5 |
| VBIO Valion Bio, Inc. | — | -0.0 | -240.8 | -48.0 | — | -281.4 | 2 | BEARISH | — |
| TNGNQ Tengion, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CELZ Creative Medical Technology Holdings, Inc. | — | -0.3 | -78.0 | 8335.2 | — | -50.0 | 2 | BEARISH | -82.2 |
| ENDV Endonovo Therapeutics, Inc. | — | -0.2 | 9.2 | 4.5 | — | -100.0 | 3 | BEARISH | -99.3 |
| VPRO Viropro Inc. | — | -0.0 | -19.7 | -4.8 | -269.7 | 155.0 | 2 | BEARISH | 0.0 |
| ZVSA ZyVersa Therapeutics, Inc. | — | -0.0 | 817.1 | 242.0 | — | -100.0 | 1 | BEARISH | -99.3 |
| EVFM Evofem Biosciences, Inc. | — | -0.1 | 20.1 | 26.0 | -419.1 | 4.5 | 2 | BEARISH | -30.7 |
| NBRVF Nabriva Therapeutics plc | — | — | — | — | — | — | — | BEARISH | 0.0 |
| KALA KALA BIO, Inc. | — | -0.0 | -345.3 | -913.5 | — | -100.0 | 4 | BEARISH | -99.5 |
| WSNAF Wesana Health Holdings Inc. | — | -0.1 | 1113.6 | 90.8 | — | — | 3 | BEARISH | -82.5 |
| BNIGF Beroni Group Limited | — | -0.1 | -1153.4 | -274.8 | -15945.7 | 40.9 | 5 | BEARISH | 0.0 |
| SILO Silo Pharma, Inc. | — | -0.2 | -91.2 | 645.1 | — | -25.0 | 3 | BEARISH | 107.8 |
| ENLV Enlivex Therapeutics Ltd. | — | 0.0 | 209.7 | -0.4 | — | — | 5 | BEARISH | -99.0 |
| EVGN Evogene Ltd. | — | -0.4 | 265.3 | 101.3 | -509.5 | -80.4 | 3 | BEARISH | -70.2 |
| XENO Xeno Transplants Corporation | — | -0.0 | -286.5 | 78.1 | — | — | 1 | BEARISH | 0.0 |
| ZHCLF Zenith Capital Corp. | — | -0.2 | 35107.2 | 37766.2 | -360.0 | — | 3 | BEARISH | 3233.3 |
| PMCB PharmaCyte Biotech, Inc. | — | -0.1 | -44.0 | 793.8 | — | — | 2 | BEARISH | -63.5 |
| MLECW Moolec Science S.A. | — | -0.0 | -174.7 | -31.5 | -91.8 | 170.4 | 3 | BEARISH | -27.4 |
| GENSF Genus plc | $1.8B | 5.4 | 45.4 | 9.0 | 80.4 | -3.8 | 5 | BEARISH | -19.4 |
| MLYS Mineralys Therapeutics, Inc. | $1.8B | -4.9 | -80.9 | 2274.6 | — | — | 2 | BEARISH | -49.6 |
| OCUL Ocular Therapeutix, Inc. | $1.4B | -4.7 | -73.0 | -31671.3 | -584.5 | -8.1 | 3 | BEARISH | -43.4 |
| GPCR Structure Therapeutics Inc. | $1.2B | -7.1 | -20.2 | -1134.3 | — | — | 3 | BEARISH | -20.6 |
| SVRA Savara Inc. | $870M | -8.4 | -105.5 | -15438.9 | — | — | 2 | BEARISH | 9.7 |
| IVEVF Inventiva S.A. | $750M | -6.2 | -988.4 | -371.6 | -347346.6 | -99.7 | 3 | BEARISH | -22.8 |
| ATTO Attovia Therapeutics, Inc. | $630M | -15.3 | -294.4 | -1137.2 | -4597.1 | -50.5 | 4 | BEARISH | 226.6 |
| PROK ProKidney Corp. | $470M | -2.7 | 9.2 | 13.2 | -18948.0 | 55.2 | 1 | BEARISH | -57.4 |
| PHAT Phathom Pharmaceuticals, Inc. | $460M | -4.7 | 26.4 | 8.9 | -23.7 | 110.2 | 4 | BEARISH | -56.4 |
| FTH Faeth Therapeutics, Inc. | $440M | — | — | — | — | — | — | BEARISH | — |
| RGNX REGENXBIO Inc. | $440M | -1.7 | -137.6 | -368.4 | 21.0 | 12.0 | 2 | BEARISH | -47.7 |
| ALLO Allogene Therapeutics, Inc. | $430M | -1.9 | -42.4 | -81.9 | -919.8 | — | 5 | BEARISH | 0.0 |
| ALT Altimmune, Inc. | $410M | -2.6 | -28.9 | -43.1 | — | 55.0 | 4 | BEARISH | -47.0 |
| ASMB Assembly Biosciences, Inc. | $400M | 37.0 | -0.0 | 56.2 | -28.8 | 125.1 | 4 | BEARISH | -28.5 |
| TECX Tectonic Therapeutic, Inc. | $390M | -4.5 | -33.8 | -6371.3 | — | — | 1 | BEARISH | 14.7 |
| AVTX Avalo Therapeutics, Inc. | $370M | -1.4 | -36.3 | -148.4 | — | -86.6 | 4 | BEARISH | -62.2 |
| CAPR Capricor Therapeutics, Inc. | $340M | -2.5 | -73.7 | -107.5 | — | -100.0 | 3 | BEARISH | -6.4 |
| KYTX Kyverna Therapeutics, Inc. | $330M | -1.9 | -87.2 | 14267.8 | — | — | 2 | BEARISH | -17.7 |
| FULC Fulcrum Therapeutics, Inc. | $280M | -3.1 | -32.4 | 2389.1 | — | — | 4 | BEARISH | -59.3 |
| CTNM Contineum Therapeutics, Inc. | $270M | -5.2 | -28.0 | -541.6 | — | — | 4 | BEARISH | -26.8 |
| ACIU AC Immune S.A. | $250M | -4.2 | -78.5 | 96.7 | 12.4 | -39.5 | 2 | BEARISH | -17.8 |
| ABEO Abeona Therapeutics Inc. | $250M | -3.9 | -43.1 | -5983.3 | -177.4 | 6280.0 | 2 | BEARISH | -20.5 |
| CABA Cabaletta Bio, Inc. | $250M | -0.9 | -93.2 | -1308.0 | — | — | 3 | BEARISH | -44.0 |
| SCTX Scribe Therapeutics Inc. | $250M | — | — | — | — | — | — | BEARISH | — |
| OCGN Ocugen, Inc. | $250M | -2.9 | 1211.7 | 190.2 | -1671.8 | -3.7 | 2 | BEARISH | -53.0 |
| PALI Palisade Bio, Inc. | $230M | -2.3 | -51.4 | 815.6 | -2114.8 | — | 5 | BEARISH | -30.5 |
| NAGE Niagen Bioscience Inc | $190M | 12.9 | 21.8 | 44.7 | 3.2 | 11.0 | 6 | BEARISH | -67.1 |
| IVVD Invivyd, Inc. | $180M | -1.5 | -95.9 | -302.5 | -310.8 | 26.3 | 2 | BEARISH | -70.0 |
| SION Sionna Therapeutics, Inc. | $160M | -1.8 | -32.3 | -137.7 | — | — | 0 | BEARISH | -90.7 |
| UPB Upstream Bio, Inc. | $150M | -1.0 | -46.0 | -1266.4 | -5136.1 | 49.2 | 3 | BEARISH | -84.1 |
| STRO Sutro Biopharma, Inc. | $150M | -0.5 | 266.8 | 43.6 | -391.6 | -56.3 | 4 | BEARISH | -16.1 |
| CNTN Canton Strategic Holdings Inc | $150M | -1.2 | -14.6 | -7.2 | -1287.2 | — | 2 | BEARISH | — |
| CMPX Compass Therapeutics, Inc. | $140M | -1.8 | -56.7 | 1526.3 | — | — | 4 | BEARISH | -80.8 |
| VYGR Voyager Therapeutics, Inc. | $110M | -1.0 | -54.1 | -131.1 | -773.2 | -19.1 | 2 | BEARISH | -61.5 |
| NERV Minerva Neurosciences, Inc. | $110M | -0.1 | 337.5 | 10.0 | — | — | 1 | BEARISH | -54.8 |
| VTVT vTv Therapeutics Inc. | $100M | -236.4 | -11.7 | 91.2 | — | 216600.0 | 4 | BEARISH | 23.9 |
| CLLS Cellectis S.A. | $100M | -1.7 | -94.6 | 118.6 | -417.3 | 0.5 | 2 | BEARISH | -73.2 |
| ENGN enGene Holdings Inc. | $100M | -5.6 | -2.3 | 134.1 | — | -100.0 | 2 | BEARISH | -79.9 |
| GNLX Genelux Corporation | $90M | -2.2 | -168.9 | 20537.7 | — | — | 2 | BEARISH | -75.2 |
| CRDF Cardiff Oncology, Inc. | $70M | -1.5 | -94.1 | 443.4 | -8876.9 | -7.0 | 3 | BEARISH | -63.6 |
| PTHS Pelthos Therapeutics Inc. | $70M | -0.3 | 4767.3 | -97.0 | -150.1 | — | 2 | BEARISH | -55.4 |
| VRCA Verrica Pharmaceuticals Inc. | $60M | -2.0 | 473.3 | 437.4 | -224.4 | 106.2 | 5 | BEARISH | -13.4 |
| XBIT XBiotech Inc. | $60M | -1.3 | -29.9 | -201.2 | — | — | 2 | BEARISH | -26.0 |
| IBIO iBio, Inc. | $50M | -2.3 | -65.7 | 21688.6 | — | -75.0 | 4 | BEARISH | -44.3 |
| RNTX Rein Therapeutics Inc. | $50M | -0.4 | -753.6 | 53.9 | — | — | 3 | BEARISH | -53.7 |
| EXOZ eXoZymes, Inc. | $40M | -3.3 | -187.2 | 913.0 | — | — | 2 | BEARISH | -69.0 |
| VERU Veru Inc. | $40M | -3.8 | -62.3 | -211.2 | — | -100.0 | 3 | BEARISH | -40.6 |
| ANVS Annovis Bio, Inc. | $40M | -0.6 | -703.7 | 170.2 | — | — | 1 | BEARISH | -52.6 |
| KLRS Kalaris Therapeutics Inc | $40M | -0.9 | -79.9 | 109.5 | — | — | 0 | BEARISH | -63.2 |
| ACET Adicet Bio, Inc. | $40M | -0.3 | -78.1 | -553.5 | — | — | 4 | BEARISH | -71.4 |
| TIL Instil Bio, Inc. | $40M | -1.3 | -25.3 | -69.1 | — | — | 4 | BEARISH | -70.7 |
| MREO Mereo BioPharma Group plc | $40M | -1.6 | -67.8 | 6194.3 | — | -100.0 | 2 | BEARISH | -86.2 |
| ALGS Aligos Therapeutics, Inc. | $30M | -0.7 | -113.6 | -1246.4 | -5.4 | 893.0 | 2 | BEARISH | -51.0 |
| EDSA Edesa Biotech, Inc. | $30M | -1.6 | -122.9 | 759.6 | — | — | 1 | BEARISH | -3.7 |
| AARD Aardvark Therapeutics, Inc. Common Stock | $30M | -0.4 | -66.0 | -3642.4 | — | — | 1 | BEARISH | -90.0 |
| BSEM BioStem Technologies, Inc. | $30M | -0.9 | -74.7 | -84.3 | -113.6 | -119.6 | 2 | BEARISH | -68.3 |
| NRXBF NurExone Biologic Inc. | $30M | — | — | — | — | — | — | BEARISH | — |
| EYPT EyePoint Pharmaceuticals, Inc. | $30M | -0.1 | -148.7 | -3014.8 | -18633.1 | -94.6 | 2 | BEARISH | -96.8 |
| BCTX BriaCell Therapeutics Corp. | $30M | -0.3 | -179.9 | -2435.2 | — | — | 2 | BEARISH | -73.4 |
| MGX Metagenomi, Inc. Common Stock | $30M | -0.3 | -60.6 | -268.2 | 10693.4 | -59.8 | 1 | BEARISH | -72.4 |
| GRCE Grace Therapeutics, Inc. | $30M | -1.4 | -38.4 | -58.9 | — | — | 2 | BEARISH | -42.5 |
| BXPHF Botanix Pharmaceuticals Limited | $20M | -0.3 | -96.3 | -131.6 | -203.1 | 495.6 | 4 | BEARISH | -89.6 |
| KYNB Kyntra Bio, Inc. | $20M | 0.1 | -115.2 | 29.6 | -812.3 | — | 2 | BEARISH | — |
| MVMDF More Life Company Corp. | $20M | -5.2 | -167.0 | -602.2 | -5006.5 | 43.0 | 4 | BEARISH | 119.2 |
| MSLE Satellos Bioscience Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| FBLG FibroBiologics, Inc. Common Stock | $10M | -0.2 | -660.1 | -511.6 | — | — | 4 | BEARISH | -88.9 |
| INAB IN8bio, Inc. | $10M | -0.5 | -111.1 | -576.1 | — | — | 4 | BEARISH | -54.0 |
| APRE Aprea Therapeutics, Inc. | $10M | -0.5 | -47.4 | 378.1 | — | -99.8 | 2 | BEARISH | -71.6 |
| PTN Palatin Technologies, Inc. | $10M | -0.9 | -877.5 | 1176.9 | -1449.1 | — | 5 | BEARISH | -18.3 |
| AIMD Ainos, Inc. | $10M | -0.3 | -196.3 | -69.4 | -3022849.3 | -87.7 | 1 | BEARISH | -78.4 |
| TRAW Traws Pharma, Inc. | $10M | -0.7 | -711.4 | 133.9 | — | -100.0 | 1 | BEARISH | -87.0 |
| BCDA BioCardia, Inc. | $10M | -1.2 | -1803.2 | 519.4 | — | — | 3 | BEARISH | -35.6 |
| ACXP Acurx Pharmaceuticals, Inc. | $10M | -0.3 | -128.1 | 241.9 | — | — | 3 | BEARISH | -83.2 |
| BLRX BioLineRx Ltd. | $10M | -1.1 | -63.5 | -113.0 | -1029.3 | -94.3 | 3 | BEARISH | -45.1 |
| MTVA MetaVia Inc. | $10M | -0.3 | -175.7 | 209.3 | — | — | 0 | BEARISH | -88.5 |
| TVRD Tvardi Therapeutics, Inc. | $10M | -0.3 | -126.2 | 296.9 | — | — | 1 | BEARISH | -83.7 |
| GTBP GT Biopharma, Inc. | $10M | -0.1 | -798.9 | 927.8 | — | — | 2 | BEARISH | -72.2 |
| PHIO Phio Pharmaceuticals Corp. | $10M | -0.6 | -113.7 | 2701.6 | — | — | 2 | BEARISH | -60.3 |
| RVPH Reviva Pharmaceuticals Holdings, Inc. | $10M | -0.1 | -32.2 | 45.6 | — | — | 4 | BEARISH | -25.0 |
| CODX Co-Diagnostics, Inc. | — | -0.0 | -174.8 | -218.8 | -3782.4 | -28.1 | 3 | BEARISH | -94.5 |
| FAMDF Futura Medical plc | — | -0.3 | -145.8 | -370.5 | -72.8 | -70.7 | 2 | BEARISH | -88.2 |
| PPBT Purple Biotech Ltd. | — | -0.0 | -111.3 | -99.1 | — | — | 2 | BEARISH | 75.0 |
| GNPX Genprex, Inc. | — | -0.0 | -203.9 | 3484.8 | — | — | 4 | BEARISH | -99.1 |
| OGEN Oragenics, Inc. | — | -0.1 | -1307.1 | 4273.7 | — | — | 3 | BEARISH | -68.9 |
| LABT Lakewood-Amedex Biotherapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| MBAI MBody AI Ltd. | — | — | — | — | — | — | — | BEARISH | — |
| DCOY Decoy Therapeutics Inc. | — | — | — | — | — | — | — | BEARISH | — |
| NSHSF NanoSphere Health Sciences Inc. | — | 9.5 | 4.6 | 11.1 | — | — | 0 | BEARISH | 0.0 |
| ELAB PMGC Holdings Inc. | — | -0.0 | -73.0 | -66.6 | -225.1 | 408.6 | 3 | BEARISH | -100.0 |
| VRXAW Veraxa Biotech AG | — | — | — | — | — | — | — | BEARISH | — |
| CLDI Calidi Biotherapeutics, Inc. | — | -0.0 | -713.6 | -1404.6 | — | — | 4 | BEARISH | -97.4 |
| MBIO Mustang Bio, Inc. | — | -0.8 | -58.1 | 36.6 | — | — | 2 | BEARISH | -75.0 |
| SCPX Scorpius Holdings, Inc. | — | -0.0 | 0.0 | 0.0 | -428.3 | -75.5 | 0 | BEARISH | -66.7 |
| MDCX Medicus Pharma Ltd. Common Stock | — | -0.0 | -3904.0 | -693.1 | — | — | 3 | BEARISH | -97.9 |
| NRSN NeuroSense Therapeutics Ltd. | — | -0.3 | 779.3 | 571.3 | — | — | 3 | BEARISH | -89.7 |
| ZLDAF Zelira Therapeutics Limited | — | -1.6 | 80.8 | 147.8 | -185107971.7 | -99.3 | 1 | BEARISH | -15.5 |
| CANF Can-Fite BioPharma Ltd. | — | -0.3 | -184.2 | 353.7 | -2277.7 | -40.1 | 2 | BEARISH | -82.4 |
| CRIS Curis, Inc. | — | -0.0 | 455.3 | -23281.0 | — | -62.2 | 3 | BEARISH | -98.8 |
| NIKI Niki BioSolutions, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| OXBOF Oxford BioDynamics Plc | — | -0.3 | -214.9 | -155.8 | -649.8 | 33.6 | 3 | BEARISH | -85.9 |
| XSNX NovAccess Global Inc. | — | -0.0 | 27.7 | 18.0 | — | — | 3 | BEARISH | 0.0 |
| INMB INmune Bio, Inc. | $40M | -2.2 | -74.8 | -475.4 | — | -100.0 | 2 | BEARISH | -20.1 |
| CCEL Cryo-Cell International, Inc. | $40M | -22.2 | 18.1 | -0.7 | 16.2 | -2.0 | 6 | BULLISH | 12.8 |
| HBIO Harvard Bioscience, Inc. | $40M | -3.6 | -89.9 | 1.8 | -12.8 | -1.1 | 7 | BULLISH | 105.9 |
| NVYTF Novacyt S.A. | $40M | -0.8 | -59.6 | -45.1 | -50.1 | -44.9 | 3 | NEUTRAL | 14.0 |
| NEPH Nephros, Inc. | $40M | 20.9 | 16.1 | 20.0 | 19.9 | 24.2 | 5 | NEUTRAL | -30.4 |
| SNWV SANUWAVE Health Inc. | $40M | 3.0 | -238.8 | 4.8 | -7.0 | 12.0 | 7 | LEAN BEAR | -83.8 |
| TCLIF Theraclion S.A. | $40M | -6.3 | -342.1 | 1171.9 | -543.9 | 61.2 | 2 | LEAN BEAR | 312841.2 |
| WORX SCWorx Corp. | $40M | -0.4 | -38.1 | -8.2 | -17.1 | 3.1 | 6 | BEARISH | 374.5 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $40M | 118.8 | 228.3 | 11.8 | -21.1 | 6.2 | 3 | BEARISH | 0.0 |
| VEXTF Vext Science, Inc. | $40M | -2.3 | -23.2 | -8.7 | -2.6 | 14.2 | 5 | BEARISH | -18.4 |
| TELA TELA Bio, Inc. | $40M | -1.3 | 1232.5 | -260.3 | -58.4 | 6.1 | 3 | BEARISH | -34.1 |
| IDXG Interpace Biosciences, Inc. | $40M | 0.2 | 221.9 | 123.7 | 1.7 | -20.3 | 6 | BEARISH | 18.0 |
| VRHI Veri Medtech Holdings Inc. | $40M | — | — | — | — | — | — | BEARISH | — |
| SNZZF Senzime AB (publ) | $40M | -4.0 | -35.1 | -36.2 | -86.6 | 27.1 | 3 | BEARISH | -63.8 |
| DRIO DarioHealth Corp. | $40M | 4.9 | 113.8 | -93.8 | -153.1 | -22.6 | 3 | BEARISH | -77.4 |
| RPID Rapid Micro Biosystems, Inc. | $40M | -0.7 | -141.6 | -183.2 | -160.5 | 16.1 | 2 | BEARISH | -71.7 |
| EUDA EUDA Health Holdings Limited | $40M | -6.6 | -50.6 | -26.7 | -22.9 | 49.4 | 5 | BEARISH | -66.4 |
| CVRX CVRx, Inc. | $40M | -0.7 | -133.4 | -260.4 | -89.4 | 12.0 | 3 | BEARISH | -85.6 |
| BMKDF BioMark Diagnostics Inc. | $40M | -34.8 | -149.8 | -103.7 | -5198.4 | -82.1 | 2 | BEARISH | 37.1 |
| OTCFF Ocumetics Technology Corp. | $40M | -6.8 | 174.3 | 2137.7 | — | — | 1 | BEARISH | -65.2 |
| XTNT Xtant Medical Holdings, Inc. | $40M | -3.5 | -25.2 | -14.8 | -40.9 | -14.3 | 4 | BEARISH | -63.2 |
| INMB INmune Bio, Inc. | $40M | -2.2 | -74.8 | -475.4 | — | -100.0 | 2 | BEARISH | -20.1 |
| AMN AMN Healthcare Services, Inc. | $1.9B | 17.2 | 15.6 | 8.9 | 3.1 | 24.0 | 8 | BULLISH | 145.7 |
| HCSG Healthcare Services Group, Inc. | $1.7B | 16.0 | 20.4 | 27.0 | 5.2 | 4.0 | 7 | BULLISH | 35.0 |
| ARDT Ardent Health Inc. | $1.7B | 21.6 | 6.0 | 13.5 | 1.0 | 3.3 | 5 | BULLISH | -17.6 |
| CERT Certara, Inc. | $1.6B | -24.5 | -6.7 | 0.6 | -59.3 | 0.7 | 6 | BULLISH | -15.1 |
| MRCHF H.U. Group Holdings, Inc. | $1.3B | 22.0 | 7.2 | 3.3 | 2.5 | 1.8 | 9 | BULLISH | -7.4 |
| LTGHY Life Healthcare Group Holdings Limited | $1.1B | 2.7 | 68.5 | 10.7 | 6.2 | -3.0 | 4 | BULLISH | 14.2 |
| HSTM HealthStream, Inc. | $1.1B | 47.8 | 6.0 | 6.5 | 8.0 | 8.8 | 8 | BULLISH | 31.7 |
| SGP SpyGlass Pharma, Inc. Common Stock | $950M | — | — | — | — | — | — | BULLISH | — |
| VSTM Verastem, Inc. | $910M | -4.1 | -471.2 | 6197.3 | -86.5 | 3995.7 | 4 | BULLISH | 28.0 |
| SOLTF Nxera Pharma Co., Ltd. | $770M | -15.8 | -12.0 | -1.7 | -2.6 | 7.5 | 4 | BULLISH | 41.9 |
| MOBI Mobia Medical, Inc. Common Stock | $350M | — | — | — | — | — | — | BULLISH | — |
| ANIK Anika Therapeutics, Inc. | $290M | -78.9 | -2.7 | -3.3 | 10.1 | 31.4 | 7 | BULLISH | 120.4 |
| OSUR OraSure Technologies, Inc. | $280M | -5.9 | -14.1 | -23.5 | 20.4 | -18.9 | 4 | BULLISH | 44.8 |
| GRDX GridAI Technologies Corp. | $40M | -1.4 | -55.6 | -51.7 | -14927.4 | 67.4 | 2 | BULLISH | 27.3 |
| INM InMed Pharmaceuticals Inc. | $10M | 14.5 | -129.6 | 732.1 | -0.2 | 37942.8 | 3 | BULLISH | -21.7 |
| GDRX GoodRx Holdings, Inc. | $1.2B | 65.6 | 2.5 | 3.5 | 4.3 | -1.8 | 6 | BULLISH | -7.8 |
| CBLL CeriBell, Inc. | $1.0B | -15.5 | -43.9 | -263.7 | -68.6 | 69.3 | 3 | BULLISH | 108.9 |
| BVS Bioventus Inc. | $1.0B | 18.1 | 28.0 | 21.3 | 21.8 | 3.1 | 7 | BULLISH | 111.5 |
| CTKB Cytek Biosciences, Inc. | $730M | -9.6 | -23.0 | -40.8 | -25.3 | 5.4 | 3 | BULLISH | 41.6 |
| AONC American Oncology Network, Inc. | $640M | -29.7 | 5.6 | -14.7 | 0.3 | 37.5 | 6 | BULLISH | 133.3 |
| KIDS OrthoPediatrics Corp. | $640M | -14.3 | -11.4 | -4.6 | -10.2 | 14.5 | 6 | BULLISH | 40.8 |
| EVH Evolent Health, Inc. | $540M | -1.0 | -79.0 | -1.8 | -4.3 | -4.5 | 5 | BULLISH | -39.6 |
| ENTX Entera Bio Ltd. | $510M | -8.8 | -138.9 | 314.4 | — | -100.0 | 1 | BULLISH | 33.6 |
| RCEL Avita Medical Inc. | $390M | -11.0 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | BULLISH | 277.6 |
| QSI Quantum-Si incorporated | $280M | -3.5 | -49.1 | -121.8 | -6841.3 | -53.0 | 3 | BULLISH | -33.6 |
| BIOYF BioSyent Inc. | $140M | 19.0 | 23.7 | 23.8 | 14.3 | 41.0 | 5 | BULLISH | 49.9 |
| ATNM Actinium Pharmaceuticals, Inc. | $50M | 4.0 | 45.9 | -197.8 | 79.7 | — | 3 | BULLISH | -2.1 |
| MCUJF Medicure Inc. | $30M | -6.3 | -49.9 | -54.9 | -19.2 | 38.3 | 4 | BULLISH | 305.1 |
| BIOE Bio Essence Corporation | $20M | 11.3 | -392.9 | 38.8 | 34.0 | 416.6 | 5 | BULLISH | 508.8 |
| OMCL Omnicell, Inc. | $1.7B | 42.8 | 3.1 | 3.2 | 7.8 | 8.5 | 9 | BULLISH | 19.7 |
| LWSCF Sienna Senior Living Inc. | $1.6B | 38.9 | 6.7 | 3.9 | 4.4 | 16.2 | 7 | BULLISH | 7.9 |
| PHR Phreesia, Inc. | $790M | 71.5 | 3.1 | 16.7 | 1.5 | 12.9 | 4 | BULLISH | -46.3 |
| XFOR X4 Pharmaceuticals, Inc. | $320M | -2.7 | -113.1 | -281.1 | -183.5 | -51.6 | 4 | BULLISH | 5.2 |
| INGN Inogen, Inc. | $190M | -7.9 | -13.1 | -27.8 | -4.0 | 3.2 | 5 | BULLISH | -20.9 |
| ESLA Estrella Immunopharma, Inc. | $40M | -3.8 | 148.1 | 102.1 | — | — | 3 | BULLISH | -60.6 |
| TNDM Tandem Diabetes Care, Inc. | $1.2B | -20.6 | -48.0 | -8.2 | -8.3 | -7.1 | 4 | BULLISH | 28.9 |
| STAA STAAR Surgical Company | $1.1B | 301.5 | 1.1 | 3.5 | 8.6 | 51.3 | 5 | BULLISH | -13.8 |
| LMRI Lumexa Imaging Holdings, Inc. Common Stock | $1.1B | -31.0 | -3.9 | 0.1 | 1.0 | — | 3 | BULLISH | — |
| NRC NRC Health | $490M | 82.2 | 42.0 | 9.9 | -9.3 | -0.2 | 6 | BULLISH | 42.5 |
| KRRO Korro Bio, Inc. | $180M | -1.3 | -97.7 | -196.6 | — | -62.1 | 2 | BULLISH | -68.0 |
| HURA TuHURA Biosciences, Inc. | $140M | -3.8 | -161.4 | -137.6 | — | — | 2 | BULLISH | -8.5 |
| AVHHL AVITA Medical, Inc. | $360M | -11.0 | 211.5 | -292.6 | -35.3 | 1.0 | 4 | BULLISH | 149.1 |
| GRRMF Gerresheimer AG | $1.2B | -2.8 | 1.6 | 2.2 | -2.3 | 11.8 | 4 | BULLISH | -27.1 |
| QDEL QuidelOrtho Corporation | $940M | -0.9 | -45.9 | -13.7 | -14.7 | 0.1 | 4 | BULLISH | -53.8 |
| TDVXF Dynavox Group AB (publ) | $900M | 27.8 | 39.7 | 17.2 | 12.8 | 8.8 | 8 | BULLISH | -22.7 |
| ZIVO ZIVO Bioscience, Inc. | $20M | -4.5 | 185.9 | 147.5 | — | -62.5 | 2 | BULLISH | -53.1 |
| SAEYY Redcare Pharmacy N.V. | $1.7B | -37.3 | -8.7 | -1.2 | 0.6 | 20.5 | 2 | BULLISH | -13.7 |
| KMTS Kestra Medical Technologies, Ltd. | $1.7B | -11.3 | -73.7 | -113.5 | -142.3 | 191.6 | 3 | BULLISH | 14.5 |
| AGL Agilon Health, Inc. | $1.5B | -5.9 | -78.9 | -273.7 | 1.2 | 0.3 | 6 | BULLISH | 266.8 |
| PNTG The Pennant Group, Inc. | $1.5B | 44.1 | 9.6 | 5.5 | 3.0 | 37.9 | 6 | BULLISH | 71.9 |
| PCRX Pacira BioSciences, Inc. | $1.4B | 103.4 | 2.0 | 1.8 | 2.4 | 5.7 | 8 | BULLISH | 68.0 |
| NWKHY Netcare Limited | $1.4B | 12.5 | 16.9 | 8.1 | 6.7 | 5.0 | 7 | BULLISH | 58.3 |
| USPH U.S. Physical Therapy, Inc. | $1.3B | 511.8 | -1.3 | 7.7 | 0.7 | 17.1 | 5 | BULLISH | -0.4 |
| ENOV Enovis Corporation | $1.2B | -1.1 | -54.3 | -13.5 | -0.2 | 4.9 | 4 | BULLISH | -35.1 |
| TDOC Teladoc Health, Inc. | $1.1B | -6.4 | -13.0 | -8.7 | -6.4 | -2.1 | 5 | BULLISH | -27.3 |
| ARRJF Arjo AB (publ) | $920M | 25.3 | 4.6 | 4.4 | 2.0 | -2.0 | 6 | BULLISH | 3.1 |
| RIGL Rigel Pharmaceuticals, Inc. | $900M | 2.8 | 126.9 | 88.5 | 22.0 | 3.3 | 4 | BULLISH | 69.9 |
| IOBCF Ion Beam Applications S.A. | $550M | 19.7 | 20.6 | 14.0 | 2.9 | 7.0 | 5 | BULLISH | 36.7 |
| VMD Viemed Healthcare, Inc. | $370M | 25.7 | 10.2 | 11.8 | 3.5 | 25.2 | 4 | BULLISH | 42.5 |
| CV CapsoVision, Inc. | $370M | -10.7 | -226.6 | -73.0 | -205.4 | — | 2 | BULLISH | 40.3 |
| RAPH Raphael Pharmaceutical Inc. | $30M | -30.7 | 59.9 | 47.0 | — | — | 2 | BULLISH | 277.5 |
| INFU InfuSystem Holdings, Inc. | $280M | 33.5 | 15.0 | 11.4 | 8.7 | 2.5 | 9 | BULLISH | 37.3 |
| IDGXF Integrated Diagnostics Holdings plc | $340M | 10.4 | 41.4 | 38.4 | 13.8 | 46.8 | 8 | BULLISH | 10.8 |
| CING Cingulate Inc. | $70M | -1.1 | -198.7 | -1452.8 | — | — | 4 | BULLISH | 44.7 |
| AGTX Agentix Corp. | — | -5.1 | 12.0 | 8.1 | — | — | 3 | BULLISH | 6.9 |
| PACB Pacific Biosciences of California, Inc. | $660M | -5.8 | -929.3 | -29.4 | -114.7 | 2.0 | 2 | BULLISH | 15.4 |
| ACUT Accustem Sciences Inc. | — | -1.4 | 49.7 | 34.0 | -256.7 | 2610.7 | 4 | BULLISH | -87.3 |
| XNCR Xencor, Inc. | $1.9B | -13.7 | -29.1 | -152.4 | -42.4 | -36.1 | 2 | BULLISH | 136.5 |
| TGLVY Top Glove Corporation Bhd. | $1.7B | 25.1 | 6.3 | 8.5 | 12.6 | 21.4 | 8 | BULLISH | 41.3 |
| KLRA Kailera Therapeutics, Inc. | $1.7B | — | — | — | — | — | — | BULLISH | — |
| TRAX First Tracks Biotherapeutics Inc | $1.6B | — | — | — | — | — | — | BULLISH | — |
| LBRX LB Pharmaceuticals Inc Common Stock | $1.2B | -13.4 | -25.8 | -768.9 | — | — | 2 | BULLISH | 148.4 |
| SIBN SI-BONE, Inc. | $960M | -63.3 | -8.3 | -32.2 | -7.3 | 15.3 | 6 | BULLISH | 38.1 |
| SLN Silence Therapeutics plc | $930M | -5.2 | -90.4 | 157.8 | — | -97.6 | 1 | BULLISH | 172.8 |
| KHTRF Knight Therapeutics Inc. | $810M | 76.5 | 1.9 | 2.6 | -2.3 | 42.4 | 8 | BULLISH | 98.5 |
| PBYI Puma Biotechnology, Inc. | $570M | 20.3 | 22.0 | 52.8 | 14.5 | -2.9 | 6 | BULLISH | 115.3 |
| OPRX OptimizeRx Corp. | $170M | 37.0 | 3.7 | 6.1 | -3.4 | -5.8 | 8 | BULLISH | -53.7 |
| MXCT MaxCyte, Inc. | $140M | -4.7 | -20.4 | -38.9 | -122.0 | -13.2 | 2 | BULLISH | -6.8 |
| CCEL Cryo-Cell International, Inc. | $40M | -22.2 | 18.1 | -0.7 | 16.2 | -2.0 | 6 | BULLISH | 12.8 |
| NEGXF NexgenRx Inc. | $30M | — | 30.1 | -9.7 | 19.7 | 12.0 | 4 | BULLISH | 120.0 |
| HBIO Harvard Bioscience, Inc. | $40M | -3.6 | -89.9 | 1.8 | -12.8 | -1.1 | 7 | BULLISH | 105.9 |
| IRLA IRulya Therapeutics Inc. | $30M | — | — | — | — | — | — | BULLISH | — |
| MBXBF Microbix Biosystems Inc. | $30M | -8.6 | -16.4 | -14.6 | -19.9 | -27.1 | 3 | BULLISH | 29.9 |
| TBIO Telesis Bio, Inc. | — | -0.0 | -180.9 | -154.3 | -424.1 | -54.9 | 3 | BULLISH | 250.9 |
| OPK OPKO Health, Inc. | $1.2B | -16.8 | -5.9 | -3.0 | -5.1 | -11.5 | 2 | BULLISH | 7.2 |
| MYGN Myriad Genetics, Inc. | $560M | -5.3 | -32.5 | -19.5 | -22.7 | -3.2 | 4 | BULLISH | -25.2 |
| BOLT Bolt Biotherapeutics, Inc. | $10M | -0.4 | -111.6 | -138.8 | -154400.0 | 12.8 | 3 | BULLISH | 14.4 |
| AZTR Azitra, Inc. | — | -0.1 | -256.7 | -959.6 | — | — | 5 | BULLISH | 118.9 |
| BDRX Biodexa Pharmaceuticals Plc | — | -0.1 | -42.3 | -117.9 | — | — | 2 | BULLISH | -89.2 |
| AZTA Azenta, Inc. | $1.6B | -14.3 | -7.7 | -1.4 | 1.5 | 1.5 | 4 | BULLISH | 14.8 |
| AHG Akso Health Group | $1.1B | -20.2 | -50.1 | -44.9 | -546.5 | 22.7 | 4 | BULLISH | -24.4 |
| OM Outset Medical, Inc. | $80M | -1.1 | -59.2 | -97.3 | -56.8 | -1.3 | 4 | BULLISH | -73.2 |
| CBDG THC Farmaceuticals, Inc. | — | -30.9 | 2.0 | -0.9 | — | 28.1 | 5 | BULLISH | -60.2 |
| PRCT PROCEPT BioRobotics Corporation | $1.1B | -10.2 | -30.2 | -47.6 | -28.4 | 22.7 | 2 | BULLISH | -42.7 |
| BBNX Beta Bionics, Inc. | $860M | -13.0 | -26.2 | -79.6 | -73.1 | 191.1 | 3 | BULLISH | 2.5 |
| PHAR Pharming Group N.V. | $710M | 81.8 | 3.6 | 3.2 | 1.8 | 7.8 | 7 | BULLISH | -19.6 |
| TCMD Tactile Systems Technology, Inc. | $540M | 21.4 | 11.9 | 13.8 | 9.1 | 17.2 | 8 | BULLISH | 56.5 |
| SI Shoulder Innovations, Inc. | $410M | -11.6 | -28.2 | -69.1 | -59.1 | — | 1 | BULLISH | 54.1 |
| INDP Indaptus Therapeutics, Inc. | $360M | -0.5 | -318.0 | 6437.4 | — | — | 4 | BULLISH | -5.9 |
| ANIX Anixa Biosciences, Inc. | $100M | -10.7 | -67.1 | -1110.2 | — | — | 3 | BULLISH | -29.9 |
| HLTRF HLS Therapeutics Inc. | $90M | -12.0 | -14.1 | -4.2 | -7.0 | -0.2 | 5 | BULLISH | -20.4 |
| NRXS NeurAxis, Inc. | $90M | -9.6 | -143.2 | 464.1 | -118.1 | 65.2 | 6 | BULLISH | 89.8 |
| BMGL Basel Medical Group Ltd Ordinary Shares | $10M | — | — | — | — | — | — | BULLISH | -75.8 |
| HYEX Healthy Extracts Inc. | $10M | -8.1 | -7.7 | -2.8 | -6.3 | 84.1 | 5 | BULLISH | -8.5 |
| OABIW OmniAb, Inc. | $1.1B | -13.8 | -16.9 | -16.8 | -43.7 | 66.9 | 6 | BULLISH | -42.2 |
| DMAC DiaMedica Therapeutics Inc. | $470M | -11.9 | -114.6 | 616.3 | — | — | 2 | BULLISH | 29.3 |
| SUSRF Surgical Science Sweden AB (publ) | $280M | 32.0 | 2.1 | 2.7 | 8.2 | 8.1 | 6 | BULLISH | -37.8 |
| SCNLF Scancell Holdings plc | $170M | -5.1 | 153.2 | 179.2 | — | -100.0 | 2 | BULLISH | 969.8 |
| ICCC ImmuCell Corporation | $90M | 124.9 | 2.6 | 10.2 | 25.5 | 8.5 | 6 | BULLISH | 69.0 |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. | $20M | -0.2 | -90.1 | -46.0 | — | — | 4 | BULLISH | 60.6 |
| SPTX Seaport Therapeutics, Inc. Common Stock | $1.1B | — | — | — | — | — | — | BULLISH | — |
| VTRLY Vitrolife AB (publ) | $1.4B | -3.1 | -46.2 | -41.3 | 14.3 | -2.0 | 5 | BULLISH | -33.7 |
| EMBC Embecta Corp. | $380M | 4.4 | -13.6 | 26.3 | 7.8 | -7.6 | 5 | BULLISH | -51.3 |
| IDTA IDenta Corp. | — | 9.8 | 13.8 | 25.0 | -9.1 | 57.3 | 8 | BULLISH | 76.8 |
| EBYH Strainsforpains, Inc. | — | -23.4 | -3.4 | 16.3 | -603.3 | 1679.9 | 5 | BULLISH | 54.5 |
| CASBF CanSino Biologics Inc. | $1.4B | 367.7 | 0.8 | -1.2 | 11.0 | 32.5 | 7 | BULLISH | -25.5 |
| TMCI Treace Medical Concepts, Inc. | $280M | -4.9 | -72.0 | -44.8 | -35.0 | -4.0 | 2 | BULLISH | -34.9 |
| CTSO Cytosorbents Corporation | $20M | -0.8 | -336.2 | -46.3 | -45.9 | 3.1 | 4 | BULLISH | -74.5 |
| GCTK GlucoTrack, Inc. | — | -0.0 | -620.6 | 427.4 | — | — | 2 | BULLISH | -98.4 |
| ODYY Odyssey Health, Inc. | — | -0.2 | 43.4 | 10.0 | — | -100.0 | 4 | BULLISH | -87.2 |
| ACUR Acura Pharmaceuticals, Inc. | — | -0.0 | 30.8 | -306.4 | 80.6 | -56.2 | 4 | BULLISH | 0.0 |
| BRVE Braveheart Bio, Inc. | $1.5B | — | — | — | — | — | — | BULLISH | — |
| TXTM ProText Mobility, Inc. | $90M | 90.0 | -0.4 | -0.3 | — | -100.0 | 1 | BULLISH | 377.3 |
| IMNN Imunon, Inc. | $10M | -0.2 | -429.7 | -226.7 | — | — | 2 | BULLISH | -75.0 |
| FZMD Fuse Medical, Inc. | — | 15.0 | -177.1 | -13.7 | 6.2 | -5.8 | 5 | BULLISH | -50.0 |
| HALB Halberd Corporation | — | -25.4 | 11.6 | 12.4 | — | -52.1 | 1 | BULLISH | -13.9 |
| SEPN Septerna Inc | $1.9B | -81.5 | -6.3 | -93.1 | -48.7 | 17878.5 | 5 | BULLISH | 89.9 |
| MAZE Maze Therapeutics, Inc. | $1.7B | -11.4 | -37.3 | -112.3 | — | — | 3 | BULLISH | 3.9 |
| COAG Hemab Therapeutics Holdings, Inc. Common Stock | $1.6B | — | — | — | — | — | — | BULLISH | — |
| PAHC Phibro Animal Health Corporation | $1.6B | 15.7 | 29.7 | 13.2 | 5.5 | 17.1 | 7 | BULLISH | -4.7 |
| CRMD CorMedix Inc. | $610M | 3.3 | 54.9 | 57.2 | 25.5 | 280.5 | 5 | BULLISH | -29.8 |
| VHIBF Vitalhub Corp. | $340M | 62.2 | 3.3 | 10.7 | 6.1 | 53.9 | 7 | BULLISH | -28.2 |
| PYPD PolyPid Ltd. | $110M | -3.9 | -1913.8 | 231.6 | — | — | 3 | BULLISH | 53.8 |
| PROCF Sofgen Pharma S.A. | $60M | — | — | — | — | — | — | BULLISH | — |
| BGMS Bio Green Med Solution, Inc. | $10M | -0.3 | -30.7 | -64.2 | -120.5 | — | 2 | BULLISH | -50.3 |
| ASTH Astrana Health, Inc. | $1.9B | 44.5 | 5.1 | 4.7 | 2.0 | 58.9 | 5 | BULLISH | 12.3 |
| MASS 908 Devices Inc. | $470M | -13.3 | -25.1 | -103.8 | -74.0 | 4.6 | 5 | BULLISH | 38.7 |
| ADCT ADC Therapeutics S.A. | $180M | -2.4 | 45.3 | 260.9 | -86.1 | 2.0 | 2 | BULLISH | -62.9 |
| POM Pomdoctor Limited | $10M | -0.1 | 48.5 | 554.8 | -124.2 | — | 3 | BULLISH | -75.5 |
| NYMXF Nymox Pharmaceutical Corporation | $10M | -0.9 | 193.9 | 89.4 | — | — | 2 | BULLISH | -62.8 |
| PRME Prime Medicine, Inc. | $670M | -4.0 | -373.3 | -271.3 | -3649.0 | -17.9 | 3 | BULLISH | -32.9 |
| JCRRF JCR Pharmaceuticals Co., Ltd. | $460M | 75.9 | 1.9 | -0.5 | -19.7 | 66.6 | 4 | BULLISH | -17.1 |
| NAUT Nautilus Biotechnolgy, Inc. | $410M | -6.5 | -41.0 | -89.2 | -6682.1 | — | 2 | BULLISH | 68.3 |
| DH Definitive Healthcare Corp. | $120M | -0.7 | -75.0 | 96.7 | -9.8 | -5.0 | 6 | BULLISH | -63.4 |
| TCRT Alaunos Therapeutics, Inc. | $10M | -1.1 | -185.9 | -607.2 | — | -50.0 | 1 | BULLISH | -21.4 |
| RARE Ultragenyx Pharmaceutical Inc. | $1.5B | -2.9 | 839.4 | -67.5 | -43.0 | 17.5 | 2 | BULLISH | -52.2 |
| COLL Collegium Pharmaceutical, Inc. | $750M | 15.0 | 17.6 | 9.4 | -7.5 | 14.3 | 6 | BULLISH | -34.7 |
| CARL Carlsmed, Inc. | $400M | -11.5 | -43.8 | -122.7 | -55.5 | — | 2 | BULLISH | 14.6 |
| IUGNF Imugene Limited | $30M | -0.1 | -389.5 | -458.5 | — | -100.0 | 1 | BULLISH | -74.4 |
| SYRA Syra Health Corp. Class A Common Stock | $10M | 97.8 | 5.2 | 11.3 | 10.5 | 0.3 | 4 | BULLISH | 1233.3 |
| PCSA Processa Pharmaceuticals, Inc. | $10M | -0.3 | -464.2 | 1977.5 | — | — | 2 | BULLISH | -76.5 |
| VPTDF VentriPoint Diagnostics Ltd. | $10M | -5.7 | 58.8 | 122.3 | -3487.7 | 8.8 | 4 | BULLISH | -12.6 |
| HDVY Health Discovery Corporation | — | -0.1 | -3852.6 | 357.6 | — | -100.0 | 1 | BULLISH | 100.0 |
| HEPA Hepion Pharmaceuticals, Inc. | — | -0.5 | -125.6 | 710.2 | — | — | 3 | BULLISH | 92.9 |
| LMAT LeMaitre Vascular, Inc. | $1.9B | 29.1 | 16.8 | 25.6 | 24.2 | 11.8 | 8 | BULLISH | -5.1 |
| INNV Innovage Holding Corp. | $1.3B | -439.5 | -1.1 | -89.6 | 3.2 | 16.4 | 6 | BULLISH | 77.6 |
| CSWYF China Shineway Pharmaceutical Group Limited | $760M | 6.0 | 19.9 | 46.7 | 21.6 | 1081.8 | 8 | BULLISH | 0.0 |
| IMCR Immunocore Holdings plc | $1.6B | -176.2 | -2.3 | -472.0 | -0.7 | 13.4 | 4 | BULLISH | -1.0 |
| CNMD CONMED Corporation | $1.5B | 25.3 | 5.5 | 5.2 | 6.7 | 3.4 | 7 | BULLISH | -1.2 |
| XERS Xeris Biopharma Holdings, Inc. | $1.9B | -107.0 | 118.2 | 18.3 | -33.8 | 36.3 | 6 | BULLISH | 11.8 |
| GMRS GMR Solutions Inc. | $580M | — | — | — | — | — | — | BULLISH | — |
| TNPH Tian'an Pharmaceutical Co., Ltd. | $20M | -1961.1 | 0.3 | 33.0 | — | -100.0 | 3 | BULLISH | 1150.0 |
| VSBC VitaSpring Biomedical Co. Ltd. | $10M | -13.8 | 10.3 | 15.9 | — | -100.0 | 4 | BULLISH | -96.8 |
| MSTH Mystic Holdings, Inc. | — | -0.2 | -35.2 | -19.8 | -27.1 | 24.7 | 5 | BULLISH | -79.2 |
| VIBEF Vibe Growth Corporation | — | -0.2 | 40.9 | -1.4 | -8.6 | 24.4 | 6 | BULLISH | 626.0 |
| UMCN UMC, Inc. | $50M | -93.7 | -840.4 | -95.6 | -590.7 | 2325.0 | 4 | BULLISH | 478.5 |
| IPIX Innovation Pharmaceuticals Inc. | — | -0.2 | -115.7 | -377.9 | — | -133.3 | 3 | BULLISH | -22.2 |
| AIBT Aibotics Inc. | — | — | — | — | — | — | — | BULLISH | — |
| CCM Concord Medical Services Holdings Limited | — | -0.0 | 7.5 | -26.9 | -13.5 | -22.5 | 2 | BULLISH | -25.7 |
| KRMD KORU Medical Systems, Inc. | $150M | -80.4 | -10.5 | -8.8 | 2.1 | 22.4 | 6 | BULLISH | -26.6 |
| IMUC EOM Pharmaceuticals Holdings, Inc. | $10M | -4.9 | 64.4 | 131.0 | — | — | 4 | BULLISH | 20.6 |
| SHWGF Shandong Weigao Group Medical Polymer Company Limited | $1.9B | 9.3 | 5.6 | 7.4 | 11.3 | 2.2 | 6 | BULLISH | -39.1 |
| ESTA Establishment Labs Holdings Inc. | $1.9B | -51.5 | -175.3 | -6.9 | -17.4 | 38.6 | 5 | BULLISH | 32.6 |
| NBTX Nanobiotix S.A. | $1.5B | -27.5 | 104.2 | 62.0 | -626.0 | 49.1 | 4 | BULLISH | 63.5 |
| CKDXF Ceryvyn Therapeutics Ltd | $10M | 0.1 | -243.9 | 2882.8 | — | -97.3 | 3 | BULLISH | -97.6 |
| HCTI Healthcare Triangle, Inc. | $10M | -0.0 | -57.4 | -19.3 | -48.0 | 116.4 | 3 | BULLISH | -95.8 |
| ZEOX Zeo ScientifiX, Inc. | $10M | -2.0 | -140.0 | 105.8 | -5.6 | — | 2 | BULLISH | — |
| CNHC China Health Management Corp. | — | 13.7 | 3.2 | 3.3 | 29.8 | -1.0 | 6 | BULLISH | 53.6 |
| CYYNF Cynata Therapeutics Limited | — | -0.3 | -326.4 | 584.9 | — | -100.0 | 1 | BULLISH | -93.9 |
| YBGJ Yubo International Biotech Limited | — | -1.7 | 28.2 | 30.1 | — | 9417.8 | 5 | BULLISH | -20.6 |
| UPHL UpHealth, Inc. | — | -0.0 | -84.2 | -4.7 | — | -46.7 | 3 | BULLISH | 50.0 |
| CDXQ China De Xiao Quan Care Group Co., Ltd | — | 0.1 | -136.1 | -277.5 | — | — | 4 | BULLISH | 2000.0 |
| APLIF Appili Therapeutics Inc. | — | — | 27.8 | 79.4 | -1441.5 | 277.2 | 2 | BULLISH | -62.6 |
| THCT THC Therapeutics, Inc. | — | -0.0 | 16.8 | 16.9 | — | — | 2 | BULLISH | 300.0 |
| DMRA Damora Therapeutics, Inc. | $1.3B | — | — | — | — | — | — | BULLISH | — |
| SGHT Sight Sciences, Inc. | $500M | -16.1 | -48.4 | -145.7 | -19.0 | 9.3 | 4 | BULLISH | 73.1 |
| KOAN Resonate Blends, Inc. | — | -0.0 | 46.5 | -991.9 | -399.0 | -32.1 | 4 | BULLISH | -97.2 |
| VIR Vir Biotechnology, Inc. | $1.8B | -6.2 | -26.1 | -38.8 | 33.5 | 1495.9 | 5 | BULLISH | 91.0 |
| CRON Cronos Group Inc. | $1.2B | 18.0 | 6.5 | 5.4 | 60.5 | 72.9 | 7 | BULLISH | 33.5 |
| SLGL Sol-Gel Technologies Ltd. | $230M | -12.4 | -35.9 | -228.0 | 36.4 | 282.9 | 3 | BULLISH | 74.5 |
| CPIVF Captiva Verde Wellness Corp. | $30M | -37.5 | -49.0 | -123.3 | — | — | 2 | BULLISH | 277.2 |
| ADMT ADM Tronics Unlimited, Inc. | — | -7.9 | -49.5 | -22.1 | 3.7 | -2.2 | 3 | BULLISH | -46.8 |
| AORT Artivion, Inc. | $1.1B | -386.5 | -0.7 | -3.4 | -10.7 | 16.4 | 4 | BULLISH | -47.0 |
| CYDY CytoDyn Inc. | $380M | -4.9 | 57.8 | 24.6 | — | 100.0 | 4 | BULLISH | -5.6 |
| CVALF Covalon Technologies Ltd. | $80M | 27.9 | 14.3 | 28.5 | 28.0 | 4.2 | 8 | BULLISH | 112.7 |
| ZYBT Zhengye Biotechnology Holding Limited | $70M | — | — | — | — | — | — | BULLISH | -43.6 |
| VYYRF Voyageur Pharmaceuticals Ltd. | $20M | -6.2 | -527.9 | -47345.4 | -6124.5 | — | 3 | BULLISH | 3.2 |
| LGNDZ Ligand Pharmaceuticals, Inc. | — | 0.0 | 20.4 | 11.3 | 76.2 | — | 3 | BULLISH | — |
| PDSB PDS Biotechnology Corporation | $60M | -2.1 | -544.0 | 456.9 | — | — | 1 | BULLISH | 16.3 |
| SOPH SOPHiA GENETICS S.A. | $630M | -6.7 | -101.2 | -155.2 | -95.9 | 23.6 | 3 | LEAN BULL | 82.5 |
| CYH Community Health Systems, Inc. | $410M | -1.2 | 19.9 | -79.1 | 1.7 | 77.2 | 5 | LEAN BULL | -9.5 |
| ABOS Acumen Pharmaceuticals, Inc. | $140M | -1.5 | -162.7 | 466.8 | — | — | 2 | LEAN BULL | 7.6 |
| LUNG Pulmonx Corporation | $80M | -1.7 | -88.9 | -92.5 | -44.3 | -3.4 | 4 | LEAN BULL | 22.6 |
| HOWL Werewolf Therapeutics, Inc. | $50M | -1.4 | -119.9 | 354.7 | 17.5 | — | 4 | LEAN BULL | -37.5 |
| ATOS Atossa Therapeutics, Inc. | $30M | -0.6 | -89.2 | -4213.1 | — | — | 2 | LEAN BULL | -82.2 |
| IGPK Integrated Cannabis Solutions, Inc. | $10M | 8.0 | -3.2 | -5.2 | 0.6 | 2762.5 | 5 | LEAN BULL | -78.2 |
| ARDS Aridis Pharmaceuticals, Inc. | — | -0.0 | 4.8 | 10.0 | -19.9 | 2227.6 | 4 | LEAN BULL | -92.3 |
| MHTX Manhattan Scientifics, Inc. | — | -0.0 | 45.1 | 23.3 | — | 104.9 | 3 | LEAN BULL | 0.0 |
| INFIQ Infinity Pharmaceuticals, Inc. | — | -0.0 | 109.5 | 60.9 | -1707.7 | — | 2 | LEAN BULL | 0.0 |
| PPCB Propanc Biopharma, Inc. | — | -0.1 | -161.9 | -166.7 | — | — | 4 | LEAN BULL | 54.7 |
| RLBD Real Brands, Inc. | — | -0.2 | 62.2 | 111.8 | — | 204.2 | 5 | LEAN BULL | 900.0 |
| GRCU Global Roundtable Corporation | — | -2.9 | 28.1 | 25.5 | -673.8 | 35.7 | 7 | LEAN BULL | 9900.0 |
| RBII Rising Biosciences, Inc. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| BSSP Baseline Productions, Inc. | — | -0.0 | 167.7 | 64.9 | — | — | 2 | LEAN BULL | 100.0 |
| MICR Micron Solutions, Inc. | — | -0.1 | -32.9 | -10.2 | -16.0 | 19.3 | 3 | LEAN BULL | 25450.0 |
| XRAY DENTSPLY SIRONA Inc. | $1.9B | -3.4 | -33.0 | 9.9 | 4.1 | -0.8 | 5 | LEAN BULL | -28.9 |
| COGZF Cogstate Limited | $410M | 34.6 | 22.4 | 37.3 | 22.4 | -14.8 | 3 | LEAN BULL | 44.9 |
| PTCHF PureTech Health plc | $390M | 157.1 | 0.2 | 50.8 | 1890.6 | 7.7 | 4 | LEAN BULL | -5.4 |
| TLTFF Theralase Technologies Inc. | $50M | -14.1 | -93.5 | -173.9 | -646.5 | -24.8 | 4 | LEAN BULL | -8.5 |
| ACHFF Arch Biopartners Inc. | $40M | -20.0 | 73.5 | 165.4 | — | 100.0 | 2 | LEAN BULL | -10.0 |
| EVGRF China Evergrande New Energy Vehicle Group Limited | $20M | -12.9 | 104.0 | 16.8 | -766929.9 | 284.5 | 4 | LEAN BULL | 114.3 |
| PRVCF PreveCeutical Medical Inc. | $10M | -16.7 | 9.9 | 96.4 | — | — | 3 | LEAN BULL | -44.7 |
| MSGP MedSmart Group Inc. | — | -0.6 | 33.6 | 85.8 | — | -100.0 | 1 | LEAN BULL | 2000.0 |
| SONX Sonendo, Inc. | — | -0.4 | -166.8 | -185.6 | -76.7 | -27.7 | 5 | LEAN BULL | 212.2 |
| MNZO Manzo Pharmaceuticals, Inc. | — | -9.8 | 4.6 | 4.1 | — | — | 2 | LEAN BULL | 0.0 |
| NEWUF Newtopia Inc. | — | -0.1 | 75.4 | 107.5 | -166.7 | -36.4 | 2 | LEAN BULL | 0.0 |
| SGMT Sagimet Biosciences Inc. | $310M | -8.2 | -24.4 | -231.4 | — | — | 3 | LEAN BULL | 30.4 |
| AMWL American Well Corporation | $230M | -2.8 | -31.0 | -215.3 | -19.1 | -19.0 | 4 | LEAN BULL | 145.2 |
| DBCCF Decibel Cannabis Company Inc. | $50M | -115.6 | -1.0 | -3.0 | 11.7 | 26.5 | 3 | LEAN BULL | -0.8 |
| IRIX IRIDEX Corporation | $10M | -3.7 | -73.1 | -73.9 | -10.1 | 3.7 | 5 | LEAN BULL | -32.1 |
| HADV Health Advance Inc. | — | -4.4 | 77.3 | -29.9 | — | — | 1 | LEAN BULL | -33.3 |
| TSMRF Tsumura & Co. | $1.7B | 9.2 | 9.9 | 6.6 | 13.0 | 10.7 | 4 | LEAN BULL | 0.0 |
| SWGHF Sawai Group Holdings Co., Ltd. | $1.3B | 22.7 | 4.3 | 4.6 | 4.7 | 11.4 | 4 | LEAN BULL | 0.0 |
| TWAPF Towa Pharmaceutical Co., Ltd. | $1.3B | 21.1 | 4.7 | 3.2 | 7.7 | 7.1 | 7 | LEAN BULL | 54.4 |
| KKPCF Kaken Pharmaceutical Co., Ltd. | $980M | 14.0 | 6.9 | 7.9 | 28.0 | -6.6 | 4 | LEAN BULL | -7.4 |
| ABPO Abpro Holdings, Inc. | — | — | — | — | — | — | — | LEAN BULL | — |
| MLTX MoonLake Immunotherapeutics | $1.0B | -3.1 | -67.4 | 2902.7 | — | — | 1 | LEAN BULL | 24.8 |
| NTRR Neutra Corp. | — | 2.0 | -139.6 | -802.5 | -3.8 | 142.2 | 7 | LEAN BULL | -33.3 |
| BCCOY BICO Group AB (publ) | $190M | -2.0 | -41.5 | -8.4 | -11.1 | -19.8 | 6 | LEAN BULL | -9.6 |
| HUMDF Hua Medicine (Shanghai) Ltd. | $300M | -17.8 | -10.3 | -30.2 | -8.0 | 73.9 | 3 | LEAN BULL | -26.1 |
| STIM Neuronetics, Inc. | $160M | -5.1 | -135.3 | -21.3 | -8.3 | 39.6 | 4 | LEAN BULL | -24.3 |
| EKDHF EKF Diagnostics Holdings plc | $140M | 42.1 | 3.5 | 5.2 | 9.3 | 2.5 | 7 | LEAN BULL | -17.8 |
| ETBI Eastgate Biotech Corp. | $10M | -2.6 | 93.4 | 134.9 | -7057.2 | -53.0 | 3 | LEAN BULL | 4900.0 |
| SMAS Somatic Systems, Inc. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| THMO ThermoGenesis Holdings, Inc. | — | -0.0 | -417.9 | -71.5 | -67.8 | -7.5 | 3 | LEAN BULL | 0.0 |
| PXMD PaxMedica, Inc. Common Stock | — | -0.0 | -7716.2 | 572.1 | — | — | 2 | LEAN BULL | 600.0 |
| HPMM Hemp Naturals, Inc. | — | -0.0 | -141.5 | -78.5 | — | — | 3 | LEAN BULL | -80.0 |
| MDCN Medican Enterprises, Inc. | — | -3.4 | 40.4 | -2.1 | — | -38.5 | 3 | LEAN BULL | -0.0 |
| ESMC Escalon Medical Corp. | — | 0.7 | 102.3 | -0.0 | 46.1 | 5.7 | 7 | LEAN BULL | 10.1 |
| OMHE OMNI Health, Inc. | — | 0.0 | 30.4 | -8.8 | -6.1 | 2046.4 | 4 | LEAN BULL | 233.3 |
| CENBF CEN Biotech, Inc. | — | -0.0 | 32.0 | -64.0 | 569.4 | -54.9 | 5 | LEAN BULL | 100.0 |
| AFIB Acutus Medical, Inc. | — | -0.0 | 153.1 | -0.4 | -19.7 | 375.7 | 2 | LEAN BULL | -80.0 |
| SIGO Sunset Island Group, Inc. | — | -0.0 | 185.8 | 85.4 | — | — | 4 | LEAN BULL | 0.0 |
| REZNF Street Capital Inc. | — | -3.3 | 20.7 | 15.0 | — | -44.3 | 5 | LEAN BULL | 74.5 |
| PXYN Praxsyn Corporation | — | -0.0 | 159.9 | 101.7 | 14.5 | 14.7 | 4 | LEAN BULL | 0.0 |
| BTAX Biostax Corp. | — | -0.0 | 7.3 | 5.8 | — | — | 2 | LEAN BULL | 100.0 |
| LYRA Lyra Therapeutics, Inc. | — | -0.0 | -6595.0 | -671.6 | -99300.0 | -74.1 | 4 | LEAN BULL | -97.7 |
| REVB Revelation Biosciences, Inc. | — | -0.1 | -154.8 | 1317.2 | — | — | 4 | LEAN BULL | 195.0 |
| CNFHF CanaFarma Hemp Products Corp. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| PBIO Pressure BioSciences, Inc. | — | -0.0 | 100.6 | 84.5 | -1687.2 | -25.3 | 3 | LEAN BULL | -98.7 |
| BGMD BG Medicine, Inc. | — | -0.0 | 747.3 | 104.5 | -311.0 | -43.8 | 5 | LEAN BULL | 0.0 |
| PMI Picard Medical, Inc. | $730M | -0.3 | -1631.2 | -469.0 | -191.6 | — | 2 | LEAN BULL | -49.1 |
| CERS Cerus Corporation | $470M | -67.3 | -10.8 | -7.4 | -5.1 | 15.1 | 5 | LEAN BULL | 57.0 |
| AHCO AdaptHealth Corp. | $820M | -3.5 | -15.5 | -0.2 | -18.1 | 22.9 | 6 | LEAN BULL | -35.8 |
| XCRT Xcelerate Inc. | $10M | -11.5 | 71.8 | 24.0 | — | -142.3 | 2 | LEAN BULL | 103.8 |
| GSAC GelStat Corporation | — | -2.8 | 25.1 | 80.4 | -124.9 | 62.9 | 6 | LEAN BULL | -25.0 |
| HBRM Herborium Group, Inc. | — | -2.3 | 0.6 | 0.6 | 0.7 | -2.7 | 5 | LEAN BULL | 0.0 |
| NXGL NEXGEL, Inc. | — | -0.0 | -128.6 | -35.8 | -98.6 | 3.4 | 2 | LEAN BULL | -92.4 |
| DIUXF Diaceutics PLC | $200M | -626.6 | -0.8 | -2.3 | -15.9 | 20.4 | 4 | LEAN BULL | 68.6 |
| MFCSF Medical Facilities Corporation | $170M | 8.0 | 46.9 | 50.2 | 2.5 | 3.2 | 7 | LEAN BULL | 4.5 |
| TRIB Trinity Biotech plc | $150M | -0.2 | 69.8 | -14.6 | -157.8 | -28.8 | 2 | LEAN BULL | 651.4 |
| NNVC NanoViricides, Inc. | $40M | -3.6 | -101.5 | -111.4 | — | — | 3 | LEAN BULL | -4.9 |
| RBOT Vicarious Surgical Inc. | — | -0.0 | -223.8 | -476.5 | — | — | 1 | LEAN BULL | -96.7 |
| HSTC HST Global, Inc. | $210M | -538.5 | -2.5 | -1.2 | -13.7 | 564.0 | 5 | LEAN BULL | 349900.0 |
| EVAX Evaxion Biotech A/S | $20M | -0.5 | -109.8 | -260.4 | — | 135.9 | 6 | LEAN BULL | -45.1 |
| PIIIW P3 Health Partners Inc. | $20M | -0.1 | -168.8 | -64.8 | 1.9 | 2.8 | 4 | LEAN BULL | 3.5 |
| OCEA Ocean Biomedical, Inc. | — | -0.0 | 36.5 | 0.3 | — | — | 1 | LEAN BULL | -20.0 |
| RXRX Recursion Pharmaceuticals, Inc. | $2.0B | -3.9 | -56.6 | -99.7 | -1708.0 | -14.9 | 4 | LEAN BULL | -33.7 |
| ENSC Ensysce Biosciences, Inc. | $10M | -0.2 | -968.3 | 792.9 | -220.8 | -77.6 | 3 | LEAN BULL | -78.7 |
| LCTX Lineage Cell Therapeutics, Inc. | $250M | -7.3 | -59.0 | -171.3 | 138.6 | 19.9 | 5 | LEAN BULL | -38.7 |
| GDTC CytoMed Therapeutics Limited | $10M | -2.5 | -66.1 | -87.8 | -1125.6 | -11.3 | 0 | LEAN BULL | -61.9 |
| SFWJ Software Effective Solutions Corp. | — | -1.3 | -21.8 | -12.6 | -51.5 | 26679.3 | 6 | LEAN BULL | 38.1 |
| FWDG FutureWorld Corp. | — | -0.1 | -1.2 | -0.5 | -507.1 | 153.6 | 5 | LEAN BULL | 0.0 |
| PAOG PAO Group, Inc. | — | -5.8 | -20.2 | 11.2 | — | — | 4 | LEAN BULL | 0.0 |
| BBBT Black Bird Biotech, Inc. | — | -0.0 | 129.1 | 137.7 | -3333.2 | -61.0 | 2 | LEAN BULL | 0.0 |
| CRYM Cryomass Technologies Inc. | — | -0.0 | 137.2 | 57.9 | -22040.0 | -96.0 | 2 | LEAN BULL | -60.0 |
| ATEC Alphatec Holdings, Inc. | $1.7B | -15.2 | -623.1 | -7.6 | -12.1 | 19.5 | 5 | LEAN BULL | -31.4 |
| IUSDF AS ONE Corporation | $1.0B | 19.2 | 12.2 | 13.4 | 8.1 | 5.7 | 6 | LEAN BULL | -39.5 |
| MLAB Mesa Laboratories, Inc. | $720M | 150.7 | 2.7 | 4.4 | 4.7 | 3.0 | 8 | LEAN BULL | 65.4 |
| CBWTF Auxly Cannabis Group Inc. | $250M | 10.4 | 16.6 | 2.2 | 16.8 | 10.8 | 7 | LEAN BULL | 72.7 |
| OKYO OKYO Pharma Limited | $70M | -6.1 | -263.8 | 88.0 | — | — | 3 | LEAN BULL | -35.7 |
| NUMIF Numinus Wellness Inc. | $10M | -0.8 | 57.6 | 40.6 | -18.7 | 429.3 | 5 | LEAN BULL | -51.6 |
| MBRX Moleculin Biotech, Inc. | $10M | -0.0 | -1371.6 | -494.1 | — | — | 3 | LEAN BULL | -43.1 |
| DVLP Golden Developing Solutions, Inc. | — | -0.0 | 450.9 | 46.1 | -166.7 | — | 6 | LEAN BULL | -90.0 |
| LPTI Longport, Inc. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| ALGWF Alliance Growers Corp. | — | — | — | — | — | — | — | LEAN BULL | 0.0 |
| ELIXF Elixxer Ltd. | — | -0.2 | 27.1 | 280.4 | — | — | 2 | LEAN BULL | -55.4 |
| REFG Medical Cannabis Payment Solutions | — | -3.0 | 1.2 | 1.5 | — | — | 2 | LEAN BULL | 200.0 |
| DNAG DNAPrint Genomics, Inc. | — | -0.0 | 63.1 | -156.0 | -826.7 | -15.2 | 3 | LEAN BULL | 100.0 |
| CSTF CuraScientific Corp | — | -0.0 | -72.1 | 17.4 | -2482.5 | 954.6 | 5 | LEAN BULL | 0.0 |
| RDDTF Radient Technologies Inc. | — | — | 98.9 | 263.2 | -131.7 | -20.4 | 3 | LEAN BULL | 0.0 |
| WHSI Wearable Health Solutions, Inc. | — | -0.1 | 37.4 | 155.3 | 98.4 | -29.7 | 2 | LEAN BULL | 0.0 |
| RBSH Rebus Holdings, Inc. | — | -0.0 | -9.7 | 8.9 | — | — | 2 | LEAN BULL | 0.0 |
| XBRAF Xebra Brands Ltd. | — | -0.1 | -542.1 | -2373.1 | — | -100.0 | 1 | LEAN BULL | -98.5 |
| OBX Obsidian Therapeutics Inc. | $10M | — | — | — | — | — | — | NEUTRAL | — |
| ERGO Entia Biosciences, Inc. | — | -0.0 | 106.8 | 92.5 | -1021.5 | -23.5 | 5 | NEUTRAL | 400.0 |
| SXTC China SXT Pharmaceuticals, Inc. | — | -0.0 | -32.7 | -254.3 | 13.7 | 42.5 | 6 | NEUTRAL | -100.0 |
| PJET Priority Aviation, Inc. | — | -0.1 | 19.5 | 31.9 | — | -83.3 | 2 | NEUTRAL | 0.0 |
| BTTX Better Therapeutics, Inc. | — | -0.0 | 2351.8 | 1050.0 | — | -100.0 | 1 | NEUTRAL | 0.0 |
| BIEI Premier Graphene, Inc. | — | -28.3 | 9.8 | 7.4 | — | -100.0 | 5 | NEUTRAL | 0.0 |
| SLDX Stella Diagnostics Inc. | — | -0.7 | 18.1 | 21.7 | -195.2 | — | 4 | NEUTRAL | -60.2 |
| NPNKF Nippon Shinyaku Co., Ltd. | $1.6B | 7.2 | 11.6 | 12.5 | 20.6 | 12.8 | 4 | NEUTRAL | -1.1 |
| CSTL Castle Biosciences, Inc. | $1.0B | -52.0 | -4.2 | -10.6 | -2.0 | 3.2 | 4 | NEUTRAL | 37.7 |
| KMDA Kamada Ltd. | $450M | 21.0 | 8.4 | 11.0 | 16.9 | 13.2 | 7 | NEUTRAL | 15.9 |
| VASO Vaso Corporation | $50M | 17.6 | 10.0 | -3055.8 | 7.5 | -8.0 | 8 | NEUTRAL | 157.2 |
| STAB Statera Biopharma, Inc. | — | -0.0 | -298.8 | 2085.4 | -769.5 | 1459.1 | 3 | NEUTRAL | -50.0 |
| LYEL Lyell Immunopharma, Inc. | $230M | -0.6 | -93.3 | -227.7 | -1118875.0 | -55.0 | 3 | NEUTRAL | -49.2 |
| PRLD Prelude Therapeutics Incorporated | $210M | -4.9 | -57.7 | 14236.3 | -244.1 | 220.3 | 5 | NEUTRAL | 146.7 |
| NMAD NOMAD Power Solutions, Inc. | $50M | — | — | — | — | — | — | NEUTRAL | — |
| EDXC Endexx Corporation | — | -0.0 | 51.8 | 0.5 | — | -125.6 | 2 | NEUTRAL | -95.5 |
| SETO SETO Holdings, Inc. | — | -13.8 | -22.5 | -8.5 | -32.2 | 9760.2 | 6 | NEUTRAL | 103.7 |
| CNBX CNBX Pharmaceuticals Inc. | — | -1.0 | 17.8 | 13.3 | — | 100.0 | 3 | NEUTRAL | -50.0 |
| CALC CalciMedica, Inc. | — | -0.2 | -365.7 | 118.3 | — | — | 4 | NEUTRAL | -91.5 |
| SGIPF Sugi Holdings Co.,Ltd. | $1.8B | 15.5 | 10.0 | 11.6 | 2.2 | 46.6 | 7 | NEUTRAL | 18.3 |
| SAFLY Safilo Group S.p.A. | $1.4B | 15.4 | 12.0 | 10.0 | 8.7 | -3.4 | 7 | NEUTRAL | 40.1 |
| VREX Varex Imaging Corporation | $780M | 35.1 | 4.6 | 7.6 | 7.5 | 5.3 | 6 | NEUTRAL | 55.0 |
| CSSPF NIOX Group Plc | $380M | 41.3 | 10.8 | 13.0 | 24.6 | 3.5 | 7 | NEUTRAL | -2.3 |
| CAIHF CPBIO Holding Company Limited | $270M | 10.2 | 10.0 | 8.1 | 3.4 | 73.4 | 8 | NEUTRAL | 282.1 |
| NWBO Northwest Biotherapeutics, Inc. | $260M | -6.7 | 55.8 | -188.7 | -1142.6 | 98.6 | 3 | NEUTRAL | -16.3 |
| MLLCF Molecular Partners AG | $150M | -2.3 | -62.1 | 650.3 | — | -100.0 | 2 | NEUTRAL | 14.6 |
| EXHI Exlites Holdings International, Inc. | $20M | -750.0 | -66.7 | -65.8 | -35.4 | 283.9 | 4 | NEUTRAL | 97.4 |
| NEPTF Neptune Wellness Solutions Inc. | — | -2.7 | 606.5 | 1351.5 | -233.6 | -24.7 | 2 | NEUTRAL | -96.0 |
| TUTH Standard Dental Labs Inc. | — | -3.0 | 22.6 | 1394.1 | -117.5 | -7.5 | 6 | NEUTRAL | -22.8 |
| ADVT Advantis Corp. | — | -0.4 | -8.4 | -3.2 | -1775.1 | — | 1 | NEUTRAL | 0.0 |
| FCGD First Colombia Gold Corp. | — | -95.6 | 23.1 | 122.7 | — | -93.9 | 2 | NEUTRAL | 9900.0 |
| MDCE Medical Care Technologies Inc. | — | 1.0 | 28.0 | 28.7 | 23.9 | 0.6 | 7 | NEUTRAL | -66.7 |
| HENC Hero Technologies Inc. | — | -0.1 | -10112.1 | 3310.9 | — | 100.0 | 4 | NEUTRAL | 0.0 |
| STHZF StateHouse Holdings Inc. | — | -0.1 | 36.1 | 3.8 | 0.8 | -2.6 | 4 | NEUTRAL | -99.3 |
| VRAYQ ViewRay, Inc. | — | -0.0 | -108.9 | -146.1 | -128.1 | 44.1 | 1 | NEUTRAL | 9900.0 |
| FLWPF The Flowr Corporation | — | — | -335.3 | 207.1 | -1827.8 | 38.5 | 3 | NEUTRAL | 900.0 |
| EHOS Ehouse Global, Inc. | — | -0.0 | 161.0 | 52.5 | — | — | 1 | NEUTRAL | 0.0 |
| HESG Health Sciences Group, Inc. | — | -0.0 | 69.4 | 44.6 | -19219.1 | 101.6 | 3 | NEUTRAL | 900.0 |
| REPL Replimune Group, Inc. | $1.1B | -4.2 | -134.3 | -1055.2 | — | — | 1 | NEUTRAL | 48.1 |
| RXST RxSight, Inc. | $210M | -4.4 | -17.3 | -66.9 | -35.9 | -18.8 | 3 | NEUTRAL | -41.5 |
| KJFI Comjoyful International Company | $210M | -98.4 | 171.5 | -1549.9 | 44.3 | 38.8 | 6 | NEUTRAL | 459.8 |
| PMHS Polomar Health Services, Inc. | — | — | — | — | — | — | — | NEUTRAL | — |
| RVVQF RavenQuest BioMed Inc. | — | -0.0 | -112.5 | -40.6 | -440.2 | 93.6 | 2 | NEUTRAL | 0.0 |
| CLVR Clever Leaves Holdings Inc. | — | -0.0 | -55.4 | -63.3 | -109.6 | 3.6 | 4 | NEUTRAL | 5500.0 |
| JWCAF James E. Wagner Cultivation Corporation | — | -0.0 | -50.3 | -16.2 | -493.1 | 315.1 | 2 | NEUTRAL | 0.0 |
| BMGP Biomagnetics Diagnostics Corp. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| RGIN Regenicin, Inc. | — | -0.0 | 16.9 | 4.1 | — | — | 4 | NEUTRAL | 0.0 |
| HEWA HealthWarehouse.com, Inc. | — | -4.8 | 24.7 | 44.2 | -6.8 | -42.5 | 3 | NEUTRAL | -34.0 |
| RCAR RenovaCare, Inc. | — | -0.0 | -436.6 | 812.3 | — | — | 2 | NEUTRAL | 9900.0 |
| NMTRQ 9 Meters Biopharma, Inc. | — | — | — | — | — | — | — | NEUTRAL | 900.0 |
| WMGR Wellness Matrix Group, Inc. | — | -0.0 | 24.4 | 19.3 | — | — | 2 | NEUTRAL | 0.0 |
| PRCNF Pure Global Cannabis Inc. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| SPBBF Speakeasy Cannabis Club Ltd. | — | -0.0 | -55.1 | -4.0 | -803.2 | 16129.5 | 3 | NEUTRAL | 0.0 |
| MSPR MSP Recovery, Inc. | — | -0.0 | 127.6 | -506.2 | -84750.5 | — | 2 | NEUTRAL | -100.0 |
| CNGGF Cann Group Limited | — | 0.3 | 157.4 | -25.1 | -150.3 | -35.4 | 5 | NEUTRAL | -40.8 |
| FRLI Frélii, Inc. | — | -0.0 | -671.6 | -265.5 | -10546.4 | 378.8 | 4 | NEUTRAL | 0.0 |
| VRSYF VMS Rehab Systems, Inc. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| AUSAF Australis Capital Inc. | — | -0.0 | -52.8 | -42.1 | -1022.3 | 1388076.3 | 3 | NEUTRAL | -90.0 |
| VPHIF Valeo Pharma Inc. | — | -0.0 | 65.5 | 19863.3 | -65.0 | -0.2 | 2 | NEUTRAL | -66.7 |
| CFRXQ ContraFect Corp. | — | -0.0 | 544.7 | 276.9 | — | — | 1 | NEUTRAL | -90.0 |
| ISOLF Isodiol International Inc. | — | -0.0 | -220.6 | -602.3 | -73.2 | -17.7 | 4 | NEUTRAL | 0.0 |
| INLB Item 9 Labs Corp. | — | -0.0 | -47.3 | -18.4 | -117.7 | -17.4 | 2 | NEUTRAL | 0.0 |
| LYCA Lycia Therapeutics Inc. | $1.6B | — | — | — | — | — | — | N/A | — |
| OFIX Orthofix Medical Inc. | $400M | -6.4 | -13.9 | -3.6 | -7.5 | 3.0 | 6 | NEUTRAL | -38.6 |
| CTY City Therapeutics Inc. | $200M | — | — | — | — | — | — | N/A | — |
| DAVI Davion Healthcare Plc | $150M | — | — | — | — | — | — | N/A | — |
| IAM Iambic Therapeutics Inc. | $130M | — | — | — | — | — | — | N/A | — |
| TRXB TRex Bio Inc. | $120M | — | — | — | — | — | — | N/A | — |
| RTSN Retension Pharmaceuticals Inc. | $60M | — | — | — | — | — | — | N/A | — |
| LONA LeonaBio, Inc. | $20M | — | — | — | — | — | — | NEUTRAL | — |
| NRTSF Nobilis Health Corp. | — | 0.0 | 1.1 | 2.8 | 1.3 | -11.1 | 3 | N/A | -100.0 |
| JUNS Jupiter Neurosciences, Inc. | — | -0.1 | -1888.7 | 5586.0 | -9380.9 | — | 3 | NEUTRAL | -97.4 |
| INDR Indie Ranch Media, Inc. | — | — | — | — | — | — | — | N/A | -90.0 |
| BIEL Bioelectronics Corporation | $10M | -13.9 | 6.3 | 24.0 | -132.4 | -63.1 | 1 | NEUTRAL | -14.3 |
| UTMD Utah Medical Products, Inc. | $240M | 22.0 | 8.8 | 24.1 | 31.5 | -7.0 | 7 | NEUTRAL | 22.3 |
| PHMMF Pharma Mar, S.A. | $1.6B | 21.2 | 24.9 | 35.9 | -2.0 | 15.5 | 7 | NEUTRAL | 1.7 |
| RKAGY RHÃN-KLINIKUM Aktiengesellschaft | $1.1B | 22.3 | 2.8 | 3.1 | 2.1 | 2.5 | 6 | NEUTRAL | 10.7 |
| LFCR Lifecore Biomedical, Inc. | $240M | -5.8 | 202.6 | 0.1 | -18.0 | -4.1 | 5 | NEUTRAL | -5.4 |
| SRZN Surrozen, Inc. | $190M | -0.7 | 387.2 | 11.1 | 1003.5 | -8.8 | 2 | NEUTRAL | 99.0 |
| NVYTF Novacyt S.A. | $40M | -0.8 | -59.6 | -45.1 | -50.1 | -44.9 | 3 | NEUTRAL | 14.0 |
| NIVF NewGenIvf Group Limited | — | -0.0 | 50.6 | -147.7 | -8.5 | — | 2 | NEUTRAL | -100.0 |
| KLDO Kaleido Biosciences, Inc. | — | -0.0 | -591.2 | 1121.9 | -4292.5 | 13.2 | 2 | NEUTRAL | -80.0 |
| CPHRF Cipher Pharmaceuticals Inc. | $240M | 8.2 | 23.5 | 24.9 | 33.3 | 3.7 | 6 | NEUTRAL | -7.9 |
| YARW Yarrow Bioscience Inc | $180M | — | — | — | — | — | — | NEUTRAL | — |
| NEPH Nephros, Inc. | $40M | 20.9 | 16.1 | 20.0 | 19.9 | 24.2 | 5 | NEUTRAL | -30.4 |
| ELUT Elutia Inc | $40M | 0.6 | -397.0 | -290.2 | -315.0 | -48.8 | 6 | NEUTRAL | -11.9 |
| NSRX Nasus Pharma Ltd. | $30M | — | — | — | — | — | — | NEUTRAL | -54.1 |
| GSTC GlobeStar Therapeutics Corporation | — | -0.0 | 60.9 | 49.1 | — | — | 4 | NEUTRAL | 9900.0 |
| BTCY Biotricity, Inc. | — | -0.4 | 8.3 | -17.1 | -22.4 | 13.4 | 6 | NEUTRAL | -91.4 |
| STEK Stemtech Corporation | — | -0.0 | 58.2 | 37.1 | -46.5 | -38.6 | 2 | NEUTRAL | -97.8 |
| GRST Ethema Health Corporation | — | -1.0 | 18.3 | 0.0 | 1.2 | 171.7 | 6 | NEUTRAL | -50.0 |
| BPTH Bio-Path Holdings, Inc. | — | -0.0 | 49.0 | 15.2 | — | -100.0 | 1 | NEUTRAL | -99.6 |
| AEGY Alternative Energy Partners, Inc. | — | -0.0 | 190.5 | 67.0 | — | -165.0 | 4 | NEUTRAL | -80.0 |
| FUNI Hypha Labs, Inc. | — | -0.3 | 26.8 | 31.4 | — | — | 2 | NEUTRAL | — |
| TGIFF 1933 Industries Inc. | — | 6.2 | -14.6 | -33.1 | 8.9 | -11.8 | 5 | NEUTRAL | -48.0 |
| LOWLF Lowell Farms Inc. | — | -0.0 | -146.8 | -63.3 | -111.9 | -35.7 | 5 | NEUTRAL | -99.3 |
| MPXOF MPX International Corp. | — | -0.0 | -179.4 | -42.1 | -411.8 | 14.3 | 4 | NEUTRAL | -0.0 |
| ABVC ABVC BioPharma, Inc. | $30M | -3.6 | -82.2 | -43.0 | — | -100.0 | 2 | NEUTRAL | -64.0 |
| USRM U.S. Stem Cell, Inc. | — | -0.0 | 20.8 | 23.4 | -2836.8 | -59.1 | 5 | NEUTRAL | 100.0 |
| IDCN Indocan Resources Inc. | — | — | — | — | — | — | — | NEUTRAL | 0.0 |
| PPJE PPJ Healthcare Enterprises, Inc. | — | 56.8 | -0.0 | -0.0 | 0.0 | -1.2 | 4 | NEUTRAL | -50.0 |
| VCRE Vicore Pharma Holding AB | $260M | — | — | — | — | — | — | NEUTRAL | — |
| KROS Keros Therapeutics, Inc. | $220M | -3.1 | -17.2 | -392.2 | — | -93.6 | 3 | NEUTRAL | -23.9 |
| EGRX Eagle Pharmaceuticals, Inc. | $10M | 0.3 | 6.4 | 3.6 | 8.0 | -5.4 | 3 | NEUTRAL | -5.0 |
| ENGNW enGene Holdings Inc. Warrants | $10M | -5.6 | -2.3 | 134.1 | — | -100.0 | 2 | NEUTRAL | -64.6 |
| PULM Pulmatrix, Inc. | $10M | -1.3 | -98.3 | -835.1 | — | -100.0 | 3 | NEUTRAL | -70.3 |
| BIOCQ Biocept, Inc. | — | -0.0 | -13593.8 | -631.8 | -616.5 | — | 2 | NEUTRAL | 200.0 |
| VLXC Veltex Corporation | — | -2.6 | 49.0 | -433.9 | -89.4 | 3.2 | 3 | NEUTRAL | -28.7 |
| SESI SES Solar Inc. | — | -0.5 | 16.7 | 1.7 | 28.0 | 324.6 | 7 | NEUTRAL | 0.0 |
| RSCF Reflect Scientific, Inc. | — | 15.8 | 12.1 | 17.0 | 15.2 | 76.0 | 6 | NEUTRAL | 20.9 |
| LCDX Caliber Imaging & Diagnostics, Inc. | — | -0.0 | 54.6 | 46.8 | -212.5 | 20.6 | 3 | NEUTRAL | 100.0 |
| LITH BioELife Corp. | — | -0.0 | -598.1 | 467.7 | — | — | 2 | NEUTRAL | 0.0 |
| ANAB AnaptysBio, Inc. | $1.5B | 7.3 | -1146.3 | 466.0 | 668.9 | 92.9 | 5 | NEUTRAL | 115.1 |
| AMPH Amphastar Pharmaceuticals, Inc. | $1.1B | 14.6 | 10.3 | 7.5 | 16.5 | 1.4 | 6 | NEUTRAL | 3.0 |
| ZJYL Jin Medical International Ltd. | $20M | 13.6 | 4.0 | 1.9 | -1.2 | -13.6 | 3 | NEUTRAL | 465.6 |
| PTLF Petlife Pharmaceuticals, Inc. | — | -0.0 | 257.0 | 178.4 | — | — | 2 | NEUTRAL | 1.0 |
| MRPI Mera Pharmaceuticals, Inc. | — | -10000.0 | 24.3 | 18.3 | -159.9 | 4.8 | 5 | NEUTRAL | 0.0 |
| CANQF CanaQuest Medical Corp. | — | -0.0 | 177.1 | 159.9 | -1515.1 | 102.7 | 4 | NEUTRAL | 0.0 |
| CBIH Cannabis Bioscience International Holdings, Inc. | — | -0.0 | 48.2 | 34.0 | -341.5 | -58.2 | 1 | NEUTRAL | -69.3 |
| KNBIF Kane Biotech Inc. | — | -2.4 | 439.7 | -2166.6 | -10238.1 | -97.9 | 2 | NEUTRAL | -37.9 |
| LIANY LianMedical | — | 1.1 | 74.7 | -612.1 | — | — | 6 | NEUTRAL | -15.0 |
| JNDOF JINS HOLDINGS Inc. | $810M | 17.8 | 22.7 | 27.1 | 5.1 | 15.0 | 6 | LEAN BEAR | 51.6 |
| MCTA Charming Medical Limited Class A Ordinary Shares | $450M | — | — | — | — | — | — | LEAN BEAR | — |
| COCH Envoy Medical, Inc. | $50M | -1.0 | 176.2 | 119.9 | -11729.4 | -6.8 | 5 | LEAN BEAR | -22.2 |
| ODTX Odyssey Therapeutics, Inc. | $940M | — | — | — | — | — | — | LEAN BEAR | — |
| OSSFF Embla Medical hf. | $1.9B | 18.0 | 10.4 | 7.7 | 10.5 | 9.9 | 7 | LEAN BEAR | -5.6 |
| STSEY Stratec SE | $1.7B | -575.0 | -0.2 | -0.2 | 7.0 | -4.8 | 4 | LEAN BEAR | -17.8 |
| AGYTF Allergy Therapeutics plc | $760M | -4.3 | 3372.3 | -97.9 | -54.9 | 19.9 | 3 | LEAN BEAR | 66.7 |
| INRLF Valneva SE | $640M | -2.8 | -118.0 | -54.8 | -89.3 | -27.2 | 1 | LEAN BEAR | -25.4 |
| OPORF hVIVO plc | $80M | -3.1 | -32.7 | -34.7 | -39.7 | -23.6 | 2 | LEAN BEAR | -54.3 |
| POLBF Poolbeg Pharma PLC | $70M | -8.5 | -58.8 | -255.9 | — | — | 1 | LEAN BEAR | 125.4 |
| CLYYF Celyad Oncology S.A. | $10M | 2.5 | -11.7 | -979.7 | 64360.6 | -88.7 | 5 | LEAN BEAR | -31.7 |
| PLUR Pluri Inc. | $10M | -0.5 | 163.6 | -483.9 | -1755.2 | -24.0 | 2 | LEAN BEAR | -73.2 |
| GBIM GlobeImmune, Inc. | — | -0.0 | -66.2 | 25.0 | -91.5 | 55.1 | 4 | LEAN BEAR | 0.0 |
| SWNM Southwestern Medical Solutions, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -70.0 |
| DECN Decision Diagnostics Corp. | — | -0.0 | -8643.1 | -51.3 | -107.0 | -2.7 | 4 | LEAN BEAR | 0.0 |
| EMED Electromedical Technologies, Inc. | — | -0.2 | 44.6 | 29.8 | -8153.1 | -66.6 | 2 | LEAN BEAR | 0.0 |
| UDOCF Unidoc Health Corp. | — | -2.4 | 392.6 | 140.6 | -352.4 | 606.8 | 3 | LEAN BEAR | -54.1 |
| ANIP ANI Pharmaceuticals, Inc. | $1.7B | 14.8 | 20.0 | 20.7 | 9.3 | 30.9 | 7 | LEAN BEAR | -23.5 |
| INVA Innoviva, Inc. | $1.5B | 4.3 | 36.7 | 15.0 | -69.8 | 19.8 | 7 | LEAN BEAR | 15.3 |
| ONMD OneMedNet Corporation | $30M | -2.7 | 231.2 | 252.1 | -743.8 | 216.5 | 3 | LEAN BEAR | -80.4 |
| MDNAF Medicenna Therapeutics Corp. | $20M | — | — | — | — | — | — | LEAN BEAR | — |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $10M | -1.0 | -130.7 | -3026.9 | -636.8 | 798.5 | 6 | LEAN BEAR | -65.9 |
| RDGT Ridgetech, Inc. | — | -0.0 | -3.6 | -5.9 | -1.7 | 170.8 | 4 | LEAN BEAR | -53.6 |
| MBCI MabCure Inc. | — | -0.0 | -127.0 | -14.0 | -2239.0 | — | 3 | LEAN BEAR | 0.0 |
| VIVE Viveve Medical, Inc. | — | -0.0 | -222.0 | -1442.3 | -314.1 | 2.4 | 3 | LEAN BEAR | 100.0 |
| DOGP Dogecoin Cash, Inc. | — | -1.9 | 30.1 | 16.3 | -76.3 | 0.2 | 3 | LEAN BEAR | -75.8 |
| ONCSQ OncoSec Medical Incorporated | — | -0.0 | -410.2 | 452.1 | — | — | 2 | LEAN BEAR | -90.0 |
| BFRGW Bullfrog AI Holdings, Inc. Warrants | — | -1.0 | -130.7 | -3026.9 | -636.8 | 798.5 | 6 | LEAN BEAR | -92.6 |
| NSTM NovelStem International Corp. | — | -1.5 | 15.3 | 31.5 | — | -100.0 | 3 | LEAN BEAR | -50.0 |
| FFNTF 4Front Ventures Corp. | — | -0.0 | 73.3 | -15.3 | -37.4 | -34.7 | 3 | LEAN BEAR | 900.0 |
| BIXT Bioxytran, Inc. | — | -0.7 | 92.2 | 68.7 | — | — | 4 | LEAN BEAR | -64.9 |
| MOTS Motus GI Holdings, Inc. | — | -0.0 | -1069.0 | -1348.2 | -3301.6 | -47.9 | 4 | LEAN BEAR | 100.0 |
| NUTX Nutex Health, Inc. | $1.4B | 7.8 | 49.2 | 53.9 | 31.2 | 6.9 | 7 | LEAN BEAR | 78.2 |
| DROR Dror Ortho-Design, Inc. | $10M | -0.0 | 15.8 | 36.4 | — | — | 1 | LEAN BEAR | — |
| NKGN NKGen Biotech, Inc. | — | -0.0 | 150.9 | — | -4511.3 | — | 3 | LEAN BEAR | -47.5 |
| GEATF Radiko Holdings Corp | — | -0.0 | 178.7 | -374.3 | -40.1 | -30.5 | 3 | LEAN BEAR | 0.0 |
| NOBDF North Bud Farms Inc. | — | -0.0 | -30.5 | -29.8 | — | — | 2 | LEAN BEAR | 0.0 |
| LFCOF Lift & Co. Corp. | — | -0.0 | 149.0 | -666.2 | -170.0 | — | 2 | LEAN BEAR | 0.0 |
| HLSQ Tessera Defense and Homeland Security Inc | — | — | — | — | — | — | — | LEAN BEAR | — |
| SKTO SK3 Group, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| GEGP Gold Entertainment Group, Inc. | — | -2.5 | 39.4 | 1402.0 | -16.8 | 39.5 | 6 | LEAN BEAR | -90.0 |
| CGNSF Cognetivity Neurosciences Ltd. | — | -0.1 | 78.7 | 25.2 | -6985.2 | — | 2 | LEAN BEAR | 0.0 |
| EMMA Emmaus Life Sciences, Inc. | — | -0.4 | 9.9 | -9.3 | 21.2 | 11.0 | 4 | LEAN BEAR | 351.0 |
| EVRRF Molecule Holdings Inc. | — | -0.1 | 97.7 | -3110.1 | -110.2 | 11.6 | 4 | LEAN BEAR | 0.0 |
| MHUAF Meihua International Medical Technologies Co., Ltd. | — | — | — | — | — | — | — | LEAN BEAR | — |
| WIBFF West Island Brands Inc. | — | -0.3 | -99.5 | -95.1 | -40.3 | 165.1 | 4 | LEAN BEAR | 0.0 |
| AJYG AJ1G, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 380.1 |
| REPCF RepliCel Life Sciences Inc. | — | -9.4 | -248.8 | -13.9 | -80.9 | 200.0 | 6 | LEAN BEAR | 0.0 |
| MCET MultiCell Technologies, Inc. | — | -0.1 | 101.2 | 99.1 | -81.8 | 1532.7 | 5 | LEAN BEAR | 900.0 |
| CMND Clearmind Medicine Inc. | — | -0.1 | -104.0 | 593.4 | — | — | 2 | LEAN BEAR | -99.8 |
| THCBF THC Biomed Intl Ltd. | — | -1.1 | -56.5 | -34.0 | -196.4 | -17.5 | 2 | LEAN BEAR | 0.0 |
| CNNXF CannAmerica Brands Corp. | — | -0.0 | 53.3 | 23.6 | -127.3 | 39.6 | 4 | LEAN BEAR | 0.0 |
| NMRD Nemaura Medical Inc. | — | -0.0 | 45.5 | -457.0 | — | -491.0 | 1 | LEAN BEAR | 0.0 |
| PEMTF Thoughtful Brands Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| VRTHF Indigenous Bloom Hemp Corp. | — | -0.3 | 77.3 | 21.2 | — | — | 3 | LEAN BEAR | 0.0 |
| MDIN MedGen, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| NURPF Neuren Pharmaceuticals Limited | $1.8B | 118.1 | 6.2 | 22.4 | 14.6 | -68.5 | 5 | LEAN BEAR | 20.8 |
| PSNL Personalis, Inc. | $1.7B | -14.7 | -50.3 | -149.3 | -141.7 | -13.3 | 2 | LEAN BEAR | 68.0 |
| BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited | $540M | 10.3 | 20.8 | 23.4 | 32.9 | 697.9 | 9 | LEAN BEAR | 0.0 |
| RSLBF RaySearch Laboratories AB (publ) | $510M | 31.8 | 26.1 | 21.8 | 7.2 | 1.2 | 6 | LEAN BEAR | -35.8 |
| DTIL Precision BioSciences, Inc. | $180M | -2.4 | -135.1 | 203.1 | — | 3473.0 | 5 | LEAN BEAR | -7.5 |
| PEPG PepGen Inc. | $170M | -1.7 | -75.5 | -327.5 | — | — | 4 | LEAN BEAR | -44.7 |
| MMIRF MedMira Inc. | $30M | -11.4 | 11.8 | 21.7 | -200.5 | 45.7 | 4 | LEAN BEAR | -20.4 |
| GMVDF G Medical Innovations Holdings Ltd | — | -0.0 | 5665.0 | 622.9 | -585.5 | 49.0 | 1 | LEAN BEAR | 0.0 |
| JBIO Jade Biosciences, Inc. | $930M | -5.4 | -47.8 | 629.9 | — | — | 3 | LEAN BEAR | 46.0 |
| ACRS Aclaris Therapeutics, Inc. | $550M | -6.6 | -59.1 | -206.5 | -1320.1 | -51.0 | 3 | LEAN BEAR | 67.7 |
| SRTA Strata Critical Medical, Inc. | $410M | 9.5 | 16.0 | -6.2 | -14.5 | 0.6 | 3 | LEAN BEAR | -5.4 |
| SNWV SANUWAVE Health Inc. | $40M | 3.0 | -238.8 | 4.8 | -7.0 | 12.0 | 7 | LEAN BEAR | -83.8 |
| GBCS Selectis Health, Inc. | $20M | 1.2 | 1850.1 | -22.2 | 171.7 | -21.3 | 4 | LEAN BEAR | 172.9 |
| CSDX CS Diagnostics Corp. | — | — | — | — | — | — | — | LEAN BEAR | — |
| ERBB American Green, Inc. | — | 0.1 | 33.3 | -15.0 | -629.5 | 17.7 | 3 | LEAN BEAR | 0.0 |
| TNON Tenon Medical, Inc. | — | -0.0 | -549.9 | -452.2 | -316.7 | 80.9 | 4 | LEAN BEAR | 83.8 |
| PARD Poniard Pharmaceuticals, Inc. | — | -0.0 | -210.4 | -442.5 | — | — | 3 | LEAN BEAR | 0.0 |
| CANN Trees Corporation | — | -2.1 | 284.2 | -3.9 | -15.1 | -24.7 | 4 | LEAN BEAR | -67.5 |
| ITNS Itonis, Inc. | — | -51.2 | 2.9 | 16.1 | -299.0 | -55.8 | 3 | LEAN BEAR | 0.0 |
| MDRSF Medartis Holding AG | $1.4B | 78.9 | 5.5 | 0.7 | 3.2 | 29.6 | 6 | LEAN BEAR | 72.5 |
| VMTHF Venus Medtech (Hangzhou) Inc. | $180M | -0.8 | -25.6 | -18.2 | -141.2 | -40.7 | 4 | LEAN BEAR | 35.7 |
| KRSA Korsana Biosciences, Inc. | $150M | — | — | — | — | — | — | LEAN BEAR | — |
| JMDMF Japan Medical Dynamic Marketing, Inc. | $130M | — | — | — | — | — | — | LEAN BEAR | 49.7 |
| TCLIF Theraclion S.A. | $40M | -6.3 | -342.1 | 1171.9 | -543.9 | 61.2 | 2 | LEAN BEAR | 312841.2 |
| LANZ Lancer Orthodontics, Inc. | — | 4.0 | 3.3 | 2.5 | -4.3 | 4.5 | 4 | LEAN BEAR | 2566.7 |
| HDRPF Epsilon Healthcare Limited | — | 70.0 | -33.3 | -22.6 | -9.6 | 161.1 | 5 | LEAN BEAR | 614.3 |
| NDATF nDatalyze Corp. | — | -16.7 | -61.8 | 1180.9 | — | -100.0 | 3 | LEAN BEAR | 633.9 |
| AOBI American Oriental Bioengineering, Inc. | — | -0.0 | -28.2 | -16.5 | -118.1 | -10.2 | 3 | LEAN BEAR | 1081.8 |
| PLSH Panacea Life Sciences Holdings, Inc. | — | -0.8 | 128.5 | -48.4 | -1581.6 | -90.2 | 5 | LEAN BEAR | 14.0 |
| TYRA Tyra Biosciences, Inc. | $1.2B | -8.9 | -45.3 | -2390.9 | — | — | 2 | LEAN BEAR | 44.6 |
| MRAI Marpai, Inc. | $80M | -3.9 | 47.4 | 28.0 | -110.0 | -29.7 | 3 | LEAN BEAR | 111.6 |
| MNDR Mobile-health Network Solutions Class A Ordinary Shares | — | -0.0 | -43.7 | -41.6 | -21.7 | -42.3 | 4 | LEAN BEAR | -99.1 |
| SNNC Sibannac, Inc. | — | -2.8 | 44.4 | 105.9 | — | -14.2 | 3 | LEAN BEAR | -72.3 |
| FOXO FOXO Technologies Inc. | — | 0.0 | -62.5 | -3.2 | 172.6 | 44.0 | 3 | LEAN BEAR | 8233.3 |
| IMMB Immunotech Laboratories, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 100.0 |
| EDVA Endovia Health Sciences, Inc. | — | — | — | — | — | — | — | LEAN BEAR | — |
| CNNA Cann American Corp. | — | 0.4 | -312.1 | -287.6 | -7986.6 | -64.9 | 3 | LEAN BEAR | 92.0 |
| INND InnerScope Hearing Technologies, Inc. | — | -0.0 | -1.4 | -0.4 | — | -56.8 | 4 | LEAN BEAR | -95.6 |
| CTTH CTT Pharmaceutical Holdings, Inc. | — | -40.5 | -272.8 | -210.7 | — | — | 2 | LEAN BEAR | 0.8 |
| FPMI FluoroPharma Medical, Inc. | — | -0.0 | 22.7 | 39.7 | — | — | 2 | LEAN BEAR | 100.0 |
| GBLX GB Sciences, Inc. | — | -0.0 | 19.5 | 17.2 | -103.2 | — | 3 | LEAN BEAR | -66.7 |
| ETST Earth Science Tech, Inc. | $30M | 6.8 | 66.8 | 212.2 | 8.0 | 8.0 | 6 | LEAN BEAR | -47.4 |
| ZBIO Zenas BioPharma, Inc. | $1.8B | -2.9 | -199.0 | 5842.1 | -11145.6 | -93.3 | 2 | LEAN BEAR | 8.9 |
| LJUIF SSY Group Limited | $1.2B | 15.2 | 6.7 | 4.6 | 13.6 | -4.4 | 5 | LEAN BEAR | 0.0 |
| SHEZF Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | $690M | 64.9 | 2.8 | 2.7 | 7.0 | -0.3 | 6 | LEAN BEAR | 0.0 |
| ENTA Enanta Pharmaceuticals, Inc. | $340M | -5.0 | -70.1 | 141.5 | -135.8 | 0.7 | 4 | LEAN BEAR | 12.5 |
| APLMW Apollomics, Inc. | $170M | -2.6 | -233.7 | 845.7 | 1188.0 | -75.9 | 3 | LEAN BEAR | -60.0 |
| ARMP Armata Pharmaceuticals, Inc. | $140M | -0.7 | 127.8 | -54.7 | 2953.8 | -35.1 | 2 | LEAN BEAR | -51.4 |
| LPCUF Lee's Pharmaceutical Holdings Limited | $110M | 3.8 | 9.9 | 0.2 | 11.9 | 81.2 | 8 | LEAN BEAR | 1.1 |
| NTHI Neonc Technologies Holdings, Inc. | $90M | — | — | — | — | — | — | LEAN BEAR | -66.2 |
| LUCD Lucid Diagnostics Inc. | $80M | -0.9 | -556.3 | -1646.4 | -792.9 | 24.9 | 6 | LEAN BEAR | -58.6 |
| TDSGF Telo Genomics Corp. | $10M | -2.1 | -2858.5 | 258.3 | — | — | 2 | LEAN BEAR | -10.2 |
| SRBCF Sirona Biochem Corp. | — | -0.7 | 111.4 | 1025.7 | -34808.5 | -119.4 | 2 | LEAN BEAR | -50.5 |
| PZRXQ PhaseRx, Inc. | — | -0.0 | -228.2 | 8803.4 | — | — | 2 | LEAN BEAR | 0.0 |
| ASFX American Scientific Resources, Incorporated | — | — | — | — | — | — | — | LEAN BEAR | -25.0 |
| ULGX Urologix, Inc. | — | -0.0 | 80.8 | 96.5 | -12.5 | -19.4 | 3 | LEAN BEAR | -0.0 |
| BNYN Banyan Corp. | — | -0.0 | 719.9 | -36.9 | -121.9 | -37.7 | 3 | LEAN BEAR | 0.0 |
| LRSV Link Reservations Inc. | — | -7.6 | 103.3 | 152.0 | -20.7 | 73995.4 | 5 | LEAN BEAR | -50.0 |
| HCANF Halo Collective Inc. | — | -0.0 | -132.7 | -43.7 | -192.0 | -43.0 | 2 | LEAN BEAR | 0.0 |
| EWPI Emerging World Pharma, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| RNAZ TransCode Therapeutics, Inc. | — | -0.0 | -59.2 | -21.0 | — | — | 1 | LEAN BEAR | -87.0 |
| TCNAF TransCanna Holdings Inc. | — | -0.0 | -246.6 | -38.8 | -338.7 | 90.3 | 3 | LEAN BEAR | 0.0 |
| FSPM FusionPharm, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| PRPH ProPhase Labs, Inc. | — | -0.0 | -544.0 | -207.6 | -301.8 | -5.5 | 3 | LEAN BEAR | -99.7 |
| NSVGF Nass Valley Gateway Ltd. | — | -3.7 | 12.1 | 2.9 | — | -95.8 | 1 | LEAN BEAR | 0.0 |
| DRWN Quantum Medical Transport, Inc. | — | 0.3 | 25.7 | 20.8 | 2.2 | -96.3 | 4 | LEAN BEAR | 0.0 |
| NNBP Nanobac Pharmaceuticals, Incorporated | — | 0.0 | 358.0 | 221.2 | -26718.6 | -92.2 | 3 | LEAN BEAR | 0.0 |
| NNLX NanoLogix, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -20.0 |
| CLAZF Claritas Pharmaceuticals, Inc. | — | 0.0 | -170.1 | 15.9 | — | — | 3 | LEAN BEAR | 0.0 |
| AHGIF Alternate Health Corp. | — | -0.0 | -611.4 | -2862.3 | -21.3 | 171.0 | 4 | LEAN BEAR | 0.0 |
| GRPS Trans American Aquaculture, Inc. | — | -0.5 | 114.2 | 17.8 | — | -96.0 | 3 | LEAN BEAR | -60.8 |
| HTGMQ HTG Molecular Diagnostics, Inc. | — | -0.0 | -343.2 | 734.2 | -489.6 | -28.2 | 2 | LEAN BEAR | 0.0 |
| CBDD CBD of Denver, Inc. | — | -7.7 | -0.1 | -28.9 | -2.7 | 19.0 | 3 | LEAN BEAR | -0.0 |
| IMVIF IMV Inc. | — | -0.2 | -503.3 | -2870.5 | — | — | 1 | LEAN BEAR | 1900.0 |
| IMRSQ IMRIS Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| SPPH Spencer Pharmaceutical Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| EVARF Lombard Medical, Inc. | — | — | — | — | — | — | — | LEAN BEAR | 0.0 |
| PREDQ Predictive Discovery Limited | — | — | — | — | — | — | — | LEAN BEAR | — |
| BHNGF Bhang Inc. | — | -0.0 | 782.7 | 270.1 | -248.2 | 78.7 | 3 | LEAN BEAR | 0.0 |
| BIOGY BioGaia AB (publ) | $1.3B | 32.0 | 31.8 | 52.6 | 27.5 | 13.1 | 5 | LEAN BEAR | 9.2 |
| OMDA Omada Health | $1.2B | 284.8 | 1.8 | -1.5 | 6.0 | 404.7 | 7 | LEAN BEAR | -25.1 |
| JXFGF Jinxin Fertility Group Limited | $730M | 26.4 | 1.9 | 1.8 | 7.8 | 1.4 | 7 | LEAN BEAR | 3.6 |
| AUNA Auna S.A. | $380M | -17.4 | 0.8 | 4.5 | 2.4 | 9.2 | 7 | LEAN BEAR | -20.2 |
| FGHQF Frontage Holdings Corporation | $360M | 36.5 | 3.1 | 3.0 | 4.6 | 9.8 | 7 | LEAN BEAR | 16.8 |
| GWIN Glorywin Entertainment Group, Inc. | $360M | -26081.4 | 11.7 | 5.1 | — | — | 1 | LEAN BEAR | 229.5 |
| CLVSF CellaVision AB (publ) | $330M | 31.6 | 15.1 | 17.1 | 16.3 | -1.9 | 6 | LEAN BEAR | -27.4 |
| SPHRY Starpharma Holdings Limited | $220M | -26.0 | -46.5 | -441.4 | -725.1 | 186.8 | 4 | LEAN BEAR | 100.0 |
| KNTPF Kintor Pharmaceutical Limited | $120M | -2.9 | -116.6 | -74.4 | -145.6 | 2237.9 | 3 | LEAN BEAR | -10.2 |
| HSTI High Sierra Technologies, Inc. | $30M | -22.8 | 225.7 | 189.7 | — | — | 4 | LEAN BEAR | 0.0 |
| MILFF 1CM Inc. | $30M | 4.5 | 15.1 | 7.4 | 2.5 | 7.3 | 7 | LEAN BEAR | -44.1 |
| LVCLF Algorae Pharmaceuticals Limited | $20M | -5.4 | -47.4 | -24288.6 | — | -100.0 | 3 | LEAN BEAR | 51.6 |
| BCLI Brainstorm Cell Therapeutics Inc. | $10M | -0.8 | 119.2 | 76.7 | — | -100.0 | 1 | LEAN BEAR | 11.9 |
| QPTFF Quest PharmaTech Inc. | $10M | 1.6 | 3.9 | -1.7 | — | — | 4 | LEAN BEAR | 125.6 |
| PLLWF Polarean Imaging plc | $10M | -0.1 | -83.4 | -772.7 | -852.0 | 39.1 | 2 | LEAN BEAR | -40.0 |
| FORU ForU Holdings, Inc. | — | -0.0 | 759.2 | -476.4 | — | -100.0 | 2 | LEAN BEAR | 100.0 |
| CHNXF ChitogenX Inc. | — | -0.2 | 23.2 | 36.2 | — | — | 2 | LEAN BEAR | 48.0 |
| ELXMF Nova Eye Medical Limited | — | -10.5 | -26.1 | -22.0 | -5.3 | 19.0 | 5 | LEAN BEAR | -85.7 |
| OMWS Omnia Wellness Inc. | — | -0.0 | 91.7 | -520.4 | -2231.0 | -14.0 | 1 | LEAN BEAR | 100.0 |
| REMI Remedent, Inc. | — | -0.1 | -11.3 | -4.3 | -86.4 | 14.2 | 6 | LEAN BEAR | 300.0 |
| HYHY Hydrogen Hybrid Technologies, Inc. | — | -0.0 | -138.6 | -342.9 | — | 16.1 | 4 | LEAN BEAR | 0.0 |
| YUKA Yuka Group, Inc. | — | -2.6 | 24.0 | 81.8 | -50.7 | -8.2 | 5 | LEAN BEAR | 174.1 |
| CLGN CollPlant Biotechnologies Ltd. | — | -0.4 | -162.0 | -369.3 | -2524.1 | -86.8 | 2 | LEAN BEAR | -83.5 |
| NMSCA Nutrition Management Services Company | — | 0.0 | 4.0 | 6.5 | -0.5 | -7.8 | 5 | LEAN BEAR | 200.0 |
| VINC Vincerx Pharma, Inc. | — | -0.0 | -3136.4 | 910.2 | — | -18.7 | 5 | LEAN BEAR | -55.9 |
| GRHY Green Hygienics, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -93.0 |
| RTSL Rapid Therapeutic Science Laboratories, Inc. | — | -0.0 | -3.4 | 35.5 | — | -100.0 | 2 | LEAN BEAR | -86.7 |
| HRAL Hear AtLast Holdings, Inc. | — | -0.3 | 16.3 | 89.4 | — | — | 3 | LEAN BEAR | -20.0 |
| AIDA Aida Pharmaceuticals, Inc. | — | 0.0 | -20.7 | 25.4 | 19.3 | 40.9 | 6 | LEAN BEAR | 50.0 |
| BRSF Brain Scientific Inc. | — | -0.0 | -633.9 | -94.8 | -77714.6 | -19.3 | 3 | LEAN BEAR | 500.0 |
| BLMS Bloomios, Inc. | — | -0.0 | 221.4 | 58.3 | -3817.0 | 46.5 | 2 | LEAN BEAR | 200.0 |
| XSVT Xsovt Brands, Inc. | — | -0.0 | 241.0 | 189.8 | -134.3 | 300584.1 | 4 | LEAN BEAR | 900.0 |
| ALEC Alector, Inc. | $200M | -1.9 | -385.1 | 66.8 | -692.5 | -82.9 | 1 | LEAN BEAR | 24.5 |
| RLYB Rallybio Corporation | $90M | 3.4 | 34.5 | -1198.7 | — | -35.6 | 6 | LEAN BEAR | 2640.0 |
| CPHI China Pharma Holdings, Inc. | $30M | -0.6 | -21.0 | -8.7 | -153.8 | -11.0 | 4 | LEAN BEAR | -63.0 |
| AEON AEON Biopharma, Inc. | $10M | -0.1 | 350.0 | 98.0 | — | — | 2 | LEAN BEAR | -73.6 |
| MJNA Medical Marijuana, Inc. | — | -1.3 | -1.3 | -2.2 | -0.9 | -22.1 | 2 | LEAN BEAR | -50.0 |
| DYNTQ Dynatronics Corporation | — | — | — | — | — | — | — | LEAN BEAR | — |
| AEMD Aethlon Medical, Inc. | — | -0.4 | -160.9 | -883.2 | — | — | 3 | LEAN BEAR | -80.3 |
| ATXI Avenue Therapeutics, Inc. | — | -0.5 | -120.0 | 178.4 | — | -100.0 | 2 | LEAN BEAR | -41.9 |
| EMYSF Easy Technologies Inc. | — | -0.3 | 192.7 | 227.8 | — | -100.0 | 1 | LEAN BEAR | 0.0 |
| STOK Stoke Therapeutics, Inc. | $1.6B | -7.8 | -61.1 | -318.5 | -660.8 | -86.2 | 2 | LEAN BEAR | -19.7 |
| PARK Park Dental Partners, Inc. Common Stock | $90M | -23.5 | -16.0 | 0.0 | 2.0 | — | 3 | LEAN BEAR | — |
| GWLL Goldenwell Biotech, Inc. | $60M | -240.7 | 31.8 | 137.0 | — | 319257.9 | 5 | LEAN BEAR | 225.0 |
| CURX Curanex Pharmaceuticals Inc Common Stock | $10M | -0.6 | -218.7 | -392.2 | — | — | 1 | LEAN BEAR | -62.8 |
| HIGR Hi-Great Group Holding Company | — | -11.1 | 30.7 | 30.8 | -177.4 | -40.3 | 1 | LEAN BEAR | -88.8 |
| WUHN Wuhan General Group (China), Inc. | — | -0.0 | 106.5 | 1.0 | -155074.0 | — | 2 | LEAN BEAR | 100.0 |
| IGNT Ingen Technologies, Inc. | — | — | — | — | — | — | — | LEAN BEAR | -50.0 |
| CWBHF Charlotte's Web Holdings, Inc. | $70M | -1.2 | -97.1 | -27.9 | -38.0 | -6.9 | 5 | LEAN BEAR | 47.6 |
| EOCN Eocene Ltd. | — | — | — | — | — | — | — | LEAN BEAR | — |
| ENZC Enzolytics Inc. | — | -11.2 | 105.9 | 1.4 | — | — | 7 | BEARISH | 66.7 |
| TRLV Trulieve Cannabis Corp. | $1.8B | — | — | — | — | — | — | BEARISH | — |
| AVLN Avalyn Pharma Inc. Common Stock | $1.1B | — | — | — | — | — | — | BEARISH | — |
| MDRX Veradigm Inc. | $830M | -7.1 | 4.3 | 7.0 | 6.2 | -39.7 | 5 | BEARISH | 0.0 |
| AMRN Amarin Corporation plc | $240M | -8.4 | -6.0 | -19.6 | -18.1 | -15.1 | 6 | BEARISH | -37.9 |
| DBVT DBV Technologies S.A. | $230M | -2.6 | -142.6 | -2201.5 | — | -100.0 | 2 | BEARISH | -32.8 |
| RNA Atrium Therapeutics, Inc. | $140M | -2.1 | -36.9 | 455.9 | -672.0 | 235.3 | 5 | BEARISH | -82.8 |
| QTI QT Imaging Holdings, Inc. | $30M | -1.5 | -1915.2 | 88.4 | -148.9 | -99.4 | 5 | BEARISH | 390.5 |
| PBIGF Paradigm Biopharmaceuticals Limited | $10M | -1.6 | -456.6 | 1081.8 | -60158.9 | 53.6 | 4 | BEARISH | -95.6 |
| AIMV AI Maverick Intel, Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| HKPD Cellyan Biotechnology Co., Ltd | — | -5.0 | -15.6 | -7.4 | -20.5 | 45.7 | 6 | BEARISH | -92.2 |
| PKTX ProtoKinetix, Incorporated | — | -1.0 | -117.2 | -115.0 | — | — | 2 | BEARISH | -95.6 |
| ICBU iMD Companies, Inc. | — | -11.8 | 27.7 | 30.0 | — | -100.0 | 3 | BEARISH | -63.6 |
| NPHC Nutra Pharma Corp. | — | -0.1 | 23.1 | 4.7 | -11458.0 | 55.8 | 3 | BEARISH | 0.0 |
| GELS Gelteq Limited Ordinary Shares | — | — | — | — | — | — | — | BEARISH | -67.0 |
| DHBUF Delivra Health Brands Inc. | — | -2.5 | -19.4 | -34.1 | -82.4 | -10.7 | 2 | BEARISH | -70.5 |
| CARM Carisma Therapeutics, Inc. | — | 0.0 | -134.1 | -376.4 | 98.8 | 159.7 | 3 | BEARISH | -99.2 |
| TRVN Trevena, Inc. | — | -0.0 | 344.3 | -3198.4 | -1745.2 | -82.9 | 3 | BEARISH | -7.5 |
| DRUG Bright Minds Biosciences Inc. | $520M | -26.2 | -13.7 | -105758.3 | — | — | 3 | BEARISH | -17.0 |
| CELG-RI Bristol-Myers Squibb Company Ce | $250M | 0.0 | 46.7 | 22.0 | 25.6 | 3.1 | 8 | BEARISH | 310.2 |
| TRDA Entrada Therapeutics, Inc. | $170M | -1.1 | -54.1 | -236.6 | -4762.0 | -94.1 | 1 | BEARISH | -25.8 |
| BDTX Black Diamond Therapeutics, Inc. | $110M | -2.4 | -37.2 | -1604.9 | — | -100.0 | 1 | BEARISH | -56.4 |
| INNMF Amplia Therapeutics Limited | $30M | -4.7 | -24.9 | -86.9 | — | -100.0 | 2 | BEARISH | -45.0 |
| ROMJF Rubicon Organics Inc. | $20M | -16.3 | -4.1 | -24.0 | 2.2 | 16.7 | 1 | BEARISH | -25.0 |
| KPTI Karyopharm Therapeutics Inc. | $10M | -0.0 | 79.0 | 36.3 | -200.5 | 6.8 | 2 | BEARISH | -92.2 |
| LFWD Lifeward Ltd. | $10M | -0.4 | -225.6 | -129.9 | -173.9 | -10.7 | 4 | BEARISH | -24.1 |
| PFHO Pacific Health Care Organization, Inc. | $10M | 13.1 | 7.5 | 60.8 | 18.4 | -2.6 | 4 | BEARISH | -18.3 |
| CBDHF Hempfusion Wellness Inc. | — | 0.0 | -82.5 | -84.6 | -190.5 | — | 1 | BEARISH | 0.0 |
| RQHTF Reliq Health Technologies Inc. | — | -5.4 | -4.5 | -8.2 | 15.4 | 119.4 | 5 | BEARISH | 0.0 |
| NASC Nascent Pharma Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| FITX Creative Edge Nutrition, Inc. | — | -0.0 | 242.9 | 120.2 | -98.6 | — | 3 | BEARISH | 0.0 |
| AAGH America Great Health | — | 2.0 | -12.2 | 22.4 | -635.8 | -5.1 | 4 | BEARISH | 100.0 |
| BXRXQ Baudax Bio, Inc. | — | — | — | — | — | — | — | BEARISH | 900.0 |
| VVOS Vivos Therapeutics, Inc. | — | -0.1 | -6663.0 | -267.4 | -106.4 | 45.2 | 3 | BEARISH | -95.6 |
| FLOOF Flower One Holdings Inc. | — | -0.0 | 111.5 | -21.8 | -15.4 | -19.8 | 2 | BEARISH | 0.0 |
| SRUTF Sproutly Canada Inc. | — | -0.0 | 7045.7 | -519.2 | -1194.7 | 28.2 | 4 | BEARISH | 0.0 |
| ADXN Addex Therapeutics Ltd | — | -0.4 | -150.5 | -168.4 | -17543.0 | -48.1 | 2 | BEARISH | -70.6 |
| FIORF Fiore Cannabis Ltd. | — | -0.0 | -417.3 | -33.3 | -383.4 | -6.2 | 2 | BEARISH | 0.0 |
| ABSI Absci Corporation | $1.6B | -13.4 | -57.7 | -213.1 | -10443.4 | -62.3 | 5 | BEARISH | 120.8 |
| SNBIF SanBio Company Limited | $1.3B | -19.5 | -55.8 | -2935.2 | — | — | 3 | BEARISH | 0.0 |
| CVSGF CVS Group plc | $1.1B | 52.6 | 5.9 | 7.3 | 2.7 | -22.7 | 6 | BEARISH | 0.7 |
| PKBFF PeakBirch Commerce Inc. | $540M | -0.0 | -16609.0 | 16544.6 | -58.8 | -69.1 | 3 | BEARISH | 0.0 |
| TSNLF Tristel PLC | $280M | 24.4 | 23.4 | 31.6 | 15.8 | 10.3 | 8 | BEARISH | 8.5 |
| FATE Fate Therapeutics, Inc. | $250M | -2.0 | -60.7 | -140.1 | -1448.6 | -23.4 | 2 | BEARISH | 106.0 |
| DYAI Dyadic International, Inc. | $20M | -1.9 | 522.6 | 1288.0 | -221.0 | 1.5 | 3 | BEARISH | -64.8 |
| BIVI BioVie Inc. | $10M | -0.4 | -0.0 | -0.0 | — | — | 3 | BEARISH | -29.6 |
| LSTA Lisata Therapeutics, Inc. | $10M | -0.6 | -99.9 | 590.1 | — | -90.7 | 2 | BEARISH | -54.9 |
| PTKFY PT Kalbe Farma Tbk | $10M | 8.9 | 15.5 | 17.8 | 9.1 | 13.6 | 6 | BEARISH | -45.4 |
| XCUR Exicure, Inc. | $10M | -0.8 | -168.4 | 779.8 | — | — | 2 | BEARISH | -77.0 |
| VRCI Verde Science, Inc. | — | -0.0 | 72.3 | 23.0 | — | — | 5 | BEARISH | 100.0 |
| PDMI Paradigm Medical Industries, Inc. | — | -0.0 | 47.4 | -40.4 | -184.3 | -30.7 | 4 | BEARISH | -90.0 |
| HLUN HEALTHeUNIVERSE, Inc. | — | — | — | — | — | — | — | BEARISH | 900.0 |
| SNNAQ Sienna Biopharmaceuticals, Inc. | — | -0.0 | -140.9 | -331.4 | — | — | 2 | BEARISH | 0.0 |
| ARYC Arrayit Corporation | — | -0.0 | 116.8 | 89.8 | -513.1 | -30.5 | 2 | BEARISH | -90.0 |
| WLDFF Wildflower Brands Inc. | — | -0.0 | -27.7 | -4.7 | 1.9 | 319.8 | 7 | BEARISH | 0.0 |
| OMDD Ormand Industries Inc | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SHOM Southern Home Medical, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| PSIQ Profile Solutions, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ROTH PharmaRoth Labs, Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| DGEN Deltagen Inc. | — | 0.0 | 19.8 | 182.7 | -27.2 | -65.8 | 4 | BEARISH | 0.0 |
| VRSEF Verisante Technology Inc. | — | 5.4 | 124.9 | 102.2 | — | — | 3 | BEARISH | -88.0 |
| NTII Neurobiological Technologies, Inc. | — | 0.0 | 48.7 | 441.6 | 89.7 | 99.7 | 4 | BEARISH | 0.0 |
| CMRA Comera Life Sciences Holdings, Inc. | — | -0.0 | 235.6 | 124.2 | -1580.0 | 81.8 | 4 | BEARISH | 0.0 |
| FORZ Forza Innovations Inc. | — | -0.0 | 91.9 | 0.0 | 11330.0 | 8.7 | 3 | BEARISH | 0.0 |
| CWWBF Plant-Based Investment Corp. | — | -0.0 | -95.9 | -3827.0 | 167.3 | -218.9 | 3 | BEARISH | 0.0 |
| IMEXF Imagin Medical Inc. | — | -0.0 | 31.8 | 185.9 | — | — | 3 | BEARISH | 0.0 |
| CYPS Cyclo3pss Corporation | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HAVLF HAVN Life Sciences Inc. | — | -0.0 | -275.3 | -163.4 | 5734.1 | 876.8 | 3 | BEARISH | 0.0 |
| AVTI Avitar, Inc. | — | -0.0 | 26.0 | -62.7 | -263.1 | -47.4 | 2 | BEARISH | 0.0 |
| UPPR Upper Street Marketing Inc. | — | -0.0 | 228.5 | -53.9 | -715.0 | — | 1 | BEARISH | 42.9 |
| CRRVF CVR Medical Corp. | — | -0.0 | 49.0 | 11.5 | — | — | 1 | BEARISH | 0.0 |
| CAAOF INDVR Brands Inc. | — | -0.0 | -111.6 | -22.0 | -159.3 | 22.0 | 4 | BEARISH | 0.0 |
| RGDXQ Response Genetics, Inc | — | -0.0 | 1186.4 | -243.6 | -110.9 | -8.1 | 3 | BEARISH | 0.0 |
| BNVIF Binovi Technologies Corp. | — | -0.0 | -433.7 | 182.0 | 17056.9 | -74.4 | 1 | BEARISH | 400.0 |
| GLSHQ Gelesis Holdings, Inc. | — | -0.0 | 391.0 | -233.6 | -693.9 | -45.8 | 3 | BEARISH | 0.0 |
| DMSI Dermisonics, Inc. | — | -0.0 | -392.2 | 1105.0 | — | — | 1 | BEARISH | 0.0 |
| IONM Assure Holdings Corp. | — | -0.0 | 237.0 | 462.9 | -25500.0 | -64.6 | 1 | BEARISH | -99.0 |
| ROSGQ Rosetta Genomics Ltd. | — | -0.0 | -44.3 | -306.4 | 136.0 | — | 1 | BEARISH | 0.0 |
| INSD Instadose Pharma Corp. | — | -0.0 | -9.7 | -3.7 | — | — | 4 | BEARISH | -90.9 |
| WCUI Wellness Center USA, Inc. | — | -0.0 | 44.8 | 1728.1 | -86.5 | 140.9 | 5 | BEARISH | -0.0 |
| CBIA Canopus Biopharma, Inc. | — | -0.0 | 1457.1 | 15327.7 | — | — | 1 | BEARISH | 0.0 |
| ALID Allied Corp. | — | -0.0 | 266.4 | 484.7 | -207842.5 | -53.9 | 2 | BEARISH | -95.5 |
| PSYBF PsyBio Therapeutics Corp | — | -0.0 | 344.6 | 135.0 | — | — | 2 | BEARISH | -90.0 |
| MRZM Marizyme, Inc. | — | -0.0 | 117.5 | -190.1 | — | -69.0 | 3 | BEARISH | 0.0 |
| IBXG iBX Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| TLOG TetraLogic Pharmaceuticals Corporation | — | -0.0 | 382.3 | 479.8 | — | — | 1 | BEARISH | 0.0 |
| DSOL Drug Free Solution, Inc. | — | -16.9 | 255.8 | 197.9 | — | — | 2 | BEARISH | -63.6 |
| IGRW Interactive Health Network | — | 0.2 | 1090.1 | 947.6 | -29882.2 | — | 2 | BEARISH | 0.0 |
| NTLA Intellia Therapeutics, Inc. | $1.6B | -3.6 | -55.4 | -92.1 | -1392.3 | 12.6 | 5 | BEARISH | -56.5 |
| JANX Janux Therapeutics, Inc. | $1.0B | -10.4 | -10.7 | 516.9 | -214.0 | 7162.0 | 4 | BEARISH | -31.8 |
| BPMUF Basilea Pharmaceutica AG | $960M | 16.9 | 39.5 | 75.9 | 23.5 | 4.5 | 7 | BEARISH | 27.1 |
| GNMLF Genomma Lab Internacional, S.A.B. de C.V. | $710M | 9.0 | 14.3 | 13.4 | 11.4 | 22.0 | 4 | BEARISH | -22.7 |
| BOIRF Boiron S.A. | $550M | 12.7 | 7.2 | 7.8 | 2.0 | 97.0 | 5 | BEARISH | 10.5 |
| IMPZY Implanet S.A. | $230M | -5.1 | 275.6 | -110.9 | -30.0 | 24.3 | 5 | BEARISH | 0.2 |
| BETRF BetterLife Pharma Inc. | $110M | -10.0 | 34.9 | 21.6 | — | — | 4 | BEARISH | 220.0 |
| WORX SCWorx Corp. | $40M | -0.4 | -38.1 | -8.2 | -17.1 | 3.1 | 6 | BEARISH | 374.5 |
| MEDS DataMEDS AI, Inc. | $10M | -0.0 | -142327.8 | -322403.1 | -1031.7 | 339160.3 | 4 | BEARISH | -20.9 |
| CSCIF COSCIENS Biopharma Inc. | $10M | -0.5 | -19.9 | -18.7 | -6.4 | — | 1 | BEARISH | -18.7 |
| BGXXQ Bright Green Corporation | — | — | — | — | — | — | — | BEARISH | — |
| VDRM ViaDerma, Inc. | — | 28.7 | 133.1 | -25.3 | -214.1 | 5.3 | 3 | BEARISH | -80.0 |
| ANTCF Aion Therapeutic Inc. | — | -0.2 | 365.1 | 64.7 | -53.7 | 563.3 | 3 | BEARISH | 17.6 |
| MSIU Medical Supply International USA, Inc. | — | — | — | — | — | — | — | BEARISH | 300.0 |
| SYGGF Synairgen plc | — | -0.2 | -71.9 | -381.4 | — | — | 1 | BEARISH | -50.0 |
| PFSA Profusa, Inc. Common Stock | — | -0.0 | 158.4 | 181.7 | — | — | 2 | BEARISH | 185.6 |
| SDCCQ SmileDirectClub Inc Class A | — | -0.0 | -72.6 | -19.0 | -17.5 | -23.4 | 3 | BEARISH | 0.0 |
| BSPM Biostar Pharmaceuticals, Inc. | — | -0.0 | 2.7 | 1.9 | — | -91.9 | 5 | BEARISH | 0.0 |
| SYDRF Delota Corp. | — | -3.8 | -139.4 | -20.5 | -1.7 | -13.0 | 4 | BEARISH | 0.0 |
| OLMM OneLife Technologies Corp. | — | -0.0 | 454.4 | -594.1 | — | — | 3 | BEARISH | 900.0 |
| CHYPF Health Logic Interactive Inc. | — | -3.5 | 20.0 | 14.2 | — | — | 1 | BEARISH | -45.2 |
| RMSL REMSleep Holdings, Inc. | — | -0.0 | 4286484750.6 | 1769.6 | -702.2 | -27.1 | 2 | BEARISH | -61.6 |
| ABMT Advanced BioMedical Technologies Inc. | — | -0.1 | 6.0 | 9.6 | 3842.6 | 264.3 | 3 | BEARISH | 400.0 |
| IDYLF Imaging Dynamics Company Ltd. | — | -0.3 | 18.7 | 39.1 | -2277.3 | -65.6 | 4 | BEARISH | 152.7 |
| VAXX Vaxxinity, Inc. | — | -0.2 | -150.6 | 2534.7 | — | — | 0 | BEARISH | 0.0 |
| PVLA Palvella Therapeutics, Inc. | $1.8B | -27.4 | -46.6 | 137.5 | — | — | 3 | BEARISH | 77.0 |
| RYHTY Ryman Healthcare Limited | $1.0B | -10.8 | -4.2 | -0.3 | -30.8 | 10.6 | 7 | BEARISH | -23.4 |
| ANGO AngioDynamics, Inc. | $520M | -15.4 | -19.2 | -20.5 | -8.8 | 8.2 | 5 | BEARISH | 1.4 |
| IFRX InflaRx N.V. | $230M | -3.0 | -38.5 | 251.5 | — | -106.2 | 4 | BEARISH | 29.5 |
| ATGGF Actinogen Medical Limited | $140M | -8.5 | -77.5 | -235.8 | — | -100.0 | 1 | BEARISH | 40.0 |
| SERA Sera Prognostics, Inc. | $80M | -3.1 | -45.0 | -184.9 | -30463.3 | -35.2 | 3 | BEARISH | -39.1 |
| CGNH CardioGenics Holdings Inc | — | -0.0 | 58.8 | 40.3 | — | — | 3 | BEARISH | 0.0 |
| RMRK Rimrock Gold Corp. | — | 204.0 | 8.6 | 6.4 | — | -100.0 | 2 | BEARISH | 0.0 |
| SQZB SQZ Biotechnologies Company | — | -0.0 | -203.4 | -410.2 | — | -44.6 | 0 | BEARISH | 4.3 |
| VSEED VSee Health, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| STLN Starling Oncology, Inc. | $670M | — | — | — | — | — | — | BEARISH | — |
| MEOBF Mesoblast Limited | $2.0B | -29.4 | -9.9 | -14.4 | -23.4 | 613.8 | 5 | BEARISH | -9.0 |
| CBGL Cannabis Global Inc. | — | -0.5 | 5.4 | 17.3 | — | 520.3 | 3 | BEARISH | -80.0 |
| CLNN Clene Inc. | $60M | -1.1 | 237.2 | 132.5 | -14915.6 | -31.1 | 2 | BEARISH | -52.9 |
| CEROW CERo Therapeutics Holdings, Inc. | — | -0.0 | 101.5 | 60.5 | — | -100.0 | 1 | BEARISH | -75.2 |
| LYPHF Luye Pharma Group Ltd. | $1.1B | 7.8 | 4.5 | 6.7 | 13.0 | -2.1 | 6 | BEARISH | 0.8 |
| OCS Oculis Holding AG | $490M | -4.7 | -44.0 | -31.0 | — | -6.9 | 3 | BEARISH | -62.7 |
| ALXO ALX Oncology Holdings Inc. | $160M | -1.0 | -80.6 | -851.1 | — | — | 4 | BEARISH | -35.4 |
| MAYNF Mayne Pharma Group Limited | $150M | 7.8 | 6.4 | -13.8 | 23.0 | -6.1 | 3 | BEARISH | -52.7 |
| FBIOP Fortress Biotech, Inc. | $130M | 0.6 | 107.5 | -87.8 | -2.5 | 15.5 | 6 | BEARISH | 140.0 |
| FHTX Foghorn Therapeutics Inc. | $120M | -2.0 | 81.9 | 26.3 | -44.7 | 52.0 | 4 | BEARISH | -47.4 |
| AURX Nuo Therapeutics, Inc. | $60M | -31.1 | 170.6 | 280.3 | -15.7 | 166.6 | 3 | BEARISH | -47.8 |
| BEAT HeartBeam, Inc. | $20M | -0.8 | -328.4 | 2958.2 | — | — | 3 | BEARISH | -74.6 |
| ALRTF ALR Technologies Inc. | $10M | -0.4 | 54.2 | 8.3 | -151734.7 | — | 2 | BEARISH | 0.2 |
| STSN Stemsation International, Inc. | $10M | -4.8 | -2.8 | -1.6 | — | — | 3 | BEARISH | 115.2 |
| PZOO Pazoo, Inc. | — | -0.0 | 49.0 | 21.1 | -972321.6 | -100.0 | 4 | BEARISH | 0.0 |
| IHGP Jun An Kang Group Inc. | — | 2.0 | 0.5 | 0.5 | 1.0 | 64.0 | 6 | BEARISH | -98.9 |
| KGET CaliPharms, Inc. | — | -0.4 | 72.6 | 7.6 | -6979.1 | — | 2 | BEARISH | 3900.0 |
| VRPX Virpax Pharmaceuticals, Inc. | — | -0.0 | 2.6 | 0.4 | — | — | 1 | BEARISH | -92.7 |
| PBMWW Psyence Biomedical Ltd. Warrant | — | — | — | — | — | — | — | BEARISH | -49.9 |
| GGBXF Green Growth Brands Inc. | — | — | — | — | — | — | — | BEARISH | -90.0 |
| JAGX Jaguar Health, Inc. | — | -0.0 | -501.9 | -118.9 | -1035.3 | 135.5 | 4 | BEARISH | -99.8 |
| HTDS Hard to Treat Diseases Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ELLXF Elixinol Wellness Limited | — | -0.7 | -52.3 | -22.6 | -14.9 | -4.8 | 1 | BEARISH | 23.1 |
| CALA Calithera Biosciences, Inc. | — | -0.0 | -141.5 | 979.6 | — | -100.0 | 1 | BEARISH | 0.0 |
| WLSI Wellstar International, Inc. | — | -0.0 | 24.2 | 35.0 | — | — | 3 | BEARISH | 0.0 |
| PHRX Pharmagen, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MRRCF Wayland Group Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| OTRKQ Ontrak, Inc. | — | -0.0 | -215.7 | -149.5 | -341.6 | -21.0 | 1 | BEARISH | -99.9 |
| KARD Kardigan, Inc. | $1.1B | — | — | — | — | — | — | BEARISH | — |
| PPTDF PeptiDream Inc. | $870M | -38.0 | -7.1 | -9.6 | -25.7 | 47.8 | 4 | BEARISH | -38.7 |
| EDTXF Spectral Medical Inc. | $210M | -7.5 | 64.9 | 19.4 | 53.3 | 1.5 | 2 | BEARISH | -37.2 |
| PROF Profound Medical Corp. | $200M | -5.8 | -73.1 | -148.0 | -384.2 | 35.5 | 3 | BEARISH | 4.5 |
| EBRCZ EBR Systems, Inc. | $80M | -0.9 | -102.2 | 22812.5 | -661.9 | 305113.7 | 3 | BEARISH | -87.9 |
| EQ Equillium, Inc. | $80M | -5.2 | -59.0 | 2703.6 | — | -100.0 | 3 | BEARISH | -6.0 |
| PETV PetVivo Holdings, Inc. | $30M | -2.1 | -384.4 | -353.6 | -478.1 | -9.5 | 4 | BEARISH | -51.2 |
| LOBEF Lobe Sciences Ltd. | $10M | -2.7 | 359.0 | 181.6 | — | — | 2 | BEARISH | 0.7 |
| SNTI Senti Biosciences, Inc. | $10M | -0.1 | -466.5 | -430.9 | -75000.0 | — | 2 | BEARISH | -91.2 |
| BJDX Bluejay Diagnostics, Inc. | — | -0.0 | -98.9 | 5625.8 | — | — | 4 | BEARISH | -94.2 |
| RDHL RedHill Biopharma Ltd. | — | -3.2 | 428.1 | 117.9 | -101.3 | 157.6 | 6 | BEARISH | -76.0 |
| ALUR Allurion Technologies Inc. | — | -0.0 | 45.2 | 39.3 | -206.8 | -55.5 | 3 | BEARISH | -99.5 |
| SRPT Sarepta Therapeutics, Inc. | $1.9B | -13.0 | -9.5 | -6.3 | -1.2 | -20.4 | 4 | BEARISH | -17.9 |
| CSPHF CStone Pharmaceuticals | $1.4B | -14.4 | -51.4 | -340.2 | -123.0 | 135.6 | 5 | BEARISH | -15.4 |
| DRTSW Alpha Tau Medical Ltd. | $1.2B | -13.0 | -141.7 | -17.1 | — | — | 3 | BEARISH | 614.5 |
| SMSZF SMS Co., Ltd. | $700M | -14.9 | -40.8 | 31.1 | 18.4 | 6.9 | 6 | BEARISH | 0.0 |
| ZRSEF DocMorris AG | $520M | -10.1 | -30.1 | -29.3 | -8.9 | 11.0 | 2 | BEARISH | 0.0 |
| NPCE NeuroPace, Inc. | $440M | -23.0 | -122.1 | -39.6 | -27.2 | 11.6 | 4 | BEARISH | 23.1 |
| OVID Ovid Therapeutics Inc. | $420M | -4.7 | -26.0 | -43.7 | -2047.6 | -76.2 | 3 | BEARISH | 37.8 |
| CTEV Claritev Corporation | $400M | -1.4 | 169.3 | 0.9 | -23.0 | 110.3 | 4 | BEARISH | -67.4 |
| NGNE Neurogene Inc. | $370M | -4.9 | -45.3 | -111469.0 | — | — | 2 | BEARISH | -18.0 |
| BHCCF Benchmark Holdings plc | $230M | -4.1 | 16.4 | -17.9 | 377.4 | -62.6 | 6 | BEARISH | 0.0 |
| FOCL EDAP TMS S.A. American Depositary Shares | $160M | — | — | — | — | — | — | BEARISH | — |
| UNHLF EC Healthcare | $100M | -1.6 | -25.3 | 1.7 | -21.3 | -9.0 | 3 | BEARISH | 0.0 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $40M | 118.8 | 228.3 | 11.8 | -21.1 | 6.2 | 3 | BEARISH | 0.0 |
| DTCFF Defence Therapeutics Inc. | $20M | -3.8 | -237.8 | -86.8 | — | — | 4 | BEARISH | -52.8 |
| MRKR Marker Therapeutics, Inc. | $20M | -2.0 | -76.9 | -1014.3 | — | -77.1 | 2 | BEARISH | -8.9 |
| TRUFF Rhelion Life Sciences Corp. | $10M | -2.1 | -37.0 | -58.5 | -804.7 | -34.3 | 3 | BEARISH | -25.3 |
| NUGS Cannabis Strategic Ventures | — | -0.2 | 115.4 | -142.7 | -3106.7 | -29.3 | 2 | BEARISH | 5400.0 |
| BIOIF Biome Grow Inc. | — | -0.0 | 56.7 | 86.9 | — | — | 3 | BEARISH | 0.0 |
| PROT Proteonomix, Inc. | — | -0.0 | 77.5 | -1239.4 | — | -63.1 | 4 | BEARISH | 0.0 |
| SIGY Sigyn Therapeutics, Inc. | — | -0.0 | 61.7 | 32.8 | — | -100.0 | 1 | BEARISH | -98.5 |
| ADLI American Medical Technologies Inc. | — | -0.0 | -34.0 | 1108.3 | -19.7 | -21.7 | 3 | BEARISH | 0.0 |
| VIAP VIA Pharmaceuticals, Inc. | — | -0.0 | 64.7 | 103.9 | — | — | 2 | BEARISH | 0.0 |
| BRAXF Braxia Scientific Corp. | — | -0.1 | -254.6 | -2393.3 | -184.2 | 27.6 | 3 | BEARISH | -99.9 |
| SPDE Speedus Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| EFTR eFFECTOR Therapeutics, Inc. | — | -0.0 | 1737.6 | 607.9 | — | -91.9 | 4 | BEARISH | 0.0 |
| SECI Sector 10, Inc. | — | 0.0 | 0.5 | 0.3 | — | — | 3 | BEARISH | 0.0 |
| SLNX Solanbridge Group, Inc. | — | -7.0 | 149.0 | 74.1 | — | — | 2 | BEARISH | 400.0 |
| LBLTF Lattice Biologics Ltd. | — | -0.0 | 27.4 | -482.6 | — | -28.9 | 4 | BEARISH | 0.0 |
| XCRP Xcorporeal, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| RNUGF ReNeuron Group plc | — | -0.0 | -106.8 | 210.1 | -1809.6 | -68.2 | 1 | BEARISH | 0.0 |
| PANC Panacos Pharmaceuticals, Inc. | — | -0.0 | -168.8 | -792.8 | -33966.7 | -45.9 | 1 | BEARISH | 0.0 |
| MCDA KMA Holding, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SYVC Synovics Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ARPC Arem Pacific Corporation | — | -9.0 | -104.2 | 50.1 | -12.7 | -7.6 | 5 | BEARISH | 0.0 |
| GSRX GSRX Industries Inc. | — | -0.0 | -119.6 | -84.3 | -81.5 | -5.5 | 5 | BEARISH | 0.0 |
| VIVXF Avivagen Inc. | — | -0.1 | 63.9 | 92.2 | -2302.1 | -7.9 | 3 | BEARISH | 0.0 |
| DHAI DIH Holding US, Inc. | — | -0.0 | 24.9 | 14.2 | -34.8 | 262.3 | 3 | BEARISH | -100.0 |
| KONEF Wellbeing Digital Sciences Inc. | — | — | 10994.4 | -1249.0 | -349.5 | — | 2 | BEARISH | 0.0 |
| CDXI Cardax, Inc. | — | -0.0 | 81.1 | 38.5 | -1740.8 | -27.3 | 2 | BEARISH | 0.0 |
| RLLVF Relevium Technologies Inc. | — | -0.3 | 969.5 | 2839.9 | -218.6 | — | 1 | BEARISH | 0.0 |
| BNKL Bionik Laboratories Corp. | — | -0.0 | -787.6 | -1107.0 | -282.5 | 41.7 | 3 | BEARISH | 0.0 |
| ZMSPF Zecotek Photonics Inc. | — | -0.0 | 21.5 | 53.8 | 1884.0 | 2081.2 | 3 | BEARISH | 0.0 |
| PFND Pathfinder Cell Therapy, Inc. | — | -0.0 | 22.4 | 46.3 | — | — | 2 | BEARISH | 0.0 |
| NBIO Nascent Biotech, Inc. | — | -0.0 | 230.6 | 328.8 | — | — | 5 | BEARISH | -75.0 |
| CTVEF Certive Solutions Inc. | — | -0.2 | 13.8 | 16.9 | -129.9 | 8.5 | 4 | BEARISH | 0.0 |
| IYXI Inyx, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CVHIF Ventura Cannabis & Wellness Corporation | — | -0.0 | -24592.2 | -12731.6 | -112.6 | -64.0 | 4 | BEARISH | 0.0 |
| SCRCQ ScripsAmerica, Inc. | — | -0.0 | 168.2 | 144.2 | -17.6 | 3510.5 | 5 | BEARISH | 0.0 |
| ADYX Adynxx, Inc. | — | -0.0 | 1148.3 | 259.7 | — | -95.1 | 2 | BEARISH | 0.0 |
| ENCW Enchanted World Inc. | — | — | — | — | — | — | — | BEARISH | -87.5 |
| SOFE SOAFEE, Inc. | — | 0.1 | 12.0 | -337.1 | 21.4 | 1539.1 | 4 | BEARISH | 45.5 |
| EXETF Extendicare Inc. | $1.9B | 20.3 | 43.8 | 14.1 | 5.0 | 31.2 | 3 | BEARISH | 74.0 |
| NPRRF Nipro Corporation | $1.4B | — | — | — | — | — | — | BEARISH | 5.8 |
| AYTU Aytu BioPharma, Inc. | $20M | -1.4 | -52.6 | -24.3 | -0.1 | -13.3 | 4 | BEARISH | -16.1 |
| OCLG Oncologix Tech Inc. | — | -0.0 | 255.0 | — | — | -20.4 | 2 | BEARISH | 0.0 |
| LADX LadRx Corporation | — | -0.0 | 278.9 | 118.4 | — | -61.0 | 1 | BEARISH | -99.0 |
| RAPP Rapport Therapeutics, Inc. Common Stock | $1.2B | -9.1 | -40.0 | 3981.5 | — | — | 4 | BEARISH | -3.3 |
| CGEM Cullinan Therapeutics, Inc. | $880M | -4.4 | -50.3 | 1635.6 | — | — | 1 | BEARISH | 88.1 |
| CLHLF COLTENE Holding AG | $330M | 19.7 | 16.1 | 12.5 | 3.6 | -2.5 | 5 | BEARISH | -8.4 |
| SMTI Sanara MedTech Inc. | $300M | -8.9 | -147.7 | 19.8 | -1.6 | 12.9 | 5 | BEARISH | 9.8 |
| ELTP Elite Pharmaceuticals, Inc. | $270M | 4.8 | 74.3 | 43.6 | 18.3 | 33.7 | 5 | BEARISH | -58.8 |
| VICP Vicapsys Life Sciences, Inc. | $10M | -20.5 | 31.3 | 17.6 | — | — | 5 | BEARISH | -77.4 |
| CNSP CNS Pharmaceuticals, Inc. | $10M | -0.2 | -106.6 | 748.6 | — | — | 3 | BEARISH | -42.5 |
| IGEX Indo Global Exchange(s) PTE, Ltd. | — | -20.1 | -12.1 | -3.5 | — | -100.0 | 5 | BEARISH | 0.0 |
| SDNI Scandia, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| ADRX ADARx Pharmaceuticals, Inc. | $1.9B | — | — | — | — | — | — | BEARISH | — |
| CASIF CASI Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| BGM BGM Group Ltd. | $100M | -1.8 | -0.5 | -0.2 | -8.7 | — | 3 | BEARISH | -97.2 |
| CGHC Capital Group Holdings, Inc. | — | -0.0 | -44.6 | -14.9 | -24.2 | — | 5 | BEARISH | 0.0 |
| VICA Rafina Innovations Inc. | — | -0.1 | -51.0 | -15.7 | — | 873.6 | 3 | BEARISH | 233.3 |
| BBLNF Babylon Holdings Limited | — | -0.0 | 348.4 | -1412.2 | -20.3 | 198.9 | 3 | BEARISH | 0.0 |
| ACBM Acro Biomedical Co., Ltd. | — | -10.8 | 36.8 | 262.2 | — | 100.0 | 3 | BEARISH | 3614.3 |
| NMXS Net Medical Xpress Solutions, Inc. | — | -0.0 | -362.8 | -352.4 | -6733.3 | -89.2 | 2 | BEARISH | 600.0 |
| OWCP OWC Pharmaceutical Research Corp. | — | -0.0 | -34.4 | 1662.7 | — | — | 2 | BEARISH | -90.0 |
| CRVS Corvus Pharmaceuticals, Inc. | $890M | -16.5 | -35.4 | -415.6 | — | — | 4 | BEARISH | 46.0 |
| GLSI Greenwich LifeSciences, Inc. | $240M | -11.0 | -951.6 | 299.9 | — | — | 2 | BEARISH | 86.4 |
| ADAPY Adaptimmune Therapeutics plc | $10M | -0.1 | -1341.1 | 268.4 | -221.8 | -54.0 | 0 | BEARISH | -64.1 |
| PCLOF PharmaCielo Ltd. | $10M | -2.7 | 39.6 | -31.4 | -103.5 | 11.2 | 4 | BEARISH | 66.7 |
| STME Stimcell Energetics, Inc. | — | -6.8 | 24.8 | 29.2 | — | — | 2 | BEARISH | — |
| ALHC Alignment Healthcare, Inc. | $1.7B | 40.0 | 20.0 | -54.4 | 2.7 | 37.2 | 8 | BEARISH | -54.4 |
| TSHA Taysha Gene Therapies, Inc. | $1.3B | -10.1 | -47.1 | 961.0 | — | -32.3 | 3 | BEARISH | -18.8 |
| ARVN Arvinas, Inc. | $470M | 39.1 | 1.6 | -519.3 | 67.8 | -15.0 | 4 | BEARISH | -20.2 |
| PRTA Prothena Corporation plc | $420M | -10.5 | -14.4 | -871.5 | -1839.9 | 427.3 | 5 | BEARISH | -13.8 |
| CCCC C4 Therapeutics, Inc. | $380M | -3.2 | -48.1 | -175.0 | -355.9 | 2.3 | 4 | BEARISH | 25.2 |
| MEDXF Medexus Pharmaceuticals Inc. | $110M | -46.0 | -4.7 | 8.1 | 1.9 | -2.9 | 5 | BEARISH | 69.3 |
| ELTX Elicio Therapeutics, Inc. | $40M | -0.8 | -774.6 | 2147.3 | — | — | 4 | BEARISH | -82.1 |
| DVHGF Devonian Health Group, Inc. | $20M | — | -76.1 | -75.1 | -1098.1 | -91.5 | 1 | BEARISH | 37.7 |
| LEXX Lexaria Bioscience Corp. | $10M | -0.6 | -150.3 | -504.2 | — | -68.5 | 4 | BEARISH | -77.8 |
| ALLR Allarity Therapeutics, Inc. | $10M | -1.2 | -157.1 | -96.5 | — | — | 2 | BEARISH | -34.2 |
| AVTBF Avant Brands Inc. | $10M | -0.7 | -39.8 | -15.3 | 2.7 | 5.1 | 5 | BEARISH | -6.9 |
| ANEB Anebulo Pharmaceuticals, Inc. | $10M | -1.7 | -69.7 | 650.7 | — | — | 1 | BEARISH | -89.9 |
| INBS Intelligent Bio Solutions Inc. | $10M | -0.2 | -292.3 | -304.3 | -341.0 | 38.1 | 4 | BEARISH | -83.9 |
| SCPS Scopus BioPharma Inc. | — | -0.0 | 132.3 | 53.6 | — | — | 2 | BEARISH | 33.3 |
| RSCI Redwood Scientific Technologies, Inc. | — | -0.0 | 2488.8 | 821.0 | — | — | 2 | BEARISH | -99.9 |
| RLFTY MindMaze Therapeutics Holding S.A. | — | -4.6 | -36.8 | -30.3 | -1182.3 | -95.8 | 2 | BEARISH | -95.2 |
| BITRF Biotron Limited | — | -3.6 | -87.5 | -87.8 | -113.4 | -71.0 | 0 | BEARISH | 0.0 |
| BIORQ Biora Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| BIIO Bionovate Technologies Corp | — | -0.0 | 47.5 | 16.6 | — | — | 3 | BEARISH | 0.0 |
| BSPK Bespoke Extracts, Inc. | — | -0.0 | 37.1 | 45.4 | -16.7 | 284.5 | 4 | BEARISH | -99.8 |
| SLXN Silexion Therapeutics Ltd. | — | -0.0 | -17022.0 | -931.4 | — | — | 3 | BEARISH | -94.5 |
| PNPL Pineapple, Inc. | — | -10.4 | 63.1 | -28.2 | -276.2 | 943.8 | 7 | BEARISH | -99.6 |
| AOXG Aoxing Pharmaceutical Company, Inc. | — | -37.5 | -0.2 | -13.9 | -405.2 | -99.8 | 1 | BEARISH | -45.2 |
| GBHPF Global Hemp Group Inc. | — | -0.1 | 61.0 | 8.0 | — | — | 2 | BEARISH | -99.2 |
| THER Theralink Technologies, Inc. | — | -0.0 | 6.0 | -69.7 | 5363.6 | 32.8 | 2 | BEARISH | 0.0 |
| ECGS Eco-Growth Strategies Inc. | — | -1.8 | 15.4 | 46.1 | — | — | 3 | BEARISH | -91.4 |
| ABTI Alterola Biotech, Inc. | — | -0.1 | -27.4 | 216.7 | — | — | 3 | BEARISH | 0.0 |
| AAPG Ascentage Pharma Group International | $1.4B | -6.1 | -236.8 | -144.8 | -270.2 | 170.9 | 3 | BEARISH | -55.2 |
| WHTCF WELL Health Technologies Corp. | $770M | 165.0 | 0.5 | 5.4 | -2.7 | 38.6 | 6 | BEARISH | -17.4 |
| FLGT Fulgent Genetics, Inc. | $550M | -7.3 | -8.0 | -12.6 | -34.6 | 6.8 | 4 | BEARISH | -14.4 |
| EOLS Evolus, Inc. | $460M | -14.2 | 138.6 | -20.7 | -9.6 | 13.9 | 5 | BEARISH | 6.2 |
| EDIT Editas Medicine, Inc. | $370M | -3.4 | -118.8 | 71.4 | -153.3 | 20.8 | 4 | BEARISH | -34.2 |
| TTRX Turn Therapeutics Inc. | $310M | -36.1 | -952.4 | 115.0 | — | — | 2 | BEARISH | 114.3 |
| NTRB Nutriband Inc. | $70M | -10.6 | -100.7 | -264.9 | -201.3 | -37.3 | 3 | BEARISH | -14.7 |
| CSBR Champions Oncology, Inc. | $70M | -60.8 | -30.7 | -7.8 | -2.8 | 6.7 | 3 | BEARISH | -28.0 |
| TLPH Talphera, Inc. | $60M | -3.4 | -143.4 | 436.3 | — | -96.3 | 2 | BEARISH | -6.1 |
| POCI Precision Optics Corporation, Inc. | $50M | -9.5 | -22.3 | -19.0 | -1.2 | 65.2 | 5 | BEARISH | 1.4 |
| VEXTF Vext Science, Inc. | $40M | -2.3 | -23.2 | -8.7 | -2.6 | 14.2 | 5 | BEARISH | -18.4 |
| HRGN Harvard Apparatus Regenerative Technology Inc. | $30M | -4.9 | 239.0 | 256.6 | -409.4 | — | 2 | BEARISH | — |
| JSPR Jasper Therapeutics, Inc. | $20M | -0.3 | -255.0 | 773.9 | — | — | 2 | BEARISH | -78.3 |
| ADVB Advanced Biomed Inc. Common Stock | $10M | 6.5 | 0.4 | -42.2 | 544.5 | — | 4 | BEARISH | -67.8 |
| NDRA ENDRA Life Sciences Inc. | $10M | -0.8 | -152.0 | -105.1 | — | — | 4 | BEARISH | -9.1 |
| CNVIF Conavi Medical Corp. | $10M | 13.3 | 57.4 | 363.8 | -4867.7 | — | 2 | BEARISH | — |
| CABR Caring Brands, Inc. | $10M | — | — | — | — | — | — | BEARISH | -70.8 |
| ADGM Adagio Medical Holdings, Inc. | — | -0.1 | -657.8 | -87.8 | — | -100.0 | 2 | BEARISH | -92.3 |
| APUS Apimeds Pharmaceuticals US, Inc | — | -0.1 | -100.1 | -12.6 | — | — | 2 | BEARISH | -83.8 |
| IBOGF Universal Ibogaine Inc. | — | -0.5 | -94.8 | 5.5 | -9.4 | 208.2 | 4 | BEARISH | -98.4 |
| CHME China Medicine Corp. | — | -145.9 | 9.7 | 9.7 | 12.7 | -4.3 | 6 | BEARISH | 1816.7 |
| ERNA Ernexa Therapeutics Inc. | — | -0.1 | -320.7 | 626.9 | — | -100.0 | 5 | BEARISH | -93.4 |
| VRAX Virax Biolabs Group Limited | — | -0.0 | -110.9 | -481.7 | -40439.1 | 121.6 | 4 | BEARISH | 101.7 |
| OWPC One World Products, Inc. | — | 0.0 | -124.8 | -16.4 | 10538.7 | 1987.1 | 5 | BEARISH | -99.7 |
| ZCMD Zhongchao Inc. | — | -0.0 | -32.0 | -103.3 | -92.6 | -28.3 | 4 | BEARISH | -99.9 |
| PHRRF PharmaTher Holdings Ltd. | — | -7.6 | -76.9 | 234.4 | — | — | 2 | BEARISH | -51.7 |
| EXMT Anything Technologies Media, Inc. | — | -7.0 | 27.0 | -24.5 | — | -100.0 | 2 | BEARISH | -25.0 |
| MRES Institute of Biomedical Research Corp. | — | -2.3 | 301783.0 | -6062.7 | — | — | 1 | BEARISH | -80.1 |
| ASBP Aspire Biopharma Holdings, Inc. | — | -1.0 | -1032.1 | 1368.4 | -2009.6 | — | 6 | BEARISH | -98.0 |
| CVGRF City View Green Holdings Inc. | — | -1.7 | 75.6 | 105.0 | — | — | 4 | BEARISH | -44.7 |
| SCNI Scinai Immunotherapeutics Ltd. | — | -0.0 | -19.2 | -53.3 | -435.4 | 162.7 | 2 | BEARISH | -62.7 |
| NVOS Novo Integrated Sciences, Inc. | — | -0.0 | -81.4 | -35.0 | 162.4 | 5.7 | 3 | BEARISH | -90.0 |
| UTRS Minerva Surgical, Inc. | — | -0.0 | -170.1 | -43.9 | -60.0 | 3.1 | 1 | BEARISH | 0.0 |
| SBFM Sunshine Biopharma, Inc. | — | -0.0 | -21.9 | -31.4 | -16.9 | -2.7 | 5 | BEARISH | -99.3 |
| UPC Universe Pharmaceuticals Inc. | — | -0.6 | -3.5 | -4.6 | -17.2 | -8.0 | 2 | BEARISH | -44.4 |
| DNA Ginkgo Bioworks Holdings, Inc. | $670M | -2.3 | -56.3 | -44.0 | -231.7 | -51.5 | 2 | BEARISH | -24.4 |
| INKT MiNK Therapeutics, Inc. | $50M | -4.4 | 57.9 | 42.8 | — | — | 4 | BEARISH | -26.3 |
| HOPHF Hemogenyx Pharmaceuticals Plc | $20M | -3.7 | -628.5 | -474.6 | — | — | 4 | BEARISH | 0.0 |
| LFPI LifePoint, Inc. | — | -0.0 | -288.4 | -229.2 | -52133.6 | 161.6 | 3 | BEARISH | 1400.0 |
| AOLS Aeolus Pharmaceuticals, Inc. | — | -0.0 | -186.4 | 1650.1 | -7300.0 | -68.7 | 1 | BEARISH | -0.0 |
| SAGD South American Gold Corp. | — | -0.5 | 106.5 | 49.7 | — | — | 1 | BEARISH | 900.0 |
| PAIYY Aesthetic Medical International Holdings Group Limited | — | — | — | — | — | — | — | BEARISH | -94.3 |
| NWCI NewCardio, Inc. | — | -0.0 | 258.3 | 352.6 | -23059.8 | 40.9 | 2 | BEARISH | 0.0 |
| BACK IMAC Holdings, Inc. | — | -0.0 | 109.1 | 67.3 | -14505.6 | 100.5 | 2 | BEARISH | -99.2 |
| INMD InMode Ltd. | $800M | 10.9 | 12.3 | 44.5 | 17.9 | -6.7 | 5 | BEARISH | -11.4 |
| TKNO Alpha Teknova, Inc. | $340M | -22.4 | -24.2 | -17.2 | -26.0 | 12.3 | 4 | BEARISH | 14.4 |
| HNSBF Hansa Biopharma AB (publ) | $330M | -4.6 | 159.8 | 1182.7 | -541.7 | -3.7 | 2 | BEARISH | -28.2 |
| INTI Inhibitor Therapeutics, Inc. | $10M | -3.2 | 358.8 | 88.0 | — | — | 1 | BEARISH | 22.2 |
| ORGS Orgenesis Inc. | — | -0.2 | 764.3 | 1083.0 | 2628.2 | -192.0 | 1 | BEARISH | -81.3 |
| CPMD CannaPharmaRX, Inc. | — | -0.1 | 42.4 | 22.4 | -691.1 | 24.8 | 3 | BEARISH | -58.3 |
| CBDY Target Group Inc. | — | -0.3 | 23.2 | -10.4 | -17.4 | -30.4 | 2 | BEARISH | -61.1 |
| AFFY Affymax, Inc. | — | -0.0 | 98.1 | -302.0 | 17164.3 | -99.9 | 5 | BEARISH | -11.1 |
| PLYX Polaryx Therapeutics, Inc. Common Stock | $90M | -15.3 | -35.9 | 437.3 | — | — | 2 | BEARISH | — |
| VBIZF Viva Biotech Holdings | $400M | 13.1 | 4.5 | 4.2 | 8.0 | 2.9 | 7 | BEARISH | -35.1 |
| SPRB Spruce Biosciences, Inc. | $130M | -1.1 | -106.0 | 772.2 | — | -100.0 | 4 | BEARISH | -66.1 |
| JYNT The Joint Corp. | $100M | 27.2 | 19.4 | -33.1 | 4.3 | 220.6 | 8 | BEARISH | -11.5 |
| OKUR OnKure Therapeutics, Inc. | $100M | -0.7 | -46.9 | 1464.5 | — | — | 4 | BEARISH | -16.8 |
| BTMD biote Corp. | $50M | 7.0 | -7.8 | 19.7 | -14.8 | -7.8 | 5 | BEARISH | -60.9 |
| NVLPF Nova Leap Health Corp. | $30M | 20.4 | 7.0 | 5.6 | 6.9 | 20.3 | 5 | BEARISH | 72.3 |
| PUMD ProUroCare Medical Inc. | — | — | — | — | — | — | — | BEARISH | -50.0 |
| SYRS Syros Pharmaceuticals, Inc. | — | -0.0 | -777.0 | 960.6 | — | -90.5 | 0 | BEARISH | -33.3 |
| LTHO Legacy Technology Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| BIMI BIMI International Medical Inc. | — | -0.0 | -159.5 | -56.3 | -124.0 | -65.7 | 4 | BEARISH | 300.0 |
| IMTX Immatics N.V. | $1.1B | -4.1 | -47.8 | -858.3 | -683.4 | -68.0 | 2 | BEARISH | -29.8 |
| HROW Harrow Health, Inc. | $1.1B | -29.5 | -114.8 | 1.9 | -24.4 | 21.1 | 5 | BEARISH | -25.9 |
| AVBP ArriVent BioPharma, Inc. | $1.0B | -4.1 | -53.1 | 2345.1 | — | — | 3 | BEARISH | -15.1 |
| ZURA Zura Bio Limited | $320M | -3.8 | -65.4 | 806.5 | — | — | 2 | BEARISH | 6.0 |
| CLVLF Clinuvel Pharmaceuticals Limited | $250M | 10.6 | 13.2 | 126.7 | 41.1 | -1.1 | 6 | BEARISH | -32.0 |
| BCYC Bicycle Therapeutics plc | $250M | -1.4 | -32.3 | -1197.0 | -8002.1 | 217.4 | 4 | BEARISH | -53.3 |
| CYBQF CYBERDYNE Inc. | $200M | 153.8 | 0.7 | -1.4 | 36.4 | -8.1 | 3 | BEARISH | 0.0 |
| CDXS Codexis, Inc. | $140M | -3.8 | -69.4 | -37.8 | -80.5 | 35.9 | 3 | BEARISH | -49.8 |
| SKIN SkinHealth Systems Inc. | $70M | -2.2 | -43.8 | -1.6 | -3.7 | -6.5 | 4 | BEARISH | -59.5 |
| POSC Positron Corporation | $60M | -5.5 | 1961.0 | -1406.8 | -734.6 | -22.9 | 2 | BEARISH | 16.4 |
| RNXT RenovoRx, Inc. | $60M | -4.3 | -125.2 | 4391.9 | -320.2 | 198.5 | 3 | BEARISH | 13.9 |
| SGMOQ Sangamo Therapeutics, Inc. | $50M | — | — | — | — | — | — | BEARISH | — |
| CTOR Citius Oncology, Inc. | $50M | -1.3 | -126.6 | -109.8 | -597.4 | — | 3 | BEARISH | -64.3 |
| SEOVF Sernova Corp. | $30M | -3.7 | 57.0 | 76.3 | — | — | 3 | BEARISH | -37.2 |
| INIS Radnostix, Inc. | $30M | -0.0 | -29489557.0 | -23.1 | -33.0 | -23.7 | 1 | BEARISH | -15.0 |
| SNANF Sona Nanotech Inc. | $20M | -12.9 | 526.4 | 236.5 | — | — | 1 | BEARISH | -63.9 |
| RVXCF Resverlogix Corp. | $20M | -1.6 | 11.5 | 25.3 | — | — | 4 | BEARISH | -25.0 |
| HMTXF Hemostemix Inc. | $10M | -2.0 | 69.9 | 190.1 | — | — | 1 | BEARISH | -44.5 |
| ASAPF Aurora Spine Corporation | $10M | -5.5 | -35.3 | -14.8 | -22.8 | -4.5 | 5 | BEARISH | -56.4 |
| IVRO InVitro International | — | 17.1 | 3.7 | 4.6 | 4.8 | -14.0 | 5 | BEARISH | -20.0 |
| AMBS Amarantus BioScience Holdings, Inc. | — | -0.0 | 7.3 | 3.8 | -4080.5 | — | 3 | BEARISH | -66.7 |
| LLBO Lifeline Biotechnologies, Inc. | — | — | — | — | — | — | — | BEARISH | -50.0 |
| ANTH Anthera Pharmaceuticals, Inc. | — | -0.0 | -251.4 | 1107.5 | — | — | 1 | BEARISH | 0.0 |
| BRTX BioRestorative Therapies, Inc. | — | -0.1 | -241.1 | 2112.9 | -9298.3 | -8.5 | 3 | BEARISH | -95.2 |
| EWLL eWellness Healthcare Corp. | — | -0.2 | 69.3 | 46.3 | — | -99.2 | 1 | BEARISH | 0.0 |
| MDIT Medite Cancer Diagnostics, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| LVRLF CordovaCann Corp. | — | -1.0 | 47.4 | -18.4 | -6.5 | -2.8 | 4 | BEARISH | 3.5 |
| EMGE Emergent Health Corp | — | -0.0 | 23.7 | 51.7 | — | -80.0 | 1 | BEARISH | 9900.0 |
| SKYI Sky Century Investment, Inc. | — | -2.5 | 26.2 | 61.1 | -11.3 | 180.9 | 3 | BEARISH | 4918.2 |
| ATRX Adhera Therapeutics Inc | — | -0.0 | 18.6 | 6.5 | — | — | 1 | BEARISH | 0.0 |
| PLWY Peoplesway.com Inc. | — | -0.0 | -6.5 | -4001.9 | -1.4 | -22.7 | 5 | BEARISH | 0.0 |
| EVAHF EGF Theramed Health Corp. | — | -0.2 | 102.2 | 4.7 | — | — | 2 | BEARISH | -71.0 |
| SKVI Skinvisible, Inc. | — | -0.8 | 10.0 | 7.2 | -5110.7 | 0.0 | 2 | BEARISH | -61.0 |
| NXGT Nexteligent Holdings, Inc. | — | -14.0 | 2.7 | -1.5 | 5.3 | -0.2 | 3 | BEARISH | -21.4 |
| AMPE Ampio Pharmaceuticals, Inc. | — | -0.0 | -114.0 | 1652.6 | -838.4 | — | 4 | BEARISH | 6681.5 |
| PMEDF Qscreen Ai Inc. | — | -13.1 | 145.2 | 82.8 | — | — | 3 | BEARISH | -46.7 |
| LIPO Lipella Pharmaceuticals Inc. | — | -0.0 | -361.8 | 4105.8 | — | -64.1 | 1 | BEARISH | -99.9 |
| CYIO CYIOS Corporation | — | 1.2 | 60.5 | 46.3 | — | -48.3 | 2 | BEARISH | -80.0 |
| CVKD Cadrenal Therapeutics, Inc. Common Stock | — | -0.2 | -275.2 | -540.4 | — | — | 3 | BEARISH | -93.2 |
| NXEN Nexien BioPharma, Inc. | — | -0.0 | 48.5 | 112.0 | — | — | 2 | BEARISH | -99.2 |
| MAJI Nextel Medical Corp. | — | 0.6 | -2.6 | 42.9 | — | — | 1 | BEARISH | — |
| PBFFF Planet Based Foods Global Inc. | — | -0.7 | 69.6 | 63.1 | — | 100.0 | 2 | BEARISH | -80.8 |
| KSPHF Kissei Pharmaceutical Co., Ltd. | $1.0B | 11.3 | 6.5 | -1.9 | 20.2 | 10.7 | 6 | BEARISH | -2.4 |
| AURA Aura Biosciences, Inc. | $650M | -3.5 | -53.5 | -1360.0 | — | — | 4 | BEARISH | 8.8 |
| IRWD Ironwood Pharmaceuticals, Inc. | $570M | 4.4 | -55.3 | 93.9 | 45.4 | 26.2 | 7 | BEARISH | 114.7 |
| ARCT Arcturus Therapeutics Holdings Inc. | $280M | -3.4 | -46.3 | -2501.0 | -803.8 | -79.1 | 1 | BEARISH | -17.4 |
| HITI High Tide Inc. | $230M | -10.0 | -27.0 | 0.8 | 5.6 | 27.2 | 3 | BEARISH | -17.2 |
| SIGA SIGA Technologies, Inc. | $220M | -73.3 | -1.5 | -18.3 | 30.4 | -70.1 | 1 | BEARISH | -62.4 |
| ATRA Atara Biotherapeutics, Inc. | $90M | -7.1 | 46.3 | 30.3 | -767.3 | -96.7 | 2 | BEARISH | -40.9 |
| GRUSF Grown Rogue International Inc. | $90M | -22.2 | -5.5 | -18.8 | -14.6 | 31.1 | 6 | BEARISH | -12.8 |
| LEEEF Leef Brands Inc. | $30M | -1.6 | 222.4 | -39.5 | -17.9 | 8.4 | 5 | BEARISH | -26.4 |
| HSCS HeartSciences Inc. | $20M | -1.0 | -1851.9 | 26.8 | -151064.0 | -27.7 | 1 | BEARISH | -4.0 |
| IMRN Immuron Limited | $10M | -2.9 | -40.2 | -187.8 | -54.4 | -29.7 | 5 | BEARISH | -57.4 |
| INBP Integrated BioPharma, Inc. | $10M | -1.9 | -15.0 | -13.1 | -13.9 | -19.3 | 2 | BEARISH | -43.3 |
| SKYE Skye Bioscience, Inc. | $10M | -0.1 | -233.9 | 389.5 | — | — | 3 | BEARISH | 8.3 |
| ERNAW Ernexa Therapeutics Inc. Warrants | — | — | — | — | — | — | — | BEARISH | — |
| BDPT BioAdaptives Inc. | — | -0.0 | 80.2 | 56.3 | 3009.0 | 169.7 | 3 | BEARISH | -96.5 |
| NXL Nexalin Technology, Inc. | — | -0.1 | -240.3 | -1401.4 | -18412.7 | 24.2 | 4 | BEARISH | 15.5 |
| EVIO EVIO, Inc. | — | 1.7 | 65.3 | 33.5 | 8.3 | -26.9 | 4 | BEARISH | 0.0 |
| KHRNF Khiron Life Sciences Corp. | — | -0.2 | -74.7 | -41.4 | -105.6 | 76.2 | 2 | BEARISH | 0.0 |
| CUBT Curative Biotechnology, Inc. | — | -1.9 | 31.0 | 15.3 | — | — | 4 | BEARISH | -24.9 |
| IDRSF Idorsia Ltd | $1.4B | -3.5 | 27.1 | -344.5 | -203.1 | -8.1 | 1 | BEARISH | -7.6 |
| QTTB Q32 Bio Inc. | $260M | 3.1 | 72.1 | 435.2 | — | — | 5 | BEARISH | 201.8 |
| BRIBF Brii Biosciences Limited | $90M | -3.3 | -10.3 | -62.6 | — | 22.5 | 4 | BEARISH | -46.0 |
| TELA TELA Bio, Inc. | $40M | -1.3 | 1232.5 | -260.3 | -58.4 | 6.1 | 3 | BEARISH | -34.1 |
| IDXG Interpace Biosciences, Inc. | $40M | 0.2 | 221.9 | 123.7 | 1.7 | -20.3 | 6 | BEARISH | 18.0 |
| ACAI Safeplus International Holdings Limited | — | -0.3 | -205.0 | -617.4 | -224.7 | -94.2 | 1 | BEARISH | 200.0 |
| AUTL Autolus Therapeutics plc | $410M | -1.5 | -132.9 | 451.5 | -85.6 | 292.0 | 3 | BEARISH | 2.0 |
| BVAXF BioVaxys Technology Corp. | — | -0.9 | 310.6 | 48.4 | — | — | 1 | BEARISH | -45.4 |
| CMOPF Cosmo N.V. | $1.1B | -158.0 | -1.2 | -2.9 | -9.5 | -43.8 | 1 | BEARISH | -23.8 |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | $70M | -0.7 | -213.1 | 3515.1 | — | — | 4 | BEARISH | -30.4 |
| RECEF Recce Pharmaceuticals Ltd | $70M | -6.0 | 151.4 | 200.5 | — | -100.0 | 2 | BEARISH | -56.0 |
| CVM CEL-SCI Corporation | $30M | -0.6 | -252.5 | -142.9 | — | -100.0 | 4 | BEARISH | -82.3 |
| SNGX Soligenix, Inc. | $10M | -0.3 | -241.7 | 304.6 | — | — | 4 | BEARISH | -87.3 |
| ARTL Artelo Biosciences, Inc. | $10M | -0.0 | -705.7 | -1031.2 | — | — | 5 | BEARISH | -92.8 |
| NEXI NexImmune, Inc. | — | -0.0 | -230.1 | 1048.5 | — | — | 4 | BEARISH | -0.0 |
| LIFS Life Stem Genetics Inc. | — | -2.5 | -126.7 | -111.5 | — | — | 2 | BEARISH | -50.0 |
| FNAM Evolutionary Genomics, Inc. | — | -0.0 | 62.2 | -99.6 | — | — | 2 | BEARISH | 0.0 |
| WINT Windtree Therapeutics, Inc. | — | -0.0 | 1111.0 | -2375.5 | — | — | 3 | BEARISH | -99.6 |
| STJO St. Joseph, Inc. | — | 0.6 | 9.1 | 6.7 | 89.6 | -23.9 | 7 | BEARISH | -83.3 |
| MDVLQ MedAvail Holdings, Inc. | — | -0.0 | -164.8 | -243.8 | -1429.9 | -28.6 | 4 | BEARISH | 0.0 |
| OHCS Optimus Healthcare Services, Inc. | — | -0.0 | 99.2 | 130.3 | -469.4 | 43.7 | 4 | BEARISH | -99.0 |
| TOMDF Todos Medical Ltd. | — | -0.0 | 89.6 | -253.6 | -355.9 | -37.1 | 3 | BEARISH | -90.0 |
| RGRX RegeneRx Biopharmaceuticals, Inc. | — | -0.0 | 53.5 | 45.8 | -2006.3 | -0.0 | 3 | BEARISH | 450.0 |
| SYBE SYBLEU Inc | — | -3.1 | 71.5 | -202.2 | -685.7 | — | 2 | BEARISH | 0.0 |
| LNDZF Evome Medical Technologies Inc. | — | -2.2 | -294.8 | -10.4 | -11.5 | -15.9 | 4 | BEARISH | -98.3 |
| TRGM Targeted Medical Pharma, Inc. | — | -0.0 | 26.6 | 20.9 | -45.1 | -26.0 | 4 | BEARISH | -90.0 |
| BICTF Biocure Technology Inc. | — | -0.1 | -889.9 | 60.0 | — | — | 1 | BEARISH | 0.0 |
| PTPI Petros Pharmaceuticals, Inc. | — | 0.0 | -124.4 | 96.3 | — | -100.0 | 1 | BEARISH | -88.9 |
| CPYT CarePayment Technologies, Inc. | — | -0.0 | 1607.0 | -66.2 | -585.5 | — | 2 | BEARISH | 0.0 |
| USAQ QHSLab, Inc. | — | 6.8 | 114.6 | 6.2 | 4.5 | 24.6 | 6 | BEARISH | 46.3 |
| VOR Vor Biopharma Inc. | $990M | 0.1 | -73.6 | 22.2 | — | — | 3 | BEARISH | -34.0 |
| LTGO Latigo Biotherapeutics Inc. | $900M | — | — | — | — | — | — | BEARISH | — |
| ASCLF Ascletis Pharma Inc. | $770M | -7.8 | -28.4 | -7144.0 | — | -60.6 | 2 | BEARISH | -40.2 |
| MTLZF Metall Zug AG | $680M | -34.8 | -2.8 | -1.4 | -5.6 | -0.3 | 6 | BEARISH | 0.0 |
| YDES YD Bio Limited Ordinary Shares | $350M | — | — | — | — | — | — | BEARISH | -70.0 |
| ELMD Electromed, Inc. | $220M | 19.3 | 23.3 | 32.5 | 17.5 | 15.3 | 8 | BEARISH | 8.1 |
| CAMP CAMP4 Therapeutics Corporation | $210M | -1.6 | -545.9 | 48.4 | -1884.8 | 40.2 | 2 | BEARISH | -7.8 |
| PDEX Pro-Dex, Inc. | $200M | 14.9 | 32.4 | 17.5 | 14.0 | 16.4 | 8 | BEARISH | 116.1 |
| RNAC Cartesian Therapeutics, Inc. | $190M | -1.1 | 241.0 | 37.3 | — | 44.0 | 2 | BEARISH | -30.2 |
| VRXA Veraxa Biotech Holding AG | $140M | — | — | — | — | — | — | BEARISH | — |
| OTLK Outlook Therapeutics, Inc. | $130M | -0.5 | 256.9 | 1372.0 | -225766.7 | -169.4 | 3 | BEARISH | -60.5 |
| SHIEF Shield Therapeutics plc | $80M | -7.4 | 65.2 | 698.4 | -7.4 | 152.4 | 3 | BEARISH | -24.5 |
| LDXHF Lumos Diagnostics Holdings Limited | $60M | -6.9 | -34.8 | -85.3 | -1.0 | 6.4 | 5 | BEARISH | -67.5 |
| ONCY Oncolytics Biotech Inc. | $50M | -1.9 | 90135.4 | 285.1 | — | — | 1 | BEARISH | -59.9 |
| CNTB Connect Biopharma Holdings Limited | $50M | -0.9 | -105.5 | 1034.1 | -1249.0 | 49.8 | 2 | BEARISH | -47.6 |
| ALPS Alps Group Inc | $50M | — | — | — | — | — | — | BEARISH | — |
| CLCS Cell Source, Inc. | $40M | -4.6 | 27.7 | 34.5 | — | — | 4 | BEARISH | 21.7 |
| ITHUF iAnthus Capital Holdings, Inc. | $30M | -0.5 | 53.1 | -9.2 | -40.8 | -9.9 | 1 | BEARISH | -42.3 |
| NSPR InspireMD, Inc. | $20M | -0.9 | -148.8 | -1383.2 | -808.8 | 53.4 | 4 | BEARISH | -80.0 |
| BYSI BeyondSpring Inc. | $20M | -2.9 | 20.3 | 15.7 | — | 100.0 | 2 | BEARISH | -77.2 |
| CNTX Context Therapeutics Inc. | $20M | -0.5 | -76.1 | 841.7 | — | — | 2 | BEARISH | -81.3 |
| CRVW CareView Communications, Inc. | $20M | -7.8 | 6.4 | -1.4 | -10.0 | 8.5 | 7 | BEARISH | -7.7 |
| RVVTF Revive Therapeutics Ltd. | $10M | -0.8 | -1114.6 | 25.7 | — | — | 2 | BEARISH | 68.2 |
| MODD Modular Medical, Inc. | $10M | -0.2 | -247.9 | -302.8 | — | — | 2 | BEARISH | -90.1 |
| RHEPB Regional Health Properties, Inc. | $10M | 0.5 | -328.8 | -0.6 | -3.2 | 200.4 | 6 | BEARISH | -4.0 |
| PLRZ Polyrizon Ltd. | $10M | -2.0 | -21.4 | -68.2 | — | — | 0 | BEARISH | 38.3 |
| BICX BioCorRx Inc. | $10M | -1.7 | 25.4 | 84.3 | -1096.7 | 151.2 | 3 | BEARISH | -47.2 |
| ADIL Adial Pharmaceuticals, Inc. | $10M | -0.2 | -2011.6 | 159.6 | — | — | 3 | BEARISH | -60.2 |
| LPCN Lipocine Inc. | $10M | -0.8 | -60.9 | 662.3 | -1379.6 | -62.7 | 2 | BEARISH | -48.8 |
| GLWLF Glow Lifetech Corp. | $10M | -50.0 | -11.1 | -21.1 | -26.6 | 59.2 | 5 | BEARISH | -19.5 |
| NMTC NeuroOne Medical Technologies Corporation | $10M | -0.9 | -119.7 | -335.0 | -101.7 | 50.8 | 5 | BEARISH | 1.1 |
| KTTA Pasithea Therapeutics Corp. | $10M | -0.2 | -65.5 | -453.2 | — | — | 4 | BEARISH | -45.2 |
| ICU SeaStar Medical Holding Corporation | $10M | -0.6 | -356.9 | 415.0 | -606.5 | 123.6 | 4 | BEARISH | -60.9 |
| APPB Applied Biosciences Corp. | — | -0.0 | -297.6 | -188.8 | -798.1 | 75.3 | 4 | BEARISH | 0.0 |
| TTOO T2 Biosystems, Inc. | — | -0.0 | 277.6 | -638.9 | -509.7 | -30.2 | 3 | BEARISH | -95.0 |
| PASO Patient Access Solutions, Inc. | — | -0.0 | 540.4 | 691.6 | 0.6 | — | 2 | BEARISH | -99.0 |
| ISCNF Isracann Biosciences Inc. | — | -0.5 | -252.3 | 2640.8 | — | — | 2 | BEARISH | -90.0 |
| ONCO Onconetix, Inc. | — | -0.1 | -105.2 | -83.7 | -16748.3 | -51.3 | 3 | BEARISH | -88.1 |
| BBLG Bone Biologics Corporation | — | -0.2 | -47.5 | 1744.6 | — | — | 2 | BEARISH | -82.9 |
| UAHC United American Healthcare Corporation | — | 179.0 | 4.6 | -10.0 | — | -100.0 | 6 | BEARISH | -14.3 |
| AFMDQ Affimed N.V. | — | — | — | — | — | — | — | BEARISH | — |
| ICCO InterCare DX, Inc. | — | -0.0 | 16.1 | 3053.3 | — | — | 5 | BEARISH | 0.0 |
| AKAN Akanda Corp. | — | -0.0 | 855.2 | -259.9 | -1532.3 | 84.2 | 3 | BEARISH | -97.7 |
| EVLO Evelo Biosciences, Inc. | — | -0.0 | 948.0 | 605.0 | — | — | 2 | BEARISH | -80.0 |
| BRGX BioRegenx, Inc. | — | -0.2 | 0.6 | 1.6 | -6.2 | — | 3 | BEARISH | — |
| VCNX Vaccinex, Inc. | — | -0.4 | 776.6 | 414.6 | -1584.0 | 226.6 | 3 | BEARISH | -20.6 |
| ENMI DH Enchantment Inc. | — | -0.5 | 52.9 | -49.5 | -32.2 | 26.9 | 5 | BEARISH | 0.0 |
| MCIC Multicorp International, Inc. | — | -15.7 | -1.1 | -0.2 | — | — | 3 | BEARISH | -0.0 |
| HLTHQ Cue Health Inc. | — | -0.0 | -90.3 | -100.6 | -789.6 | -85.3 | 1 | BEARISH | 0.0 |
| VIVS VivoSim Labs, Inc. | — | -0.0 | -343.1 | 241.9 | -7433.3 | 202.7 | 2 | BEARISH | -93.1 |
| SYUP Anbc, Inc. | — | — | — | — | — | — | — | BEARISH | 50.0 |
| SXTP 60 Degrees Pharmaceuticals, Inc. | — | -0.1 | -321.8 | -390.2 | -1089.2 | 68.0 | 3 | BEARISH | -40.1 |
| LVVV LiveWire Ergogenics, Inc. | — | -0.4 | -188.5 | -4.0 | -2585.3 | -89.5 | 3 | BEARISH | -77.8 |
| POAS Phaos Technology Holdings (Caym | — | — | — | — | — | — | — | BEARISH | — |
| SPRC SciSparc Ltd. | — | -0.0 | -519.9 | -161.9 | -1891.2 | -26.8 | 5 | BEARISH | -67.6 |
| LMLLF Pharmadrug Inc. | — | -0.9 | 37.6 | 446.5 | — | — | 2 | BEARISH | -54.0 |
| GXXY Galexxy Holdings, Inc. | — | -0.0 | 370.1 | 271.5 | -385.0 | -88.8 | 2 | BEARISH | -98.5 |
| MTNB Matinas BioPharma Holdings, Inc. | — | -0.1 | -154.3 | -504.1 | — | — | 4 | BEARISH | -93.1 |
| NCEL NewcelX Ltd. | — | 8.0 | -48.0 | -39.1 | — | — | 2 | BEARISH | — |
| SSKN STRATA Skin Sciences, Inc. | — | -0.0 | -164.6 | -42.5 | 0.6 | -8.5 | 4 | BEARISH | -100.0 |
| BMCS BioTech Medics, Inc. | — | -13.9 | -0.0 | -0.0 | — | — | 5 | BEARISH | -97.7 |
| AIMLF AI/ML Innovations Inc. | — | -1.5 | 1433.6 | -1620.8 | -92486.4 | -73.9 | 1 | BEARISH | -31.0 |
| BMMJ Body and Mind Inc. | — | -0.1 | 267.1 | 411.6 | -58.9 | -48.9 | 2 | BEARISH | -98.0 |
| CLABF Core One Labs Inc. | — | -0.3 | -233.7 | -70.3 | -897.6 | -69.3 | 3 | BEARISH | -90.0 |
| DRMA Dermata Therapeutics, Inc. | — | -0.2 | -183.9 | 734.5 | — | — | 2 | BEARISH | -82.8 |
| ITMC Itoco Inc. | — | -0.0 | 303.4 | 96.7 | — | — | 2 | BEARISH | 0.0 |
| TRCNF Transnational Cannabis Ltd. | — | -0.0 | -178.2 | -75.5 | — | — | 1 | BEARISH | -99.9 |
| IRMD IRadimed Corporation | $1.1B | 46.0 | 23.5 | 50.1 | 25.5 | 11.2 | 6 | BEARISH | 9.4 |
| OBIO Orchestra BioMed Holdings, Inc. | $340M | -5.6 | -397.3 | 468.3 | -26994.3 | 986.1 | 4 | BEARISH | 46.0 |
| XGN Exagen Inc. | $180M | -9.5 | -113.8 | -79.2 | -16.0 | 20.8 | 3 | BEARISH | -37.3 |
| ACOG Alpha Cognition Inc | $130M | -8.1 | -55.3 | -198.4 | -144.3 | 232.7 | 2 | BEARISH | -3.3 |
| LITS Lite Strategy, Inc. | $40M | -0.1 | -170.9 | -28.2 | — | — | 2 | BEARISH | -40.1 |
| NXTC NextCure, Inc. | $20M | -0.5 | -195.2 | 949.7 | — | — | 2 | BEARISH | -41.2 |
| BCTXZ BriaCell Therapeutics Corp. Warrant | — | -0.3 | -168.1 | -2016.9 | — | — | 1 | BEARISH | -72.9 |
| TRVI Trevi Therapeutics, Inc. | $1.8B | -39.6 | -19.7 | -1451.7 | — | — | 3 | BEARISH | 17.5 |
| QURE uniQure N.V. | $1.6B | -5.9 | -157.6 | 37.9 | -1387.8 | 30.2 | 4 | BEARISH | -63.5 |
| MGTX MeiraGTx Holdings plc | $880M | 12.3 | 72.3 | 96.7 | 50.0 | 948.3 | 7 | BEARISH | 4.9 |
| ABUS Arbutus Biopharma Corp | $830M | 5.4 | 89.6 | 86.7 | -507.2 | 1078.8 | 4 | BEARISH | -1.9 |
| AMGXF AnGes, Inc. | $140M | -3.0 | -160.6 | -111.8 | -531.3 | -16.1 | 4 | BEARISH | 0.0 |
| BBIXF Bonus BioGroup Ltd. | $50M | -17.4 | 3245.0 | 2543.1 | — | — | 2 | BEARISH | 100.0 |
| XTLB XTL Biopharmaceuticals Ltd. | — | -0.6 | -26.8 | -38.7 | -88.2 | — | 3 | BEARISH | 46.8 |
| IRME IR-Med Inc. | — | -0.1 | 1793.9 | 264.1 | — | -23.5 | 2 | BEARISH | -91.6 |
| IHTI Integrative Health Technologies, Inc. | — | 0.0 | -13.8 | -11.8 | 53.8 | 263.8 | 4 | BEARISH | -95.0 |
| SLHPF Skylight Health Group Inc. | — | -0.0 | -109.3 | -44.8 | -21.4 | — | 2 | BEARISH | -90.0 |
| MYMX Mymetics Corporation | — | -0.0 | 16.6 | 357.9 | -3012.0 | -62.8 | 2 | BEARISH | 0.0 |
| NWPHF Newron Pharmaceuticals S.p.A. | $410M | -6.7 | 83.9 | -32.1 | -513.4 | — | 1 | BEARISH | — |
| BLEVF Beleave Inc. | — | -0.0 | -105.9 | -25.1 | -653.1 | 117.7 | 4 | BEARISH | -99.0 |
| KKUR ChromoCure, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| SRNE Sorrento Therapeutics, Inc. | — | -0.0 | 1502.8 | 468.4 | -633.7 | 16.9 | 2 | BEARISH | -96.0 |
| PBLA Panbela Therapeutics, Inc. | — | -0.0 | 270.3 | 240.0 | — | 100.0 | 3 | BEARISH | -91.0 |
| CPMV Mosaic ImmunoEngineering Inc. | — | -2.0 | 9.2 | 7.5 | — | — | 2 | BEARISH | -87.7 |
| IMCC IM Cannabis Corp. | — | -0.0 | 1556.1 | -129.3 | -57.5 | -21.1 | 1 | BEARISH | -98.3 |
| MNKD MannKind Corporation | $1.0B | -23.4 | 71.4 | 4.0 | -17.4 | 30.5 | 2 | BEARISH | -41.2 |
| APMD Apnimed, Inc. | $790M | — | — | — | — | — | — | BEARISH | — |
| SABS SAB Biotherapeutics, Inc. | $260M | 0.9 | -11.3 | -48.4 | — | -100.0 | 3 | BEARISH | -4.5 |
| IMRX Immuneering Corporation | $240M | -3.7 | -52.1 | -112.8 | — | — | 4 | BEARISH | -34.1 |
| HWAIF Healwell AI Inc. | $150M | -5.3 | -21.9 | -10.8 | 19.4 | 54.1 | 5 | BEARISH | -54.0 |
| OGI Organigram Global Inc. | $130M | 2.1 | 18.4 | -1.3 | 99.8 | 38.1 | 5 | BEARISH | -46.0 |
| HUMA Humacyte, Inc. | $120M | -0.9 | -547.9 | -500.7 | -9064.5 | -73.6 | 3 | BEARISH | -76.3 |
| ORXOY Orexo AB (publ) | $20M | -0.5 | 3924.8 | -872.8 | -12050.0 | -97.8 | 4 | BEARISH | -83.4 |
| NSCIF Nanalysis Scientific Corp. | $10M | -3.5 | -33.5 | -6.2 | -6.9 | -6.2 | 5 | BEARISH | -33.8 |
| RNVA Rennova Health, Inc. | — | -0.5 | 23.5 | -4.3 | -241.1 | 43.3 | 5 | BEARISH | 0.0 |
| MEDD Medical Imaging Corp. | — | — | — | — | — | — | — | BEARISH | 100.0 |
| BTAIQ BioXcel Therapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| OILFF Nextleaf Solutions Ltd. | — | -1.8 | -41.0 | -53.4 | -19.9 | -18.2 | 3 | BEARISH | -55.8 |
| FITY Fifty 1 Labs, Inc. | — | -1.0 | 132.4 | 345.2 | -58137.6 | -75.6 | 4 | BEARISH | -84.6 |
| TSOI Therapeutic Solutions International, Inc. | — | -0.1 | -187.6 | -130.3 | -5123.0 | -99.7 | 4 | BEARISH | -99.0 |
| ACNV Accelera Innovations, Inc | — | -0.0 | 197.1 | 28.9 | — | -97.0 | 1 | BEARISH | 0.0 |
| BCRX BioCryst Pharmaceuticals, Inc. | $1.9B | -5.6 | 87.8 | 62.3 | 35.9 | 68.7 | 5 | BEARISH | 9.6 |
| BFLY Butterfly Network, Inc. | $1.8B | -25.4 | -35.5 | -74.8 | -39.6 | 28.1 | 4 | BEARISH | 199.6 |
| NVCR Novocure Ltd | $1.7B | -11.2 | -43.2 | -93.1 | -8.5 | 11.0 | 6 | BEARISH | 3.5 |
| GENB Generate Biomedicines, Inc. | $1.6B | -7.9 | -28.2 | -175.0 | -1065.2 | — | 1 | BEARISH | — |
| CMPS COMPASS Pathways plc | $1.6B | -2.1 | -319.1 | 48.8 | — | — | 2 | BEARISH | 77.1 |
| INBX Inhibrx Biosciences Inc. | $1.4B | -11.2 | -1773.6 | 55.8 | — | -100.0 | 4 | BEARISH | 212.4 |
| OMER Omeros Corporation | $1.2B | 9.1 | -89.2 | 71.8 | 46.4 | — | 5 | BEARISH | 112.9 |
| ACHV Achieve Life Sciences, Inc. | $670M | -4.4 | -845.0 | 24.6 | — | — | 2 | BEARISH | 32.9 |
| NVCT Nuvectis Pharma, Inc. | $650M | -14.0 | -214.6 | 174.4 | — | — | 1 | BEARISH | 207.7 |
| MDXG MiMedx Group, Inc. | $570M | 96.6 | 2.9 | 5.8 | -23.1 | -2.4 | 6 | BEARISH | -42.0 |
| STTK Shattuck Labs, Inc. | $550M | -11.4 | -39.2 | -29.3 | — | -66.6 | 4 | BEARISH | 199.5 |
| CBIO Crescent Biopharma, Inc. | $480M | -1.8 | -107.7 | 1928.6 | — | — | 5 | BEARISH | -0.2 |
| VRNO Verano Holdings Corp | $370M | -1.4 | -4.5 | 1.5 | -6.0 | — | 3 | BEARISH | — |
| RZLT Rezolute, Inc. | $370M | -5.4 | -59.0 | 1060.6 | — | — | 2 | BEARISH | -57.6 |
| FENC Fennec Pharmaceuticals Inc. | $350M | -81.5 | -18.6 | -76.2 | 11.0 | 77.8 | 6 | BEARISH | 13.3 |
| EBS Emergent BioSolutions Inc. | $320M | -1.9 | -40.3 | -5.5 | -76.9 | -9.6 | 5 | BEARISH | -34.4 |
| DMTRF 3-D Matrix, Ltd. | $310M | 11.9 | 75.0 | 31.1 | 9.4 | 57.0 | 6 | BEARISH | 61.3 |
| SPOK Spok Holdings, Inc. | $220M | 17.0 | 8.4 | 10.0 | 11.8 | -3.4 | 5 | BEARISH | -35.4 |
| LFMDP LifeMD, Inc. | $150M | -4.2 | -687.6 | 135.4 | -15.0 | -16.7 | 4 | BEARISH | -9.7 |
| CUE Cue Biopharma, Inc. | $140M | -0.7 | -1603.5 | 1241.9 | -1943.2 | 354.4 | 3 | BEARISH | -21.2 |
| CPIX Cumberland Pharmaceuticals Inc. | $130M | -7.0 | -46.7 | -41.6 | -2472.5 | -25.7 | 3 | BEARISH | 23.9 |
| CORBF Global Cord Blood Corporation | $130M | 1.5 | 104.3 | -167.2 | 35.9 | — | 4 | BEARISH | 26.7 |
| HCAT Health Catalyst, Inc. | $130M | -0.4 | -118.1 | -27.1 | -57.5 | -7.5 | 5 | BEARISH | -46.7 |
| VANI Vivani Medical, Inc. | $100M | -3.3 | -220.4 | -127.1 | — | — | 4 | BEARISH | -30.7 |
| PXMBF Paxman AB (publ) | $80M | -305.7 | -1.2 | -1.7 | 2.4 | 33.5 | 3 | BEARISH | 0.0 |
| MNOV MediciNova, Inc. | $70M | -6.5 | -25.6 | -78.2 | -504.8 | 583.9 | 3 | BEARISH | 14.8 |
| NDTP NDT Pharmaceuticals Inc. | $50M | -39.2 | -3.8 | -1.5 | -458.3 | — | 4 | BEARISH | -77.5 |
| INCR InterCure Ltd. | $50M | -4.0 | -15.9 | -10.2 | -1.3 | -10.8 | 2 | BEARISH | -41.9 |
| CRVO CervoMed Inc. | $30M | -0.7 | -107.6 | 1244.8 | — | — | 2 | BEARISH | -68.4 |
| NSYS Nortech Systems Incorporated | $30M | 28.4 | 3.0 | 3.2 | 0.9 | 6.0 | 7 | BEARISH | 6.5 |
| CELU Celularity Inc. | $30M | -0.4 | 150.9 | 40592.8 | 13.0 | -58.1 | 4 | BEARISH | -62.3 |
| TELIF Telescope Innovations Corp. | $20M | 6.0 | -229.2 | -80.7 | -116.8 | 66.3 | 2 | BEARISH | -15.9 |
| COCP Cocrystal Pharma, Inc. | $20M | -1.2 | -311.7 | -3697.6 | -3013.3 | — | 2 | BEARISH | -8.3 |
| SCYX SCYNEXIS, Inc. | $20M | -2.1 | -18.4 | -120.7 | 3147.7 | 489.8 | 5 | BEARISH | 394.8 |
| PVCT Provectus Biopharmaceuticals, Inc. | $20M | -4.3 | 78.1 | 83.4 | — | -100.0 | 5 | BEARISH | -29.7 |
| BIAF bioAffinity Technologies, Inc. | $20M | -0.0 | -1860.2 | -352.6 | -222.8 | -23.2 | 4 | BEARISH | -92.8 |
| LTRN Lantern Pharma Inc. | $10M | -0.4 | -400.9 | 115.9 | — | — | 2 | BEARISH | -83.6 |
| HLYK HealthLynked Corp. | $10M | -1.4 | 63.5 | -580.7 | -328.1 | -46.7 | 3 | BEARISH | 55.6 |
| INNPF InnoCan Pharma Corporation | $10M | -6.5 | -21.0 | -13488.5 | -0.6 | -19.2 | 3 | BEARISH | -86.2 |
| AMS American Shared Hospital Services | $10M | -5.1 | -7.5 | -5.5 | -6.1 | 4.0 | 5 | BEARISH | -44.7 |
| GTHP Guided Therapeutics, Inc. | $10M | -3.6 | 66.3 | 57.9 | — | 450.8 | 3 | BEARISH | -42.6 |
| PHYOF IXICO plc | $10M | -6.0 | -15.8 | -23.6 | -28.5 | 13.2 | 2 | BEARISH | 0.0 |
| PASG Passage Bio, Inc. | $10M | -0.3 | -169.1 | 159.0 | — | — | 3 | BEARISH | -55.2 |
| RVLWF Revitalist Lifestyle and Wellness Ltd. | $10M | -0.1 | 613.5 | -129.3 | -263.6 | — | 2 | BEARISH | 0.0 |
| CBSC Cardiac Biotech Solutions Inc. | $10M | -6.8 | 87.3 | 51.1 | -341.6 | 78.5 | 3 | BEARISH | -26.1 |
| AMBD American Mobile Dental Corp. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HTPRF HTC Purenergy Inc. | — | -0.0 | 13.4 | -6.6 | — | 100.0 | 5 | BEARISH | -99.8 |
| CDT CDT Equity Inc. | — | -0.0 | 13.1 | 5.4 | 9.1 | — | 7 | BEARISH | -97.0 |
| ADTX Aditxt, Inc. | — | -0.0 | 622.6 | 49.4 | -131159.8 | -74.1 | 1 | BEARISH | -100.0 |
| YDESW YD Bio Limited Warrants | — | — | — | — | — | — | — | BEARISH | -81.8 |
| BBAL New York Health Care, Inc. | — | -0.0 | -9.2 | -21.4 | -1.7 | 3.5 | 6 | BEARISH | 0.0 |
| WPHM Winston Pharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | -66.7 |
| BIGG Big Tree Group, Inc. | — | 0.0 | 0.4 | -0.6 | -0.6 | 55.4 | 5 | BEARISH | 0.0 |
| PHMB PharmaCom BioVet, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| HMGN Hemagen Diagnostics, Inc. | — | -0.0 | 29.1 | -24.6 | -18.6 | -21.4 | 2 | BEARISH | 100.0 |
| YECO EV Biologics, Inc. | — | -0.0 | 16.2 | 18.1 | 18.6 | 264.7 | 5 | BEARISH | -99.9 |
| AZFL Amazonas Florestal, Ltd | — | 3.3 | 19.8 | 13.9 | 13.6 | — | 5 | BEARISH | 0.0 |
| CNNC Cannonau Corp. | — | 0.0 | -96.5 | -93.3 | — | -100.0 | 2 | BEARISH | -66.7 |
| DKSC Dakshidin Corporation | — | -34.4 | -113.2 | -9.1 | — | — | 2 | BEARISH | 200.0 |
| FCHS First Choice Healthcare Solutions, Inc. | — | -0.0 | 61.1 | 51.6 | — | 140.3 | 4 | BEARISH | -33.3 |
| VSMD Vasamed, Inc. | — | -0.0 | 54566.1 | 395.4 | -334.5 | 70.0 | 4 | BEARISH | 0.0 |
| GPFT Grapefruit USA, Inc. | — | -0.1 | 11.4 | 5.9 | — | — | 2 | BEARISH | -75.0 |
| GREH Green Rain Energy Holdings Inc. | — | 0.4 | 28.6 | -43.9 | -94.2 | — | 3 | BEARISH | 158.6 |
| LIMNW Liminatus Pharma, Inc. Warrants | — | -0.1 | -4165.9 | 252.1 | — | — | 2 | BEARISH | -83.3 |
| BBRRF Blueberries Medical Corp. | — | -7.1 | -218.7 | -2675.7 | -588.1 | -36.9 | 4 | BEARISH | -29.4 |
| AXIM AXIM Biotechnologies, Inc. | — | -1.6 | 3.0 | 24.9 | -90.9 | 2142.6 | 5 | BEARISH | -60.0 |
| RGBPP Regen BioPharma, Inc. | — | -0.0 | 20.3 | 12.8 | -1079.8 | 0.0 | 4 | BEARISH | -98.5 |
| CHMMF Chimeric Therapeutics Limited | — | -0.0 | 655.2 | 80.8 | — | -100.0 | 2 | BEARISH | 0.0 |
| HEMP Hemp, Inc | — | -0.2 | -38.7 | -6.0 | -4131.8 | 333.7 | 4 | BEARISH | 0.0 |
| CBDL CBD Life Sciences Inc. | — | -115.1 | -79.7 | -382.6 | 45.8 | -47.8 | 3 | BEARISH | -25.0 |
| UNVC Univec, Inc. | — | -3.8 | 6.9 | 5.9 | -1481.4 | 78.3 | 4 | BEARISH | -48.4 |
| BLEG Branded Legacy, Inc. | — | -0.0 | 2011.7 | 147.0 | — | -29.4 | 2 | BEARISH | -99.5 |
| GRI GRI Bio, Inc. | — | -0.0 | -142.0 | 1227.5 | — | — | 5 | BEARISH | -97.4 |
| OXIHF Oxford Investments Holdings Inc. | — | -0.2 | 19.5 | 9.8 | 6887.8 | -90.6 | 2 | BEARISH | 0.0 |
| NMLSF Restart Life Sciences Corp. | — | -1.8 | -214.3 | -153.9 | -307.0 | — | 2 | BEARISH | -69.2 |
| AGNPF Grey Matters Health Inc. | — | — | -140.9 | -64.7 | — | — | 3 | BEARISH | -58.6 |
| CRFTF BC Craft Supply Co. Ltd. | — | -0.0 | 152.6 | 13.1 | — | -82.0 | 2 | BEARISH | -90.0 |
| NHEL Natural Health Farm Holdings Inc. | — | -0.0 | -37.2 | -15.8 | 9.3 | 6892.6 | 4 | BEARISH | 0.0 |
| LNAI Lunai Bioworks Inc. | — | -0.3 | -21.6 | 30.2 | — | — | 2 | BEARISH | -96.8 |
| SNDA Sonida Senior Living, Inc. | $1.6B | -5.3 | -25.2 | -2.9 | -11.8 | 49.4 | 4 | BEARISH | 28.4 |
| ETON Eton Pharmaceuticals, Inc. | $1.4B | 109.0 | 36.0 | 33.3 | 30.8 | 81.5 | 7 | BEARISH | 170.6 |
| MEDOF Medios AG | $1.3B | 23.5 | 2.1 | 2.8 | 0.6 | 10.0 | 6 | BEARISH | 0.0 |
| GHRS GH Research PLC | $1.2B | -20.0 | -18.8 | 2015.5 | — | — | 2 | BEARISH | 44.5 |
| CSBTF Kuros Biosciences AG | $950M | 109.9 | 9.6 | 9.2 | 4.8 | 29.1 | 4 | BEARISH | -43.1 |
| IART Integra LifeSciences Holdings Corporation | $930M | 70.5 | 1.2 | 13.4 | 3.6 | 0.8 | 6 | BEARISH | -23.8 |
| ANRO Alto Neuroscience, Inc. | $860M | -9.3 | -49.2 | -201.4 | — | — | 3 | BEARISH | 97.7 |
| AKTS Aktis Oncology, Inc. | $850M | -15.8 | -29.9 | 276.4 | -713.5 | -36.1 | 5 | BEARISH | 245681.2 |
| DSGN Design Therapeutics, Inc. | $640M | -9.1 | -34.1 | 1787.8 | — | — | 1 | BEARISH | 81.4 |
| SLDB Solid Biosciences Inc. | $630M | -3.2 | -65.5 | -1012.6 | — | — | 3 | BEARISH | 5.2 |
| LXRX Lexicon Pharmaceuticals, Inc. | $630M | -9.8 | -40.2 | -99.7 | -4591.8 | -29.0 | 3 | BEARISH | 18.9 |
| ANL Adlai Nortye Ltd. | $560M | -5.5 | -22.4 | -317.5 | -36.3 | 223.4 | 4 | BEARISH | 537.4 |
| MNPR Monopar Therapeutics Inc. | $470M | -30.7 | -19.5 | 523.8 | — | — | 2 | BEARISH | -13.2 |
| AVIR Atea Pharmaceuticals, Inc. | $320M | -2.0 | -58.1 | 974.6 | — | — | 3 | BEARISH | 30.4 |
| ARTV Artiva Biotherapeutics, Inc. | $300M | -1.3 | -36.6 | -954.6 | — | — | 3 | BEARISH | 27.3 |
| SY So-Young International Inc. | $280M | -7.6 | -15.7 | -22.3 | -11.4 | 14.1 | 4 | BEARISH | -30.0 |
| WHWK Whitehawk Therapeutics Inc | $180M | -3.0 | -45.0 | 963.4 | — | -100.0 | 1 | BEARISH | 28.2 |
| PFGTF Pacific Edge Limited | $170M | -6.0 | -194.5 | -709.2 | -299.7 | -49.4 | 2 | BEARISH | 36.9 |
| ANTX AN2 Therapeutics, Inc. | $130M | -3.5 | -50.1 | 1243.3 | — | — | 2 | BEARISH | 210.3 |
| NRXP NRx Pharmaceuticals, Inc. | $110M | -3.6 | 131.2 | 61.3 | -1500.5 | — | 5 | BEARISH | -20.3 |
| RTGN RetinalGenix Technologies Inc. | $80M | -36.0 | 90.4 | -10.3 | — | -100.0 | 4 | BEARISH | 12.7 |
| ECOR electroCore, Inc. | $60M | -4.6 | 1761.5 | 336.0 | -32.4 | 33.5 | 3 | BEARISH | 51.8 |
| ELOX Eloxx Pharmaceuticals, Inc. | $40M | -8.5 | -107.5 | 81.5 | — | — | 4 | BEARISH | 13029900.4 |
| BMEA Biomea Fusion, Inc. | $40M | -1.2 | -164.1 | 210.3 | — | — | 2 | BEARISH | -53.9 |
| RMTI Rockwell Medical, Inc. | $30M | -4.8 | -15.5 | -14.8 | -6.6 | -21.1 | 6 | BEARISH | 508.7 |
| TVGN Tevogen Bio Holdings Inc. | $30M | -1.2 | 235.3 | 244.1 | — | — | 5 | BEARISH | 917.3 |
| MLSS Milestone Scientific Inc. | $30M | -6.5 | -121.7 | -160.5 | -37.3 | 3.7 | 4 | BEARISH | -28.9 |
| AVEFF Avecho Biotechnology Limited | $20M | -9.3 | -268.2 | 103.4 | -3227.5 | -46.6 | 3 | BEARISH | 0.0 |
| CMMB Chemomab Therapeutics Ltd. | $10M | -1.0 | -82.7 | -314.7 | — | — | 1 | BEARISH | -65.3 |
| BNGO Bionano Genomics, Inc. | $10M | -0.3 | -83.6 | -89.6 | -90.8 | 10.0 | 6 | BEARISH | -39.3 |
| KZIA Kazia Therapeutics Ltd ADR | $10M | -1.1 | -104.5 | 62.7 | — | -99.2 | 4 | BEARISH | 16.8 |
| SYBX Synlogic, Inc. | $10M | -19.6 | -5.3 | 306.3 | — | — | 2 | BEARISH | -39.0 |
| BFRI Biofrontera Inc. | $10M | -1.4 | -988.4 | -39.2 | -5.0 | 17.8 | 4 | BEARISH | -28.8 |
| XAIR Beyond Air, Inc. | — | -0.0 | -429.9 | 409.7 | -448.8 | 60.7 | 6 | BEARISH | 4.8 |
| PRMD PrimeMD Inc | — | -0.0 | 42.8 | 34.3 | 159.9 | — | 3 | BEARISH | 200.0 |
| XRTX XORTX Therapeutics Inc. | — | -0.4 | -99.1 | -68.5 | — | — | 3 | BEARISH | 47.6 |
| IVIXF Invion Limited | — | -0.6 | -83.6 | -69.7 | -537.3 | — | 3 | BEARISH | 0.0 |
| HXBM Helix BioMedix, Inc. | — | — | — | — | — | — | — | BEARISH | -6.0 |
| PAVS Paranovus Entertainment Technology Ltd. | — | -0.0 | -25.4 | -20.6 | -5.5 | 3788.4 | 3 | BEARISH | -95.7 |
| OZYMF Strategic Partners A/S | — | 19.0 | 0.8 | -117.5 | 1019.0 | — | 6 | BEARISH | 0.0 |
| GNLKQ GeneLink, Inc. | — | -0.0 | 73.0 | 82.1 | -183.0 | -33.6 | 3 | BEARISH | 0.0 |
| RMTG Regenerative Medical Technology Group Inc. | — | -0.1 | 9.6 | -3.3 | -72.2 | — | 3 | BEARISH | — |
| RXEI RxElite, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| GLABF Gemina Laboratories Ltd. | — | -3.0 | 42.7 | 32.4 | -7838.5 | — | 5 | BEARISH | -78.3 |
| HBMHF HBM Holdings Limited | $1.3B | 12.5 | 24.1 | 53.0 | 53.0 | 54.6 | 4 | BEARISH | -38.1 |
| RAFLF Raffles Medical Group Ltd | $1.2B | 22.0 | 5.8 | 7.3 | 8.2 | -2.8 | 7 | BEARISH | -20.0 |
| BCAX Bicara Therapeutics Inc. Common Stock | $1.1B | -5.6 | -41.0 | 583.9 | — | — | 2 | BEARISH | -0.2 |
| NKTR Nektar Therapeutics | $1.1B | -5.7 | -35.8 | -29.2 | -401.0 | -27.2 | 3 | BEARISH | -41.1 |
| EBOSY EBOS Group Limited | $1.0B | 15.3 | 5.0 | 4.4 | 1.7 | -8.1 | 6 | BEARISH | -47.5 |
| GLUE Monte Rosa Therapeutics, Inc. | $920M | -4.8 | -42.7 | 149.9 | -483.9 | -83.9 | 3 | BEARISH | 1.0 |
| ALMS Alumis Inc. | $880M | -1.8 | -93.6 | 2645.2 | -8557.2 | -63.1 | 2 | BEARISH | 41.2 |
| XVIPY Xvivo Perfusion AB (publ) | $690M | 49.4 | 5.9 | 4.6 | 17.7 | 17.5 | 6 | BEARISH | — |
| AGMB AgomAb Therapeutics N.V. American Depositary Shares | $450M | — | — | — | — | — | — | BEARISH | — |
| BLSM BlossomHill Therapeutics, Inc. | $430M | — | — | — | — | — | — | BEARISH | — |
| EIKN Eikon Therapeutics, Inc. Common Stock | $390M | — | — | — | — | — | — | BEARISH | — |
| SWDCF Swedencare AB (publ) | $370M | 35.2 | 1.2 | 1.7 | 3.9 | 1.4 | 7 | BEARISH | -35.8 |
| RLMD Relmada Therapeutics, Inc. | $350M | -3.5 | -55.7 | 460.5 | — | — | 3 | BEARISH | 46.1 |
| BNTC Benitec Biopharma Inc. | $300M | -8.9 | -33.2 | 1840.8 | — | — | 3 | BEARISH | -38.6 |
| IPSC Century Therapeutics, Inc. | $260M | -1.4 | -49.7 | -60.0 | — | -100.0 | 2 | BEARISH | 140.7 |
| RCKT Rocket Pharmaceuticals, Inc. | $250M | -15.5 | -4.8 | -137.8 | — | — | 3 | BEARISH | -39.0 |
| BOVNF BioInvent International AB (publ) | $220M | -2.8 | -88.2 | 20101.5 | -964.0 | -87.2 | 1 | BEARISH | 0.0 |
| CRLBF Cresco Labs Inc. | $210M | -2.0 | -25.8 | 5.5 | 9.7 | -4.5 | 2 | BEARISH | -49.0 |
| CHRS Coherus Oncology, Inc. | $160M | -1.0 | -145.4 | 1854.0 | -144.2 | -64.3 | 2 | BEARISH | -39.5 |
| ONVVF Oneview Healthcare PLC | $130M | -6.4 | -147.3 | -2982.0 | -100.1 | -2.9 | 3 | BEARISH | -6.2 |
| VXRT Vaxart, Inc. | $100M | 2.7 | 67.0 | 149.6 | -49.6 | 201.1 | 6 | BEARISH | 12.5 |
| IMUX Immunic, Inc. | $100M | -1.6 | -138.2 | 345.6 | — | — | 5 | BEARISH | -6.7 |
| ADAG Adagene Inc. | $90M | -5.6 | -28.6 | 111.8 | -1011.1 | 8927.0 | 5 | BEARISH | 39.1 |
| NMRA Neumora Therapeutics, Inc. Common Stock | $70M | -0.3 | -187.1 | 231.9 | — | — | 2 | BEARISH | -75.0 |
| TENX Tenax Therapeutics, Inc. | $50M | -1.2 | -59.8 | 1235.8 | — | — | 1 | BEARISH | -77.6 |
| IMA ImageneBio Inc | $50M | -0.8 | -40.7 | -594.7 | — | — | 3 | BEARISH | -45.1 |
| SRTS Sensus Healthcare, Inc. | $50M | -3.0 | -34.8 | -47.6 | -382.1 | -53.4 | 3 | BEARISH | -14.3 |
| IBO Impact BioMedical Inc. | $30M | -3.0 | 10.8 | -30.4 | -23300.0 | — | 5 | BEARISH | -49.4 |
| NEUP Neuphoria Therapeutics Inc. | $20M | -0.5 | -0.2 | -0.2 | -417.7 | -91.9 | 4 | BEARISH | -16.5 |
| PRRUF Immutep Limited | $20M | -0.4 | -77.3 | 1092.5 | -328.8 | 255.0 | 3 | BEARISH | -89.5 |
| LDDD Longduoduo Company Limited | $20M | -26.6 | 47.5 | -421.7 | -13.8 | -36.8 | 5 | BEARISH | -45.4 |
| YI 111, Inc. | $20M | -1.7 | 30.0 | 15.9 | -1.7 | -20.9 | 2 | BEARISH | -31.7 |
| CLRB Cellectar Biosciences, Inc. | $10M | -0.3 | -119.6 | 717.6 | — | — | 3 | BEARISH | -68.0 |
| CNSY Cerenome, Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| AIM AIM ImmunoTech Inc. | $10M | -0.0 | -2382.3 | -513.5 | -14569.2 | -21.5 | 5 | BEARISH | -93.2 |
| AIXN AiXin Life International, Inc. | $10M | -4.9 | 37.6 | 39.5 | -191.9 | -61.1 | 4 | BEARISH | -61.6 |
| CTXR Citius Pharmaceuticals, Inc. | $10M | -0.2 | -70.3 | -85.4 | -593.3 | 4456.8 | 3 | BEARISH | -73.9 |
| VYND Vynleads, Inc. | $10M | -27.0 | 74.2 | 89.5 | — | — | 4 | BEARISH | 62.6 |
| JMPHF Leveljump Healthcare Corp. | $10M | -1.5 | -21.1 | 0.7 | -9.7 | 5.4 | 3 | BEARISH | 677.3 |
| CMHSF Comprehensive Healthcare Systems, Inc. | $10M | -1.8 | 78.3 | 144.6 | -37.9 | -22.6 | 3 | BEARISH | -36.6 |
| RADX Radiopharm Theranostics Limited | — | — | — | — | — | — | — | BEARISH | -82.1 |
| RSHN RushNet, Inc. | — | -1.0 | -1202.9 | -22.5 | — | -43.0 | 2 | BEARISH | -98.0 |
| WLSS Welsis Corp. | — | -51.7 | 6.2 | 3.3 | — | — | 1 | BEARISH | -82.9 |
| TSTTF TripSitter Clinic Ltd. | — | -19.2 | -0.1 | 30.7 | — | 100.0 | 4 | BEARISH | -56.2 |
| AYURF Ayurcann Holdings Corp. | — | -0.5 | 315.5 | 53.8 | -13.0 | 47.1 | 4 | BEARISH | -98.8 |
| SCNX Scienture Holdings, Inc. | — | -0.1 | -53.5 | -15.4 | -821.3 | 540.6 | 4 | BEARISH | -95.5 |
| RSLT Resilient Healthcare Corp | — | — | — | — | — | — | — | BEARISH | — |
| LGVN Longeveron Inc. | — | -0.2 | -203.6 | -2062.6 | -2116.0 | -42.7 | 4 | BEARISH | -81.1 |
| LUDG Ludwig Enterprises, Inc. | — | -0.4 | 43.5 | 103.5 | — | 100.0 | 4 | BEARISH | -91.3 |
| APVO Aptevo Therapeutics Inc. | — | -0.0 | -420.3 | -4688.7 | — | — | 1 | BEARISH | -94.5 |
| ARNI Arno Therapeutics, Inc. | — | -0.0 | 250.7 | 111.6 | — | — | 3 | BEARISH | 0.0 |
| MYNDF MYND Life Sciences Inc. | — | -2.2 | 9.5 | 34.0 | — | — | 5 | BEARISH | -41.3 |
| SEPSF Asep Medical Holdings Inc | — | -0.3 | -36.4 | -75.5 | -844.8 | 208.8 | 5 | BEARISH | -97.2 |
| IPAH Interpharm Holdings, Inc. | — | -0.0 | -342.5 | -47.0 | -67.2 | -5.1 | 1 | BEARISH | -99.8 |
| BIOAF Bioasis Technologies Inc. | — | -0.1 | 135.1 | 538.8 | -661.8 | 614.1 | 2 | BEARISH | -50.0 |
| KAYS Kaya Holdings, Inc. | — | -0.0 | 141.1 | -11929.1 | -158865.8 | -102.0 | 3 | BEARISH | -96.8 |
| MDXL Medixall Group, Inc. | — | -0.1 | 48.8 | 48.2 | 678.9 | 29.4 | 6 | BEARISH | 3200.0 |
| ARUXF Acrux Limited | — | -7.1 | -48.5 | -74.2 | -26.5 | 289.9 | 7 | BEARISH | -93.4 |
| AQSZF Aequus Pharmaceuticals Inc. | — | 3.1 | 10.0 | 17.6 | 147.2 | 122.3 | 5 | BEARISH | -85.7 |
| WGS GeneDx Holdings Corp. | $1.7B | -17.2 | -40.8 | -17.2 | -15.5 | 25.4 | 4 | BEARISH | -51.0 |
| ORIC ORIC Pharmaceuticals, Inc. | $1.4B | -6.7 | -39.8 | -102.9 | — | — | 3 | BEARISH | -27.9 |
| KURA Kura Oncology, Inc. | $850M | -2.9 | -167.7 | 56.3 | -327.3 | -7.3 | 1 | BEARISH | 5.7 |
| HELP Helus Pharma Inc. | $630M | -2.6 | -56.3 | -143.0 | — | — | 2 | BEARISH | — |
| FDMT 4D Molecular Therapeutics, Inc. | $600M | -4.3 | -43.3 | -182.0 | -1929.0 | 278712.1 | 4 | BEARISH | 10.3 |
| ZVRA Zevra Therapeutics, Inc. | $580M | 10.5 | 34.8 | -1356.4 | 22.1 | 119.4 | 6 | BEARISH | -10.8 |
| AQST Aquestive Therapeutics, Inc. | $500M | -6.2 | 121.1 | 43.4 | -165.5 | 22.6 | 5 | BEARISH | -43.5 |
| DCTH Delcath Systems, Inc. | $500M | 1344.2 | 0.5 | -2.7 | 9.2 | 35.8 | 6 | BEARISH | 39.8 |
| EPRX Eupraxia Pharmaceuticals Inc. | $450M | -6.9 | -68.6 | 8742.2 | — | — | 3 | BEARISH | 20.6 |
| AGEN Agenus Inc. | $290M | 2.4 | -33.2 | -20.4 | -1.6 | 30.5 | 6 | BEARISH | 47.4 |
| IRD Opus Genetics, Inc. | $290M | -2.7 | -4796.5 | 59.8 | -1072.6 | -36.1 | 3 | BEARISH | 66.0 |
| ACB Aurora Cannabis Inc. | $250M | -3.0 | -20.5 | -17.0 | -6.0 | -16.6 | 3 | BEARISH | -23.7 |
| TLSI TriSalus Life Sciences, Inc. | $220M | -2.9 | 438.3 | 453.7 | -80.5 | 25.2 | 4 | BEARISH | -29.4 |
| GALT Galectin Therapeutics Inc. | $210M | -8.0 | 21.9 | 99.4 | — | — | 2 | BEARISH | -37.8 |
| ETRA Electra Therapeutics Inc. | $180M | — | — | — | — | — | — | BEARISH | — |
| CGEN Compugen Ltd. | $180M | 5.2 | 49.6 | -90.2 | -269.3 | 886.7 | 5 | BEARISH | 12.6 |
| BDSX Biodesix, Inc. | $170M | -7.0 | -540.0 | -31.9 | -27.1 | 34.5 | 6 | BEARISH | 230.6 |
| LOVFF Cannara Biotech Inc. | $140M | 17.7 | 11.4 | 12.2 | 15.2 | 15.4 | 7 | BEARISH | 20.0 |
| MGNX MacroGenics, Inc. | $140M | -10.8 | -32.6 | 33.8 | 59.4 | 2.3 | 2 | BEARISH | 19.7 |
| SEER Seer, Inc. | $110M | -1.6 | -26.4 | -58.8 | -544.8 | -13.3 | 3 | BEARISH | -11.1 |
| COYA Coya Therapeutics, Inc. | $90M | -3.9 | -60.5 | -18820.6 | -2723.4 | 1793.8 | 4 | BEARISH | -43.4 |
| AAWH Ascend Wellness Holdings, Inc. | $80M | -0.7 | 388.6 | 3.1 | -7.8 | -8.4 | 3 | BEARISH | -52.3 |
| ACRV Acrivon Therapeutics, Inc. Common Stock | $70M | -0.9 | -64.6 | 5251.5 | — | — | 1 | BEARISH | -14.0 |
| PMVP PMV Pharmaceuticals, Inc. | $70M | -0.9 | -70.9 | 815.8 | — | — | 2 | BEARISH | -28.5 |
| HRTX Heron Therapeutics, Inc. | $60M | -1.6 | 334.6 | -7.6 | -14.6 | 1.0 | 3 | BEARISH | -74.7 |
| OSTX OS Therapies Incorporated | $60M | -1.1 | 1924.5 | 268.9 | — | — | 1 | BEARISH | -33.1 |
| SPRO Spero Therapeutics, Inc. | $60M | 7.9 | 19.2 | -128.5 | — | -7.0 | 7 | BEARISH | -51.4 |
| XLO Xilio Therapeutics, Inc. | $50M | -4.9 | -55.0 | 43.1 | -34.1 | 327.3 | 6 | BEARISH | 845.5 |
| MYO Myomo, Inc. | $50M | -3.5 | -123.8 | -74.2 | -34.4 | 6.1 | 3 | BEARISH | 14.3 |
| DGNOF DIAGNOS Inc. | $30M | -8.8 | -988.8 | -2061.6 | -7539.8 | -36.9 | 3 | BEARISH | 7.3 |
| AKTX Akari Therapeutics, Plc | $20M | -0.0 | -139.9 | -175.8 | — | — | 3 | BEARISH | -74.2 |
| KPRX Kiora Pharmaceuticals, Inc. | $10M | -0.9 | -56.4 | -2884.1 | — | — | 2 | BEARISH | -13.0 |
| OTLC Oncotelic Therapeutics, Inc. | $10M | 0.0 | 181.4 | -1.4 | 155.3 | — | 5 | BEARISH | -82.0 |
| ADIA Adia Med Inc. | $10M | -0.1 | 32.2 | -16.3 | 8.3 | — | 1 | BEARISH | 247.2 |
| ENVB Enveric Biosciences, Inc. | $10M | -0.1 | -170.0 | 3225.6 | — | — | 4 | BEARISH | -81.1 |
| SNOA Sonoma Pharmaceuticals, Inc. | $10M | -1.0 | -41.1 | -55.7 | -5.2 | 47.0 | 4 | BEARISH | -69.6 |
| CHOOF Choom Holdings Inc. | — | -0.0 | 3772.9 | -35.1 | -140.0 | 4.6 | 4 | BEARISH | -90.0 |
| MDRM Modern Mobility Aids, Inc. | — | -58.8 | 146.1 | 120.5 | — | — | 2 | BEARISH | -33.3 |
| PTIX Protagenic Therapeutics, Inc. | — | 0.2 | -485.4 | -367.8 | — | 100.0 | 6 | BEARISH | -78.3 |
| ISCO International Stem Cell Corporation | — | -2.4 | 30.4 | -10.8 | -2.7 | 3.4 | 6 | BEARISH | -6.7 |
| PBM Psyence Biomedical Ltd. | — | — | — | — | — | — | — | BEARISH | 9.9 |
| RVLPQ RVL Pharmaceuticals plc | — | -0.0 | -182.4 | -101.1 | -289.3 | 5.6 | 3 | BEARISH | -90.0 |
| JUVAF Juva Life Inc. | — | -0.0 | -105.0 | -21.4 | -24.6 | 43.5 | 4 | BEARISH | -90.0 |
| ESVNF Apptly Health Technologies Corp. | — | -1.5 | -22.3 | -40.4 | — | — | 2 | BEARISH | -33.8 |
| ARSUF Fagron N.V. | $2.0B | 18.9 | 16.7 | 10.8 | 8.4 | 11.8 | 4 | BEARISH | 9.8 |
| CURLF Curaleaf Holdings, Inc. | $1.8B | -62.5 | -4.2 | 0.5 | 3.7 | 2.7 | 7 | BEARISH | -9.0 |
| URGN UroGen Pharma Ltd. | $1.7B | -17.2 | 86.5 | 119.0 | -19.8 | 169.5 | 2 | BEARISH | 96.4 |
| NVAX Novavax, Inc. | $1.6B | -6.6 | 323.7 | 29.2 | -94.2 | -61.6 | 2 | BEARISH | 12.4 |
| NUVB Nuvation Bio Inc. | $1.6B | -10.3 | -47.8 | 70.2 | -198.3 | 1083.6 | 4 | BEARISH | 2.7 |
| ELEAF EL.En. S.p.A. | $1.4B | 13.7 | 13.2 | 29.1 | 6.0 | 25.8 | 8 | BEARISH | 37.9 |
| DRTS Alpha Tau Medical Ltd | $1.2B | -13.0 | -141.7 | -17.1 | — | — | 3 | BEARISH | 206.2 |
| MDCLF MedinCell S.A. | $1.1B | -29.2 | 472.2 | 81.6 | -152.1 | -14.8 | 3 | BEARISH | 333.5 |
| IMMX Immix Biopharma, Inc. | $680M | -9.3 | -34.2 | 1509.2 | — | — | 4 | BEARISH | 135.0 |
| CADL Candel Therapeutics, Inc. | $610M | -5.9 | -81.8 | 219.4 | — | — | 2 | BEARISH | 46.7 |
| CLYM Climb Bio, Inc. | $590M | -11.6 | -27.1 | -88.6 | — | — | 2 | BEARISH | 342.7 |
| AVR Anteris Technologies Global Corp. | $570M | -2.2 | -75.1 | 3136.2 | -2884.3 | 31.1 | 5 | BEARISH | 3.4 |
| GNFTF Genfit S.A. | $470M | -5.2 | -5084.0 | -322.7 | -124.0 | 27.5 | 3 | BEARISH | 153.5 |
| AVCTF Avacta Group Plc | $420M | -6.7 | -2083.2 | -753.6 | -33970.3 | -99.7 | 5 | BEARISH | -18.7 |
| SENS Senseonics Holdings, Inc. | $400M | -3.7 | -118.2 | -901.4 | -253.4 | 79.0 | 3 | BEARISH | 1.8 |
| VREOF Vireo Growth Inc. | $310M | -4.1 | -4.6 | -0.7 | -0.0 | — | 3 | BEARISH | — |
| IKT Inhibikase Therapeutics, Inc. | $220M | -3.3 | -52.0 | 920.5 | — | — | 3 | BEARISH | -0.7 |
| PLX Protalix BioTherapeutics, Inc. | $210M | 10.5 | 31.2 | 47.1 | 19.0 | 30.1 | 5 | BEARISH | 6.9 |
| PRQR ProQR Therapeutics N.V. | $180M | -3.0 | -57.9 | 139.7 | -99.6 | 12.7 | 2 | BEARISH | -56.0 |
| ORMP Oramed Pharmaceuticals Inc. | $170M | 1.0 | 74.1 | -4.3 | — | -100.0 | 4 | BEARISH | 72.2 |
| CRDL Cardiol Therapeutics Inc. | $140M | -4.7 | -204.6 | 1592.3 | — | — | 4 | BEARISH | -4.3 |
| TRGNF Transgene S.A. | $120M | -4.1 | -64.1 | -184.9 | -5760.7 | -185.8 | 4 | BEARISH | -53.1 |
| PYXS Pyxis Oncology, Inc. | $110M | -1.3 | -179.1 | 1953.9 | — | 291.4 | 2 | BEARISH | -50.0 |
| PRNAF Alterity Therapeutics Limited | $50M | -2.2 | -55.0 | -401.1 | — | -100.0 | 2 | BEARISH | 8233.3 |
| BOLD Boundless Bio, Inc. | $50M | -0.8 | -67.9 | 807.9 | — | — | 2 | BEARISH | 68.8 |
| VRHI Veri Medtech Holdings Inc. | $40M | — | — | — | — | — | — | BEARISH | — |
| PRPO Precipio, Inc. | $40M | -30.1 | -9.0 | -8.1 | -3.1 | 33.5 | 6 | BEARISH | -11.7 |
| ABDXF Abingdon Health Plc | $30M | -16.4 | -36.9 | -48.9 | 3.9 | 28.3 | 4 | BEARISH | 83.0 |
| CLIFF Cordlife Group Limited | $30M | -2.9 | -9.9 | -15.8 | -11.3 | 11.3 | 5 | BEARISH | 2.6 |
| BMNDF Biomind Labs Inc. | $20M | -13.3 | 85.8 | 101.7 | — | — | 2 | BEARISH | 1483.5 |
| SER Serina Therapeutics, Inc. | $20M | -0.9 | -206.3 | 1868.6 | — | -100.0 | 3 | BEARISH | -67.9 |
| CMPD CompuMed, Inc. | $10M | -27.9 | -8.7 | -11.2 | 1.1 | 22.4 | 6 | BEARISH | 95.8 |
| ALZN Alzamend Neuro Inc | $10M | -0.5 | -163.2 | 401.5 | — | — | 1 | BEARISH | -52.4 |
| PCYN Procyon Corporation | — | 80.4 | -13.9 | -10.8 | 2.7 | 6.4 | 3 | BEARISH | 52.9 |
| PAIOF Paion AG | — | -0.6 | -385.3 | -130.5 | -98.8 | -18.0 | 1 | BEARISH | 0.0 |
| XBIO Xenetic Biosciences, Inc. | — | -1.5 | -47.0 | 523.4 | -140.7 | 33.3 | 4 | BEARISH | -55.2 |
| ADDLF AddLife AB (publ) | $1.9B | 34.5 | 11.3 | 7.0 | 4.9 | 1.1 | 4 | BEARISH | -62.5 |
| VIMGF Vimian Group AB (publ) | $1.5B | 48.7 | 5.4 | 6.4 | 7.4 | 8.9 | 7 | BEARISH | -8.0 |
| SNDX Syndax Pharmaceuticals, Inc. | $1.2B | -5.4 | -255.9 | -270.9 | -67.8 | 222.3 | 4 | BEARISH | -9.9 |
| SHPHF Sihuan Pharmaceutical Holdings Group Ltd. | $1.1B | 18.6 | 5.7 | 8.4 | 19.4 | 24.4 | 6 | BEARISH | 20.0 |
| TTALF Terveystalo Oyj | $910M | 13.3 | 10.3 | 6.3 | 2.1 | -8.7 | 4 | BEARISH | -44.5 |
| CHIZF China Traditional Chinese Medicine Holdings Co. Limited | $820M | -4.8 | -4.9 | 0.0 | -14.3 | 5.6 | 6 | BEARISH | -40.3 |
| ARDX Ardelyx, Inc. | $770M | -13.2 | -38.6 | -22.7 | -13.8 | 16.8 | 4 | BEARISH | -40.7 |
| GERN Geron Corporation | $720M | -11.5 | -29.2 | -74.1 | -29.0 | 24.4 | 2 | BEARISH | -5.7 |
| SANA Sana Biotechnology, Inc. | $700M | -3.2 | -152.9 | -242.3 | — | — | 3 | BEARISH | -57.8 |
| TGRNF Tong Ren Tang Technologies Co. Ltd. | $660M | 10.8 | 4.1 | 12.2 | 8.2 | -18.2 | 6 | BEARISH | -43.0 |
| SLBT SL Science Holding Ltd | $640M | — | — | — | — | — | — | BEARISH | — |
| WVE Wave Life Sciences Ltd. | $630M | -3.2 | -80.0 | -1243.7 | -470.5 | -35.1 | 4 | BEARISH | -54.5 |
| CRWRF Craneware plc | $620M | 25.9 | 6.0 | 6.8 | 9.7 | 4.2 | 7 | BEARISH | -43.9 |
| GYRE Gyre Therapeutics, Inc. | $620M | -32.8 | -15.6 | -22.3 | -36.4 | 16.8 | 3 | BEARISH | -26.2 |
| ANNX Annexon, Inc. | $610M | -3.2 | -105.3 | -11323.3 | — | — | 2 | BEARISH | 21.3 |
| OLMA Olema Pharmaceuticals, Inc. | $560M | -3.3 | -52.7 | 585.3 | — | — | 2 | BEARISH | -18.2 |
| CTMX CytomX Therapeutics, Inc. | $510M | -5.2 | -37.8 | 305.9 | -1457.4 | -87.0 | 2 | BEARISH | -32.4 |
| KSRBF Kossan Rubber Industries Bhd | $480M | 16.9 | 5.0 | 8.5 | 11.3 | 1.0 | 5 | BEARISH | -43.2 |
| BWAY BrainsWay Ltd. | $440M | 47.1 | 13.0 | 31.1 | 15.8 | 32.3 | 5 | BEARISH | 34.7 |
| SPRY ARS Pharmaceuticals, Inc. | $400M | -1.7 | -210.3 | -424.3 | -185.2 | 4.1 | 2 | BEARISH | -59.4 |
| MPLT MapLight Therapeutics, Inc. | $340M | -1.6 | -57.5 | -366.6 | — | — | 2 | BEARISH | — |
| TLRY Tilray Brands, Inc. | $310M | -2.0 | -8.8 | -3.4 | -16.8 | -16.9 | 3 | BEARISH | -81.6 |
| CGC Canopy Growth Corporation | $290M | -1.5 | -40.1 | -11.7 | -18.0 | 6.8 | 4 | BEARISH | -49.4 |
| SPHDF Santhera Pharmaceuticals Holding AG | $280M | -6.6 | 729.6 | 111.3 | -44.5 | 106.3 | 7 | BEARISH | 49.1 |
| VOGX Vogenx Inc. | $260M | — | — | — | — | — | — | BEARISH | — |
| ORYZF Oryzon Genomics S.A. | $250M | -80.4 | -3.0 | -7.2 | -1.6 | 12.6 | 4 | BEARISH | -14.1 |
| CUVL Clinuvel Pharmaceuticals Ltd. | $250M | — | — | — | — | — | — | BEARISH | — |
| VNDA Vanda Pharmaceuticals Inc. | $240M | -0.9 | -77.8 | -201.0 | -123.7 | 6.0 | 3 | BEARISH | -28.2 |
| LRMR Larimar Therapeutics, Inc. | $240M | -1.2 | -139.6 | 590.9 | — | — | 2 | BEARISH | -43.3 |
| HLOSF Healios K.K. | $240M | 56.3 | 3.7 | -129.2 | 17028.6 | -47.1 | 4 | BEARISH | -48.6 |
| LXEO Lexeo Therapeutics, Inc. Common Stock | $230M | -2.5 | -46.8 | -249.1 | — | — | 3 | BEARISH | -70.0 |
| IPHYF Innate Pharma S.A. | $210M | -2.5 | 267.9 | 119.2 | -343.8 | 32.0 | 3 | BEARISH | -24.5 |
| BBOT BridgeBio Oncology Therapeutics Inc. | $210M | -0.0 | -56.4 | -157.3 | — | — | 1 | BEARISH | -75.7 |
| ELDN Eledon Pharmaceuticals, Inc. | $190M | -2.4 | -110.7 | 411.1 | — | — | 2 | BEARISH | -32.8 |
| BIOA BioAge Labs Inc. | $190M | -2.3 | -28.2 | -142.3 | -1064.7 | 168.1 | 4 | BEARISH | -37.2 |
| EVMN Evommune, Inc. | $190M | -1.5 | -29.6 | -82.4 | — | — | 2 | BEARISH | — |
| NNNN Anbio Biotechnology Class A Ordinary Shares | $170M | — | — | — | — | — | — | BEARISH | -85.4 |
| AKBA Akebia Therapeutics, Inc. | $160M | -6.1 | -109.4 | 15.6 | -18.1 | 7.5 | 6 | BEARISH | -78.4 |
| ZNTL Zentalis Pharmaceuticals, Inc. | $160M | -0.8 | -83.7 | -2245.4 | — | -100.0 | 2 | BEARISH | 26.2 |
| NBP NovaBridge Biosciences | $160M | -2.2 | -45.7 | -617.8 | — | — | 1 | BEARISH | -72.2 |
| NGEN NervGen Pharma Corp. Common stock | $150M | — | — | — | — | — | — | BEARISH | — |
| PHCUF Photocure ASA | $150M | 16.9 | 14.5 | 37.4 | -0.5 | 29.5 | 5 | BEARISH | 1.2 |
| MDWD MediWound Ltd. | $150M | -7.7 | -72.4 | -255.1 | -239.1 | -40.3 | 2 | BEARISH | -34.8 |
| DERM Journey Medical Corporation | $140M | -22.0 | -23.8 | -7.4 | -1.7 | 20.9 | 5 | BEARISH | -33.7 |
| QTRX Quanterix Corporation | $140M | -1.1 | -46.5 | -59.0 | -148.7 | 23.4 | 2 | BEARISH | -51.7 |
| TARA Protara Therapeutics, Inc. | $140M | -1.8 | -45.8 | -41.3 | — | — | 2 | BEARISH | -54.5 |
| NKTX Nkarta, Inc. | $130M | -1.1 | -38.8 | -75.4 | — | — | 1 | BEARISH | -8.0 |
| MENS Jyong Biotech Ltd. Ordinary Shares | $130M | — | — | — | — | — | — | BEARISH | -97.0 |
| AVXL Anavex Life Sciences Corp. | $120M | -4.9 | -23.6 | 411.7 | — | — | 2 | BEARISH | -85.3 |
| UNCY Unicycive Therapeutics, Inc. | $110M | -2.1 | -101.1 | 349.9 | — | — | 4 | BEARISH | -26.3 |
| CBUS Cibus, Inc. | $110M | -0.8 | -225.9 | -157.2 | -2227.9 | -10.3 | 2 | BEARISH | -11.4 |
| LENZ LENZ Therapeutics, Inc. | $100M | -0.8 | -59.2 | 17313.3 | -581.8 | 329.5 | 3 | BEARISH | -90.0 |
| STXS Stereotaxis, Inc. | $100M | -4.0 | -184.3 | -142.6 | -58.3 | -5.5 | 5 | BEARISH | -68.1 |
| APYX Apyx Medical Corporation | $100M | -12.1 | -96.4 | -12.3 | -23.4 | 25.6 | 5 | BEARISH | -15.2 |
| ORPOF OSE Immunotherapeutics S.A. | $100M | — | — | — | — | — | — | BEARISH | — |
| TNYA Tenaya Therapeutics, Inc. | $90M | -0.7 | -121.9 | 1769.3 | -3909.3 | — | 3 | BEARISH | -75.7 |
| RVRC Revium Recovery Inc. | $90M | -6.4 | -0.0 | 0.0 | — | — | 2 | BEARISH | 175.0 |
| TNXP Tonix Pharmaceuticals Holding Corp. | $90M | -0.4 | -81.8 | -276.2 | -299.4 | 196.0 | 3 | BEARISH | -71.5 |
| CNXU Conexeu Sciences Inc. | $90M | — | — | — | — | — | — | BEARISH | — |
| ABSCF AB Science S.A. | $80M | -6.6 | 21.5 | 34.7 | -1813.1 | 12.3 | 5 | BEARISH | -11.1 |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | $80M | -0.6 | -95.6 | 738.2 | — | — | 1 | BEARISH | -77.0 |
| MIST Milestone Pharmaceuticals Inc. | $80M | -1.0 | -35522.6 | 587.8 | -5118.8 | — | 5 | BEARISH | -67.0 |
| JWCTF JW (Cayman) Therapeutics Co. Ltd | $80M | -2.3 | -49.0 | -68.1 | -45.3 | 60.7 | 3 | BEARISH | -55.3 |
| NYXH Nyxoah S.A. | $80M | -0.4 | -125.8 | -181.3 | -429.5 | 359.2 | 2 | BEARISH | -85.3 |
| PMN ProMIS Neurosciences, Inc. | $70M | -0.6 | -172.3 | 844.3 | — | — | 2 | BEARISH | -24.9 |
| HYPR Hyperfine, Inc. | $70M | -2.0 | -97.0 | -395.6 | -238.2 | 53.2 | 5 | BEARISH | -42.1 |
| MBOT Microbot Medical Inc. | $70M | -4.0 | -32.9 | -600.2 | -2334.9 | — | 3 | BEARISH | -61.9 |
| THOXF BioPorto A/S | $70M | 77.4 | 12.3 | 43.6 | 520.6 | 3.4 | 4 | BEARISH | -48.3 |
| LNSR LENSAR Inc | $70M | 4.7 | 1231.0 | -218.4 | 21.4 | 3.3 | 5 | BEARISH | -50.2 |
| MAIA MAIA Biotechnology, Inc. | $70M | -1.9 | -218.7 | 330.4 | — | — | 3 | BEARISH | -24.0 |
| CGTX Cognition Therapeutics, Inc. | $70M | -3.9 | -83.8 | 6061.8 | — | — | 3 | BEARISH | -59.1 |
| CRBU Caribou Biosciences, Inc. | $60M | -0.4 | -78.3 | -695.0 | -1619.9 | 10.0 | 3 | BEARISH | -80.3 |
| TLSA Tiziana Life Sciences Ltd | $60M | -4.3 | -780.6 | 375.0 | — | — | 1 | BEARISH | -53.6 |
| GOSS Gossamer Bio, Inc. | $60M | -0.2 | 178.7 | 117.2 | 182.9 | 32.4 | 3 | BEARISH | -94.5 |
| HBPCF Helix BioPharma Corp. | $60M | -23.6 | -50.8 | -21.5 | — | — | 3 | BEARISH | -55.5 |
| INO Inovio Pharmaceuticals, Inc. | $60M | -0.8 | -409.9 | 257.7 | — | -100.0 | 1 | BEARISH | -61.3 |
| VTIAF FamiCord AG | $50M | -6.4 | -84.3 | -13.6 | -5.1 | 0.1 | 5 | BEARISH | -43.6 |
| PLRX Pliant Therapeutics, Inc. | $50M | -0.6 | -50.3 | -438.3 | — | — | 3 | BEARISH | -51.4 |
| MYCOF Noveris Health Sciences Inc. | $50M | -6.6 | 22.3 | 49.3 | — | — | 5 | BEARISH | 228.5 |
| GANX Gain Therapeutics, Inc. | $50M | -2.4 | -268.3 | 1288.8 | — | — | 4 | BEARISH | -41.6 |
| MDAI Spectral AI, Inc. | $50M | -4.4 | 99.0 | 97.9 | -118.5 | -45.0 | 2 | BEARISH | -32.4 |
| SOMNF SomnoMed Limited | $50M | -24.8 | -5.6 | 2.2 | -6.4 | 2.6 | 6 | BEARISH | -47.8 |
| HYFT MindWalk Holdings Corp. | $50M | -4.4 | -123.5 | -481.3 | -158.7 | -15.9 | 4 | BEARISH | -25.3 |
| SNZZF Senzime AB (publ) | $40M | -4.0 | -35.1 | -36.2 | -86.6 | 27.1 | 3 | BEARISH | -63.8 |
| DRIO DarioHealth Corp. | $40M | 4.9 | 113.8 | -93.8 | -153.1 | -22.6 | 3 | BEARISH | -77.4 |
| RPID Rapid Micro Biosystems, Inc. | $40M | -0.7 | -141.6 | -183.2 | -160.5 | 16.1 | 2 | BEARISH | -71.7 |
| DWTX Dogwood Therapeutics, Inc. | $40M | -0.1 | -47.8 | -39.7 | — | — | 2 | BEARISH | -80.2 |
| EUDA EUDA Health Holdings Limited | $40M | -6.6 | -50.6 | -26.7 | -22.9 | 49.4 | 5 | BEARISH | -66.4 |
| ALDX Aldeyra The | $40M | -1.6 | -49.5 | 269.3 | — | — | 4 | BEARISH | -87.5 |
| CVRX CVRx, Inc. | $40M | -0.7 | -133.4 | -260.4 | -89.4 | 12.0 | 3 | BEARISH | -85.6 |
| RANI Rani Therapeutics Holdings, Inc. | $40M | -2.2 | -179.1 | 245.5 | -432.7 | 306.4 | 5 | BEARISH | -70.8 |
| IGC IGC Pharma, Inc. | $30M | -3.0 | -129.2 | -127.6 | -1107.9 | -15.4 | 1 | BEARISH | -33.7 |
| AIRDF Rocket Doctor AI Inc. | $30M | -1.7 | -6105.0 | -2497.4 | -909.1 | — | 2 | BEARISH | -51.4 |
| FLNA Filana Therapeutics, Inc. | $30M | -0.7 | -13.5 | 38.9 | — | — | 2 | BEARISH | — |
| TDMMF Mach7 Technologies Limited | $30M | -6.8 | -22.3 | -41.4 | -22.3 | -17.5 | 3 | BEARISH | -72.0 |
| IXHL Incannex Healthcare Limited | $30M | -2.4 | -31.9 | 5284.2 | — | -100.0 | 4 | BEARISH | -74.5 |
| DCGO DocGo Inc. | $30M | -0.1 | -92.4 | -73.3 | -21.5 | -32.4 | 3 | BEARISH | -77.4 |
| MCRB Seres Therapeutics, Inc. | $20M | -0.8 | -66.6 | -87.8 | 622.4 | — | 3 | BEARISH | -88.8 |
| PAVM PAVmed Inc. | $20M | -0.1 | -31.9 | -43.6 | -16315.2 | -89.0 | 3 | BEARISH | 426.6 |
| SCLX Scilex Holding Company | $20M | -0.0 | 160.5 | 105.7 | -1485.2 | -28.5 | 3 | BEARISH | -84.0 |
| RVP Retractable Technologies, Inc. | $20M | -4.8 | -4.5 | -53.2 | 39.3 | -11.2 | 4 | BEARISH | -38.9 |
| ATYR aTyr Pharma, Inc. | $20M | -0.2 | -98.4 | -1890.1 | — | — | 2 | BEARISH | -84.2 |
| TCRX TScan Therapeutics, Inc. | $10M | -0.2 | -95.8 | -159.4 | -2888.6 | 2.2 | 2 | BEARISH | -91.9 |
| MDXHF Medx Health Corp. | $10M | — | 63.5 | 166.6 | -1353.4 | 19.2 | 3 | BEARISH | 150.0 |
| RDTCF Rapid Dose Therapeutics Corp. | $10M | -4.2 | 49.3 | 80.2 | -86.2 | 4.3 | 4 | BEARISH | -58.4 |
| GUTS Fractyl Health, Inc. | $10M | -0.1 | 1063.0 | -568.7 | — | -100.0 | 5 | BEARISH | -93.5 |
| TPST Tempest Therapeutics, Inc. | $10M | -0.1 | -931.1 | -564.2 | — | — | 1 | BEARISH | -95.1 |
| AVCNF Avicanna Inc. | $10M | -3.2 | -109.4 | -64.5 | -18.1 | -0.2 | 3 | BEARISH | -61.3 |
| HIND Vyome Holdings, Inc. | $10M | -0.1 | -193.1 | 516.3 | -2543.3 | -98.0 | 4 | BEARISH | -68.7 |
| ACTU Actuate Therapeutics Inc | $10M | -0.4 | 2457.6 | 541.3 | — | — | 3 | BEARISH | -92.7 |
| QNRX Quoin Pharmaceuticals, Ltd. | $10M | -0.3 | -578.6 | 221.3 | — | — | 1 | BEARISH | -70.1 |
| NCNA NuCana plc | $10M | -0.3 | -70.7 | -739.9 | — | — | 4 | BEARISH | -75.2 |
| GSGTF GenSight Biologics S.A. | $10M | -1.0 | 46.5 | 47.3 | 1190.6 | -401.7 | 3 | BEARISH | -57.9 |
| INTS Intensity Therapeutics, Inc. | $10M | -0.7 | -195.9 | 4123.4 | — | — | 5 | BEARISH | -46.8 |
| IMMVF Immunovia AB | $10M | -0.4 | -425.5 | 808.2 | -5991.9 | 31.4 | 3 | BEARISH | -80.8 |
| PXXLF Poxel S.A. | $10M | -0.4 | 34.8 | 129.6 | -624.6 | 41.5 | 4 | BEARISH | -12.0 |
| TOVX Theriva Biologics, Inc. | $10M | -0.3 | -101.9 | -213.5 | — | — | 2 | BEARISH | -43.5 |
| QNTM Quantum BioPharma Ltd. | $10M | -0.4 | -425.3 | 175.1 | — | — | 4 | BEARISH | -84.7 |
| CDIO Cardio Diagnostics Holdings, Inc. | $10M | -0.6 | -75.4 | -230.9 | -28012.5 | -25.9 | 3 | BEARISH | -56.6 |
| PDRX PD-Rx Pharmaceuticals, Inc. | $10M | — | — | — | — | — | — | BEARISH | 8.8 |
| VTGN VistaGen Therapeutics, Inc. | $10M | -0.1 | -166.5 | 851.1 | -882.8 | 287.3 | 4 | BEARISH | -95.8 |
| PLSM Pulsenmore Ltd. Ordinary Shares | $10M | — | — | — | — | — | — | BEARISH | — |
| OPTBF OptiBiotix Health Plc | $10M | -1.4 | -102.1 | -102.1 | -231.5 | -12.9 | 4 | BEARISH | 109900.0 |
| VRCDF Verici Dx plc | $10M | -0.6 | -192.7 | -151.0 | -227.8 | 84.7 | 3 | BEARISH | -60.5 |
| DARE Dare Bioscience, Inc. | $10M | -0.8 | 165.3 | 136.8 | -1590.4 | 7816.7 | 3 | BEARISH | -69.2 |
| AREVF AREV Life Sciences Global Corp | — | -1.9 | 23.9 | 15.1 | — | -96.1 | 2 | BEARISH | -95.0 |
| RPGLF Regent Pacific Group Limited | — | -16.8 | 38.3 | 5.9 | 10.3 | 491.5 | 6 | BEARISH | -94.1 |
| PMSNF Proteome Sciences plc | — | -2.0 | 25.2 | -36.8 | -74.6 | -16.5 | 4 | BEARISH | -66.7 |
| USMJ North American Cannabis Holdings, Inc. | — | -3.5 | 40.1 | 1.5 | — | 14.2 | 2 | BEARISH | 0.0 |
| CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | — | — | — | — | — | — | — | BEARISH | -74.7 |
| NUNZ Nunzia Pharmaceutical Company | — | -0.0 | 69398.6 | 176728.6 | — | — | 2 | BEARISH | 0.0 |
| OVATF Ovation Science Inc. | — | -1.7 | 44.0 | 34.6 | -690.6 | -27.1 | 3 | BEARISH | -74.6 |
| VNRX VolitionRX Ltd | — | -0.0 | 80.1 | 66.5 | -1837.7 | 86.3 | 3 | BEARISH | -58.0 |
| OJSY OJsys, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| MRDH Meridian Holdings, Inc. | — | -0.6 | 29.2 | -2410.8 | — | -100.0 | 1 | BEARISH | -19.0 |
| HRTT Heart Tronics, Inc. | — | -0.0 | -1320.1 | -1322.8 | — | — | 1 | BEARISH | 0.0 |
| PPRG Patient Portal Technologies, Inc. | — | -0.0 | -4.5 | -0.3 | -3.5 | -23.2 | 2 | BEARISH | 0.0 |
| AVCRF Avricore Health Inc. | — | -2.8 | -131.4 | -548.9 | -354.9 | -93.8 | 2 | BEARISH | -97.7 |
| AXRX Amexdrug Corporation | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CEVE Ceres Ventures, Inc. | — | -0.0 | 175.9 | 280.3 | — | — | 3 | BEARISH | 0.0 |
| LUFFF Herbal Dispatch Inc. | — | -1.0 | -124.8 | -42.8 | -26.7 | 4.6 | 6 | BEARISH | 46.0 |
| RASP Actavia Life Sciences, Inc. | — | -0.1 | 20.1 | 14.5 | — | — | 2 | BEARISH | -87.5 |
| MCOA Marijuana Company of America, Inc. | — | -0.1 | 295.5 | 51.6 | — | -72.4 | 1 | BEARISH | 0.0 |
| CHALF Chalice Brands Ltd | — | -0.0 | -51.3 | -9.0 | 9.4 | 36.2 | 5 | BEARISH | -99.0 |
| PPII Coenzyme-A Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CYDX CYduct Diagnostics, Inc. | — | -11.1 | 15.8 | 13.7 | -394.2 | -16.3 | 3 | BEARISH | 14.2 |
| NLVVF New Leaf Ventures Inc | — | -0.2 | -2466.1 | -179.6 | -152.9 | -39.2 | 1 | BEARISH | 0.0 |
| HMPQ HempAmericana, Inc | — | -0.5 | 25.6 | 14.8 | — | 184.6 | 2 | BEARISH | -99.0 |
| LIMN Liminatus Pharma, Inc. Class A Common Stock | — | -0.1 | 294.4 | 252.1 | — | — | 4 | BEARISH | -95.5 |
| STLNW Starling Oncology Inc. Wt | — | — | — | — | — | — | — | BEARISH | — |
| BZYR Burzynski Research Institute, Inc. | — | -0.0 | 2902.9 | 1462.7 | — | — | 4 | BEARISH | -99.4 |
| ISHI Islet Holdings, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| KALY Kali, Inc. | — | -8.6 | 32.3 | 47.0 | 20.9 | 28.1 | 4 | BEARISH | -98.0 |
| STMH Stem Holdings, Inc. | — | -0.0 | -274.8 | 873.4 | 98.5 | -100.0 | 3 | BEARISH | -90.0 |
| CBDX Curative Biosciences, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| NAVBQ Navidea Biopharmaceuticals, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| AJOY Ayujoy Herbals Ltd. | — | -1.0 | -54.8 | 142.7 | — | -100.0 | 3 | BEARISH | -53.7 |
| AGFAF Digicann Ventures Inc. | — | -0.0 | 30.8 | 63.6 | — | — | 2 | BEARISH | -76.8 |
| GENX Genex Pharmaceutical, Inc. | — | 0.0 | 7.8 | 5.1 | -8.1 | 32.8 | 5 | BEARISH | 0.0 |
| SUVZ Suvanza Pharma, LLC | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CVSI CV Sciences, Inc. | — | -1.0 | -118.9 | -46.0 | -26.0 | -14.9 | 1 | BEARISH | -73.1 |
| HCWB HCW Biologics Inc. | — | -0.0 | -133.5 | -36.8 | -3849.9 | 707.0 | 3 | BEARISH | -95.3 |
| EDNEF Eden Empire Inc. | — | — | 64.3 | -88.8 | -1382.1 | — | 2 | BEARISH | -90.9 |
| ACUS Acusphere, Inc. | — | -0.0 | -363.3 | -4565.0 | -3033.3 | -5.2 | 2 | BEARISH | 0.0 |
| KAPA Kairos Pharma, Ltd. | — | -0.3 | -114.0 | -301.0 | — | — | 3 | BEARISH | -93.0 |
| WOWU WOWI, Inc. | — | 0.0 | 51.5 | 49.7 | -38.1 | — | 4 | BEARISH | -50.0 |
| OMID OMID Holdings, Inc. | — | 25.2 | -127.5 | -314.5 | 40.6 | 57.1 | 5 | BEARISH | -62.9 |
| BUDZ WEED, Inc. | — | -2.0 | 176.9 | 220.9 | — | -100.0 | 1 | BEARISH | -58.6 |
| NGMDF NuGen Medical Devices Inc. | — | -0.3 | 81.2 | -448.2 | -19565.6 | -86.3 | 2 | BEARISH | -71.1 |
| XTXXF Adastra Holdings Ltd. | — | -0.7 | -227.3 | -93.3 | -9.6 | -33.9 | 2 | BEARISH | -98.6 |
| GENPF Genix Pharmaceuticals Corporation | — | -5.1 | 19.6 | 11.6 | — | -100.0 | 2 | BEARISH | -20.7 |
| GOVX GeoVax Labs, Inc. | — | -0.0 | -891.6 | 1530.7 | — | -100.0 | 3 | BEARISH | -98.5 |
| KLYG Kelyniam Global, Inc. | — | -23.3 | -26.9 | 10.0 | -16.7 | 2.0 | 5 | BEARISH | -24.8 |
| VBIO Valion Bio, Inc. | — | -0.0 | -240.8 | -48.0 | — | -281.4 | 2 | BEARISH | — |
| MMTC Micro Imaging Technology, Inc. | — | -0.0 | 83.3 | 72.6 | — | — | 1 | BEARISH | 0.0 |
| TNGNQ Tengion, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CELZ Creative Medical Technology Holdings, Inc. | — | -0.3 | -78.0 | 8335.2 | — | -50.0 | 2 | BEARISH | -82.2 |
| WEQL WellQuest Medical & Wellness Corporation | — | -0.0 | 16.1 | -19.9 | -36.3 | 126.5 | 3 | BEARISH | 100.0 |
| ENDV Endonovo Therapeutics, Inc. | — | -0.2 | 9.2 | 4.5 | — | -100.0 | 3 | BEARISH | -99.3 |
| SVSO SheerVision, Inc. | — | -0.0 | 31.8 | -24.5 | 42.2 | -32.8 | 3 | BEARISH | 0.0 |
| NEUN Neurogenesis, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| VPRO Viropro Inc. | — | -0.0 | -19.7 | -4.8 | -269.7 | 155.0 | 2 | BEARISH | 0.0 |
| DPAT Dental Patient Care America, Inc. | — | 320.0 | 117.2 | 10.7 | 26.9 | -3.7 | 5 | BEARISH | 64.1 |
| GRPI Grupo International Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CATV Opus Holdings, Inc. | — | -16.9 | -0.8 | -1.4 | 91.7 | 47.8 | 5 | BEARISH | -99.6 |
| AQQRF Aquarius Surgical Technologies Inc. | — | -0.3 | 26.1 | -39.2 | -855.7 | 8.7 | 4 | BEARISH | 0.0 |
| ZVSA ZyVersa Therapeutics, Inc. | — | -0.0 | 817.1 | 242.0 | — | -100.0 | 1 | BEARISH | -99.3 |
| AMHD HLK Biotech Holding Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| EVFM Evofem Biosciences, Inc. | — | -0.1 | 20.1 | 26.0 | -419.1 | 4.5 | 2 | BEARISH | -30.7 |
| ETAOF Etao International Co., Ltd. | — | -0.0 | -1369.5 | 4843.5 | -1544.0 | — | 5 | BEARISH | -66.7 |
| HSMD Healthcare Solutions Management Group, Inc. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| NBRVF Nabriva Therapeutics plc | — | — | — | — | — | — | — | BEARISH | 0.0 |
| YCBD cbdMD, Inc. | — | -1.2 | -40.3 | -27.6 | -20.3 | 10.0 | 2 | BEARISH | -64.9 |
| JNHMF Jack Nathan Medical Corp. | — | -0.7 | -152.9 | 25.0 | -471.3 | -108.0 | 4 | BEARISH | -75.0 |
| KALA KALA BIO, Inc. | — | -0.0 | -345.3 | -913.5 | — | -100.0 | 4 | BEARISH | -99.5 |
| SZLSF StageZero Life Sciences Ltd. | — | -0.0 | 23.1 | 18.6 | -79.9 | -29.3 | 2 | BEARISH | -80.4 |
| NSRS Medcann Industries, Inc. | — | -0.0 | -92.1 | -21.1 | — | — | 2 | BEARISH | 0.0 |
| WSNAF Wesana Health Holdings Inc. | — | -0.1 | 1113.6 | 90.8 | — | — | 3 | BEARISH | -82.5 |
| LVCE LiveCare, Inc. | — | — | — | — | — | — | — | BEARISH | -77.2 |
| BNIGF Beroni Group Limited | — | -0.1 | -1153.4 | -274.8 | -15945.7 | 40.9 | 5 | BEARISH | 0.0 |
| CHHE China Health Industries Holdings, Inc. | — | -0.0 | -6.9 | -35.0 | -164082.8 | 77.5 | 2 | BEARISH | -0.0 |
| OVIT OncoVista Innovative Therapies, Inc. | — | -0.0 | 61.2 | 43.6 | — | — | 1 | BEARISH | 0.0 |
| ISPC iSpecimen Inc. | — | -0.0 | -968.5 | 305.3 | -896.9 | -92.1 | 4 | BEARISH | -97.3 |
| ICCM IceCure Medical Ltd | — | -0.1 | -228.3 | 36140.9 | -496.3 | 41.6 | 7 | BEARISH | -95.7 |
| SILO Silo Pharma, Inc. | — | -0.2 | -91.2 | 645.1 | — | -25.0 | 3 | BEARISH | 107.8 |
| QMDT Quick-Med Technologies, Inc. | — | -0.0 | 8.3 | 3.4 | -78.6 | -6.9 | 5 | BEARISH | 400.0 |
| PNDHF Pond Technologies Holdings Inc. | — | -0.4 | 43.2 | 90.7 | -114.9 | -47.3 | 2 | BEARISH | 33.3 |
| MBGNF Many Bright Ideas Technologies Inc. | — | -2.2 | 20.4 | 126.7 | — | — | 2 | BEARISH | 0.0 |
| IONKF Ionic Brands Corp. | — | -0.0 | -395.1 | -29.9 | -53.6 | 179.4 | 4 | BEARISH | 0.0 |
| AYRWF Ayr Wellness Inc. | — | -0.0 | -65.7 | -16.1 | -53.2 | -2.4 | 3 | BEARISH | -100.0 |
| ENLV Enlivex Therapeutics Ltd. | — | 0.0 | 209.7 | -0.4 | — | — | 5 | BEARISH | -99.0 |
| IVF INVO Fertility, Inc. | — | -0.0 | -55.3 | -28.1 | 40.9 | 13.8 | 4 | BEARISH | -97.8 |
| VYCO Vycor Medical, Inc. | — | -19.4 | 1.5 | -1.1 | -5.3 | 1.6 | 6 | BEARISH | -71.3 |
| ECIA Encision Inc. | — | -0.7 | -21.1 | -7.4 | 2.0 | -8.7 | 3 | BEARISH | -95.9 |
| EVGN Evogene Ltd. | — | -0.4 | 265.3 | 101.3 | -509.5 | -80.4 | 3 | BEARISH | -70.2 |
| APYI Aspyra Inc. | — | -0.0 | -102.5 | 49.8 | -82.7 | -15.6 | 1 | BEARISH | 0.0 |
| NNRX Nutranomics, Inc. | — | -0.1 | 58.6 | -70.9 | -150.9 | 46.4 | 4 | BEARISH | -98.0 |
| XENO Xeno Transplants Corporation | — | -0.0 | -286.5 | 78.1 | — | — | 1 | BEARISH | 0.0 |
| ZHCLF Zenith Capital Corp. | — | -0.2 | 35107.2 | 37766.2 | -360.0 | — | 3 | BEARISH | 3233.3 |
| PERCF Percheron Therapeutics Limited | — | — | — | — | — | — | — | BEARISH | — |
| BLFE BioLife Sciences Inc. | — | -0.0 | 318059.1 | -92210.0 | — | — | 2 | BEARISH | -99.0 |
| MJARF MJardin Group, Inc. | — | -0.0 | 59.5 | -11.0 | -1614.6 | -42.3 | 3 | BEARISH | -99.0 |
| PMCB PharmaCyte Biotech, Inc. | — | -0.1 | -44.0 | 793.8 | — | — | 2 | BEARISH | -63.5 |
| MLECW Moolec Science S.A. | — | -0.0 | -174.7 | -31.5 | -91.8 | 170.4 | 3 | BEARISH | -27.4 |
| USPS Ultimate Sports, Inc. | — | -15.1 | 14.7 | 11.0 | — | — | 1 | BEARISH | -9.5 |
| ULIHF The United Laboratories International Holdings Limited | $1.9B | 20.5 | 3.3 | 4.4 | 5.6 | -16.6 | 4 | BEARISH | -49.9 |
| GENSF Genus plc | $1.8B | 5.4 | 45.4 | 9.0 | 80.4 | -3.8 | 5 | BEARISH | -19.4 |
| MLYS Mineralys Therapeutics, Inc. | $1.8B | -4.9 | -80.9 | 2274.6 | — | — | 2 | BEARISH | -49.6 |
| FDMDF 4DMedical Limited | $1.6B | -9.2 | -174.5 | 43.4 | -1194.8 | 20.5 | 3 | BEARISH | 132.8 |
| OCUL Ocular Therapeutix, Inc. | $1.4B | -4.7 | -73.0 | -31671.3 | -584.5 | -8.1 | 3 | BEARISH | -43.4 |
| GTBIF Green Thumb Industries Inc. | $1.4B | 11.8 | 7.0 | 2.5 | 1.6 | 4.8 | 7 | BEARISH | -17.0 |
| GPCR Structure Therapeutics Inc. | $1.2B | -7.1 | -20.2 | -1134.3 | — | — | 3 | BEARISH | -20.6 |
| MCRPF MicroPort Scientific Corp. | $1.1B | 31.2 | 6.1 | -1.7 | 21.3 | -3.5 | 5 | BEARISH | -64.8 |
| LFTSF LifeTech Scientific Corporation | $1.0B | 103.0 | 7.3 | 6.9 | -5.7 | 103.7 | 4 | BEARISH | -14.3 |
| SVRA Savara Inc. | $870M | -8.4 | -105.5 | -15438.9 | — | — | 2 | BEARISH | 9.7 |
| IVEVF Inventiva S.A. | $750M | -6.2 | -988.4 | -371.6 | -347346.6 | -99.7 | 3 | BEARISH | -22.8 |
| ATTO Attovia Therapeutics, Inc. | $630M | -15.3 | -294.4 | -1137.2 | -4597.1 | -50.5 | 4 | BEARISH | 226.6 |
| NNCSF Nanosonics Limited | $620M | 53.0 | 8.3 | 15.6 | 8.1 | 2.4 | 4 | BEARISH | -39.9 |
| EVOTF Evotec SE | $590M | -2.6 | -26.1 | -14.9 | -32.5 | -7.7 | 2 | BEARISH | -54.3 |
| PROK ProKidney Corp. | $470M | -2.7 | 9.2 | 13.2 | -18948.0 | 55.2 | 1 | BEARISH | -57.4 |
| PHAT Phathom Pharmaceuticals, Inc. | $460M | -4.7 | 26.4 | 8.9 | -23.7 | 110.2 | 4 | BEARISH | -56.4 |
| SSII SS Innovations International, Inc. | $450M | -39.0 | -26.1 | -15.6 | -19.1 | 108.5 | 3 | BEARISH | -74.4 |
| FTH Faeth Therapeutics, Inc. | $440M | — | — | — | — | — | — | BEARISH | — |
| RGNX REGENXBIO Inc. | $440M | -1.7 | -137.6 | -368.4 | 21.0 | 12.0 | 2 | BEARISH | -47.7 |
| ALLO Allogene Therapeutics, Inc. | $430M | -1.9 | -42.4 | -81.9 | -919.8 | — | 5 | BEARISH | 0.0 |
| CALZF PolyNovo Limited | $430M | 82.1 | 8.4 | 9.3 | 10.0 | 12.8 | 7 | BEARISH | -34.2 |
| ALT Altimmune, Inc. | $410M | -2.6 | -28.9 | -43.1 | — | 55.0 | 4 | BEARISH | -47.0 |
| ASMB Assembly Biosciences, Inc. | $400M | 37.0 | -0.0 | 56.2 | -28.8 | 125.1 | 4 | BEARISH | -28.5 |
| TECX Tectonic Therapeutic, Inc. | $390M | -4.5 | -33.8 | -6371.3 | — | — | 1 | BEARISH | 14.7 |
| AVTX Avalo Therapeutics, Inc. | $370M | -1.4 | -36.3 | -148.4 | — | -86.6 | 4 | BEARISH | -62.2 |
| NIKA Nika Pharmaceuticals Inc. | $370M | -4711.6 | 26.8 | 18.5 | — | 100.0 | 3 | BEARISH | 8.5 |
| CAPR Capricor Therapeutics, Inc. | $340M | -2.5 | -73.7 | -107.5 | — | -100.0 | 3 | BEARISH | -6.4 |
| KYTX Kyverna Therapeutics, Inc. | $330M | -1.9 | -87.2 | 14267.8 | — | — | 2 | BEARISH | -17.7 |
| CLPT ClearPoint Neuro, Inc. | $280M | -8.2 | -226.5 | -54.1 | -104.2 | 25.9 | 3 | BEARISH | -64.2 |
| FULC Fulcrum Therapeutics, Inc. | $280M | -3.1 | -32.4 | 2389.1 | — | — | 4 | BEARISH | -59.3 |
| CTNM Contineum Therapeutics, Inc. | $270M | -5.2 | -28.0 | -541.6 | — | — | 4 | BEARISH | -26.8 |
| ACIU AC Immune S.A. | $250M | -4.2 | -78.5 | 96.7 | 12.4 | -39.5 | 2 | BEARISH | -17.8 |
| ABEO Abeona Therapeutics Inc. | $250M | -3.9 | -43.1 | -5983.3 | -177.4 | 6280.0 | 2 | BEARISH | -20.5 |
| CABA Cabaletta Bio, Inc. | $250M | -0.9 | -93.2 | -1308.0 | — | — | 3 | BEARISH | -44.0 |
| SCTX Scribe Therapeutics Inc. | $250M | — | — | — | — | — | — | BEARISH | — |
| OCGN Ocugen, Inc. | $250M | -2.9 | 1211.7 | 190.2 | -1671.8 | -3.7 | 2 | BEARISH | -53.0 |
| LAB Standard BioTools Inc. | $240M | -2.7 | -18.1 | -69.4 | -133.1 | -45.2 | 5 | BEARISH | -56.5 |
| PALI Palisade Bio, Inc. | $230M | -2.3 | -51.4 | 815.6 | -2114.8 | — | 5 | BEARISH | -30.5 |
| GLAS Glass House Brands Inc | $190M | — | — | — | — | — | — | BEARISH | — |
| NAGE Niagen Bioscience Inc | $190M | 12.9 | 21.8 | 44.7 | 3.2 | 11.0 | 6 | BEARISH | -67.1 |
| IVVD Invivyd, Inc. | $180M | -1.5 | -95.9 | -302.5 | -310.8 | 26.3 | 2 | BEARISH | -70.0 |
| CATX Perspective Therapeutics, Inc. | $180M | -0.8 | -39.5 | -108.8 | -33069.1 | -35.3 | 3 | BEARISH | -58.7 |
| TSNDF TerrAscend Corp. | $170M | -3.8 | -22.6 | -28.1 | -13.6 | — | 3 | BEARISH | — |
| SION Sionna Therapeutics, Inc. | $160M | -1.8 | -32.3 | -137.7 | — | — | 0 | BEARISH | -90.7 |
| CHHHF CareRx Corporation | $150M | 7.8 | 27.3 | 40.1 | 0.4 | 3.0 | 6 | BEARISH | -10.8 |
| UPB Upstream Bio, Inc. | $150M | -1.0 | -46.0 | -1266.4 | -5136.1 | 49.2 | 3 | BEARISH | -84.1 |
| STRO Sutro Biopharma, Inc. | $150M | -0.5 | 266.8 | 43.6 | -391.6 | -56.3 | 4 | BEARISH | -16.1 |
| CNTN Canton Strategic Holdings Inc | $150M | -1.2 | -14.6 | -7.2 | -1287.2 | — | 2 | BEARISH | — |
| CMPX Compass Therapeutics, Inc. | $140M | -1.8 | -56.7 | 1526.3 | — | — | 4 | BEARISH | -80.8 |
| ORGO Organogenesis Holdings Inc. | $130M | -1.1 | -27.8 | -7.7 | -227.0 | 6.4 | 3 | BEARISH | -78.1 |
| OWLT Owlet, Inc. | $120M | -9.7 | 180.6 | -50.5 | -1.8 | 28.0 | 6 | BEARISH | -56.8 |
| VYGR Voyager Therapeutics, Inc. | $110M | -1.0 | -54.1 | -131.1 | -773.2 | -19.1 | 2 | BEARISH | -61.5 |
| NERV Minerva Neurosciences, Inc. | $110M | -0.1 | 337.5 | 10.0 | — | — | 1 | BEARISH | -54.8 |
| VTVT vTv Therapeutics Inc. | $100M | -236.4 | -11.7 | 91.2 | — | 216600.0 | 4 | BEARISH | 23.9 |
| CLLS Cellectis S.A. | $100M | -1.7 | -94.6 | 118.6 | -417.3 | 0.5 | 2 | BEARISH | -73.2 |
| FRNM Freenome, Inc. | $100M | — | — | — | — | — | — | BEARISH | — |
| ENGN enGene Holdings Inc. | $100M | -5.6 | -2.3 | 134.1 | — | -100.0 | 2 | BEARISH | -79.9 |
| AIRS AirSculpt Technologies, Inc. | $90M | -7.0 | -12.0 | -6.0 | -2.6 | -8.7 | 5 | BEARISH | -89.0 |
| IMDX Insight Molecular Diagnostics Inc. | $90M | -2.1 | 488.7 | 92.7 | -4711.3 | -60.8 | 2 | BEARISH | -53.3 |
| GNLX Genelux Corporation | $90M | -2.2 | -168.9 | 20537.7 | — | — | 2 | BEARISH | -75.2 |
| CCLD CareCloud, Inc. | $80M | 24.9 | 21.8 | 15.7 | 3.5 | 15.1 | 4 | BEARISH | -46.6 |
| EAPIF Euroapi S.A. | $80M | -0.2 | -39.9 | 2.1 | -39.7 | -10.3 | 3 | BEARISH | -73.6 |
| CRDF Cardiff Oncology, Inc. | $70M | -1.5 | -94.1 | 443.4 | -8876.9 | -7.0 | 3 | BEARISH | -63.6 |
| PTHS Pelthos Therapeutics Inc. | $70M | -0.3 | 4767.3 | -97.0 | -150.1 | — | 2 | BEARISH | -55.4 |
| VRCA Verrica Pharmaceuticals Inc. | $60M | -2.0 | 473.3 | 437.4 | -224.4 | 106.2 | 5 | BEARISH | -13.4 |
| XBIT XBiotech Inc. | $60M | -1.3 | -29.9 | -201.2 | — | — | 2 | BEARISH | -26.0 |
| IBIO iBio, Inc. | $50M | -2.3 | -65.7 | 21688.6 | — | -75.0 | 4 | BEARISH | -44.3 |
| RNTX Rein Therapeutics Inc. | $50M | -0.4 | -753.6 | 53.9 | — | — | 3 | BEARISH | -53.7 |
| DXR Daxor Corporation | $50M | 7.4 | 14.2 | 13.5 | -14382.9 | -78.3 | 3 | BEARISH | -32.3 |
| EXOZ eXoZymes, Inc. | $40M | -3.3 | -187.2 | 913.0 | — | — | 2 | BEARISH | -69.0 |
| BMKDF BioMark Diagnostics Inc. | $40M | -34.8 | -149.8 | -103.7 | -5198.4 | -82.1 | 2 | BEARISH | 37.1 |
| VERU Veru Inc. | $40M | -3.8 | -62.3 | -211.2 | — | -100.0 | 3 | BEARISH | -40.6 |
| ANVS Annovis Bio, Inc. | $40M | -0.6 | -703.7 | 170.2 | — | — | 1 | BEARISH | -52.6 |
| KLRS Kalaris Therapeutics Inc | $40M | -0.9 | -79.9 | 109.5 | — | — | 0 | BEARISH | -63.2 |
| ACET Adicet Bio, Inc. | $40M | -0.3 | -78.1 | -553.5 | — | — | 4 | BEARISH | -71.4 |
| OTCFF Ocumetics Technology Corp. | $40M | -6.8 | 174.3 | 2137.7 | — | — | 1 | BEARISH | -65.2 |
| XTNT Xtant Medical Holdings, Inc. | $40M | -3.5 | -25.2 | -14.8 | -40.9 | -14.3 | 4 | BEARISH | -63.2 |
| TIL Instil Bio, Inc. | $40M | -1.3 | -25.3 | -69.1 | — | — | 4 | BEARISH | -70.7 |
| MREO Mereo BioPharma Group plc | $40M | -1.6 | -67.8 | 6194.3 | — | -100.0 | 2 | BEARISH | -86.2 |
| ALGS Aligos Therapeutics, Inc. | $30M | -0.7 | -113.6 | -1246.4 | -5.4 | 893.0 | 2 | BEARISH | -51.0 |
| EDSA Edesa Biotech, Inc. | $30M | -1.6 | -122.9 | 759.6 | — | — | 1 | BEARISH | -3.7 |
| MDDVF Medical Developments International Limited | $30M | 66.5 | 1.1 | 3.6 | 4.1 | 8.9 | 7 | BEARISH | -15.1 |
| AARD Aardvark Therapeutics, Inc. Common Stock | $30M | -0.4 | -66.0 | -3642.4 | — | — | 1 | BEARISH | -90.0 |
| BSEM BioStem Technologies, Inc. | $30M | -0.9 | -74.7 | -84.3 | -113.6 | -119.6 | 2 | BEARISH | -68.3 |
| NRXBF NurExone Biologic Inc. | $30M | — | — | — | — | — | — | BEARISH | — |
| COSM Cosmos Health Inc. | $30M | -0.4 | -104.0 | -41.2 | -32.1 | 33.8 | 4 | BEARISH | -77.4 |
| BIOQ Bioqual, Inc. | $30M | -6.2 | -2.8 | -4.3 | -0.8 | -16.6 | 3 | BEARISH | -23.4 |
| PLNH Planet 13 Holdings Inc. | $30M | -0.4 | -90.5 | -50.0 | -24.4 | -21.2 | 2 | BEARISH | -59.5 |
| MIRA MIRA Pharmaceuticals, Inc. | $30M | -0.4 | -710.9 | -15187.8 | — | — | 3 | BEARISH | -65.6 |
| EYPT EyePoint Pharmaceuticals, Inc. | $30M | -0.1 | -148.7 | -3014.8 | -18633.1 | -94.6 | 2 | BEARISH | -96.8 |
| BCTX BriaCell Therapeutics Corp. | $30M | -0.3 | -179.9 | -2435.2 | — | — | 2 | BEARISH | -73.4 |
| NNOX Nano-X Imaging Ltd. | $30M | -0.2 | -99.0 | -164.5 | -1335.1 | 31.5 | 2 | BEARISH | -91.6 |
| MGX Metagenomi, Inc. Common Stock | $30M | -0.3 | -60.6 | -268.2 | 10693.4 | -59.8 | 1 | BEARISH | -72.4 |
| GRCE Grace Therapeutics, Inc. | $30M | -1.4 | -38.4 | -58.9 | — | — | 2 | BEARISH | -42.5 |
| BXPHF Botanix Pharmaceuticals Limited | $20M | -0.3 | -96.3 | -131.6 | -203.1 | 495.6 | 4 | BEARISH | -89.6 |
| ACIXF Acarix AB (publ) | $20M | -5.4 | -86.1 | -207.4 | -410.8 | 65.2 | 4 | BEARISH | -33.1 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $20M | -1.2 | -234.4 | -475.2 | -504.1 | 36.6 | 3 | BEARISH | -30.5 |
| KYNB Kyntra Bio, Inc. | $20M | 0.1 | -115.2 | 29.6 | -812.3 | — | 2 | BEARISH | — |
| ARAY Accuray Incorporated | $20M | -0.3 | -80.1 | -11.3 | -1.9 | -12.3 | 2 | BEARISH | -92.3 |
| ITOC iTonic Holdings Ltd. | $20M | — | — | — | — | — | — | BEARISH | — |
| ACH Accendra Health, Inc. | $20M | -0.1 | -1.1 | 4.3 | -14.5 | -99.1 | 3 | BEARISH | -98.0 |
| SYMQY SymBio Pharmaceuticals Limited | $20M | -0.5 | -334.3 | 639.4 | -515.2 | -54.2 | 1 | BEARISH | -57.1 |
| MEDIF MediPharm Labs Corp. | $20M | -5.6 | -13.2 | -15.4 | 0.0 | -6.7 | 4 | BEARISH | -16.0 |
| TXMD TherapeuticsMD, Inc. | $20M | -95.4 | -0.8 | -12.9 | 17.8 | 27.8 | 6 | BEARISH | 37.4 |
| QUCY Quantum Cyber N.V. | $20M | — | — | — | — | — | — | BEARISH | — |
| MVMDF More Life Company Corp. | $20M | -5.2 | -167.0 | -602.2 | -5006.5 | 43.0 | 4 | BEARISH | 119.2 |
| ORXOF Orexo AB | $20M | -0.5 | 3924.8 | -872.8 | -12050.0 | -97.8 | 4 | BEARISH | -81.0 |
| OPTH Optimi Health Corp. | $20M | — | — | — | — | — | — | BEARISH | — |
| RDGL Vivos Inc. | $20M | -5.7 | -132.5 | -427.2 | -2280.7 | 91.5 | 3 | BEARISH | -45.2 |
| MDXH MDxHealth S.A. | $20M | -0.3 | 193.7 | -23.4 | -42.4 | -19.1 | 2 | BEARISH | -95.6 |
| MRMD MariMed Inc. | $20M | -1.4 | -28.4 | -0.9 | -8.6 | 4.2 | 4 | BEARISH | -63.4 |
| MDBIF TrivarX Limited | $10M | -0.0 | -61.2 | -48.7 | — | -100.0 | 4 | BEARISH | -70.8 |
| ACON Aclarion, Inc. | $10M | -0.3 | -59.0 | -1069.5 | -10899.5 | 33.1 | 3 | BEARISH | -74.7 |
| BMRA Biomerica, Inc. | $10M | -1.1 | -113.8 | -132.4 | -97.4 | -11.2 | 1 | BEARISH | -41.9 |
| ANPCF CelLBxHealth plc | $10M | — | -239.7 | -609.1 | -452.4 | -32.8 | 2 | BEARISH | -60.8 |
| MSLE Satellos Bioscience Inc. | $10M | — | — | — | — | — | — | BEARISH | — |
| FBLG FibroBiologics, Inc. Common Stock | $10M | -0.2 | -660.1 | -511.6 | — | — | 4 | BEARISH | -88.9 |
| INAB IN8bio, Inc. | $10M | -0.5 | -111.1 | -576.1 | — | — | 4 | BEARISH | -54.0 |
| RGNT Regentis Biomaterials Ltd. | $10M | — | — | — | — | — | — | BEARISH | — |
| IPDQF ImpediMed Limited | $10M | -0.3 | -162.3 | 295.0 | -177.9 | 14.7 | 3 | BEARISH | -67.0 |
| IZOZF Izotropic Corporation | $10M | -4.3 | 40.2 | 39.2 | — | — | 3 | BEARISH | -69.9 |
| LUCY Lucyd, Inc | $10M | -0.6 | -84.6 | -209.4 | -165.3 | 72.5 | 4 | BEARISH | -55.3 |
| APRE Aprea Therapeutics, Inc. | $10M | -0.5 | -47.4 | 378.1 | — | -99.8 | 2 | BEARISH | -71.6 |
| PTN Palatin Technologies, Inc. | $10M | -0.9 | -877.5 | 1176.9 | -1449.1 | — | 5 | BEARISH | -18.3 |
| AIMD Ainos, Inc. | $10M | -0.3 | -196.3 | -69.4 | -3022849.3 | -87.7 | 1 | BEARISH | -78.4 |
| TRAW Traws Pharma, Inc. | $10M | -0.7 | -711.4 | 133.9 | — | -100.0 | 1 | BEARISH | -87.0 |
| BCDA BioCardia, Inc. | $10M | -1.2 | -1803.2 | 519.4 | — | — | 3 | BEARISH | -35.6 |
| BDMD Baird Medical Investment Holdings Limited | $10M | -0.5 | -45.3 | -23.2 | 0.4 | -23.1 | 4 | BEARISH | -70.1 |
| ACXP Acurx Pharmaceuticals, Inc. | $10M | -0.3 | -128.1 | 241.9 | — | — | 3 | BEARISH | -83.2 |
| FEMY Femasys Inc. | $10M | -0.3 | -443.7 | -188.1 | -1346.8 | 21.9 | 5 | BEARISH | -88.4 |
| MGRX Mangoceuticals, Inc. | $10M | -0.2 | -95.1 | -82.6 | -1909.1 | -38.9 | 4 | BEARISH | -89.6 |
| BLRX BioLineRx Ltd. | $10M | -1.1 | -63.5 | -113.0 | -1029.3 | -94.3 | 3 | BEARISH | -45.1 |
| MTVA MetaVia Inc. | $10M | -0.3 | -175.7 | 209.3 | — | — | 0 | BEARISH | -88.5 |
| CNTMF Fluent Corp. | $10M | -0.1 | 119.7 | -49.4 | -65.1 | -34.7 | 4 | BEARISH | -74.0 |
| BNR Burning Rock Biotech Limited | $10M | -1.2 | -12.8 | -41.7 | -13.7 | -6.6 | 2 | BEARISH | 6.2 |
| UEEC United Health Products, Inc. | $10M | -6.8 | 37.4 | 34.4 | — | — | 4 | BEARISH | -46.9 |
| TVRD Tvardi Therapeutics, Inc. | $10M | -0.3 | -126.2 | 296.9 | — | — | 1 | BEARISH | -83.7 |
| SINT Sintx Technologies, Inc. | $10M | -0.3 | -408.3 | -216.8 | -598.7 | 0.2 | 3 | BEARISH | -54.9 |
| GTBP GT Biopharma, Inc. | $10M | -0.1 | -798.9 | 927.8 | — | — | 2 | BEARISH | -72.2 |
| PHIO Phio Pharmaceuticals Corp. | $10M | -0.6 | -113.7 | 2701.6 | — | — | 2 | BEARISH | -60.3 |
| RVPH Reviva Pharmaceuticals Holdings, Inc. | $10M | -0.1 | -32.2 | 45.6 | — | — | 4 | BEARISH | -25.0 |
| CODX Co-Diagnostics, Inc. | — | -0.0 | -174.8 | -218.8 | -3782.4 | -28.1 | 3 | BEARISH | -94.5 |
| TRLFF Maven Brands Inc. | — | -0.3 | 54.0 | -28.1 | — | -200.0 | 3 | BEARISH | -99.0 |
| LTUS Lotus Pharmaceuticals, Inc. | — | -315.8 | 14.7 | -340.1 | — | — | 3 | BEARISH | -10.0 |
| AMIX Autonomix Medical, Inc. | — | -0.0 | -316.0 | 4343.4 | — | — | 2 | BEARISH | -91.1 |
| SCAL Stem Cell Authority, Ltd. | — | — | — | — | — | — | — | BEARISH | 0.0 |
| CLRD Clearday, Inc. | — | -0.0 | 41.6 | 33.3 | -296.5 | -39.1 | 3 | BEARISH | -90.0 |
| FAMDF Futura Medical plc | — | -0.3 | -145.8 | -370.5 | -72.8 | -70.7 | 2 | BEARISH | -88.2 |
| PPBT Purple Biotech Ltd. | — | -0.0 | -111.3 | -99.1 | — | — | 2 | BEARISH | 75.0 |
| GNPX Genprex, Inc. | — | -0.0 | -203.9 | 3484.8 | — | — | 4 | BEARISH | -99.1 |
| OGEN Oragenics, Inc. | — | -0.1 | -1307.1 | 4273.7 | — | — | 3 | BEARISH | -68.9 |
| NUMD Nu-Med Plus, Inc. | — | -24.0 | 8.1 | 29.2 | — | -100.0 | 4 | BEARISH | -76.0 |
| TBRIF Therma Bright Inc. | — | -0.4 | 711.8 | 33.4 | -336.3 | 202.0 | 3 | BEARISH | -51.0 |
| LABT Lakewood-Amedex Biotherapeutics, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| MBAI MBody AI Ltd. | — | — | — | — | — | — | — | BEARISH | — |
| DCOY Decoy Therapeutics Inc. | — | — | — | — | — | — | — | BEARISH | — |
| NSHSF NanoSphere Health Sciences Inc. | — | 9.5 | 4.6 | 11.1 | — | — | 0 | BEARISH | 0.0 |
| ELAB PMGC Holdings Inc. | — | -0.0 | -73.0 | -66.6 | -225.1 | 408.6 | 3 | BEARISH | -100.0 |
| SPLM Sentry Petroleum Ltd | — | -0.1 | -184.2 | -129.4 | — | — | 1 | BEARISH | -99.0 |
| VRXAW Veraxa Biotech AG | — | — | — | — | — | — | — | BEARISH | — |
| CLDI Calidi Biotherapeutics, Inc. | — | -0.0 | -713.6 | -1404.6 | — | — | 4 | BEARISH | -97.4 |
| LXGTF Registered Plan Private Investments Inc. | — | -0.0 | 7.6 | 5.5 | — | — | 1 | BEARISH | -99.0 |
| MBIO Mustang Bio, Inc. | — | -0.8 | -58.1 | 36.6 | — | — | 2 | BEARISH | -75.0 |
| MILC Millennium Sustainable Ventures Corp. | — | -0.0 | 763.2 | -36.7 | — | 584982.1 | 2 | BEARISH | 0.0 |
| SCPX Scorpius Holdings, Inc. | — | -0.0 | 0.0 | 0.0 | -428.3 | -75.5 | 0 | BEARISH | -66.7 |
| IAGX Imagenetix, Inc. | — | -0.1 | -88.3 | -8.5 | -12.9 | -69.1 | 4 | BEARISH | 0.0 |
| WOK WORK Medical Technology Group Ltd. Class A | — | -0.0 | -20.9 | -10.5 | -63.0 | -0.2 | 4 | BEARISH | -73.7 |
| TWSI Tristar Wellness Solutions Inc. | — | -1.5 | 61.9 | 93.6 | -80.6 | -29.1 | 3 | BEARISH | -99.7 |
| MDCX Medicus Pharma Ltd. Common Stock | — | -0.0 | -3904.0 | -693.1 | — | — | 3 | BEARISH | -97.9 |
| CXBS Corix Bioscience, Inc. | — | — | — | — | — | — | — | BEARISH | -99.0 |
| SHMN SOHM, Inc. | — | 7.0 | -15.3 | -2.9 | -130.8 | -3.6 | 4 | BEARISH | -39.1 |
| RAFA Rafarma Pharmaceuticals, Inc. | — | 7.6 | 2.9 | 3.4 | 26.6 | -66.0 | 3 | BEARISH | -66.7 |
| JRSS JRSIS Health Care Corporation | — | -6.8 | -10.1 | -10.3 | 4.5 | -94.6 | 6 | BEARISH | 73.3 |
| ATTBF Abattis Bioceuticals Corp. | — | -0.0 | -27.0 | -30.2 | -400.9 | 4163.2 | 4 | BEARISH | -96.7 |
| NRSN NeuroSense Therapeutics Ltd. | — | -0.3 | 779.3 | 571.3 | — | — | 3 | BEARISH | -89.7 |
| OMRX Orthometrix, Inc. | — | 0.0 | 30.7 | -48.6 | -238.0 | -29.6 | 2 | BEARISH | -99.0 |
| SNNVF Sunniva Inc. | — | -0.2 | -85.4 | -22.5 | -381.7 | 126.7 | 3 | BEARISH | -90.0 |
| DOSEF Doseology Sciences Inc. | — | -0.7 | -95.4 | -103.8 | -1609.9 | 161.1 | 1 | BEARISH | -90.4 |
| MEDVF Medivolve Inc. | — | -0.2 | 149.7 | 23.5 | -322.7 | -93.6 | 3 | BEARISH | -100.0 |
| ZLDAF Zelira Therapeutics Limited | — | -1.6 | 80.8 | 147.8 | -185107971.7 | -99.3 | 1 | BEARISH | -15.5 |
| EKGGF CardioComm Solutions, Inc. | — | — | 92.7 | 515.6 | -152.3 | -41.9 | 2 | BEARISH | 51.1 |
| ALST AllStar Health Brands Inc | — | -0.3 | 12.9 | 2.5 | — | — | 4 | BEARISH | -50.0 |
| CANF Can-Fite BioPharma Ltd. | — | -0.3 | -184.2 | 353.7 | -2277.7 | -40.1 | 2 | BEARISH | -82.4 |
| AIDX 20/20 Biolabs Inc. | — | — | — | — | — | — | — | BEARISH | — |
| IBXXF Imagion Biosystems Limited | — | -0.4 | 127.1 | 360.0 | -376.2 | -50.2 | 3 | BEARISH | -86.7 |
| MAHN Mid-Atlantic Home Health Network, Inc. | — | — | — | — | — | — | — | BEARISH | -93.0 |
| CRIS Curis, Inc. | — | -0.0 | 455.3 | -23281.0 | — | -62.2 | 3 | BEARISH | -98.8 |
| NUWE Nuwellis, Inc. | — | -0.0 | 202.0 | 173.3 | -245.2 | 8.4 | 5 | BEARISH | -88.6 |
| UPDC UPD Holding Corp. | — | -0.0 | 198.3 | 1243.8 | -858.8 | — | 2 | BEARISH | 0.0 |
| NIKI Niki BioSolutions, Inc. | — | — | — | — | — | — | — | BEARISH | — |
| PRFX PRF Technologies Ltd. | — | -0.1 | -57.8 | -88.3 | -19978.6 | 137249010644668.4 | 6 | BEARISH | -42.9 |
| EAPH Parallel Industries Inc. | — | -0.2 | 26.8 | 19.0 | — | 0.0 | 4 | BEARISH | 0.0 |
| YOURF YourWay Cannabis Brands Inc. | — | -0.0 | 19.0 | 18.4 | 3.3 | 253.3 | 8 | BEARISH | -90.0 |
| DXBRF BellRock Brands Inc. | — | — | — | — | — | — | — | BEARISH | -99.0 |
| OXBOF Oxford BioDynamics Plc | — | -0.3 | -214.9 | -155.8 | -649.8 | 33.6 | 3 | BEARISH | -85.9 |
| NVNO enVVeno Medical Corporation | — | -0.0 | -58.5 | 4255.8 | — | — | 4 | BEARISH | 815.5 |
| CDIX Cardiff Lexington Corporation | — | -0.0 | -481.3 | -3.3 | -114.8 | 0.3 | 2 | BEARISH | -99.9 |
| CLCFF Christina Lake Cannabis Corp. | — | -1.6 | -37.8 | -14.8 | -10.0 | -18.1 | 2 | BEARISH | -35.7 |
| XSNX NovAccess Global Inc. | — | -0.0 | 27.7 | 18.0 | — | — | 3 | BEARISH | 0.0 |
| DTMXF Quanta AI Inc. | — | — | 6074.2 | 6923.2 | -413.2 | 15.3 | 3 | BEARISH | -73.6 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
INMB vs Benchmarks
ROIC
Revenue Growth
P/E Ratio
ROE
Piotroski F